syndrome	score	normalized_score
CRANIOSYNOSTOSIS 4; CRS4	0.75	100.0
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 5	0.506854682	67.58062426666666
BRANCHIOOTORENAL SYNDROME 1	0.5	66.66666666666666
DEVELOPMENTAL AND SPEECH DELAY DUE TO SOX5 DEFICIENCY	0.340189709	45.358627866666666
EPIDERMAL NEVUS SYNDROME	0.333878554	44.51714053333333
ANGIOMATOSIS, DIFFUSE CORTICOMENINGEAL, OF DIVRY AND VAN BOGAERT	0.333874419	44.5165892
NEUROMYELITIS OPTICA	0.333333	44.4444
CONGENITAL HEMIDYSPLASIA WITH ICHTHYOSIFORM ERYTHRODERMA AND LIMB DEFECTS	0.333333	44.4444
CANAVAN DISEASE	0.333333	44.4444
DOORS SYNDROME	0.27073444399999996	36.097925866666664
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 2; HPMRS2	0.260559797	34.74130626666667
SPONDYLOEPIPHYSEAL DYSPLASIA, NISHIMURA TYPE	0.25658612399999997	34.211483199999996
METAPHYSEAL CHONDRODYSPLASIA, SPAHR TYPE	0.25	33.33333333333333
HYPERPARATHYROIDISM 2	0.25	33.33333333333333
DYSTONIA 6, TORSION	0.25	33.33333333333333
DIFFUSE NEONATAL HEMANGIOMATOSIS	0.20840336	27.787114666666668
PROGRESSIVE NON-INFECTIOUS ANTERIOR VERTEBRAL FUSION	0.20553607	27.40480933333333
6P22 MICRODELETION SYNDROME	0.20124533	26.832710666666664
POLYARTERITIS NODOSA	0.2	26.666666666666668
XERODERMA PIGMENTOSUM, COMPLEMENTATION GROUP F; XPF	0.2	26.666666666666668
JUVENILE HYALINE FIBROMATOSIS	0.2	26.666666666666668
MALARIA	0.2	26.666666666666668
BENIGN SCHWANNOMA	0.2	26.666666666666668
INFANTILE MYOFIBROMATOSIS	0.2	26.666666666666668
BETA-THALASSEMIA	0.2	26.666666666666668
PEROXISOMAL ACYL-COA OXIDASE DEFICIENCY	0.17146844300000003	22.86245906666667
CEREBROOCULONASAL SYNDROME	0.17023843	22.698457333333334
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, NEONATAL FORM	0.167208419	22.294455866666667
MUCOLIPIDOSIS TYPE II	0.166667	22.22226666666667
CHRONIC INTESTINAL PSEUDOOBSTRUCTION	0.166667	22.22226666666667
DERMATOLEUKODYSTROPHY	0.166667	22.22226666666667
DISTAL MONOSOMY 7Q36	0.14593074899999997	19.457433199999997
LÉRI-WEILL DYSCHONDROSTEOSIS	0.14482163999999997	19.309551999999996
PIEBALDISM	0.14482163999999997	19.309551999999996
MACROSOMIA-MICROPHTHALMIA-CLEFT PALATE SYNDROME	0.14285699999999998	19.0476
PACMAN DYSPLASIA	0.14285699999999998	19.0476
INCLUSION BODY MYOPATHY WITH PAGET DISEASE OF BONE AND FRONTOTEMPORAL DEMENTIA	0.14285699999999998	19.0476
NEUROGENIC ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.14285699999999998	19.0476
TRICHOHEPATONEURODEVELOPMENTAL SYNDROME; THNS	0.090955118	12.127349066666666
WIEDEMANN-STEINER SYNDROME	0.05681497900000001	7.575330533333334
INTELLECTUAL DISABILITY-MACROCEPHALY-HYPOTONIA-BEHAVIORAL ABNORMALITIES SYNDROME	0.056053110999999996	7.473748133333332
MACROCEPHALY-INTELLECTUAL DISABILITY-LEFT VENTRICULAR NON COMPACTION SYNDROME	0.054673176999999996	7.289756933333333
DE BARSY SYNDROME	0.054229874000000004	7.230649866666668
JOUBERT SYNDROME 2	0.053459972	7.127996266666667
HYPOTONIA-SPEECH IMPAIRMENT-SEVERE COGNITIVE DELAY SYNDROME	0.053033532999999994	7.071137733333332
JOUBERT SYNDROME WITH JEUNE ASPHYXIATING THORACIC DYSTROPHY	0.051300682	6.840090933333333
TARP SYNDROME	0.051247591	6.833012133333334
INTELLECTUAL DISABILITY-MICROCEPHALY-STRABISMUS-BEHAVIORAL ABNORMALITIES SYNDROME	0.049750843999999995	6.6334458666666665
PRADER-WILLI SYNDROME	0.049502249	6.600299866666666
TURNPENNY-FRY SYNDROME; TPFS	0.049470474	6.596063200000001
PRESYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.049220159	6.562687866666667
CONGENITAL MYASTHENIC SYNDROME	0.049220159	6.562687866666667
UNDETERMINED EARLY-ONSET EPILEPTIC ENCEPHALOPATHY	0.048831542	6.510872266666666
TARP SYNDROME; TARPS	0.046950031999999996	6.260004266666666
O'DONNELL-LURIA-RODAN SYNDROME; ODLURO	0.046813811000000004	6.241841466666667
MACROCEPHALY-INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER-SMALL THORAX SYNDROME	0.04655618400000001	6.207491200000001
COFFIN-SIRIS SYNDROME 2; CSS2	0.045526811	6.070241466666667
COFFIN-SIRIS SYNDROME 3; CSS3	0.045526811	6.070241466666667
COFFIN-SIRIS SYNDROME 4; CSS4	0.045526811	6.070241466666667
PALLISTER-HALL SYNDROME	0.045310854000000005	6.0414472
JOUBERT SYNDROME 7	0.044985392	5.998052266666667
CEDNIK SYNDROME	0.044565273	5.9420364
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 13	0.044439838	5.925311733333333
SUSAC SYNDROME	0.044439838	5.925311733333333
POLYMICROGYRIA WITH OR WITHOUT VASCULAR-TYPE EHLERS-DANLOS SYNDROME; PMGEDSV	0.044019719000000006	5.8692958666666675
GLIOBLASTOMA	0.044019719000000006	5.8692958666666675
DEAFNESS-GENITAL ANOMALIES-METACARPAL AND METATARSAL SYNOSTOSIS SYNDROME	0.043478300000000004	5.797106666666667
SHPRINTZEN-GOLDBERG CRANIOSYNOSTOSIS SYNDROME; SGS	0.04347156199999999	5.796208266666666
INTELLECTUAL DISABILITY-SEIZURES-HYPOPHOSPHATASIA-OPHTHALMIC-SKELETAL ANOMALIES SYNDROME	0.041668090000000005	5.555745333333334
XIA-GIBBS SYNDROME	0.040962712	5.461694933333333
AHDC1-RELATED INTELLECTUAL DISABILITY-OBSTRUCTIVE SLEEP APNEA-MILD DYSMORPHISM SYNDROME	0.040542592999999995	5.405679066666666
CONGENITAL HYPOTONIA, EPILEPSY, DEVELOPMENTAL DELAY, AND DIGITAL ANOMALIES; CHEDDA	0.039640182999999996	5.285357733333332
COSTELLO SYNDROME; CSTLO	0.038765643999999995	5.168752533333333
FG SYNDROME TYPE 1	0.038443313	5.125775066666667
RUBINSTEIN-TAYBI SYNDROME 1; RSTS1	0.037263007	4.968400933333333
THUMBS, CONGENITAL CLASPED	0.0361093	4.814573333333333
13Q12.3 MICRODELETION SYNDROME	0.035205990000000006	4.694132000000001
HALLERMANN-STREIFF SYNDROME; HSS	0.03467516	4.623354666666666
9Q33.3Q34.11 MICRODELETION SYNDROME	0.033959869000000004	4.527982533333334
16P13.2 MICRODELETION SYNDROME	0.033671213	4.489495066666667
MARSHALL-SMITH SYNDROME; MRSHSS	0.033469948	4.462659733333333
SHORT STATURE, RHIZOMELIC, WITH MICROCEPHALY, MICROGNATHIA, AND DEVELOPMENTAL DELAY; SRMMD	0.031581959	4.210927866666666
MARFANOID HABITUS WITH SITUS INVERSUS	0.03104054	4.138738666666667
EMANUEL SYNDROME	0.031023111000000003	4.136414800000001
RAPID-ONSET CHILDHOOD OBESITY-HYPOTHALAMIC DYSFUNCTION-HYPOVENTILATION-AUTONOMIC DYSREGULATION SYNDROME	0.030619911000000003	4.0826548
MICROPHTHALMIA, SYNDROMIC 6; MCOPS6	0.030447624	4.0596832
INTELLECTUAL DISABILITY-COARSE FACE-MACROCEPHALY-CEREBELLAR HYPOTROPHY SYNDROME	0.030256199	4.034159866666666
AURICULOCONDYLAR SYNDROME	0.030078492000000002	4.0104656
CONTRACTURES-DEVELOPMENTAL DELAY-PIERRE ROBIN SYNDROME	0.02981673	3.9755640000000003
CONGENITAL MUSCULAR DYSTROPHY, FUKUYAMA TYPE	0.029702043	3.9602724
OROFACIODIGITAL SYNDROME TYPE 6	0.029663491000000004	3.955132133333334
DNA2-RELATED MITOCHONDRIAL DNA DELETION SYNDROME	0.029532938	3.9377250666666668
CARDIOFACIOCUTANEOUS SYNDROME 1; CFC1	0.029515137000000007	3.935351600000001
ALACRIMIA-CHOREOATHETOSIS-LIVER DYSFUNCTION SYNDROME	0.029116954	3.8822605333333335
MUCOPOLYSACCHARIDOSIS, TYPE II	0.029112819	3.8817092000000004
DYSOSTEOSCLEROSIS	0.029112819	3.8817092000000004
INTELLECTUAL DISABILITY-STRABISMUS SYNDROME	0.028883853	3.8511804000000005
THROMBOCYTOPENIA 3	0.02867182	3.822909333333333
SCHEIE SYNDROME	0.0285714	3.8095200000000005
ACHONDROPLASIA	0.0285714	3.8095200000000005
SHORT STATURE, FACIAL DYSMORPHISM, AND SKELETAL ANOMALIES WITH OR WITHOUT CARDIAC ANOMALIES; SSFSC	0.0285714	3.8095200000000005
HURLER-SCHEIE SYNDROME	0.0285714	3.8095200000000005
CHERUBISM	0.0285714	3.8095200000000005
HEREDITARY MOTOR AND SENSORY NEUROPATHY, TYPE IIC; HMSN2C	0.0285714	3.8095200000000005
APNEA, OBSTRUCTIVE SLEEP	0.0285714	3.8095200000000005
COFFIN-SIRIS SYNDROME 6; CSS6	0.028319332	3.7759109333333334
PITT-HOPKINS-LIKE SYNDROME	0.028002099	3.7336132
ACROMELIC FRONTONASAL DYSOSTOSIS; AFND	0.027817929	3.7090572
NEURODEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND DISTAL LIMB ANOMALIES; NEDDFL	0.027701722	3.6935629333333337
LINEAR NEVUS SEBACEUS SYNDROME	0.027661368999999998	3.6881825333333333
BRAIN MALFORMATIONS-MUSCULOSKELETAL ABNORMALITIES-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROME	0.027496314000000004	3.6661752000000005
CORTICAL DYSGENESIS WITH PONTOCEREBELLAR HYPOPLASIA DUE TO TUBB3 MUTATION	0.026758109999999998	3.567748
SEVERE INTELLECTUAL DISABILITY-POOR LANGUAGE-STRABISMUS-GRIMACING FACE-LONG FINGERS SYNDROME	0.026740184	3.5653578666666665
CAREY-FINEMAN-ZITER SYNDROME; CFZS	0.026697762	3.5597016000000004
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 2; IHPRF2	0.026484907	3.5313209333333333
SMITH-MAGENIS SYNDROME	0.026231863000000005	3.497581733333334
ALKURAYA-KUCINSKAS SYNDROME; ALKKUCS	0.025868341000000003	3.449112133333334
HYDROCEPHALUS, SKELETAL ANOMALIES, AND MENTAL DISTURBANCE	0.025714884	3.4286512
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIK	0.025253201000000003	3.367093466666667
AUTOSOMAL DOMINANT INTELLECTUAL DISABILITY-CRANIOFACIAL ANOMALIES-CARDIAC DEFECTS SYNDROME	0.025083953	3.3445270666666667
HYPERPHOSPHATASIA-INTELLECTUAL DISABILITY SYNDROME	0.025082504	3.344333866666666
CORNELIA DE LANGE SYNDROME 5; CDLS5	0.024859881	3.3146508
RING CHROMOSOME 7 SYNDROME	0.02453695	3.2715933333333327
CONGENITAL MUSCULAR DYSTROPHY WITHOUT INTELLECTUAL DISABILITY	0.024166228	3.2221637333333337
MITOCHONDRIAL NEUROGASTROINTESTINAL ENCEPHALOMYOPATHY	0.02414227	3.2189693333333333
ACROMELIC FRONTONASAL DYSPLASIA	0.023989203	3.1985604
BAND HETEROTOPIA; BH	0.023891883000000003	3.1855844
113480 BRACHYTELEPHALANGY WITH CHARACTERISTIC FACIES AND KALLMANN SYNDROME	0.02341335	3.12178
CHROMOSOME 1P36 DELETION SYNDROME	0.023253231000000003	3.1004308000000003
CHROMOSOME 3Q13.31 DELETION SYNDROME	0.02303621	3.071494666666667
ECTODERMAL DYSPLASIA, HYPOHIDROTIC, WITH HYPOTHYROIDISM AND AGENESISOF THE CORPUS CALLOSUM	0.02280491	3.0406546666666667
OSTEOPETROSIS AND INFANTILE NEUROAXONAL DYSTROPHY	0.02280491	3.0406546666666667
CORNELIA DE LANGE SYNDROME 3	0.022786993	3.038265733333333
HEART AND BRAIN MALFORMATION SYNDROME	0.022317141000000006	2.975618800000001
ADNP SYNDROME	0.022181939	2.9575918666666667
WHITE-SUTTON SYNDROME; WHSUS	0.022140982000000003	2.952130933333334
DUBOWITZ SYNDROME	0.022136539000000004	2.9515385333333337
NEURODEVELOPMENTAL DISORDER AND LANGUAGE DELAY WITH OR WITHOUT STRUCTURAL BRAIN ABNORMALITIES; NEDLBA	0.022076651	2.9435534666666667
RERE-RELATED NEURODEVELOPMENTAL SYNDROME	0.022012503	2.9350004
ACROCALLOSAL SYNDROME; ACLS	0.021985137000000002	2.9313516
PITT-HOPKINS SYNDROME	0.021982793000000004	2.931039066666667
7Q11.23 MICRODUPLICATION SYNDROME	0.021928167000000002	2.9237556000000002
CHROMOSOME 18Q DELETION SYNDROME	0.021892387	2.9189849333333333
CHROMOSOME 2P16.1-P15 DELETION SYNDROME	0.021878172	2.9170896
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 33; MC1DN33	0.021803212000000002	2.9070949333333336
AL KAISSI SYNDROME; ALKAS	0.021631871	2.8842494666666667
SMITH-LEMLI-OPITZ SYNDROME	0.021478293000000002	2.8637724
MONOSOMY 13Q34	0.021378684000000002	2.8504912000000004
CORNELIA DE LANGE SYNDROME	0.021363829	2.848510533333333
MITOCHONDRIAL DNA DEPLETION SYNDROME 13 (ENCEPHALOMYOPATHIC TYPE); MTDPS13	0.021269621000000002	2.835949466666667
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 15; COXPD15	0.021150941000000003	2.820125466666667
PONTOCEREBELLAR HYPOPLASIA, TYPE 8	0.021145622000000003	2.8194162666666673
HYPERPHOSPHATASIA WITH MENTAL RETARDATION	0.021086096999999998	2.8114795999999997
BRANCHIOOCULOFACIAL SYNDROME	0.021026689	2.8035585333333337
DUBOWITZ SYNDROME	0.020942308	2.7923077333333333
GABRIELE-DE VRIES SYNDROME; GADEVS	0.020934984	2.7913312
BEEMER LETHAL MALFORMATION SYNDROME	0.02083254	2.777672
MOWAT-WILSON SYNDROME; MOWS	0.020821157000000003	2.776154266666667
304950 DYGGVE-MELCHIOR-CLAUSEN SYNDROME, X-LINKED	0.02081283	2.7750440000000003
CRANIOSYNOSTOSIS 6; CRS6	0.020787162	2.7716216
SPLENOGONADAL FUSION-LIMB DEFECTS-MICROGNATHIA SYNDROME	0.020758079	2.7677438666666667
HERMANSKY-PUDLAK SYNDROME 8; HPS8	0.02074764	2.766352
SMITH-LEMLI-OPITZ SYNDROME; SLOS	0.020659077	2.7545436000000003
NEURODEVELOPMENTAL DISORDER-CRANIOFACIAL DYSMORPHISM-CARDIAC DEFECT-SKELETAL ANOMALIES SYNDROME	0.020575149	2.7433532
PONTOCEREBELLAR HYPOPLASIA, TYPE 10; PCH10	0.020570423	2.7427230666666667
DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM SYNDROME DUE TO MED13L DEFICIENCY	0.020364063999999998	2.715208533333333
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 5; MDDGA5	0.020326240000000002	2.7101653333333338
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 5A	0.02029612	2.7061493333333337
SPASTIC PARAPLEGIA TYPE 7	0.02029612	2.7061493333333337
AUTOSOMAL RECESSIVE PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.02029612	2.7061493333333337
SEVERE FEEDING DIFFICULTIES-FAILURE TO THRIVE-MICROCEPHALY DUE TO ASXL3 DEFICIENCY SYNDROME	0.020189403	2.6919204000000003
109740 BIFID NOSE, AUTOSOMAL DOMINANT	0.0201549	2.68732
MENTAL RETARDATION, X-LINKED, SYNDROMIC, 35; MRXS35	0.020018801	2.6691734666666664
HEART DEFECTS, CONGENITAL, AND OTHER CONGENITAL ANOMALIES; HDCA	0.019954873	2.6606497333333334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 32; MRD32	0.019950803	2.660107066666667
ACYL-COA DEHYDROGENASE, SHORT-CHAIN, DEFICIENCY OF	0.019905611000000004	2.654081466666667
MITOCHONDRIAL DNA DEPLETION SYNDROME 4B (MNGIE TYPE); MTDPS4B	0.019905611000000004	2.654081466666667
DEVELOPMENTAL DELAY WITH VARIABLE INTELLECTUAL IMPAIRMENT AND BEHAVIORAL ABNORMALITIES; DDVIBA	0.019860711	2.6480948
49,XXXYY SYNDROME	0.01982174	2.642898666666667
8Q24.3 MICRODELETION SYNDROME	0.019800161	2.6400214666666666
WAC-RELATED FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY-BEHAVIORAL ABNORMALITIES SYNDROME	0.019602034	2.6136045333333335
CHRISTIANSON SYNDROME	0.0195787	2.6104933333333333
%600176 PACHYGYRIA WITH MENTAL RETARDATION, SEIZURES, AND ARACHNOID CYSTS;;PACHYGYRIA WITH MENTAL RETARDATION AND SEIZURES	0.019413454	2.5884605333333335
WOLFRAM SYNDROME, MITOCHONDRIAL FORM	0.019409319	2.5879092000000004
HHHH SYNDROME	0.019409319	2.5879092000000004
COPPER DEFICIENCY, FAMILIAL BENIGN	0.019409319	2.5879092000000004
1P36 DELETION SYNDROME	0.019377553	2.5836737333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 25, WITH AMELOGENESIS IMPERFECTA; EIEE25	0.019364192000000002	2.5818922666666673
3-METHYLGLUTACONIC ACIDURIA, TYPE IX; MGCA9	0.019364192000000002	2.5818922666666673
PEROXISOME BIOGENESIS DISORDER 6B	0.019364192000000002	2.5818922666666673
METACHROMATIC LEUKODYSTROPHY	0.019360057000000003	2.5813409333333337
LISSENCEPHALY 5; LIS5	0.019360057	2.5813409333333333
INTELLECTUAL DISABILITY-CARDIAC ANOMALIES-SHORT STATURE-JOINT LAXITY SYNDROME	0.019255010000000003	2.567334666666667
CRANIOFRONTONASAL SYNDROME; CFNS	0.019222262	2.5629682666666667
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE	0.01920604	2.5608053333333336
MENTAL RETARDATION, X-LINKED, SYNDROMIC 33	0.019110971	2.548129466666667
EARLY-ONSET SEIZURES-DISTAL LIMB ANOMALIES-FACIAL DYSMORPHISM-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.018955141000000002	2.5273521333333338
LISSENCEPHALY 1; LIS1	0.018944073000000002	2.5258764000000005
3-HYDROXY-3-METHYLGLUTARYL-COA LYASE DEFICIENCY; HMGCLD	0.018944073000000002	2.5258764000000005
TOE, MISSHAPEN	0.0188679	2.51572
LETTERER-SIWE DISEASE	0.0188679	2.51572
RAYNAUD DISEASE	0.0188679	2.51572
275230 TIBIA, ABSENCE OF, WITH CONGENITAL DEAFNESS	0.0188679	2.51572
TRACHEOBRONCHOMEGALY	0.0188679	2.51572
PUBIC BONE DYSPLASIA	0.0188679	2.51572
MICROPHTHALMIA, SYNDROMIC 4	0.0188679	2.51572
DOUBLE NAIL FOR FIFTH TOE	0.0188679	2.51572
DYSPLASIA EPIPHYSEALIS HEMIMELICA	0.0188679	2.51572
248100 MACROSOMIA ADIPOSA CONGENITA	0.0188679	2.51572
275220 TIBIAL HEMIMELIA;;THM;;TIBIA, ABSENCE OF	0.0188679	2.51572
SCAPULA, CONTOUR OF VERTEBRAL BORDER OF	0.0188679	2.51572
CIRCUMVALLATE PLACENTA SYNDROME	0.0188679	2.51572
TOES, RELATIVE LENGTH OF FIRST AND SECOND	0.0188679	2.51572
HYPOURICEMIA, HYPERCALCINURIA, AND DECREASED BONE DENSITY	0.0188679	2.51572
SPINAL ARACHNOIDITIS	0.0188679	2.51572
CARPAL DISPLACEMENT	0.0188679	2.51572
DERMOCHONDROCORNEAL DYSTROPHY	0.0188679	2.51572
%122450 CORNEAL HYPESTHESIA, FAMILIAL;;TRIGEMINAL ANESTHESIA, FAMILIAL	0.0188679	2.51572
HYPERBILIRUBINEMIA, ROTOR TYPE	0.0188679	2.51572
271322 SPINOCEREBELLAR DEGENERATION WITH SLOW EYE MOVEMENTS; SDSEM	0.0188679	2.51572
THALIDOMIDE SUSCEPTIBILITY	0.0188679	2.51572
VESICOURETERAL REFLUX 1	0.0188679	2.51572
THROMBOCYTHEMIA, ESSENTIAL	0.0188679	2.51572
PRIMARY HYPEROXALURIA TYPE 1	0.0188679	2.51572
TRACHEOPATHIA OSTEOPLASTICA	0.0188679	2.51572
TOE, FIFTH, NUMBER OF PHALANGES IN	0.0188679	2.51572
256020 NAIL-PATELLA-LIKE RENAL DISEASE;;GLOMERULAR BASEMENT MEMBRANE DISEASE, NAIL-PATELLA SYNDROME TYPE	0.0188679	2.51572
PALMARIS LONGUS MUSCLE, ABSENCE OF	0.0188679	2.51572
KNUCKLE PADS	0.0188679	2.51572
MONOPHALANGY OF GREAT TOE	0.0188679	2.51572
FACIAL CLEFTING, OBLIQUE, 1; OBLFC1	0.0188679	2.51572
PACHYDERMODACTYLY, FAMILIAL	0.0188679	2.51572
%600343 PAROTID SALIVARY GLANDS, POLYCYSTIC DYSGENETIC DISEASE OF; PDDP	0.0188679	2.51572
NEPHROSIALIDOSIS	0.0188679	2.51572
VAN DEN BOSCH SYNDROME	0.0188679	2.51572
MEGAEPIPHYSEAL DWARFISM	0.0188679	2.51572
CRANIOFRONTONASAL DYSPLASIA-POLAND ANOMALY SYNDROME	0.018863829999999998	2.5151773333333334
PIERPONT SYNDROME	0.018828383	2.5104510666666666
DISTAL MONOSOMY 10Q	0.018740872999999998	2.4987830666666664
OPITZ GBBB SYNDROME, TYPE I; GBBB1	0.018564824	2.4753098666666666
JUNG SYNDROME	0.01855829	2.474438666666667
ENDOCARDIAL FIBROELASTOSIS	0.0185284	2.4704533333333334
WILLIAMS-BEUREN SYNDROME; WBS	0.018492808000000003	2.4657077333333337
CRANIOFRONTONASAL DYSPLASIA	0.01847201	2.4629346666666665
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 36; MRT36	0.018459997000000002	2.461332933333334
AUTOSOMAL SPASTIC PARAPLEGIA TYPE 58	0.018402654	2.4536872
LIPOYLTRANSFERASE 1 DEFICIENCY; LIPT1D	0.018402654	2.4536872
RIDDLE SYNDROME	0.018402654	2.4536872
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 2; PEBEL2	0.018398519000000002	2.453135866666667
JUVENILE HUNTINGTON DISEASE	0.018398519000000002	2.453135866666667
METHYLCOBALAMIN DEFICIENCY TYPE CBLE	0.018398519000000002	2.453135866666667
OCULODENTODIGITAL DYSPLASIA; ODDD	0.018398519000000002	2.453135866666667
MERCURY POISONING	0.018398519000000002	2.453135866666667
NEURODEVELOPMENTAL DISORDER WITH SPASTICITY AND POOR GROWTH; NEDSG	0.018398519000000002	2.453135866666667
ADRENOLEUKODYSTROPHY	0.018398519000000002	2.453135866666667
MEGALENCEPHALY WITH DYSMYELINATION	0.018398519000000002	2.453135866666667
AYMÉ-GRIPP SYNDROME	0.018339924	2.4453232000000003
NEURODEVELOPMENTAL DISORDER WITH COARSE FACIES AND MILD DISTAL SKELETAL ABNORMALITIES; NEDCFSA	0.018320181	2.4426908000000003
MICROGASTRIA-LIMB REDUCTION DEFECT SYNDROME	0.01830946	2.4412613333333333
UNILATERAL POLYMICROGYRIA	0.018278500000000003	2.437133333333334
HOLOPROSENCEPHALY	0.018268323000000003	2.4357764000000004
MENTAL RETARDATION AND DISTINCTIVE FACIAL FEATURES WITH OR WITHOUT CARDIAC DEFECTS	0.018137152	2.4182869333333334
MICROCEPHALY-CORPUS CALLOSUM HYPOPLASIA-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.017959923	2.3946564
JACOBSEN SYNDROME	0.017924313	2.3899084
BOHRING-OPITZ SYNDROME	0.017920421000000002	2.389389466666667
STEROID-RESPONSIVE ENCEPHALOPATHY ASSOCIATED WITH AUTOIMMUNE THYROIDITIS	0.0178571	2.3809466666666665
%300660 LEUKOENCEPHALOPATHY WITH METAPHYSEAL CHONDRODYSPLASIA; LKMCD	0.0178571	2.3809466666666665
ATAXIA-PANCYTOPENIA SYNDROME	0.0178571	2.3809466666666665
NEPHROPATHIC INFANTILE CYSTINOSIS	0.0178571	2.3809466666666665
PROGRESSIVE NON-FLUENT APHASIA	0.0178571	2.3809466666666665
AMISH INFANTILE EPILEPSY SYNDROME	0.0178571	2.3809466666666665
SPASTIC PARAPLEGIA 64, AUTOSOMAL RECESSIVE; SPG64	0.0178571	2.3809466666666665
BEHAVIORAL VARIANT OF FRONTOTEMPORAL DEMENTIA	0.0178571	2.3809466666666665
49,XYYYY SYNDROME	0.0178571	2.3809466666666665
POLYGLUCOSAN BODY NEUROPATHY, ADULT FORM	0.0178571	2.3809466666666665
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 4; SCAR4	0.0178571	2.3809466666666665
AUTOSOMAL DOMINANT CEREBELLAR ATAXIA-DEAFNESS-NARCOLEPSY SYNDROME	0.0178571	2.3809466666666665
NEONATAL LUPUS ERYTHEMATOSUS	0.0178571	2.3809466666666665
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 64	0.0178571	2.3809466666666665
MENTAL RETARDATION, X-LINKED, SYNDROMIC, TURNER TYPE; MRXST	0.017850661	2.3800881333333335
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME	0.017710809	2.3614412000000002
AGENESIS OF THE CORPUS CALLOSUM AND CONGENITAL LYMPHEDEMA	0.017693612	2.3591482666666668
KOOLEN-DE VRIES SYNDROME	0.017632143000000003	2.3509524000000006
CRANIOFACIAL DYSSYNOSTOSIS WITH SHORT STATURE	0.017611187000000004	2.348158266666667
CRANIOECTODERMAL DYSPLASIA 2; CED2	0.017581944	2.3442591999999998
ZUNICH NEUROECTODERMAL SYNDROME	0.017565327000000002	2.3420436000000002
6Q25 MICRODELETION SYNDROME	0.017514922999999998	2.3353230666666667
PETERS PLUS SYNDROME	0.017452184000000003	2.326957866666667
DISTAL XQ28 MICRODUPLICATION SYNDROME	0.017441674	2.3255565333333337
HYPOTONIA, ATAXIA, AND DELAYED DEVELOPMENT SYNDROME; HADDS	0.017416792	2.3222389333333333
COGNITIVE IMPAIRMENT-COARSE FACIES-HEART DEFECTS-OBESITY-PULMONARY INVOLVEMENT-SHORT STATURE-SKELETAL DYSPLASIA SYNDROME	0.017387143999999997	2.3182858666666664
PMM2-CDG	0.017378283	2.3171044000000003
X-LINKED FEMALE RESTRICTED FACIAL DYSMORPHISM-SHORT STATURE-CHOANAL ATRESIA-INTELLECTUAL DISABILITY	0.017292603	2.3056804
SCHINZEL-GIEDION SYNDROME	0.01728845	2.3051266666666668
KAGAMI-OGATA SYNDROME	0.017276943	2.3035924
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 3; MDDGA3	0.017265627000000006	2.3020836000000005
223300 DISSEMINATED SCLEROSIS WITH NARCOLEPSY	0.0172414	2.2988533333333336
TRANSSEXUALITY	0.0172414	2.2988533333333336
ARTHROGRYPOSIS MULTIPLEX CONGENITA WITH WHISTLING FACE	0.0172414	2.2988533333333336
INTRINSIC FACTOR AND R BINDER, COMBINED CONGENITAL DEFICIENCY OF	0.0172414	2.2988533333333336
ANDROSTENONE, ABILITY TO SMELL	0.0172414	2.2988533333333336
GRANULOMAS, CONGENITAL CEREBRAL	0.0172414	2.2988533333333336
206600 ANHIDROSIS, FAMILIAL GENERALIZED, WITH ABNORMAL OR ABSENT SWEAT GLANDS	0.0172414	2.2988533333333336
DIASTEMATOMYELIA	0.0172414	2.2988533333333336
269800 SENILE PLAQUE FORMATION	0.0172414	2.2988533333333336
SPASTIC PSEUDOSCLEROSIS	0.0172414	2.2988533333333336
ASPARAGUS, SPECIFIC SMELL HYPERSENSITIVITY	0.0172414	2.2988533333333336
TRICHORHINOPHALANGEAL SYNDROME, TYPE III; TRPS3	0.0172414	2.2988533333333336
SPATIAL VISUALIZATION, APTITUDE FOR	0.0172414	2.2988533333333336
COGNITIVE FUNCTION 1, SOCIAL	0.0172414	2.2988533333333336
ALCOHOL DEPENDENCE	0.0172414	2.2988533333333336
JUMPING FRENCHMAN OF MAINE	0.0172414	2.2988533333333336
TRICARBOXYLIC ACID CYCLE, DEFECT OF	0.0172414	2.2988533333333336
GLUTATHIONE SYNTHETASE DEFICIENCY	0.0172414	2.2988533333333336
MYOPATHY, CONGENITAL	0.0172414	2.2988533333333336
RHEUMATOID ARTHRITIS	0.0172414	2.2988533333333336
PALMOMENTAL REFLEX	0.0172414	2.2988533333333336
%600511 SCHIZOPHRENIA 3; SCZD3;;SCHIZOPHRENIA SUSCEPTIBILITY LOCUS, CHROMOSOME 6-RELATED	0.0172414	2.2988533333333336
DISCRIMINATION, TWO-POINT, REDUCTION IN	0.0172414	2.2988533333333336
THROMBOPHILIA, HEREDITARY, DUE TO PROTEIN C DEFICIENCY, AUTOSOMALDOMINANT	0.0172414	2.2988533333333336
PERONEAL NERVE, ACCESSORY DEEP	0.0172414	2.2988533333333336
CEREBRAL SCLEROSIS SIMILAR TO PELIZAEUS-MERZBACHER DISEASE	0.0172414	2.2988533333333336
%609939 SYSTEMIC LUPUS ERYTHEMATOSUS, SUSCEPTIBILITY TO, 6; SLEB6	0.0172414	2.2988533333333336
CEREBRAL ANGIOPATHY, DYSPHORIC	0.0172414	2.2988533333333336
POLYCYSTIC LIVER DISEASE 1 WITH OR WITHOUT KIDNEY CYSTS; PCLD1	0.0172414	2.2988533333333336
NEUROVISCERAL STORAGE DISEASE WITH CURVILINEAR BODIES	0.0172414	2.2988533333333336
MOTION SICKNESS	0.0172414	2.2988533333333336
CARDIAC ARRHYTHMIA	0.0172414	2.2988533333333336
190400 TRIGEMINAL NEURALGIA;;TIC DOULOUREUX	0.0172414	2.2988533333333336
600416 MUSCULAR DYSTROPHY, SCAPULOHUMERAL	0.0172414	2.2988533333333336
141405 HEMIFACIAL SPASM, FAMILIAL	0.0172414	2.2988533333333336
NOVELTY SEEKING PERSONALITY TRAIT	0.0172414	2.2988533333333336
CERVICAL RIB	0.0172414	2.2988533333333336
VESTIBULOCOCHLEAR DYSFUNCTION, PROGRESSIVE	0.0172414	2.2988533333333336
%160700 MYOPIA 2, AUTOSOMAL DOMINANT; MYP2	0.0172414	2.2988533333333336
PANCREATIC TRIACYLGLYCEROL LIPASE DEFICIENCY	0.0172414	2.2988533333333336
MODIFIER, X-LINKED, FOR NEUROFUNCTIONAL DEFECTS	0.0172414	2.2988533333333336
601668 SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH ABNORMAL DENTITION; SEMDAD	0.0172414	2.2988533333333336
ERYTHERMALGIA, PRIMARY	0.0172414	2.2988533333333336
HYPEREOSINOPHILIC SYNDROME, IDIOPATHIC	0.0172414	2.2988533333333336
COCHLEOSACCULAR DEGENERATION OF THE INNER EAR WITH PROGRESSIVE CATARACTS	0.0172414	2.2988533333333336
CONGENITAL TRACHEAL STENOSIS	0.0172414	2.2988533333333336
SICKLE CELL ANEMIA	0.0172414	2.2988533333333336
MERALGIA PARAESTHETICA, FAMILIAL	0.0172414	2.2988533333333336
MEDIAN-ULNAR NERVE COMMUNICATIONS	0.0172414	2.2988533333333336
MOSAIC TRISOMY 15	0.0172414	2.2988533333333336
SAETHRE-CHOTZEN SYNDROME	0.017171479	2.2895305333333336
SCHAAF-YANG SYNDROME; SHFYNG	0.017163843	2.2885124
TEMTAMY SYNDROME	0.017139204	2.2852272000000005
X-LINKED INTELLECTUAL DISABILITY, BROOKS TYPE	0.017129268	2.2839024
MOWAT-WILSON SYNDROME	0.017086589000000003	2.278211866666667
OROFACIODIGITAL SYNDROME VI	0.017073872	2.276516266666667
BRANCHIOSKELETOGENITAL SYNDROME	0.016995829	2.2661105333333333
OPITZ GBBB SYNDROME, TYPE II; GBBB2	0.016925542000000002	2.2567389333333336
SPINOCEREBELLAR ATAXIA, X-LINKED 3	0.016808261	2.241101466666667
19P13.3 MICRODUPLICATION SYNDROME	0.016753884	2.2338512
TRISOMY 20P	0.01663006	2.217341333333333
ALPHA-THALASSEMIA-X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.016626169	2.216822533333333
PAI SYNDROME	0.01659365	2.212486666666667
HARTSFIELD SYNDROME	0.01659365	2.212486666666667
MUENKE SYNDROME	0.016430033	2.1906710666666664
WILLIAMS-BEUREN REGION DUPLICATION SYNDROME	0.016408781	2.1878374666666667
MICRO SYNDROME	0.016386813000000004	2.1849084000000003
MARFAN SYNDROME; MFS	0.01629131	2.172174666666667
RICHIERI COSTA-DA SILVA SYNDROME	0.016261190000000002	2.168158666666667
CHROMOSOME 3PTER-P25 DELETION SYNDROME	0.016247573	2.1663430666666668
X-LINKED INTELLECTUAL DISABILITY WITH MARFANOID HABITUS	0.016161049	2.1548065333333333
236410 HUMERORADIAL SYNOSTOSIS WITH CRANIOFACIAL ANOMALIES	0.01606237	2.141649333333333
EARLY-ONSET PROGRESSIVE DIFFUSE BRAIN ATROPHY-MICROCEPHALY-MUSCLE WEAKNESS-OPTIC ATROPHY SYNDROME	0.015920514	2.1227352
49,XXXXY SYNDROME	0.015915663	2.1220884
KAGAMI-OGATA SYNDROME	0.015799461	2.1065948
SOTOS SYNDROME	0.015667503	2.0890004
SHORT RIB-POLYDACTYLY SYNDROME	0.015619630000000002	2.0826173333333338
CUTIS LAXA	0.015617303999999999	2.0823072
DONNAI-BARROW SYNDROME	0.015604313000000002	2.080575066666667
COFFIN-SIRIS SYNDROME 1; CSS1	0.015590283	2.0787044
CRANIOLENTICULOSUTURAL DYSPLASIA	0.01557237	2.076316
%300612 BROOKS-WISNIEWSKI-BROWN SYNDROME;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, BROOKS-WISNIEWSKI-BROWN TYPE;MRXSBWB	0.015422149000000001	2.0562865333333336
CEREBELLAR ATROPHY, VISUAL IMPAIRMENT, AND PSYCHOMOTOR RETARDATION; CAVIPMR	0.015401871	2.0535828
NEUROFACIODIGITORENAL SYNDROME	0.01538473	2.0512973333333333
PONTOCEREBELLAR HYPOPLASIA, TYPE 11; PCH11	0.015371751	2.0495668
HOLOPROSENCEPHALY-CRANIOSYNOSTOSIS SYNDROME	0.015343059999999999	2.045741333333333
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 3; MCAHS3	0.015339851	2.045313466666667
CHROMOSOME 14Q11-Q22 DELETION SYNDROME	0.015309912999999998	2.041321733333333
MICROCEPHALY-CORPUS CALLOSUM AND CEREBELLAR VERMIS HYPOPLASIA-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY SYNDROM	0.015309912999999998	2.041321733333333
ENDOCRINE-CEREBROOSTEODYSPLASIA; ECO	0.015299840000000002	2.039978666666667
FRONTONASAL DYSPLASIA	0.015299840000000002	2.039978666666667
2P15P16.1 MICRODELETION SYNDROME	0.015272962000000001	2.0363949333333338
X-LINKED INTELLECTUAL DISABILITY, CANTAGREL TYPE	0.015271789	2.0362385333333335
6Q TERMINAL DELETION SYNDROME	0.015268242999999999	2.035765733333333
MEHMO SYNDROME; MEHMO	0.015264821	2.0353094666666665
612948 STARGARDT MACULAR DEGENERATION, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM,MENTAL RETARDATION, AND DYSMORPHIC FEATURES	0.015229734	2.0306312
KAUFMAN OCULOCEREBROFACIAL SYNDROME; KOS	0.015202528	2.0270037333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 23; EIEE23	0.015134262999999998	2.017901733333333
C SYNDROME	0.015121949	2.0162598666666667
PYRUVATE DEHYDROGENASE DEFICIENCY	0.015099813000000002	2.0133084
FAMILIAL LAMBDOID SYNOSTOSIS	0.015071749999999998	2.0095666666666663
ATELOSTEOGENESIS TYPE II	0.015071749999999998	2.0095666666666663
MENTAL RETARDATION, AUTOSOMAL DOMINANT 36; MRD36	0.014984450999999998	1.9979268
DISTAL MONOSOMY 12Q	0.014971562	1.996208266666667
AURICULAR ABNORMALITIES-CLEFT LIP WITH OR WITHOUT CLEFT PALATE-OCULAR ABNORMALITIES SYNDROME	0.014960079999999999	1.994677333333333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 57; MRD57	0.014931491000000002	1.9908654666666667
ARTHROGRYPOSIS, DISTAL, TYPE 2A	0.014931429	1.9908572
VELO-FACIAL-SKELETAL SYNDROME	0.014913450000000002	1.9884600000000003
PEROXISOME BIOGENESIS DISORDER 1A (ZELLWEGER)	0.014838157000000001	1.9784209333333334
LEUKODYSTROPHY, HYPOMYELINATING, 3; HLD3	0.014837923	1.9783897333333331
DUANE RETRACTION SYNDROME	0.014823243	1.9764324
PYCR2-RELATED MICROCEPHALY-PROGRESSIVE LEUKOENCEPHALOPATHY	0.01482123	1.976164
VASCULAR EHLERS-DANLOS SYNDROME	0.014781364000000002	1.9708485333333334
MYOPATHY, CONGENITAL, BAILEY-BLOCH; MYPBB	0.01475147	1.9668626666666664
3-PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY, INFANTILE/JUVENILE FORM	0.01473037	1.964049333333333
PITT-HOPKINS SYNDROME	0.014724857	1.9633142666666665
MALAN OVERGROWTH SYNDROME	0.014722688999999999	1.9630251999999997
DUPLICATION/INVERSION 15Q11	0.014698917	1.9598556
CRANIOSYNOSTOSIS-ANAL ANOMALIES-POROKERATOSIS SYNDROME	0.014643284	1.9524378666666664
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 1; EDSMC1	0.014625442	1.9500589333333336
YUNIS-VARON SYNDROME	0.014588908000000001	1.9451877333333336
FRONTONASAL DYSPLASIA-ALOPECIA-GENITAL ANOMALIES SYNDROME	0.01458622	1.9448293333333335
NEURODEGENERATION DUE TO 3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.014580530000000001	1.9440706666666667
FEMORAL-FACIAL SYNDROME	0.014580530000000001	1.9440706666666667
8Q21.11 MICRODELETION SYNDROME	0.014580530000000001	1.9440706666666667
MENTAL RETARDATION, AUTOSOMAL DOMINANT 58; MRD58	0.014539450999999998	1.9385934666666664
8Q12 MICRODUPLICATION SYNDROME	0.014473224	1.9297631999999998
CORPUS CALLOSUM AGENESIS-MACROCEPHALY-HYPERTELORISM SYNDROME	0.01446331	1.9284413333333332
OPTIC ATROPHY-INTELLECTUAL DISABILITY SYNDROME	0.014440333	1.9253777333333333
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, HYPOTONIA, AND VARIABLE BRAIN ANOMALIES; NMIHBA	0.014438896999999997	1.9251862666666664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 72; EIEE72	0.014410213	1.9213617333333333
JOUBERT SYNDROME WITH OCULORENAL DEFECT	0.014380503000000001	1.9174004000000002
JOUBERT SYNDROME	0.014380503000000001	1.9174004000000002
SCHIZENCEPHALY	0.014380503000000001	1.9174004000000002
AICARDI SYNDROME	0.014372449999999998	1.9163266666666665
MICROPHTHALMIA, SYNDROMIC 13; MCOPS13	0.014367724000000002	1.9156965333333336
ANOPHTHALMIA-MEGALOCORNEA-CARDIOPATHY-SKELETAL ANOMALIES SYNDROME	0.014282439999999999	1.9043253333333332
PENTASOMY X	0.014281823999999999	1.9042431999999998
PRADER-WILLI SYNDROME; PWS	0.014279231	1.9038974666666666
WRINKLY SKIN SYNDROME	0.014272344	1.9029792
AXENFELD-RIEGER ANOMALY WITH PARTIALLY ABSENT EYE MUSCLES, DISTINCTIVE FACE, HYDROCEPHALY, AND SKELETAL ABNORMALITIES	0.014260758	1.9014343999999999
RICHIERI-COSTA/GUION-ALMEIDA SYNDROME	0.014252878	1.9003837333333333
FETAL AKINESIA DEFORMATION SEQUENCE; FADS	0.014235810000000002	1.8981080000000001
FRONTOMETAPHYSEAL DYSPLASIA 2; FMD2	0.01418999	1.8919986666666666
311450 PALLISTER W SYNDROME;;W SYNDROME	0.014143709	1.8858278666666668
WIEDEMANN-RAUTENSTRAUCH SYNDROME	0.014127713	1.8836950666666668
MICROFORM HOLOPROSENCEPHALY	0.014127119	1.883615866666667
300064 MENTAL RETARDATION, X-LINKED, WITH CRANIOFACIAL DYSMORPHISM;;MENTAL RETARDATION, X-LINKED, HYDE-FORSTER TYPE	0.01409773	1.879697333333333
X-LINKED INTELLECTUAL DISABILITY-PLAGIOCEPHALY SYNDROME	0.01409773	1.879697333333333
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IL; CDG1L	0.014094521	1.879269466666667
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY-CORTICAL BLINDNESS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.01404729	1.872972
AICARDI-GOUTIÈRES SYNDROME	0.014022912999999998	1.8697217333333331
WHITE MATTER HYPOPLASIA-CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY SYNDROME	0.014012840000000002	1.868378666666667
AMINOPTERIN/METHOTREXATE EMBRYOFETOPATHY	0.014012840000000002	1.868378666666667
9P13 MICRODELETION SYNDROME	0.014010650000000001	1.8680866666666667
22Q11.2 DELETION SYNDROME	0.013975543	1.8634057333333331
CARDIOFACIOCUTANEOUS SYNDROME	0.013950384	1.8600512
WARBURG MICRO SYNDROME 1	0.013942778	1.8590370666666665
TRISOMY 18	0.013880754000000002	1.8507672000000004
9Q21.13 MICRODELETION SYNDROME	0.013876619000000001	1.8502158666666668
OCULOCEREBROCUTANEOUS SYNDROME	0.013876619000000001	1.8502158666666668
MICROPHTHALMIA, LENZ TYPE	0.013876619000000001	1.8502158666666668
TMEM70-RELATED MITOCHONDRIAL ENCEPHALO-CARDIO-MYOPATHY	0.013876619000000001	1.8502158666666668
PDE4D HAPLOINSUFFICIENCY SYNDROME	0.013874429	1.8499238666666669
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND CEREBELLAR ATAXIA; CCAFCA	0.013839084000000001	1.8452112000000003
ANTERIOR SEGMENT DEVELOPMENTAL ANOMALY	0.013839084000000001	1.8452112000000003
JOUBERT SYNDROME WITH HEPATIC DEFECT	0.013834949000000001	1.8446598666666667
COFFIN-LOWRY SYNDROME	0.013834949000000001	1.8446598666666667
PRIMARY CUTIS VERTICIS GYRATA	0.013834949000000001	1.8446598666666667
LINEAR VERRUCOUS NEVUS SYNDROME	0.013834949000000001	1.8446598666666667
NEURODEVELOPMENTAL DISORDER WITH MOVEMENT ABNORMALITIES, ABNORMAL GAIT, AND AUTISTIC FEATURES; NEDMAGA	0.013827822	1.8437096
DDOST-CDG	0.013823687	1.8431582666666664
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND BEHAVIORAL ABNORMALITIES; IDDFBA	0.013820141	1.8426854666666665
PALLISTER-KILLIAN SYNDROME	0.013816657000000001	1.8422209333333335
ROBERTS SYNDROME	0.013807344000000001	1.8409792
FACIOCARDIORENAL SYNDROME	0.013777939999999999	1.8370586666666664
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE SPASTIC DIPLEGIA SYNDROME	0.013757729	1.8343638666666666
RESTRICTIVE DERMOPATHY, LETHAL	0.013750950000000001	1.8334600000000003
TRICHOTHIODYSTROPHY	0.013737812	1.8317082666666669
KLEEFSTRA SYNDROME	0.013728563	1.8304750666666665
MENTAL RETARDATION, X-LINKED 99, SYNDROMIC, FEMALE-RESTRICTED	0.013708691	1.8278254666666667
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 2; MC5DN2	0.013703511	1.8271348
B4GALT7-RELATED SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.013690233999999999	1.8253645333333333
POLYHYDRAMNIOS, MEGALENCEPHALY, AND SYMPTOMATIC EPILEPSY; PMSE	0.013661841000000001	1.8215788
INHERITED ISOLATED ADRENAL INSUFFICIENCY DUE TO PARTIAL CYP11A1 DEFICIENCY	0.01362737	1.8169826666666666
HYDROLETHALUS	0.01362737	1.8169826666666666
46,XY DISORDER OF SEX DEVELOPMENT-ADRENAL INSUFFICIENCY DUE TO CYP11A1 DEFICIENCY	0.01362737	1.8169826666666666
134780 FEMORAL-FACIAL SYNDROME; FFS;;FEMORAL HYPOPLASIA-UNUSUAL FACIES SYNDROME; FHUFS	0.01360773	1.8143639999999999
TEEBI-SHALTOUT SYNDROME; TBSH	0.01360229	1.8136386666666666
AUTOSOMAL RECESSIVE FRONTOTEMPORAL PACHYGYRIA	0.013565584000000002	1.8087445333333336
FOCAL DERMAL HYPOPLASIA; FDH	0.01356154	1.8082053333333334
MOSAIC TRISOMY 8	0.01356154	1.8082053333333334
PACHYGYRIA, FRONTOTEMPORAL	0.013561449000000001	1.8081932000000003
SILVER-RUSSELL SYNDROME	0.01353651	1.8048680000000001
HERMANSKY-PUDLAK SYNDROME	0.013518390000000002	1.8024520000000002
XP21 MICRODELETION SYNDROME	0.013498563000000002	1.7998084
INTELLECTUAL DISABILITY-FEEDING DIFFICULTIES-DEVELOPMENTAL DELAY-MICROCEPHALY SYNDROME	0.013470679999999999	1.7960906666666665
CONGENITAL LABIOSCROTAL AGENESIS-CEREBELLAR MALFORMATION-CORNEAL DYSTROPHY-FACIAL DYSMORPHISM SYNDROME	0.013470679999999999	1.7960906666666665
OROFACIODIGITAL SYNDROME IX; OFD9	0.013428533999999999	1.7904712
OROFACIODIGITAL SYNDROME VIII; OFD8	0.013428533999999999	1.7904712
PROLIFERATIVE VASCULOPATHY AND HYDRANENCEPHALY-HYDROCEPHALY SYNDROME; PVHH	0.013427343000000001	1.7903124000000004
GABRIELE-DE VRIES SYNDROME	0.013424430000000001	1.789924
MENTAL RETARDATION, X-LINKED 98; MRX98	0.013407703	1.7876937333333331
SCHOLTE SYNDROME; SHLTS	0.013401328	1.7868437333333334
MENTAL RETARDATION, X-LINKED 19	0.013401327999999999	1.7868437333333331
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIC; ARCL2C	0.013401327999999999	1.7868437333333331
SHPRINTZEN-GOLDBERG SYNDROME	0.01339307	1.7857426666666665
XQ28 (MECP2) DUPLICATION	0.013353213	1.7804284
LAURIN-SANDROW SYNDROME	0.013335200000000002	1.7780266666666669
DIABETIC EMBRYOPATHY	0.013335200000000002	1.7780266666666669
HOLOPROSENCEPHALY-POSTAXIAL POLYDACTYLY SYNDROME	0.013335200000000002	1.7780266666666669
CRANE-HEISE SYNDROME	0.013335200000000002	1.7780266666666669
TRIPLOIDY	0.013335200000000002	1.7780266666666669
MECKEL SYNDROME	0.013335200000000002	1.7780266666666669
ACROCALLOSAL SYNDROME	0.013335200000000002	1.7780266666666669
PRADER-WILLI-LIKE SYNDROME	0.013317693	1.7756924
OCULAR ANOMALIES-AXONAL NEUROPATHY-DEVELOPMENTAL DELAY SYNDROME	0.013317693	1.7756924
EMANUEL SYNDROME	0.013305771	1.7741027999999999
FRONTORHINY	0.013293530000000001	1.772470666666667
MICROCEPHALY-SEIZURES-INTELLECTUAL DISABILITY-HEART DISEASE SYNDROME	0.013258193	1.7677590666666667
GAUCHER DISEASE, TYPE II	0.013245903000000002	1.7661204000000004
NEUROLOGICAL CONDITIONS ASSOCIATED WITH AMINOACYLASE 1 DEFICIENCY	0.013135173000000002	1.7513564000000001
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME	0.013135173000000002	1.7513564000000001
DISTAL MONOSOMY 1Q	0.013135173000000002	1.7513564000000001
HALLERMANN-STREIFF SYNDROME	0.01311835	1.7491133333333335
WILSON-TURNER X-LINKED MENTAL RETARDATION SYNDROME; WTS	0.013037603	1.7383470666666667
BOHRING-OPITZ SYNDROME	0.013021873	1.7362497333333333
%606772 MENTAL RETARDATION, OBESITY, MANDIBULAR PROGNATHISM, AND EYE AND SKINANOMALIES;;MOMES SYNDROME	0.013020030000000002	1.7360040000000003
INTELLECTUAL DISABILITY-OBESITY-PROGNATHISM-EYE AND SKIN ANOMALIES SYNDROME	0.013020030000000002	1.7360040000000003
MULTIPLE JOINT DISLOCATIONS, SHORT STATURE, AND CRANIOFACIAL DYSMORPHISM WITH OR WITHOUT CONGENITAL HEART DEFECTS	0.013007548	1.7343397333333332
POTOCKI-SHAFFER SYNDROME	0.012995933000000001	1.7327910666666668
FRONTONASAL DYSPLASIA 1; FND1	0.012993850000000001	1.7325133333333336
MENTAL RETARDATION-HYPOTONIC FACIES SYNDROME, X-LINKED, 1; MRXHF1	0.012986799	1.7315732000000001
INTELLECTUAL DISABILITY-BALDING-PATELLA LUXATION-ACROMICRIA SYNDROME	0.012981209	1.7308278666666665
IMMUNOSKELETAL DYSPLASIA WITH NEURODEVELOPMENTAL ABNORMALITIES; ISDNA	0.012981209	1.7308278666666665
NEURODEVELOPMENTAL DISORDER WITH REGRESSION, ABNORMAL MOVEMENTS, LOSS OF SPEECH, AND SEIZURES; NEDAMSS	0.012962111	1.7282814666666666
CORNELIA DE LANGE SYNDROME 1	0.012960469	1.7280625333333335
BLOMSTRAND LETHAL CHONDRODYSPLASIA	0.012948810000000002	1.7265080000000002
SPASTIC PARAPLEGIA-INTELLECTUAL DISABILITY-NYSTAGMUS-OBESITY SYNDROME	0.012935939999999998	1.7247919999999997
MENTAL RETARDATION, AUTOSOMAL DOMINANT 13	0.012935939999999998	1.7247919999999997
ADAMS-OLIVER SYNDROME 1; AOS1	0.012932731	1.7243641333333333
%129900 ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME1; EEC1;;EEC;;EEC SYNDROME 1	0.01292465	1.7232866666666666
CLASSICAL EHLERS-DANLOS SYNDROME	0.01283714	1.7116186666666668
X-LINKED INTELLECTUAL DISABILITY-GLOBAL DEVELOPMENT DELAY-FACIAL DYSMORPHISM-SACRAL CAUDAL REMNANT SYNDROME	0.012795681	1.7060908
TYSHCHENKO SYNDROME	0.012645554	1.6860738666666666
GAUCHER DISEASE, PERINATAL LETHAL	0.012629129000000001	1.683883866666667
GORLIN SYNDROME	0.01261385	1.6818466666666667
OCULO-PALATO-CEREBRAL SYNDROME	0.012593754000000002	1.6791672000000004
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 11	0.012589619000000002	1.6786158666666668
FRONTAL ENCEPHALOCELE	0.012589619000000002	1.6786158666666668
SPONTANEOUS PERIODIC HYPOTHERMIA	0.012589619000000002	1.6786158666666668
3-HYDROXYISOBUTYRIC ACIDURIA	0.012589619000000002	1.6786158666666668
INFANTILE SPASMS-BROAD THUMBS SYNDROME	0.012589619000000002	1.6786158666666668
LOWRY-MACLEAN SYNDROME	0.012589619000000002	1.6786158666666668
CHROMOSOME 15Q11.2 DELETION SYNDROME	0.012574810999999998	1.6766414666666662
KLEEFSTRA SYNDROME 2; KLEFS2	0.012574810999999998	1.6766414666666662
FACIOCARDIORENAL SYNDROME	0.012490939999999999	1.6654586666666664
HAREL-YOON SYNDROME; HAYOS	0.012450812	1.6601082666666667
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 35; COXPD35	0.012450812	1.6601082666666667
GLOBAL DEVELOPMENTAL DELAY, ABSENT OR HYPOPLASTIC CORPUS CALLOSUM, AND DYSMORPHIC FACIES; GDACCF	0.012399192000000002	1.6532256000000003
OCULOCEREBROFACIAL SYNDROME, KAUFMAN TYPE	0.012376904000000001	1.6502538666666666
BRESEK SYNDROME	0.012358853999999999	1.6478471999999997
MENTAL RETARDATION AND MICROCEPHALY WITH PONTINE AND CEREBELLAR HYPOPLASIA; MICPCH	0.012350681	1.646757466666667
HELSMOORTEL-VAN DER AA SYNDROME	0.012350681	1.646757466666667
SHORT STATURE, BRACHYDACTYLY, INTELLECTUAL DEVELOPMENTAL DISABILITY, AND SEIZURES; SBIDDS	0.012350681	1.646757466666667
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 2	0.012349472	1.6465962666666667
SPINAL MUSCULAR ATROPHY WITH CONGENITAL BONE FRACTURES 1; SMABF1	0.012349472	1.6465962666666667
INFANTILE HYPOTONIA-OCULOMOTOR ANOMALIES-HYPERKINETIC MOVEMENTS-DEVELOPMENTAL DELAY SYNDROME	0.01232073	1.6427640000000001
ISOLATED PLAGIOCEPHALY	0.012317183999999998	1.6422911999999998
BAINBRIDGE-ROPERS SYNDROME; BRPS	0.012250127	1.6333502666666666
AXIAL MESODERMAL DYSPLASIA SPECTRUM	0.01224951	1.633268
15Q OVERGROWTH SYNDROME	0.012233849000000002	1.6311798666666668
ZELLWEGER SYNDROME	0.012196419	1.6261892
W SYNDROME	0.012183204	1.6244272
STICKLER SYNDROME	0.01210607	1.6141426666666667
MONOSOMY 22Q13.3	0.012080103000000002	1.6106804000000001
FONTAINE PROGEROID SYNDROME; FPS	0.012075757999999999	1.6101010666666666
19P13.12 MICRODELETION SYNDROME	0.012069513	1.6092684
MICROCEPHALY-MICROMELIA SYNDROME; MIMIS	0.012048200000000002	1.6064266666666671
DISTAL MONOSOMY 13Q	0.012048200000000002	1.6064266666666671
PROGRESSIVE MYOCLONIC EPILEPSY TYPE 3	0.012048200000000002	1.6064266666666671
HOLZGREVE SYNDROME	0.012048200000000002	1.6064266666666671
LOWRY-WOOD SYNDROME	0.012048200000000002	1.6064266666666671
LETHAL INTRAUTERINE GROWTH RESTRICTION-CORTICAL MALFORMATION-CONGENITAL CONTRACTURES SYNDROME	0.012048200000000002	1.6064266666666671
DISTAL TRISOMY 14Q	0.012048200000000002	1.6064266666666671
ISOLATED DANDY-WALKER MALFORMATION	0.012048200000000002	1.6064266666666671
MARTSOLF SYNDROME	0.01195063	1.5934173333333332
LIG4 SYNDROME	0.011914074	1.5885432000000002
SPASTIC PARAPLEGIA 49, AUTOSOMAL RECESSIVE	0.011875730999999999	1.5834308
WARBURG MICRO SYNDROME 3; WARBM3	0.011870079	1.5826772
MULTIPLE PTERYGIUM-MALIGNANT HYPERTHERMIA SYNDROME	0.011813299999999999	1.5751066666666664
SUMMITT SYNDROME	0.011771629999999998	1.5695506666666663
ROBINOW-SORAUF SYNDROME	0.011771629999999998	1.5695506666666663
CHROMOSOME 2Q37 DELETION SYNDROME	0.011750603	1.5667470666666665
DESANTO-SHINAWI SYNDROME	0.011744051	1.5658734666666667
LUBS X-LINKED MENTAL RETARDATION SYNDROME; MRXSL	0.011685019	1.5580025333333332
RAHMAN SYNDROME	0.011683924000000002	1.5578565333333336
FIBULO-ULNAR HYPOPLASIA-RENAL ANOMALIES SYNDROME	0.011655	1.554
%601927 LYMPHEDEMA, CARDIAC SEPTAL DEFECTS, AND CHARACTERISTIC FACIES;;IRONS-BIANCHI SYNDROME;;LYMPHEDEMA, ATRIAL SEPTAL DEFECT, AND CHARACTERISTIC FACIES	0.01163765	1.5516866666666664
TOE SYNDACTYLY, TELECANTHUS, AND ANOGENITAL AND RENAL MALFORMATIONS; STAR	0.01163765	1.5516866666666664
%252100 MOHR SYNDROME;;OROFACIODIGITAL SYNDROME II; OFD2;;OFDS II;;ORAL-FACIAL-DIGITAL SYNDROME, TYPE II	0.01163765	1.5516866666666664
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 3	0.01163765	1.5516866666666664
MICROCORNEA, MYOPIC CHORIORETINAL ATROPHY, AND TELECANTHUS; MMCAT	0.01163765	1.5516866666666664
CONGENITAL HEART DEFECTS, DYSMORPHIC FACIAL FEATURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER; CHDFIDD	0.011605131	1.5473507999999998
CARDIOSPONDYLOCARPOFACIAL SYNDROME; CSCF	0.01160157	1.546876
HERMANSKY-PUDLAK SYNDROME 6; HPS6	0.011594804	1.5459738666666667
FRYNS SYNDROME	0.011576219	1.5434958666666667
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, X-LINKED; ATRX	0.011567713	1.5423617333333333
CHROMOSOME 5P13 DUPLICATION SYNDROME	0.011521591000000001	1.5362121333333334
GLOBAL DEVELOPMENTAL DELAY-VISUAL ANOMALIES-PROGRESSIVE CEREBELLAR ATROPHY-TRUNCAL HYPOTONIA SYNDROME	0.011489274	1.5319032000000001
PSYCHOMOTOR DELAY DUE TO S-ADENOSYLHOMOCYSTEINE HYDROLASE DEFICIENCY	0.011429774	1.5239698666666668
MONOSOMY 18P	0.011429214	1.5238952000000001
CONTRACTURAL ARACHNODACTYLY, CONGENITAL	0.011388160000000001	1.5184213333333334
MICROPHTHALMIA, SYNDROMIC 2; MCOPS2	0.011330258999999999	1.5107011999999997
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES, SEIZURES, AND DISTAL LIMB ANOMALIES	0.011281221	1.5041628
VERTEBRAL ANOMALIES AND VARIABLE ENDOCRINE AND T-CELL DYSFUNCTION; VETD	0.011209184	1.4945578666666668
MONOSOMY 9P	0.011127743	1.4836990666666667
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 3; HPMRS3	0.011105351	1.4807134666666666
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 4	0.011105351	1.4807134666666666
TEMTAMY PREAXIAL BRACHYDACTYLY SYNDROME	0.011071853999999999	1.4762472
RAINE SYNDROME	0.011071853999999999	1.4762472
INTELLECTUAL DISABILITY-CATARACTS-CALCIFIED PINNAE-MYOPATHY SYNDROME	0.011067718999999998	1.4756958666666664
SEVERE INTELLECTUAL DISABILITY-EPILEPSY-ANAL ANOMALIES-DISTAL PHALANGEAL HYPOPLASIA	0.011067718999999998	1.4756958666666664
GERMAN SYNDROME	0.011052974	1.4737298666666667
HERMANSKY-PUDLAK SYNDROME 5; HPS5	0.01104925	1.4732333333333334
INTELLECTUAL DISABILITY, BIRK-BAREL TYPE	0.011038312	1.4717749333333334
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 1; IHPRF1	0.011036883	1.4715844
48,XXXY SYNDROME	0.011036883	1.4715844
OROFACIODIGITAL SYNDROME I; OFD1	0.010988519000000002	1.465135866666667
OROFACIODIGITAL SYNDROME TYPE 1	0.010988519000000002	1.465135866666667
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.010988519000000002	1.465135866666667
PEROXISOME BIOGENESIS DISORDER 2B; PBD2B	0.010980639	1.4640852000000002
HYPEREKPLEXIA 2; HKPX2	0.01094372	1.4591626666666668
PROGRESSIVE BIFOCAL CHORIORETINAL ATROPHY	0.01094372	1.4591626666666668
611961 STEVENSON-CAREY SYNDROME	0.010914192999999999	1.4552257333333332
MOEBIUS SYNDROME; MBS	0.0109136	1.4551466666666668
FACIAL PARESIS, HEREDITARY CONGENITAL, 3; HCFP3	0.0109136	1.4551466666666668
ADULT-ONSET CHRONIC PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL MYOPATHY	0.0109136	1.4551466666666668
CLASSICAL-LIKE EHLERS-DANLOS SYNDROME TYPE 2	0.010894614	1.4526152
WYBURN-MASON SYNDROME	0.010890893	1.4521190666666668
CHÉDIAK-HIGASHI SYNDROME	0.010890893	1.4521190666666668
MICROCEPHALY 16, PRIMARY, AUTOSOMAL RECESSIVE	0.010856433000000002	1.4475244000000003
MENTAL RETARDATION, AUTOSOMAL DOMINANT 18; MRD18	0.010847724	1.4463632
EPIDERMOLYSIS BULLOSA SIMPLEX WITH PYLORIC ATRESIA	0.01084238	1.4456506666666666
SEVERE CONGENITAL NEMALINE MYOPATHY	0.01084238	1.4456506666666666
INTERMEDIATE NEMALINE MYOPATHY	0.01084238	1.4456506666666666
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT ANOMALIES OF THE BRAIN, EYE, OR HEART; NEDBEH	0.010836631	1.444884133333333
CRI-DU-CHAT SYNDROME	0.01081226	1.4416346666666668
WILLIAMS SYNDROME	0.01081226	1.4416346666666668
SHORT STATURE, HEARING LOSS, RETINITIS PIGMENTOSA, AND DISTINCTIVE FACIES; SHRF	0.01080667	1.4408893333333335
CEREBROOCULOFACIOSKELETAL SYNDROME 1	0.010787557000000001	1.4383409333333335
CLEFT PALATE, PSYCHOMOTOR RETARDATION, AND DISTINCTIVE FACIAL FEATURES	0.010739802	1.4319736
CORPUS CALLOSUM, AGENESIS OF, WITH FACIAL ANOMALIES AND ROBIN SEQUENCE	0.010730998000000002	1.4307997333333335
DISTAL MONOSOMY 15Q	0.010711503	1.4282004000000001
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2	0.010703093	1.4270790666666666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 32; COXPD32	0.010700832	1.4267776
ACROFRONTOFACIONASAL DYSOSTOSIS	0.01066363	1.4218173333333333
SPASTIC TETRAPLEGIA-THIN CORPUS CALLOSUM-PROGRESSIVE POSTNATAL MICROCEPHALY SYNDROME	0.01065945	1.42126
TEMPLE SYNDROME	0.010651898	1.4202530666666666
POTOCKI-SHAFFER SYNDROME	0.010622939000000001	1.4163918666666668
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIIA	0.010621411	1.4161881333333335
OCULODENTODIGITAL DYSPLASIA, AUTOSOMAL RECESSIVE	0.010586020000000002	1.4114693333333337
DYRK1A-RELATED INTELLECTUAL DISABILITY SYNDROME	0.010557483999999999	1.407664533333333
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME DUE TO SETD5 HAPLOINSUFFICIENCY	0.01053754	1.4050053333333332
FRONTOFACIONASAL DYSPLASIA	0.010526520000000001	1.4035360000000001
POSTAXIAL POLYDACTYLY-DENTAL AND VERTEBRAL ANOMALIES SYNDROME	0.010526299999999999	1.4035066666666665
ARTHROGRYPOSIS, CLEFT PALATE, CRANIOSYNOSTOSIS, AND IMPAIRED INTELLECTUAL DEVELOPMENT; ACCIID	0.010526299999999999	1.4035066666666665
SPORADIC FETAL BRAIN DISRUPTION SEQUENCE	0.010526299999999999	1.4035066666666665
FIBROCHONDROGENESIS	0.010526299999999999	1.4035066666666665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 42; EIEE42	0.010523091	1.4030788
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 13	0.010523091	1.4030788
GALLOWAY-MOWAT SYNDROME 2, X-LINKED; GAMOS2	0.010523091	1.4030788
CHROMOSOME 5Q12 DELETION SYNDROME	0.010523091	1.4030788
INTELLECTUAL DEVELOPMENTAL DISORDER WITH OR WITHOUT EPILEPSY OR CEREBELLAR ATAXIA; IDDECA	0.010523091	1.4030788
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IA; CDG1A	0.010523091	1.4030788
NEURODEVELOPMENTAL DELAY-SEIZURES-OPHTHALMIC ANOMALIES-OSTEOPENIA-CEREBELLAR ATROPHY SYNDROME	0.010522878	1.4030504
INFANTILE SIALIC ACID STORAGE DISEASE	0.010451871	1.3935828
SCLEROSTEOSIS 1; SOST1	0.01043922	1.391896
BLEPHAROPHIMOSIS WITH PTOSIS, SYNDACTYLY, AND SHORT STATURE	0.01043922	1.391896
GOLDBERG-SHPRINTZEN SYNDROME	0.010426822	1.3902429333333335
LARSEN-LIKE SYNDROME	0.010426112	1.3901482666666667
16Q24.3 MICRODELETION SYNDROME	0.010391549	1.3855398666666665
IMPERFORATE OROPHARYNX-COSTOVERTEBRAL ANOMALIES SYNDROME	0.010368	1.3824
MENTAL RETARDATION, X-LINKED, SYNDROMIC 34; MRXS34	0.010350577	1.3800769333333331
PRIMARY HYPERALDOSTERONISM-SEIZURES-NEUROLOGICAL ABNORMALITIES SYNDROME	0.010349474	1.3799298666666668
MUSCULOCONTRACTURAL EHLERS-DANLOS SYNDROME	0.01034906	1.3798746666666668
GRANULOMATOSIS WITH POLYANGIITIS	0.010345339	1.3793785333333335
VIRAL HEMORRHAGIC FEVER	0.010345339	1.3793785333333335
BERNARD-SOULIER SYNDROME	0.010345339	1.3793785333333335
HEREDITARY HEMORRHAGIC TELANGIECTASIA	0.010345339	1.3793785333333335
EBOLA HEMORRHAGIC FEVER	0.010345339	1.3793785333333335
PULMONARY ARTERIOVENOUS MALFORMATION	0.010345339	1.3793785333333335
MICROPHTHALMIA, SYNDROMIC 12	0.01034384	1.3791786666666668
RING CHROMOSOME 12 SYNDROME	0.010307134	1.3742845333333336
BRANCHIO-OCULO-FACIAL SYNDROME	0.01030217	1.3736226666666664
MEND SYNDROME	0.010290601	1.3720801333333332
1Q44 MICRODELETION SYNDROME	0.010273344	1.3697792
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIM; CDG2M	0.010268941	1.3691921333333334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 43; MRD43	0.010268941	1.3691921333333334
DEAFNESS-INTELLECTUAL DISABILITY SYNDROME, MARTIN-PROBST TYPE	0.010266230000000001	1.368830666666667
MENTAL RETARDATION, X-LINKED, SYNDROMIC, MARTIN-PROBST TYPE	0.010266230000000001	1.368830666666667
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPES I AND III	0.010235914	1.3647885333333334
KLEEFSTRA SYNDROME	0.010207537000000001	1.3610049333333334
X-LINKED INTELLECTUAL DISABILITY, SNYDER TYPE	0.01020602	1.3608026666666666
ADAMS-OLIVER SYNDROME	0.010190109000000001	1.3586812000000001
1Q41Q42 MICRODELETION SYNDROME	0.010165949	1.3554598666666666
GENITOPATELLAR SYNDROME	0.010157133	1.3542844
CARDIAC-VALVULAR EHLERS-DANLOS SYNDROME	0.010149033000000002	1.3532044
MONOSOMY 18Q	0.010149033000000002	1.3532044
MICROCEPHALIC PRIMORDIAL DWARFISM DUE TO RTTN DEFICIENCY	0.010139709	1.3519612
RUBINSTEIN-TAYBI SYNDROME	0.010129393	1.3505857333333335
1P21.3 MICRODELETION SYNDROME	0.010106894	1.3475858666666667
MICROCEPHALY WITH OR WITHOUT CHORIORETINOPATHY, LYMPHEDEMA, OR MENTAL RETARDATION; MCLMR	0.010102759	1.3470345333333333
OSTEOCHONDRODYSPLASIA, COMPLEX LETHAL, SYMOENS-BARNES-GISTELINCK TYPE	0.01008152	1.3442026666666667
300232 SPONDYLOEPIMETAPHYSEAL DYSPLASIA, X-LINKED, WITH MENTAL DETERIORATION;;SEMD, X-LINKED, WITH MENTAL DETERIORATION	0.010043258999999999	1.3391012
CATARACTS, GROWTH HORMONE DEFICIENCY, SENSORY NEUROPATHY, SENSORINEURAL HEARING LOSS, AND SKELETAL DYSPLASIA; CAGSSS	0.009981672	1.3308896000000001
GENERALIZED EPILEPSY-PAROXYSMAL DYSKINESIA SYNDROME	0.009981672	1.3308896000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 18	0.009981672	1.3308896000000001
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PYRAMIDAL SIGNS-NYSTAGMUS-OCULOMOTOR APRAXIA SYNDROME	0.009981672	1.3308896000000001
ARTHROGRYPOSIS MULTIPLEX CONGENITA, NEUROGENIC, WITH MYELIN DEFECT	0.009977537	1.3303382666666668
INTELLECTUAL DISABILITY-SEIZURES-ABNORMAL GAIT-FACIAL DYSMORPHISM SYNDROME	0.00997026	1.329368
PROGRESSIVE SPONDYLOEPIMETAPHYSEAL DYSPLASIA-SHORT STATURE-SHORT FOURTH METATARSALS-INTELLECTUAL DISABILITY SYNDROME	0.009964098	1.3285463999999998
DISTAL MONOSOMY 3P	0.009945299000000001	1.3260398666666668
SWEENEY-COX SYNDROME; SWCOS	0.009927774	1.3237032000000002
ROIFMAN SYNDROME; RFMN	0.009910452	1.3213936000000002
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 25; MC1DN25	0.009910452	1.3213936000000002
SEVERE MICROBRACHYCEPHALY-INTELLECTUAL DISABILITY-ATHETOID CEREBRAL PALSY SYNDROME	0.009903629	1.3204838666666667
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE	0.009902763	1.3203684
TENORIO SYNDROME; TNORS	0.009894557	1.3192742666666666
WHISTLING FACE SYNDROME, RECESSIVE FORM	0.00989304	1.319072
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 41; EIEE41	0.009805741	1.3074321333333332
IDIOPATHIC APLASTIC ANEMIA	0.00980392	1.3071893333333335
THROMBOCYTOPENIA 5; THC5	0.00980392	1.3071893333333335
ACQUIRED VON WILLEBRAND SYNDROME	0.00980392	1.3071893333333335
GAUCHER DISEASE, TYPE I	0.00980392	1.3071893333333335
SEBASTIAN SYNDROME	0.00980392	1.3071893333333335
PLATELET DISORDER, FAMILIAL, WITH ASSOCIATED MYELOID MALIGNANCY	0.00980392	1.3071893333333335
BLEEDING DISORDER, PLATELET-TYPE, 19; BDPLT19	0.00980392	1.3071893333333335
GLANZMANN THROMBASTHENIA	0.00980392	1.3071893333333335
HERMANSKY-PUDLAK SYNDROME 1; HPS1	0.00980392	1.3071893333333335
RELAPSING FEVER	0.00980392	1.3071893333333335
LINEAR IGA DERMATOSIS	0.00980392	1.3071893333333335
BLEEDING DISORDER, PLATELET-TYPE, 15; BDPLT15	0.00980392	1.3071893333333335
EVANS SYNDROME	0.00980392	1.3071893333333335
PRIMARY FAMILIAL POLYCYTHEMIA	0.00980392	1.3071893333333335
TYPHOID	0.00980392	1.3071893333333335
VON WILLEBRAND DISEASE, TYPE 3; VWD3	0.00980392	1.3071893333333335
LEUKOCYTE ADHESION DEFICIENCY, TYPE III	0.00980392	1.3071893333333335
GIANT CELL ARTERITIS	0.00980392	1.3071893333333335
VITAMIN K-DEPENDENT CLOTTING FACTORS, COMBINED DEFICIENCY OF, 1; VKCFD1	0.00980392	1.3071893333333335
FACTOR V DEFICIENCY	0.00980392	1.3071893333333335
FAMILIAL HYPERALDOSTERONISM TYPE III	0.00980392	1.3071893333333335
CRIMEAN-CONGO HEMORRHAGIC FEVER	0.00980392	1.3071893333333335
WISKOTT-ALDRICH SYNDROME	0.00980392	1.3071893333333335
DENGUE FEVER	0.00980392	1.3071893333333335
KAPOSIFORM LYMPHANGIOMATOSIS	0.00980392	1.3071893333333335
%605735 BLEEDING DISORDER, PLATELET-TYPE, 12; BDPLT12;;PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE 1 DEFICIENCY, PLATELET;;PGHS1 DEFICIENCY;;PLATELET CYCLOOXYGENASE 1 DEFICIENCY;;PLATELET COX1 DEFICIENCY	0.00980392	1.3071893333333335
RHEUMATIC FEVER	0.00980392	1.3071893333333335
BLEEDING DISORDER, PLATELET-TYPE, 17; BDPLT17	0.00980392	1.3071893333333335
BERNARD-SOULIER SYNDROME, TYPE A2, AUTOSOMAL DOMINANT; BSSA2	0.00980392	1.3071893333333335
CONGENITAL FACTOR II DEFICIENCY	0.00980392	1.3071893333333335
CONGENITAL FACTOR X DEFICIENCY	0.00980392	1.3071893333333335
FAMILIAL HYPERALDOSTERONISM TYPE II	0.00980392	1.3071893333333335
POLYCYTHEMIA VERA	0.00980392	1.3071893333333335
WALDENSTRÖM MACROGLOBULINEMIA	0.00980392	1.3071893333333335
FACTOR XIII, A SUBUNIT, DEFICIENCY OF	0.00980392	1.3071893333333335
SEVERE HEMOPHILIA A	0.00980392	1.3071893333333335
BLEEDING DISORDER, PLATELET-TYPE, 11; BDPLT11	0.00980392	1.3071893333333335
600903 WISKOTT-ALDRICH SYNDROME, AUTOSOMAL DOMINANT FORM	0.00980392	1.3071893333333335
EPISTAXIS, HEREDITARY	0.00980392	1.3071893333333335
CONGENITAL FACTOR XIII DEFICIENCY	0.00980392	1.3071893333333335
ATTENUATED CHÉDIAK-HIGASHI SYNDROME	0.00980392	1.3071893333333335
VON WILLEBRAND DISEASE, TYPE 2; VWD2	0.00980392	1.3071893333333335
ECTOPIC ALDOSTERONE-PRODUCING TUMOR	0.00980392	1.3071893333333335
BLEEDING DISORDER, PLATELET-TYPE, 14; BDPLT14	0.00980392	1.3071893333333335
ADRENOCORTICAL CARCINOMA WITH PURE ALDOSTERONE HYPERSECRETION	0.00980392	1.3071893333333335
PURPURA SIMPLEX	0.00980392	1.3071893333333335
PRIMARY UNILATERAL ADRENAL HYPERPLASIA	0.00980392	1.3071893333333335
JUVENILE POLYPOSIS/HEREDITARY HEMORRHAGIC TELANGIECTASIA SYNDROME; JPHT	0.00980392	1.3071893333333335
PLATELET SIGNAL PROCESSING DEFECT	0.00980392	1.3071893333333335
+173470 INTEGRIN, BETA-3; ITGB3;;PLATELET GLYCOPROTEIN IIIA; GP3A;;GP IIIA;;PLATELET FIBRINOGEN RECEPTOR, BETA SUBUNIT;;CD61THROMBOCYTOPENIA, NEONATAL ALLOIMMUNE, INCLUDED; NAIT, INCLUDED;;POSTTRANSFUSION PURPURA, INCLUDED; PTP, INCLUDED	0.00980392	1.3071893333333335
GRAY PLATELET SYNDROME	0.00980392	1.3071893333333335
168830 PASSOVOY FACTOR DEFECT	0.00980392	1.3071893333333335
MICROSCOPIC POLYANGIITIS	0.00980392	1.3071893333333335
HERMANSKY-PUDLAK SYNDROME 4; HPS4	0.00980392	1.3071893333333335
FAMILIAL HYPOFIBRINOGENEMIA	0.00980392	1.3071893333333335
CONGENITAL FACTOR XI DEFICIENCY	0.00980392	1.3071893333333335
BLEEDING DISORDER, PLATELET-TYPE, 18; BDPLT18	0.00980392	1.3071893333333335
CONGENITAL PROTHROMBIN DEFICIENCY	0.00980392	1.3071893333333335
CONGENITAL FACTOR VII DEFICIENCY	0.00980392	1.3071893333333335
COMBINED DEFICIENCY OF FACTOR V AND FACTOR VIII	0.00980392	1.3071893333333335
ACUTE PROMYELOCYTIC LEUKEMIA	0.00980392	1.3071893333333335
BLEEDING DISORDER, PLATELET-TYPE, 8; BDPLT8	0.00980392	1.3071893333333335
FAMILIAL DYSFIBRINOGENEMIA	0.00980392	1.3071893333333335
FAMILIAL AFIBRINOGENEMIA	0.00980392	1.3071893333333335
PSEUDOXANTHOMA ELASTICUM-LIKE DISORDER WITH MULTIPLE COAGULATION FACTOR DEFICIENCY	0.00980392	1.3071893333333335
MACROTHROMBOCYTOPENIA AND GRANULOCYTE INCLUSIONS WITH OR WITHOUT NEPHRITIS OR SENSORINEURAL HEARING LOSS; MATINS	0.00980392	1.3071893333333335
IMMUNE THROMBOCYTOPENIC PURPURA	0.00980392	1.3071893333333335
CONGENITAL FACTOR V DEFICIENCY	0.00980392	1.3071893333333335
STORMORKEN SYNDROME; STRMK	0.00980392	1.3071893333333335
FAMILIAL HYPERALDOSTERONISM TYPE I	0.00980392	1.3071893333333335
JUVENILE NASOPHARYNGEAL ANGIOFIBROMA	0.00980392	1.3071893333333335
THROMBOCYTOPENIA 1	0.00980392	1.3071893333333335
BLEEDING DISORDER, PLATELET-TYPE, 20	0.00980392	1.3071893333333335
OROFACIODIGITAL SYNDROME XIV; OFD14	0.009749182	1.2998909333333335
TORIELLO-LACASSIE-DROSTE SYNDROME	0.00972779	1.2970386666666667
TEMPLE SYNDROME	0.00969036	1.292048
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.00969036	1.292048
BECKWITH-WIEDEMANN SYNDROME	0.00969036	1.292048
ATELOSTEOGENESIS, TYPE I; AO1	0.00969036	1.292048
DIETHYLSTILBESTROL SYNDROME	0.00969036	1.292048
VACTERL/VATER ASSOCIATION	0.00969036	1.292048
DIAMOND-BLACKFAN ANEMIA 1	0.00964869	1.286492
NON-RHIZOMELIC CHONDRODYSPLASIA PUNCTATA	0.00964869	1.286492
16P13.11 MICRODELETION SYNDROME	0.009615714000000001	1.2820952
ROBINOW SYNDROME, AUTOSOMAL RECESSIVE 2; RRS2	0.009602394	1.2803191999999999
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA WITH CHARACTERISTIC FACIES	0.009602394	1.2803191999999999
INTELLECTUAL DEVELOPMENTAL DISORDER WITH HYPERTELORISM AND DISTINCTIVE FACIES; IDDHDF	0.009602394	1.2803191999999999
CODAS SYNDROME	0.009591301	1.2788401333333332
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 2	0.009585649	1.2780865333333333
POLYMICROGYRIA, BILATERAL FRONTOPARIETAL	0.009561553	1.2748737333333335
SSR4-CDG	0.009549631	1.2732841333333333
SEVERE INTELLECTUAL DISABILITY-SHORT STATURE-BEHAVIORAL ABNORMALITIES-FACIAL DYSMORPHISM SYNDROME	0.009548114	1.2730818666666666
1Q21.1 MICRODELETION SYNDROME	0.009520953	1.2694604
WOLF-HIRSCHHORN SYNDROME	0.009520953	1.2694604
SYNDACTYLY-TELECANTHUS-ANOGENITAL AND RENAL MALFORMATIONS SYNDROME	0.009520649	1.2694198666666667
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND SPEECH AND WALKING IMPAIRMENT; NEDSSWI	0.009490333	1.2653777333333334
PACHYGYRIA-INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.009490333	1.2653777333333334
BARTTER SYNDROME, TYPE 1, ANTENATAL	0.009490333	1.2653777333333334
DISTAL 22Q11.2 MICRODELETION SYNDROME	0.009490333	1.2653777333333334
GALLOWAY-MOWAT SYNDROME	0.009490333	1.2653777333333334
PYRIDOXAMINE 5-PRIME-PHOSPHATE OXIDASE DEFICIENCY	0.009490333	1.2653777333333334
BARTTER SYNDROME, ANTENATAL, TYPE 2	0.009490333	1.2653777333333334
CONGENITAL TOXOPLASMOSIS	0.009490333	1.2653777333333334
WILSON-TURNER SYNDROME	0.009466173	1.2621564
MICROCEPHALY, GROWTH RETARDATION, CATARACT, HEARING LOSS, AND UNUSUAL APPEARANCE	0.009466173	1.2621564
MIDFACE HYPOPLASIA, HEARING IMPAIRMENT, ELLIPTOCYTOSIS, AND NEPHROCALCINOSIS; MFHIEN	0.009436118	1.2581490666666668
CONGENITAL MUSCULAR DYSTROPHY, ULLRICH TYPE	0.009436118	1.2581490666666668
AUTOSOMAL RECESSIVE CUTIS LAXA TYPE 2, CLASSIC TYPE	0.009424503	1.2566004
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, SEIZURES, AND CORTICAL ATROPHY; NDMSCA	0.009366310999999999	1.2488414666666665
NEMALINE MYOPATHY 10	0.009364898	1.2486530666666666
BARTTER SYNDROME, TYPE 4B, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	1.2486530666666666
BARTTER SYNDROME, TYPE 4A, NEONATAL, WITH SENSORINEURAL DEAFNESS	0.009364898	1.2486530666666666
HYPOPIGMENTATION, ORGANOMEGALY, AND DELAYED MYELINATION AND DEVELOPMENT; HOD	0.009364898	1.2486530666666666
HYPERURICEMIA, PULMONARY HYPERTENSION, RENAL FAILURE, AND ALKALOSIS SYNDROME	0.009364898	1.2486530666666666
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 1; CDGF1	0.009360741	1.2480988
KLEEFSTRA SYNDROME DUE TO 9Q34 MICRODELETION	0.009340994	1.2454658666666667
14Q22Q23 MICRODELETION SYNDROME	0.009340994	1.2454658666666667
MÜLLERIAN DERIVATIVES-LYMPHANGIECTASIA-POLYDACTYLY SYNDROME	0.009340738	1.2454317333333333
ANGELMAN SYNDROME	0.009334411	1.2445881333333333
CLCN4-RELATED X-LINKED INTELLECTUAL DISABILITY SYNDROME	0.009333674	1.2444898666666668
BRACHYCEPHALY, DEAFNESS, CATARACT, MICROSTOMIA, AND MENTAL RETARDATION	0.009316580999999999	1.2422107999999998
MENTAL RETARDATION WITH LANGUAGE IMPAIRMENT AND WITH OR WITHOUT AUTISTIC FEATURES	0.009299067999999999	1.2398757333333332
HAMAMY SYNDROME; HMMS	0.00926209	1.2349453333333336
MARSHALL SYNDROME	0.00925054	1.2334053333333332
CARTILAGE-HAIR HYPOPLASIA	0.00925054	1.2334053333333332
MACROCEPHALY AND EPILEPTIC ENCEPHALOPATHY	0.009240364	1.2320485333333333
BARAITSER-WINTER SYNDROME 1; BRWS1	0.009237161	1.2316214666666667
CAMPTODACTYLY SYNDROME, GUADALAJARA TYPE 1	0.009203853000000001	1.2271804000000002
GENITOPATELLAR SYNDROME; GTPTS	0.009170122	1.2226829333333333
WIEDEMANN-RAUTENSTRAUCH SYNDROME; WDRTS	0.009170122	1.2226829333333333
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 4; MDDGA4	0.009154437	1.2205915999999999
MICROPHTHALMIA, SYNDROMIC 3	0.009140742	1.2187656
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY, CATARACTS, FEEDING DIFFICULTIES, AND DELAYED BRAIN MYELINATION	0.009140711	1.2187614666666666
SHASHI-PENA SYNDROME; SHAPNS	0.009140711	1.2187614666666666
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 41; MRT41	0.009140711	1.2187614666666666
MENTAL RETARDATION, AUTOSOMAL DOMINANT 23; MRD23	0.009118454	1.2157938666666666
PHELAN-MCDERMID SYNDROME	0.009104631	1.2139508
MICROGASTRIA-LIMB REDUCTION DEFECTS ASSOCIATION; MLRD	0.00907016	1.2093546666666668
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR I RESISTANCE	0.00905684	1.2075786666666666
CARPENTER-WAZIRI SYNDROME	0.00905684	1.2075786666666666
BARAITSER-WINTER SYNDROME 2; BRWS2	0.009023879000000002	1.203183866666667
MENTAL RETARDATION, ANTERIOR MAXILLARY PROTRUSION, AND STRABISMUS; MRAMS	0.009020134	1.2026845333333334
MICROPHTHALMIA, ISOLATED, WITH COLOBOMA 9; MCOPCB9	0.009020134	1.2026845333333334
BILATERAL POLYMICROGYRIA	0.009020134	1.2026845333333334
X-LINKED SPINOCEREBELLAR ATAXIA TYPE 3	0.009020134	1.2026845333333334
MARFANOID HABITUS-AUTOSOMAL RECESSIVE INTELLECTUAL DISABILITY SYNDROME	0.009020134	1.2026845333333334
SPASTIC PARAPLEGIA, INTELLECTUAL DISABILITY, NYSTAGMUS, AND OBESITY; SINO	0.009020134	1.2026845333333334
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO MGLUR1 DEFICIENCY	0.009015999	1.2021332
HEREDITARY METHEMOGLOBINEMIA	0.009015999	1.2021332
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 66; EIEE66	0.009014621	1.2019494666666666
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC DEFECTS AND DYSMORPHIC FACIES; IDDCDF	0.009014621	1.2019494666666666
CRANIOECTODERMAL DYSPLASIA 1	0.008979230000000001	1.1972306666666668
SHORT SYNDROME	0.008979230000000001	1.1972306666666668
ACROOSTEOLYSIS DOMINANT TYPE	0.008979230000000001	1.1972306666666668
WITTEVEEN-KOLK SYNDROME	0.008955121	1.1940161333333332
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 2	0.008948914	1.1931885333333334
PYRIDOXAL PHOSPHATE-RESPONSIVE SEIZURES	0.008948914	1.1931885333333334
RADIOULNAR SYNOSTOSIS-MICROCEPHALY-SCOLIOSIS SYNDROME	0.008948914	1.1931885333333334
CINCA SYNDROME	0.008948914	1.1931885333333334
PEDIATRIC-ONSET GRAVES DISEASE	0.008948914	1.1931885333333334
VENTRICULOMEGALY WITH CYSTIC KIDNEY DISEASE; VMCKD	0.008944779	1.1926371999999998
PELIZAEUS-MERZBACHER DISEASE	0.008944779	1.1926371999999998
OMPHALOCELE SYNDROME, SHPRINTZEN-GOLDBERG TYPE	0.008937154	1.1916205333333332
SHORT STATURE, MICROCEPHALY, AND ENDOCRINE DYSFUNCTION; SSMED	0.008924754	1.1899672
SAY-BARBER-MILLER SYNDROME	0.008924754	1.1899672
SHORT-RIB THORACIC DYSPLASIA 16 WITH OR WITHOUT POLYDACTYLY; SRTD16	0.00891973	1.1892973333333334
OSTEOGENESIS IMPERFECTA, TYPE XI; OI11	0.00891902	1.1892026666666666
CRANIOFACIAL DYSOSTOSIS WITH DIAPHYSEAL HYPERPLASIA	0.00891902	1.1892026666666666
LOEYS-DIETZ SYNDROME 5	0.00891902	1.1892026666666666
ARTHROGRYPOSIS AND ECTODERMAL DYSPLASIA	0.00891902	1.1892026666666666
MULTICENTRIC OSTEOLYSIS, NODULOSIS, AND ARTHROPATHY; MONA	0.00891902	1.1892026666666666
HOMOCYSTINURIA DUE TO CYSTATHIONINE BETA-SYNTHASE DEFICIENCY	0.008903703	1.1871604
CHAR SYNDROME	0.008883084	1.1844111999999998
GM1 GANGLIOSIDOSIS	0.008878949	1.1838598666666666
INTELLECTUAL DISABILITY-SEVERE SPEECH DELAY-MILD DYSMORPHISM SYNDROME	0.008878949	1.1838598666666666
XP22.13P22.2 DUPLICATION SYNDROME	0.008878949	1.1838598666666666
CEREBROFACIOARTICULAR SYNDROME	0.008856844000000001	1.1809125333333335
PRIMARY MICROCEPHALY-MILD INTELLECTUAL DISABILITY-YOUNG-ONSET DIABETES SYNDROME	0.008844203	1.1792270666666667
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 5	0.008842393	1.1789857333333333
610680 HOLOPROSENCEPHALY, RECURRENT INFECTIONS, AND MONOCYTOSIS	0.00879544	1.1727253333333334
MICROPHTHALMIA WITH BRAIN AND DIGIT ANOMALIES	0.008780123	1.1706830666666668
PETERS-PLUS SYNDROME; PTRPLS	0.008780122999999999	1.1706830666666665
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 1, WITH OR WITHOUT FRACTURES; SEMDJL1	0.008778268	1.1704357333333333
OKAMOTO SYNDROME	0.008765984	1.1687978666666665
BROWN-VIALETTO-VAN LAERE SYNDROME 2; BVVLS2	0.008748148	1.1664197333333335
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 8; MC1DN8	0.008748148	1.1664197333333335
CONGENITAL MUSCULAR DYSTROPHY WITH CEREBELLAR INVOLVEMENT	0.008738453	1.1651270666666667
CORPUS CALLOSUM AGENESIS-NEURONOPATHY SYNDROME	0.008738453	1.1651270666666667
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, GENEVIEVE TYPE; SEMDG	0.008729357	1.1639142666666666
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS; ECCL	0.008720623	1.1627497333333334
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 1	0.008678953	1.1571937333333333
211910 CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE I; GCS1;;FACIOTHORACOSKELETAL SYNDROME; FTSS	0.008658299000000001	1.1544398666666669
PROXIMAL 16P11.2 MICRODELETION SYNDROME	0.008647593	1.1530124000000002
CK SYNDROME	0.008641431	1.1521907999999998
WEBB-DATTANI SYNDROME; WEDAS	0.008629763	1.1506350666666667
TREACHER-COLLINS SYNDROME	0.008613954	1.1485272
CHROMOSOME 6Q11-Q14 DELETION SYNDROME	0.008599292	1.1465722666666667
CRANIOFACIAL DYSPLASIA-SHORT STATURE-ECTODERMAL ANOMALIES-INTELLECTUAL DISABILITY SYNDROME	0.008595413	1.1460550666666667
NON-DISTAL MONOSOMY 20Q	0.008595156999999999	1.1460209333333333
BASAL CELL NEVUS SYNDROME	0.00855756	1.141008
CORNELIA DE LANGE SYNDROME 2; CDLS2	0.008504553	1.1339404
INTELLECTUAL DISABILITY-OBESITY-BRAIN MALFORMATIONS-FACIAL DYSMORPHISM SYNDROME	0.008491264	1.1321685333333333
FETAL AKINESIA SYNDROME, X-LINKED	0.00848246	1.1309946666666668
FIBROSIS OF EXTRAOCULAR MUSCLES, CONGENITAL, 1; CFEOM1	0.00847458	1.129944
MUCOEPITHELIAL DYSPLASIA, HEREDITARY	0.00847458	1.129944
X-LINKED ENDOTHELIAL CORNEAL DYSTROPHY	0.00847458	1.129944
BLINDNESS-SCOLIOSIS-ARACHNODACTYLY SYNDROME	0.00847458	1.129944
PIGMENTED PARAVENOUS CHORIORETINAL ATROPHY	0.00847458	1.129944
ACHALASIA-MICROCEPHALY SYNDROME	0.00847458	1.129944
DUANE RETRACTION SYNDROME 1	0.00847458	1.129944
TUFTED ANGIOMA	0.00847458	1.129944
108450 ASYMMETRIC SHORT STATURE SYNDROME	0.00847458	1.129944
RADIAL RAY HYPOPLASIA WITH CHOANAL ATRESIA	0.00847458	1.129944
BLEPHAROPHIMOSIS-PTOSIS-ESOTROPIA-SYNDACTYLY-SHORT STATURE SYNDROME	0.00847458	1.129944
TRICHOTHIODYSTROPHY 6, NONPHOTOSENSITIVE; TTD6	0.00847458	1.129944
COLOBOMA, OCULAR, AUTOSOMAL RECESSIVE	0.00847458	1.129944
JABERI-ELAHI SYNDROME; JABELS	0.008454661	1.1272881333333333
TEMTAMY SYNDROME; TEMTYS	0.008454661	1.1272881333333333
SEIZURES, SCOLIOSIS, AND MACROCEPHALY/MICROCEPHALY SYNDROME; SSMS	0.008426991	1.1235988000000001
ROTHMUND-THOMSON SYNDROME	0.008425474	1.1233965333333333
PULMONARY ATRESIA-INTACT VENTRICULAR SEPTUM SYNDROME	0.00840336	1.120448
MARFAN LIPODYSTROPHY SYNDROME; MFLS	0.00840336	1.120448
DISTAL MONOSOMY 17Q	0.00840336	1.120448
BRONCHOPULMONARY DYSPLASIA	0.00840336	1.120448
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY 3	0.00840336	1.120448
HOLOPROSENCEPHALY-CAUDAL DYSGENESIS SYNDROME	0.00840336	1.120448
CONGENITAL ENTEROVIRUS INFECTION	0.00840336	1.120448
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	1.120448
CONGENITAL ANALBUMINEMIA	0.00840336	1.120448
GMS SYNDROME	0.00840336	1.120448
AUTOSOMAL DOMINANT MYOPIA-MIDFACIAL RETRUSION-SENSORINEURAL HEARING LOSS-RHIZOMELIC DYSPLASIA SYNDROME	0.00840336	1.120448
RENAL TUBULAR DYSGENESIS	0.00840336	1.120448
KNIEST-LIKE DYSPLASIA, LETHAL	0.00840336	1.120448
DOUBLE UTERUS-HEMIVAGINA-RENAL AGENESIS SYNDROME	0.00840336	1.120448
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 30; MC1DN30	0.00840336	1.120448
HEC SYNDROME	0.00840336	1.120448
ACROFACIAL DYSOSTOSIS 1, NAGER TYPE; AFD1	0.00840336	1.120448
SCHISIS ASSOCIATION	0.00840336	1.120448
CHOLESTASIS, INTRAHEPATIC, OF PREGNANCY, 1; ICP1	0.00840336	1.120448
CONGENITAL PULMONARY AIRWAY MALFORMATION	0.00840336	1.120448
SPINAL MUSCULAR ATROPHY, DISTAL, AUTOSOMAL RECESSIVE, 1; DSMA1	0.00840336	1.120448
OSTEOGENESIS IMPERFECTA, TYPE IIA	0.00840336	1.120448
BARTTER SYNDROME, TYPE 5, ANTENATAL, TRANSIENT	0.00840336	1.120448
CONGENITAL HERPES SIMPLEX VIRUS INFECTION	0.00840336	1.120448
INDOMETHACIN EMBRYOFETOPATHY	0.00840336	1.120448
ICHTHYOSIS-PREMATURITY SYNDROME	0.00840336	1.120448
EBSTEIN MALFORMATION	0.00840336	1.120448
ACITRETIN/ETRETINATE EMBRYOPATHY	0.00840336	1.120448
OMPHALOCELE	0.00840336	1.120448
LOWER LIMB MALFORMATION-HYPOSPADIAS SYNDROME	0.00840336	1.120448
FIBULAR APLASIA-ECTRODACTYLY SYNDROME	0.00840336	1.120448
PTOSIS-VOCAL CORD PARALYSIS SYNDROME	0.00840336	1.120448
PEMPHIGOID GESTATIONIS	0.00840336	1.120448
CORNEODERMATOOSSEOUS SYNDROME	0.00840336	1.120448
FATCO SYNDROME	0.00840336	1.120448
RETINOPATHY OF PREMATURITY	0.00840336	1.120448
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 24; COXPD24	0.008395161	1.1193548
BRAIN MALFORMATIONS WITH OR WITHOUT URINARY TRACT DEFECTS; BRMUTD	0.008395161	1.1193548
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY AND STRUCTURAL BRAIN ANOMALIES; NEDMIBA	0.008395161	1.1193548
X-LINKED INTELLECTUAL DISABILITY, SIDERIUS TYPE	0.0083792	1.1172266666666666
MEGALOCORNEA-MENTAL RETARDATION SYNDROME	0.008375757000000001	1.1167676000000002
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 2	0.008372648	1.1163530666666666
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 9	0.008362284000000001	1.1149712
FLYNN-AIRD SYNDROME	0.008358149	1.1144198666666667
8Q22.1 MICRODELETION SYNDROME	0.008342644	1.1123525333333333
OVERGROWTH-MACROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.00833753	1.1116706666666665
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIB; ARCL2B	0.008328714000000001	1.1104952000000001
14Q12 MICRODELETION SYNDROME	0.008324579	1.1099438666666668
POTOCKI-LUPSKI SYNDROME	0.008304301	1.1072401333333335
FLOATING-HARBOR SYNDROME	0.008300974000000001	1.1067965333333334
LEUKODYSTROPHY, HYPOMYELINATING, 17; HLD17	0.008298649	1.1064865333333334
SIMPSON-GOLABI-BEHMEL SYNDROME	0.008275623000000001	1.1034164000000002
COG1-CDG	0.008273768	1.103169066666667
ICHTHYOSIS FOLLICULARIS-ALOPECIA-PHOTOPHOBIA SYNDROME	0.008234569	1.0979425333333335
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 3; LSDMCA3	0.008192899	1.0923865333333334
MENTAL RETARDATION WITH OPTIC ATROPHY, FACIAL DYSMORPHISM, MICROCEPHALY, AND SHORT STATURE	0.008179173	1.0905563999999999
SEVERE NEURODEVELOPMENTAL DISORDER WITH FEEDING DIFFICULTIES-STEREOTYPIC HAND MOVEMENT-BILATERAL CATARACT	0.008179173	1.0905563999999999
OCULOCEREBROCUTANEOUS SYNDROME	0.008175069	1.0900092
SPASTIC PARAPLEGIA AND PSYCHOMOTOR RETARDATION WITH OR WITHOUT SEIZURES	0.008172621	1.0896827999999998
X-LINKED INTELLECTUAL DISABILITY-HYPOGONADISM-ICHTHYOSIS-OBESITY-SHORT STATURE SYNDROME	0.008164753	1.0886337333333334
KBG SYNDROME	0.008164753	1.0886337333333334
RECOMBINANT CHROMOSOME 8 SYNDROME	0.008152271	1.0869694666666667
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 1	0.008150188000000001	1.0866917333333335
PONTINE TEGMENTAL CAP DYSPLASIA	0.008142501	1.0856668
LISSENCEPHALY 9 WITH COMPLEX BRAINSTEM MALFORMATION; LIS9	0.008142501	1.0856668
MICROPHTHALMIA, SYNDROMIC 1	0.008137547	1.0850062666666667
MENTAL RETARDATION, X-LINKED, SYNDROMIC, SNYDER-ROBINSON TYPE	0.008137547	1.0850062666666667
POLYMICROGYRIA DUE TO TUBB2B MUTATION	0.008137534	1.0850045333333334
CONGENITAL CATARACT-MICROCEPHALY-NEVUS FLAMMEUS SIMPLEX-SEVERE INTELLECTUAL DISABILITY SYNDROME	0.008133399	1.0844531999999998
%229400 FRONTOFACIONASAL DYSPLASIA;;FFND;;FRONTOFACIONASAL DYSOSTOSIS	0.00811688	1.0822506666666667
AUTOSOMAL RECESSIVE FACIODIGITOGENITAL SYNDROME	0.00811688	1.0822506666666667
%263210 POLYCYSTIC KIDNEY DISEASE, POTTER TYPE I, WITH MICROBRACHYCEPHALY,HYPERTELORISM, AND BRACHYMELIA	0.00811688	1.0822506666666667
GÓMEZ-LÓPEZ-HERNÁNDEZ SYNDROME	0.00811688	1.0822506666666667
EHLERS-DANLOS SYNDROME, MUSCULOCONTRACTURAL TYPE, 2; EDSMC2	0.00811688	1.0822506666666667
ARTERIAL TORTUOSITY SYNDROME	0.008106173999999999	1.0808232
HYPERTELORISM, TEEBI TYPE	0.0080684	1.0757866666666667
EVEN-PLUS SYNDROME	0.008053994	1.0738658666666667
VERVERI-BRADY SYNDROME; VERBRAS	0.008053738	1.0738317333333331
FAMILIAL ADENOMATOUS POLYPOSIS DUE TO 5Q22.2 MICRODELETION	0.008053738	1.0738317333333331
JACOBSEN SYNDROME	0.008039318	1.0719090666666666
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY DUE TO TECPR2 MUTATION	0.008029581	1.0706107999999999
MICROCEPHALY-FACIAL DYSMORPHISM-OCULAR ANOMALIES-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.00800521	1.0673613333333334
COFFIN-SIRIS SYNDROME	0.007993583	1.0658110666666667
TRISOMY 8P	0.007972297	1.0629729333333333
MARDEN-WALKER SYNDROME	0.007972297	1.0629729333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 65; MRT65	0.007956664	1.0608885333333333
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY	0.007956664	1.0608885333333333
PYRUVATE DEHYDROGENASE E1-ALPHA DEFICIENCY; PDHAD	0.007950161	1.0600214666666667
20Q11.2 MICRODUPLICATION SYNDROME	0.007910043	1.0546724
MCDONOUGH SYNDROME	0.00787992	1.050656
TREMOR-ATAXIA-CENTRAL HYPOMYELINATION SYNDROME	0.007863354	1.0484472
LISSENCEPHALY 3; LIS3	0.007849607000000001	1.046614266666667
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, SEIZURES, AND ABSENT LANGUAGE; NDHSAL	0.007839291	1.0452388
6Q16 MICRODELETION SYNDROME	0.007831454	1.0441938666666666
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO FKBP22 DEFICIENCY	0.007816730000000001	1.0422306666666667
SCHWARTZ-JAMPEL SYNDROME, TYPE 1; SJS1	0.007816730000000001	1.0422306666666667
SPONDYLOMETAPHYSEAL DYSPLASIA, SCHMIDT TYPE	0.007816730000000001	1.0422306666666667
MYOPATHIC EHLERS-DANLOS SYNDROME	0.007816730000000001	1.0422306666666667
EHLERS-DANLOS SYNDROME, KYPHOSCOLIOTIC TYPE, 2; EDSKSCL2	0.007816730000000001	1.0422306666666667
SPONDYLOMETAPHYSEAL DYSPLASIA, ALGERIAN TYPE	0.007816730000000001	1.0422306666666667
X-LINKED INTELLECTUAL DISABILITY DUE TO GRIA3 MUTATIONS	0.007813624	1.0418165333333333
FLAT FACE-MICROSTOMIA-EAR ANOMALY SYNDROME	0.0077970900000000004	1.039612
%601499 AXENFELD-RIEGER SYNDROME, TYPE 2; RIEG2;;RIEGER SYNDROME, TYPE 2	0.0077970900000000004	1.039612
FACIAL DYSMORPHISM-SHAWL SCROTUM-JOINT LAXITY SYNDROME	0.0077970900000000004	1.039612
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.0077970900000000004	1.039612
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 3; DRS3	0.0077970900000000004	1.039612
OSSIFICATION ANOMALIES-PSYCHOMOTOR DEVELOPMENTAL DELAY SYNDROME	0.0077922619999999995	1.0389682666666666
AUTOSOMAL DOMINANT PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA	0.007788127000000001	1.0384169333333333
PRIMARY DYSTONIA, DYT4 TYPE	0.00778661	1.0382146666666667
KYPHOSCOLIOSIS-LATERAL TONGUE ATROPHY-HEREDITARY SPASTIC PARAPLEGIA SYNDROME	0.00778661	1.0382146666666667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIE; CDG2E	0.007758747	1.0344996
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 44	0.007758747	1.0344996
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2X; CMT2X	0.00775723	1.0342973333333334
NEURODEVELOPMENTAL DISORDER WITH SPASTIC QUADRIPLEGIA AND BRAIN ABNORMALITIES WITH OR WITHOUT SEIZURES; NEDSBAS	0.00775723	1.0342973333333334
BLEPHAROPHIMOSIS, PTOSIS, AND EPICANTHUS INVERSUS	0.007755420000000001	1.034056
WAARDENBURG SYNDROME TYPE 1	0.007755420000000001	1.034056
8P INVERTED DUPLICATION/DELETION SYNDROME	0.007730069000000001	1.0306758666666667
FRYNS SYNDROME; FRNS	0.007730069000000001	1.0306758666666667
GREIG CEPHALOPOLYSYNDACTYLY SYNDROME	0.007730069000000001	1.0306758666666667
DEVELOPMENTAL DELAY WITH OR WITHOUT DYSMORPHIC FACIES AND AUTISM; DEDDFA	0.0077097910000000006	1.0279721333333334
TAKENOUCHI-KOSAKI SYNDROME; TKS	0.007709790999999999	1.0279721333333331
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 77	0.007679893	1.0239857333333333
ZTTK SYNDROME; ZTTKS	0.007668121	1.0224161333333335
X-LINKED NON-SYNDROMIC INTELLECTUAL DISABILITY	0.007637754	1.0183672
HURLER SYNDROME	0.007637754	1.0183672
HYPERTELORISM, MICROTIA, FACIAL CLEFTING SYNDROME	0.007637754	1.0183672
CLARK-BARAITSER SYNDROME	0.0076336189999999995	1.0178158666666666
ATKIN-FLAITZ SYNDROME	0.0076336189999999995	1.0178158666666666
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA-SPONDYLO-EPIPHYSEAL DYSPLASIA SYNDROME	0.007602289999999999	1.0136386666666666
600123 ATRIOVENTRICULAR SEPTAL DEFECT WITH BLEPHAROPHIMOSIS AND ANAL ANDRADIAL DEFECTS	0.007601674	1.0135565333333334
SEVERE GROWTH DEFICIENCY-STRABISMUS-EXTENSIVE DERMAL MELANOCYTOSIS-INTELLECTUAL DISABILITY SYNDROME	0.007601082	1.0134776
PERIPHERAL DEMYELINATING NEUROPATHY-CENTRAL DYSMYELINATING LEUKODYSTROPHY-WAARDENBURG SYNDROME-HIRSCHSPRUNG DISEASE	0.007597063	1.0129417333333333
BARAITSER-WINTER CEREBROFRONTOFACIAL SYNDROME	0.007597063	1.0129417333333333
SMITH-MAGENIS SYNDROME; SMS	0.007584581	1.0112774666666666
SEPTO-OPTIC DYSPLASIA SPECTRUM	0.007556313	1.0075084
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE III	0.007554458	1.0072610666666668
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY	0.007525889000000001	1.0034518666666667
OROFACIODIGITAL SYNDROME TYPE 14	0.007500644000000001	1.0000858666666668
STAG1-RELATED INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-GASTROESOPHAGEAL REFLUX SYNDROME	0.007465453	0.9953937333333335
48,XXYY SYNDROME	0.007465453	0.9953937333333335
1Q21.1 MICRODUPLICATION SYNDROME	0.007465453	0.9953937333333335
CEREBELLAR-FACIAL-DENTAL SYNDROME	0.007452164000000001	0.9936218666666669
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 7	0.007433623	0.9911497333333333
LISSENCEPHALY, X-LINKED, 2	0.0074046070000000005	0.9872809333333334
SEVERE CANAVAN DISEASE	0.007372142999999999	0.9829524
ELSAHY-WATERS SYNDROME; ESWS	0.007368624000000001	0.9824832
NOONAN SYNDROME WITH MULTIPLE LENTIGINES	0.007368624000000001	0.9824832
ACHONDROPLASIA, SEVERE, WITH DEVELOPMENTAL DELAY AND ACANTHOSIS NIGRICANS; SADDAN	0.007342763	0.9790350666666667
CHIARI MALFORMATION TYPE II	0.007337568000000001	0.9783424000000001
RENPENNING SYNDROME 1; RENS1	0.007322819	0.9763758666666668
ARTHROGRYPOSIS, DISTAL, WITH IMPAIRED PROPRIOCEPTION AND TOUCH; DAIPT	0.0073178819999999995	0.9757176
CONGENITAL CONTRACTURES OF THE LIMBS AND FACE, HYPOTONIA, AND DEVELOPMENTAL DELAY	0.0073178819999999995	0.9757176
LEUKODYSTROPHY, HYPOMYELINATING, 8, WITH OR WITHOUT OLIGODONTIA AND/OR HYPOGONADOTROPIC HYPOGONADISM	0.007317799999999999	0.9757066666666666
OSTEOPATHIA STRIATA WITH CRANIAL SCLEROSIS	0.007313747000000001	0.9751662666666667
DOWN SYNDROME	0.0072859	0.9714533333333333
SHORT STATURE, OPTIC NERVE ATROPHY, AND PELGER-HUET ANOMALY; SOPH	0.0072859	0.9714533333333333
WARBURG MICRO SYNDROME 2; WARBM2	0.00726807	0.9690759999999999
3-HYDROXYISOBUTYRYL-COA HYDROLASE DEFICIENCY	0.007230851	0.9641134666666668
NOONAN SYNDROME 6; NS6	0.007227872	0.9637162666666665
CEREBROFACIOTHORACIC DYSPLASIA	0.007226399999999999	0.9635199999999998
CRANIOFACIAL DYSMORPHISM, SKELETAL ANOMALIES, AND MENTAL RETARDATION SYNDROME	0.007226399999999999	0.9635199999999998
11Q22.2Q22.3 MICRODELETION SYNDROME	0.007211083	0.9614777333333333
TONNE-KALSCHEUER SYNDROME; TOKAS	0.007197752	0.9597002666666666
X-LINKED INTELLECTUAL DISABILITY, ARMFIELD TYPE	0.007190733	0.9587644000000001
3Q13 MICRODELETION SYNDROME	0.00718865	0.9584866666666667
LAMB-SHAFFER SYNDROME	0.007186202000000001	0.9581602666666668
MENTAL RETARDATION, AUTOSOMAL DOMINANT 47; MRD47	0.007181660999999999	0.9575547999999998
ARTHROGRYPOSIS, DISTAL, TYPE 3; DA3	0.007180144	0.9573525333333335
TALL STATURE-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.0071760090000000006	0.9568012000000001
CONGENITAL DISORDER OF GLYCOSYLATION WITH DEFECTIVE FUCOSYLATION 2; CDGF2	0.007139991	0.9519988
INCONTINENTIA PIGMENTI; IP	0.007134339	0.9512451999999999
ATKIN-FLAITZ SYNDROME	0.0070922	0.9456266666666666
INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM-HAND ANOMALIES SYNDROME	0.0070922	0.9456266666666666
SIX2-RELATED FRONTONASAL DYSPLASIA	0.0070922	0.9456266666666666
MULTIPLE EPIPHYSEAL DYSPLASIA WITH ROBIN PHENOTYPE	0.0070922	0.9456266666666666
9Q31.1Q31.3 MICRODELETION SYNDROME	0.0070922	0.9456266666666666
MULTIPLE EPIPHYSEAL DYSPLASIA, LOWRY TYPE	0.0070922	0.9456266666666666
AUTOSOMAL RECESSIVE DISTAL OSTEOLYSIS SYNDROME	0.0070922	0.9456266666666666
X-LINKED INTELLECTUAL DISABILITY, STOLL TYPE	0.0070922	0.9456266666666666
BREASTS AND/OR NIPPLES, APLASIA OR HYPOPLASIA OF, 2; BNAH2	0.0070922	0.9456266666666666
SPONDYLOCARPOTARSAL SYNOSTOSIS SYNDROME; SCT	0.0070922	0.9456266666666666
HYPOHIDROSIS-ENAMEL HYPOPLASIA-PALMOPLANTAR KERATODERMA-INTELLECTUAL DISABILITY SYNDROME	0.0070922	0.9456266666666666
259610 OSTEOLYSIS SYNDROME, RECESSIVE;;OSTEOLYSIS, DISTAL, WITH SHORT STATURE, MENTAL RETARDATION, AND CHARACTERISTICFACIAL APPEARANCE	0.0070922	0.9456266666666666
FRANK-TER HAAR SYNDROME; FTHS	0.0070922	0.9456266666666666
SIDERIUS X-LINKED MENTAL RETARDATION SYNDROME; MRXSSD	0.0070922	0.9456266666666666
MELANOCYTIC NEVUS SYNDROME, CONGENITAL; CMNS	0.0070922	0.9456266666666666
AUTOSOMAL RECESSIVE MULTIPLE PTERYGIUM SYNDROME	0.0070777800000000005	0.9437040000000001
OROFACIODIGITAL SYNDROME TYPE 2	0.007055644000000001	0.9407525333333335
OPITZ G/BBB SYNDROME	0.007055644000000001	0.9407525333333335
MUCOPOLYSACCHARIDOSIS-PLUS SYNDROME; MPSPS	0.007055644000000001	0.9407525333333335
SCHUURS-HOEIJMAKERS SYNDROME; SHMS	0.007049981	0.9399974666666666
ALOPECIA-CONTRACTURES-DWARFISM MENTAL RETARDATION SYNDROME	0.00701459	0.9352786666666666
MESOMELIA-SYNOSTOSES SYNDROME	0.00701459	0.9352786666666666
ACROCRANIOFACIAL DYSOSTOSIS	0.00701459	0.9352786666666666
KOOLEN-DE VRIES SYNDROME; KDVS	0.006990481	0.9320641333333333
FANCONI ANEMIA, COMPLEMENTATION GROUP I; FANCI	0.006951704	0.9268938666666667
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 1; CSCSC1	0.006942607999999999	0.9256810666666665
PRIMROSE SYNDROME; PRIMS	0.006942607999999999	0.9256810666666665
CHARGE SYNDROME	0.006924034	0.9232045333333333
OCULOCEREBRORENAL SYNDROME OF LOWE	0.006919899	0.9226532000000001
KBG SYNDROME	0.006919423	0.9225897333333334
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND SPASTICITY; PEBAS	0.006917449000000001	0.9223265333333335
ALEXANDER DISEASE	0.006917449000000001	0.9223265333333335
TBCK-RELATED INTELLECTUAL DISABILITY SYNDROME	0.0069066100000000005	0.9208813333333334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 62; EIEE62	0.0068971710000000006	0.9196228000000001
NEURODEVELOPMENTAL DISORDER WITH INVOLUNTARY MOVEMENTS; NEDIM	0.0068971710000000006	0.9196228000000001
PARTIAL TRISOMY/TETRASOMY OF THE SHORT ARM OF CHROMOSOME 9	0.006892204	0.9189605333333333
MICROCEPHALY 5, PRIMARY, AUTOSOMAL RECESSIVE	0.006888069	0.9184091999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 31; MRD31	0.006877753	0.9170337333333334
ADENYLOSUCCINASE DEFICIENCY	0.006865271000000001	0.9153694666666669
CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG	0.006865271000000001	0.9153694666666669
FACIAL DYSMORPHISM WITH MULTIPLE MALFORMATIONS	0.006863188000000001	0.9150917333333335
RING CHROMOSOME 13 SYNDROME	0.006863188000000001	0.9150917333333335
FAMILIAL DYSAUTONOMIA	0.006856708999999999	0.9142278666666664
MEVALONIC ACIDURIA; MEVA	0.006854682000000001	0.9139576000000001
YOU-HOOVER-FONG SYNDROME; YHFS	0.006854682000000001	0.9139576000000001
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 2; EDSSPD2	0.006854682000000001	0.9139576000000001
MUSCULAR DYSTROPHY, CONGENITAL MEROSIN-DEFICIENT, 1A; MDC1A	0.006850547	0.9134062666666667
OCCIPITAL HORN SYNDROME	0.006830724	0.9107631999999999
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, CATARACTS, AND RENAL ABNORMALITIES; NEDMCR	0.006826589	0.9102118666666668
PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.006826589	0.9102118666666668
ROBERTS SYNDROME; RBS	0.0068230700000000005	0.9097426666666667
ACRODYSOSTOSIS	0.0068230700000000005	0.9097426666666667
SLC35A2-CDG	0.006801343999999999	0.9068458666666666
17P11.2 MICRODUPLICATION SYNDROME	0.006801343999999999	0.9068458666666666
RETT SYNDROME, CONGENITAL VARIANT	0.006797209	0.9062945333333334
INTELLECTUAL DISABILITY-HYPOPLASTIC CORPUS CALLOSUM-PREAURICULAR TAG SYNDROME	0.006797209	0.9062945333333334
NEUROPATHY, CONGENITAL HYPOMYELINATING, 3; CHN3	0.006797209	0.9062945333333334
157980 MOMO SYNDROME;;MACROSOMIA, OBESITY, MACROCEPHALY, AND OCULAR ABNORMALITIES	0.0067814	0.9041866666666667
BRACHYMORPHISM-ONYCHODYSPLASIA-DYSPHALANGISM SYNDROME	0.0067814	0.9041866666666667
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IC; ARCL1C	0.006772327999999999	0.9029770666666666
PONTOCEREBELLAR HYPOPLASIA TYPE 7	0.006748252999999999	0.8997670666666666
MENTAL RETARDATION, X-LINKED 104; MRX104	0.006706583	0.8942110666666667
MATERNAL PHENYLKETONURIA	0.006706583	0.8942110666666667
CRANIOSYNOSTOSIS-FIBULAR APLASIA SYNDROME	0.006645179	0.8860238666666668
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLJ TYPE	0.006640242	0.8853656
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 54	0.006639544	0.8852725333333333
CONGENITAL FIBER-TYPE DISPROPORTION MYOPATHY	0.00663459	0.8846120000000001
CARPENTER SYNDROME	0.00663459	0.8846120000000001
VAN MALDERGEM SYNDROME 2; VMLDS2	0.006622817999999999	0.8830423999999998
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IR	0.0065985720000000005	0.8798096
MENTAL RETARDATION, AUTOSOMAL DOMINANT 40; MRD40	0.0065985720000000005	0.8798096
INTELLECTUAL DEVELOPMENTAL DISORDER WITH GASTROINTESTINAL DIFFICULTIES AND HIGH PAIN THRESHOLD	0.0065985720000000005	0.8798096
MENTAL RETARDATION, AUTOSOMAL DOMINANT 54; MRD54	0.006594437	0.8792582666666666
MELNICK-NEEDLES SYNDROME	0.00659292	0.8790560000000001
AUTISM SPECTRUM DISORDER DUE TO AUTS2 DEFICIENCY	0.0065454810000000006	0.8727308000000001
C SYNDROME	0.0065454810000000006	0.8727308000000001
KABUKI SYNDROME 1	0.0065454810000000006	0.8727308000000001
CHROMOSOME 10Q26 DELETION SYNDROME	0.0065454810000000006	0.8727308000000001
LYMPHEDEMA-HYPOPARATHYROIDISM SYNDROME	0.0065100900000000005	0.8680120000000001
SIMOSA CRANIOFACIAL SYNDROME	0.0065100900000000005	0.8680120000000001
TRISOMY 18P	0.0065100900000000005	0.8680120000000001
ALAR CARTILAGES HYPOPLASIA-COLOBOMA-TELECANTHUS SYNDROME	0.0065100900000000005	0.8680120000000001
DAHLBERG-BORER-NEWCOMER SYNDROME	0.0065100900000000005	0.8680120000000001
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME; NPLCS	0.0065100900000000005	0.8680120000000001
BARBER-SAY SYNDROME	0.0065100900000000005	0.8680120000000001
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0065100900000000005	0.8680120000000001
DEAFNESS, X-LINKED 7; DFNX7	0.0065100900000000005	0.8680120000000001
WAARDENBURG SYNDROME, TYPE 1; WS1	0.0065100900000000005	0.8680120000000001
METAPHYSEAL ACROSCYPHODYSPLASIA	0.0065100900000000005	0.8680120000000001
CRANIOMETAPHYSEAL DYSPLASIA	0.0065100900000000005	0.8680120000000001
WAARDENBURG-SHAH SYNDROME	0.0065100900000000005	0.8680120000000001
AXENFELD-RIEGER SYNDROME	0.0065100900000000005	0.8680120000000001
CYSTIC FIBROSIS-GASTRITIS-MEGALOBLASTIC ANEMIA SYNDROME	0.0065100900000000005	0.8680120000000001
WAARDENBURG SYNDROME	0.0065100900000000005	0.8680120000000001
SHORT SYNDROME	0.0065100900000000005	0.8680120000000001
TRISOMY 18-LIKE SYNDROME	0.0065100900000000005	0.8680120000000001
RING CHROMOSOME 1 SYNDROME	0.0065100900000000005	0.8680120000000001
HYPOGLOSSIA-HYPODACTYLY SYNDROME	0.0065100900000000005	0.8680120000000001
MULTICENTRIC CARPO-TARSAL OSTEOLYSIS WITH OR WITHOUT NEPHROPATHY	0.0065100900000000005	0.8680120000000001
CYSTIC FIBROSIS WITH HELICOBACTER PYLORI GASTRITIS, MEGALOBLASTIC ANEMIA, AND MENTAL RETARDATION	0.0065100900000000005	0.8680120000000001
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 15; GPIBD15	0.006482290999999999	0.8643054666666665
TOWNES-BROCKS SYNDROME	0.0064693400000000005	0.8625786666666668
CRANIOSYNOSTOSIS-MENTAL RETARDATION SYNDROME OF LIN AND GETTIG	0.0064693400000000005	0.8625786666666668
MICROPHTHALMIA WITH LINEAR SKIN DEFECTS SYNDROME	0.006447204000000001	0.8596272
X-LINKED INTELLECTUAL DISABILITY-CARDIOMEGALY-CONGESTIVE HEART FAILURE SYNDROME	0.006434563000000001	0.8579417333333333
HYPEREKPLEXIA 4; HKPX4	0.006434563000000001	0.8579417333333333
PONTOCEREBELLAR HYPOPLASIA, TYPE 7; PCH7	0.006422790999999999	0.8563721333333332
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 9; MDDGA9	0.006385871999999999	0.8514495999999998
MEIER-GORLIN SYNDROME 6; MGORS6	0.00637848	0.8504639999999999
COSTELLO SYNDROME	0.00637848	0.8504639999999999
MEIER-GORLIN SYNDROME 1; MGORS1	0.00637848	0.8504639999999999
ENDOCARDIAL FIBROELASTOSIS	0.006373869000000001	0.8498492000000002
3C SYNDROME	0.006356344	0.8475125333333333
FETAL ALCOHOL SYNDROME	0.006336334000000001	0.8448445333333334
GOMEZ-LOPEZ-HERNANDEZ SYNDROME; GLHS	0.006319717000000001	0.8426289333333334
MENTAL RETARDATION, X-LINKED 1	0.006319716999999999	0.8426289333333331
WALKER-WARBURG SYNDROME	0.006310983000000001	0.8414644000000001
X-LINKED LISSENCEPHALY WITH ABNORMAL GENITALIA	0.006310983000000001	0.8414644000000001
CAMPOMELIC DYSPLASIA	0.006309128000000001	0.8412170666666668
OSTEOGENESIS IMPERFECTA, TYPE XIII	0.006309128000000001	0.8412170666666668
NEMALINE MYOPATHY 4	0.006309128000000001	0.8412170666666668
HYPERTROPHIC NEUROPATHY OF DEJERINE-SOTTAS	0.006309128000000001	0.8412170666666668
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.006309128000000001	0.8412170666666668
LIMITED CUTANEOUS SYSTEMIC SCLEROSIS	0.00628517	0.8380226666666666
DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS	0.00628517	0.8380226666666666
EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS	0.00628517	0.8380226666666666
CARCINOMA OF ESOPHAGUS	0.00628517	0.8380226666666666
PALMOPLANTAR KERATODERMA-ESOPHAGEAL CARCINOMA SYNDROME	0.00628517	0.8380226666666666
CHRONIC GRAFT VERSUS HOST DISEASE	0.00628517	0.8380226666666666
FAMILIAL INFANTILE BILATERAL STRIATAL NECROSIS	0.00628517	0.8380226666666666
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-HEARING LOSS-PONS HYPOPLASIA-BRAIN ATROPHY SYNDROME	0.00628517	0.8380226666666666
REYNOLDS SYNDROME	0.00628517	0.8380226666666666
EOSINOPHILIC ESOPHAGITIS	0.00628517	0.8380226666666666
ESOPHAGEAL ATRESIA	0.00628517	0.8380226666666666
LAMININ SUBUNIT ALPHA 2-RELATED CONGENITAL MUSCULAR DYSTROPHY	0.00628517	0.8380226666666666
PHACE SYNDROME	0.006269313	0.8359084000000001
JOUBERT SYNDROME WITH RENAL DEFECT	0.006269313	0.8359084000000001
JOUBERT SYNDROME WITH OCULAR DEFECT	0.006269313	0.8359084000000001
FACIAL DYSMORPHISM-MACROCEPHALY-MYOPIA-DANDY-WALKER MALFORMATION SYNDROME	0.0062621989999999995	0.8349598666666667
X-LINKED INTELLECTUAL DISABILITY, NAJM TYPE	0.006220529000000001	0.8294038666666668
SEIZURES-SCOLIOSIS-MACROCEPHALY SYNDROME	0.006220123	0.8293497333333334
MIRAGE SYNDROME; MIRAGE	0.006220123	0.8293497333333334
PALATAL ANOMALIES-WIDELY SPACED TEETH-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.006206834	0.8275778666666666
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.006185548000000001	0.8247397333333335
PSEUDOTRISOMY 13 SYNDROME	0.006185548000000001	0.8247397333333335
CEREBELLAR ATAXIA, NONPROGRESSIVE, WITH MENTAL RETARDATION; CANPMR	0.006178453	0.8237937333333334
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY	0.006178453	0.8237937333333334
STOCCO DOS SANTOS X-LINKED MENTAL RETARDATION SYNDROME; SDSX	0.006178453	0.8237937333333334
INSULIN-LIKE GROWTH FACTOR I, RESISTANCE TO; IGF1RES	0.006165164000000001	0.8220218666666668
LAURENCE-MOON SYNDROME	0.00610376	0.8138346666666666
ALAGILLE SYNDROME	0.00610376	0.8138346666666666
CONGENITAL MUSCULAR DYSTROPHY-RESPIRATORY FAILURE-SKIN ABNORMALITIES-JOINT HYPERLAXITY SYNDROME	0.006094687999999999	0.8126250666666666
FATTY ACID HYDROXYLASE-ASSOCIATED NEURODEGENERATION	0.0060939900000000005	0.812532
COHEN SYNDROME	0.006088443000000001	0.8117924000000001
OSTEOPATHIA STRIATA-CRANIAL SCLEROSIS SYNDROME	0.006081624000000001	0.8108832000000001
ACROFRONTOFACIONASAL DYSOSTOSIS 1	0.006077489	0.8103318666666667
AYME-GRIPP SYNDROME; AYGRP	0.006077489	0.8103318666666667
PITT-HOPKINS-LIKE SYNDROME 2; PTHSL2	0.006053018	0.8070690666666667
CAMPTODACTYLY SYNDROME, GUADALAJARA, TYPE III	0.006052542000000001	0.8070056000000001
JOUBERT SYNDROME 35; JBTS35	0.006052542000000001	0.8070056000000001
BLEPHAROPHIMOSIS WITH FACIAL AND GENITAL ANOMALIES AND MENTAL RETARDATION	0.0060484070000000004	0.8064542666666668
COFFIN-LOWRY SYNDROME; CLS	0.0060484070000000004	0.8064542666666668
OSTEOPENIA-MYOPIA-HEARING LOSS-INTELLECTUAL DISABILITY-FACIAL DYSMORPHISM SYNDROME	0.00604057	0.8054093333333333
HUNTER-MACDONALD SYNDROME	0.00604057	0.8054093333333333
SHORT STATURE-BRACHYDACTYLY-OBESITY-GLOBAL DEVELOPMENTAL DELAY SYNDROME	0.006028943	0.8038590666666666
PERIVENTRICULAR NODULAR HETEROTOPIA 7; PVNH7	0.006028943	0.8038590666666666
CONGENITAL ANOMALIES OF KIDNEY AND URINARY TRACT SYNDROME WITH OR WITHOUT HEARING LOSS, ABNORMAL EARS, OR DEVELOPMENTAL DELAY; CAKUTHED	0.006004062000000001	0.8005416000000001
LOPES-MACIEL-RODAN SYNDROME; LOMARS	0.005995133	0.7993510666666667
RING CHROMOSOME 22 SYNDROME	0.005985521000000001	0.7980694666666668
MENTAL RETARDATION, AUTOSOMAL DOMINANT 22; MRD22	0.005985521000000001	0.7980694666666668
BRAIN ABNORMALITIES, NEURODEGENERATION, AND DYSOSTEOSCLEROSIS; BANDDOS	0.005985521000000001	0.7980694666666668
VICI SYNDROME; VICIS	0.005985521000000001	0.7980694666666668
CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME, X-LINKED	0.005985521000000001	0.7980694666666668
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 16; MC1DN16	0.005985521000000001	0.7980694666666668
HOLOPROSENCEPHALY 1; HPE1	0.005985521000000001	0.7980694666666668
HOLOPROSENCEPHALY 2; HPE2	0.005985521000000001	0.7980694666666668
CEREBROOCULONASAL SYNDROME	0.00598107	0.797476
CHROMOSOME 9P DELETION SYNDROME	0.005940872	0.7921162666666667
COHEN-GIBSON SYNDROME; COGIS	0.005940872	0.7921162666666667
ZIMMERMANN-LABAND SYNDROME 1	0.005936736999999999	0.7915649333333332
CHILDHOOD-ONSET MOTOR AND COGNITIVE REGRESSION SYNDROME WITH EXTRAPYRAMIDAL MOVEMENT DISORDER	0.005935632999999999	0.7914177333333333
LEUKODYSTROPHY, HYPOMYELINATING, 15; HLD15	0.005935632999999999	0.7914177333333333
NEURODEGENERATION, CHILDHOOD-ONSET, WITH BRAIN ATROPHY; CONDBA	0.005935632999999999	0.7914177333333333
19P13.13 MICRODELETION SYNDROME	0.005903733	0.7871644000000001
CLOVERLEAF SKULL-MULTIPLE CONGENITAL ANOMALIES SYNDROME	0.0059016500000000005	0.7868866666666666
MOSAIC TRISOMY 1	0.0059016500000000005	0.7868866666666666
FRONTONASAL DYSPLASIA-SEVERE MICROPHTHALMIA-SEVERE FACIAL CLEFTING SYNDROME	0.0059016500000000005	0.7868866666666666
FRONTONASAL DYSPLASIA-BIFID NOSE-UPPER LIMB ANOMALIES SYNDROME	0.0059016500000000005	0.7868866666666666
STROMME SYNDROME; STROMS	0.0059016500000000005	0.7868866666666666
MECKEL SYNDROME 12; MKS12	0.0059016500000000005	0.7868866666666666
OROFACIODIGITAL SYNDROME XV; OFD15	0.0059016500000000005	0.7868866666666666
INTELLECTUAL DEVELOPMENTAL DISORDER WITH MACROCEPHALY, SEIZURES, AND SPEECH DELAY; IDDMSSD	0.005894661000000001	0.7859548000000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 9; IIAE9	0.005894661000000001	0.7859548000000001
MULTIPLE CONGENITAL ANOMALIES-HYPOTONIA-SEIZURES SYNDROME 1; MCAHS1	0.005894661000000001	0.7859548000000001
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 4; PEOA4	0.005894661000000001	0.7859548000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, BAIN TYPE; MRXSB	0.005894661000000001	0.7859548000000001
CEREBROOCULOFACIOSKELETAL SYNDROME 2; COFS2	0.005893144	0.7857525333333334
MEGALENCEPHALY-SEVERE KYPHOSCOLIOSIS-OVERGROWTH SYNDROME	0.005893144	0.7857525333333334
CONGENITAL CATARACTS, FACIAL DYSMORPHISM, AND NEUROPATHY; CCFDN	0.005893144	0.7857525333333334
GALLOWAY-MOWAT SYNDROME 7; GAMOS7	0.005893144	0.7857525333333334
SECKEL SYNDROME 8; SCKL8	0.005893144	0.7857525333333334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 9B	0.005893144	0.7857525333333334
SHORT STATURE, AMELOGENESIS IMPERFECTA, AND SKELETAL DYSPLASIA WITH SCOLIOSIS; SSASKS	0.005893144	0.7857525333333334
CRISPONI/COLD-INDUCED SWEATING SYNDROME 1; CISS1	0.005889009000000001	0.7852012
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 23	0.005889009000000001	0.7852012
SCHIMMELPENNING-FEUERSTEIN-MIMS SYNDROME; SFM	0.005889009000000001	0.7852012
PATTERSON PSEUDOLEPRECHAUNISM SYNDROME	0.005889009000000001	0.7852012
TELO2-RELATED INTELLECTUAL DISABILITY-NEURODEVELOPMENTAL DISORDER	0.005889009000000001	0.7852012
X-LINKED INTELLECTUAL DISABILITY-PSYCHOSIS-MACROORCHIDISM SYNDROME	0.005889009000000001	0.7852012
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IID; ARCL2D	0.005877237	0.7836316000000001
GLUTAMINE DEFICIENCY, CONGENITAL	0.005877237	0.7836316000000001
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 7; NBIA7	0.005810198	0.7746930666666666
TETRASOMY 9P	0.005804650999999999	0.7739534666666665
ANIRIDIA-RENAL AGENESIS-PSYCHOMOTOR RETARDATION SYNDROME	0.005790780000000001	0.7721040000000001
CHONDRODYSPLASIA-DISORDER OF SEX DEVELOPMENT SYNDROME	0.005790780000000001	0.7721040000000001
LAMBOTTE SYNDROME	0.005790780000000001	0.7721040000000001
TETRASOMY 12P	0.005790780000000001	0.7721040000000001
BENCZE SYNDROME	0.005790780000000001	0.7721040000000001
HARTSFIELD SYNDROME; HRTFDS	0.0057695640000000005	0.7692752
ANOPHTHALMIA/MICROPHTHALMIA-ESOPHAGEAL ATRESIA SYNDROME	0.0057695640000000005	0.7692752
LENZ-MAJEWSKI HYPEROSTOTIC DWARFISM	0.0057695640000000005	0.7692752
YUNIS-VARON SYNDROME	0.0057695640000000005	0.7692752
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE I	0.005765429000000001	0.7687238666666668
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 18; LGMDR18	0.005762981	0.7683974666666666
MENTAL RETARDATION, AUTOSOMAL DOMINANT 35; MRD35	0.005762981	0.7683974666666666
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 5; MC1DN5	0.0057328610000000006	0.7643814666666667
SEVERE INTELLECTUAL DISABILITY-CORPUS CALLOSUM AGENESIS-FACIAL DYSMORPHISM-CEREBELLAR ATAXIA SYNDROME	0.005727894000000001	0.7637192000000002
4Q21 MICRODELETION SYNDROME	0.005723759	0.7631678666666667
CORPUS CALLOSUM AGENESIS-ABNORMAL GENITALIA SYNDROME	0.005723759	0.7631678666666667
HYDROCEPHALUS WITH STENOSIS OF THE AQUEDUCT OF SYLVIUS	0.005723759	0.7631678666666667
21Q22.11Q22.12 MICRODELETION SYNDROME	0.005723759	0.7631678666666667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IY; CDG1Y	0.005703481	0.7604641333333333
NKX6-2-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.005703481	0.7604641333333333
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND BRAIN ATROPHY; NEDMEBA	0.005703481	0.7604641333333333
BASEL-VANAGAITE-SMIRIN-YOSEF SYNDROME; BVSYS	0.005703481	0.7604641333333333
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL RECESSIVE; NDHMSR	0.005703481	0.7604641333333333
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT VARIABLE BRAIN ABNORMALITIES; NEDBA	0.005703481	0.7604641333333333
PSYCHOMOTOR RETARDATION, EPILEPSY, AND CRANIOFACIAL DYSMORPHISM	0.005703481	0.7604641333333333
GALLOWAY-MOWAT SYNDROME 3; GAMOS3	0.005703481	0.7604641333333333
SKRABAN-DEARDORFF SYNDROME; SKDEAS	0.005703481	0.7604641333333333
HYDROCEPHALUS-COSTOVERTEBRAL DYSPLASIA-SPRENGEL ANOMALY SYNDROME	0.00567911	0.7572146666666667
MENTAL RETARDATION, BUENOS AIRES TYPE	0.00567911	0.7572146666666667
CHOPS SYNDROME; CHOPS	0.005678704	0.7571605333333332
TOWNES-BROCKS SYNDROME 1; TBS1	0.005678704	0.7571605333333332
INTELLECTUAL DISABILITY-CRANIOFACIAL DYSMORPHISM-CRYPTORCHIDISM SYNDROME	0.005678704	0.7571605333333332
X-LINKED MICROCEPHALY-GROWTH RETARDATION-PROGNATHISM-CRYPTORCHIDISM SYNDROME	0.005674569	0.7566092
MILLER-DIEKER LISSENCEPHALY SYNDROME; MDLS	0.0056612799999999994	0.7548373333333332
2Q23.1 MICRODUPLICATION SYNDROME	0.005637034	0.7516045333333333
16P11.2P12.2 MICRODELETION SYNDROME	0.005637034	0.7516045333333333
BAKER-GORDON SYNDROME; BAGOS	0.005637034	0.7516045333333333
FRAGILE X SYNDROME	0.005632899	0.7510532000000001
HADDAD SYNDROME	0.005632899	0.7510532000000001
MANDIBULOFACIAL DYSOSTOSIS, GUION-ALMEIDA TYPE; MFDGA	0.005632423	0.7509897333333334
CHROMOSOME 6PTER-P24 DELETION SYNDROME	0.005619941	0.7493254666666667
NEUROLOGIC, ENDOCRINE, AND PANCREATIC DISEASE, MULTISYSTEM, INFANTILE-ONSET; IMNEPD	0.005619941	0.7493254666666667
CRANIOFACIAL DYSSYNOSTOSIS	0.005619610000000001	0.7492813333333335
8P23.1 MICRODELETION SYNDROME	0.005583943	0.7445257333333334
MEIER-GORLIN SYNDROME 7	0.005547024	0.7396032
SPONDYLODYSPLASTIC EHLERS-DANLOS SYNDROME	0.005547024	0.7396032
HIRSUTISM, SKELETAL DYSPLASIA, AND MENTAL RETARDATION	0.005536070000000001	0.7381426666666667
HUMERORADIAL SYNOSTOSISHUMERORADIAL/MULTIPLE SYNOSTOSIS SYNDROME	0.005536070000000001	0.7381426666666667
HYPERTELORISM-HYPOSPADIAS-POLYSYNDACTYLY SYNDROME	0.005536070000000001	0.7381426666666667
MEGALOCORNEA-INTELLECTUAL DISABILITY SYNDROME	0.005520753	0.7361004
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION; IHPMR	0.005487524000000001	0.7316698666666667
SPASTIC PARAPLEGIA 47, AUTOSOMAL RECESSIVE; SPG47	0.005461252999999999	0.7281670666666666
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM TYPE II	0.005461252999999999	0.7281670666666666
MACROTHROMBOCYTOPENIA-LYMPHEDEMA-DEVELOPMENTAL DELAY-FACIAL DYSMORPHISM-CAMPTODACTYLY SYNDROME	0.005461252999999999	0.7281670666666666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 75; EIEE75	0.005461252999999999	0.7281670666666666
FUMARASE DEFICIENCY; FMRD	0.005444102000000001	0.7258802666666668
GAZE PALSY, FAMILIAL HORIZONTAL, WITH PROGRESSIVE SCOLIOSIS 2, WITH IMPAIRED INTELLECTUAL DEVELOPMENT; HGPPS2	0.005444102	0.7258802666666667
X-LINKED NEURODEGENERATIVE SYNDROME, BERTINI TYPE	0.005444102	0.7258802666666667
GLYCINE ENCEPHALOPATHY; GCE	0.005439967	0.7253289333333334
DIHYDROPYRIMIDINE DEHYDROGENASE DEFICIENCY	0.005439967	0.7253289333333334
LINEAR SKIN DEFECTS WITH MULTIPLE CONGENITAL ANOMALIES 2; LSDMCA2	0.005424333999999999	0.7232445333333333
LEUKODYSTROPHY, HYPOMYELINATING, 11; HLD11	0.005424333999999999	0.7232445333333333
SPASTIC PARAPLEGIA-SEVERE DEVELOPMENTAL DELAY-EPILEPSY SYNDROME	0.005424333999999999	0.7232445333333333
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 1; MDDGB1	0.005424333999999999	0.7232445333333333
CREE MENTAL RETARDATION SYNDROME	0.0054039840000000006	0.7205312000000001
%600325 AMINOPTERIN SYNDROME SINE AMINOPTERIN; ASSA;;PSEUDOAMINOPTERIN SYNDROME	0.0054039840000000006	0.7205312000000001
2Q23.1 MICRODELETION SYNDROME	0.005399849	0.7199798666666667
SMITH-FINEMAN-MYERS SYNDROME	0.005399849	0.7199798666666667
CRANIOSYNOSTOSIS-HYDROCEPHALUS-ARNOLD-CHIARI MALFORMATION TYPE I-RADIOULNAR SYNOSTOSIS SYNDROME	0.005399849	0.7199798666666667
GLYCINE ENCEPHALOPATHY WITH NORMAL SERUM GLYCINE	0.005394214	0.7192285333333333
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 27	0.005394214	0.7192285333333333
NEURODEVELOPMENTAL DISORDER WITH PROGRESSIVE MICROCEPHALY, SPASTICITY, AND BRAIN ANOMALIES; NDMSBA	0.005394214	0.7192285333333333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 21	0.005394214	0.7192285333333333
MICROBRACHYCEPHALY-PTOSIS-CLEFT LIP SYNDROME	0.005362314	0.7149751999999999
MENTAL RETARDATION, AUTOSOMAL DOMINANT 26	0.005362314	0.7149751999999999
2Q32Q33 MICRODELETION SYNDROME	0.005362314	0.7149751999999999
FETAL TRIMETHADIONE SYNDROME	0.005362314	0.7149751999999999
MOMO SYNDROME	0.005358179	0.7144238666666667
CHIME SYNDROME	0.005358179	0.7144238666666667
CROUZON SYNDROME	0.005358179	0.7144238666666667
ANGELMAN SYNDROME	0.005358178999999999	0.7144238666666666
RAJAB INTERSTITIAL LUNG DISEASE WITH BRAIN CALCIFICATIONS; RILDBC	0.0053491070000000005	0.7132142666666668
MYOTONIA WITH SKELETAL ABNORMALITIES AND MENTAL RETARDATION	0.00534759	0.713012
EPISODIC ATAXIA TYPE 1	0.00534759	0.713012
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, SPONASTRIME TYPE; SEMDSP	0.00534759	0.713012
SPONDYLOEPIPHYSEAL DYSPLASIA WITH CONGENITAL JOINT DISLOCATIONS	0.00534759	0.713012
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1B; CMT1B	0.00534759	0.713012
CHARCOT-MARIE-TOOTH DISEASE, DEMYELINATING, TYPE 1A	0.00534759	0.713012
HYDROCEPHALUS, TALL STATURE, JOINT LAXITY, AND KYPHOSCOLIOSIS	0.00534759	0.713012
SPINAL MUSCULAR ATROPHY, RYUKYUAN TYPE	0.00534759	0.713012
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B2; CMT4B2	0.00534759	0.713012
ROUSSY-LEVY HEREDITARY AREFLEXIC DYSTASIA	0.00534759	0.713012
PROTEUS SYNDROME	0.00534759	0.713012
MICROCEPHALY-BRACHYDACTYLY-KYPHOSCOLIOSIS SYNDROME	0.00534759	0.713012
3Q27.3 MICRODELETION SYNDROME	0.00534759	0.713012
SPONDYLOEPIPHYSEAL DYSPLASIA, STANESCU TYPE	0.00534759	0.713012
GERODERMA OSTEODYSPLASTICUM; GO	0.00534759	0.713012
CHARCOT-MARIE-TOOTH DISEASE TYPE 1A	0.00534759	0.713012
ANE SYNDROME	0.00534759	0.713012
%600384 APHALANGIA, PARTIAL, WITH SYNDACTYLY AND DUPLICATION OF METATARSALIV	0.00534759	0.713012
CENTRAL CORE DISEASE	0.00534759	0.713012
PARKINSON-DEMENTIA SYNDROMESUPRANUCLEAR PALSY, PROGRESSIVE ATYPICAL, INCLUDED	0.00534759	0.713012
CHST3-RELATED SKELETAL DYSPLASIA	0.00534759	0.713012
264475 PSEUDOPAPILLEDEMA, OCULAR HYPOTELORISM, BLEPHAROPHIMOSIS, AND HANDANOMALIES;;ACROOTOOCULAR SYNDROME;;AOO SYNDROME	0.00534759	0.713012
263540 POLYDACTYLY, POSTAXIAL, WITH DENTAL AND VERTEBRAL ANOMALIES	0.00534759	0.713012
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4K; CMT4K	0.00534759	0.713012
ICHTHYOSIS--CHEEK--EYEBROW SYNDROME	0.00534759	0.713012
%271630 BRACHYOLMIA TYPE 1, TOLEDO TYPE;;SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, TOLEDO TYPE;;SED, CHONDROITIN SULFATE TYPE;;PAPS-CHONDROITIN SULFATE SULFOTRANSFERASE DEFICIENCY	0.00534759	0.713012
CERVICAL HYPERTRICHOSIS WITH UNDERLYING KYPHOSCOLIOSIS	0.00534759	0.713012
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2B1; CMT2B1	0.00534759	0.713012
DYSSPONDYLOENCHONDROMATOSIS	0.00534759	0.713012
ATAXIA-OCULOMOTOR APRAXIA TYPE 4	0.00534759	0.713012
ARTHROPATHY, PROGRESSIVE PSEUDORHEUMATOID, OF CHILDHOOD	0.00534759	0.713012
NEUROFIBROMA	0.00534759	0.713012
SPONDYLOENCHONDRODYSPLASIA WITH IMMUNE DYSREGULATION; SPENCDI	0.00534759	0.713012
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2K; CMT2K	0.00534759	0.713012
212540 CATARACT, MICROCEPHALY, FAILURE TO THRIVE, KYPHOSCOLIOSIS SYNDROME;;CAMFAK SYNDROMECATARACT, MICROCEPHALY, ARTHROGRYPOSIS, KYPHOSIS SYNDROME, INCLUDED;;CAMAK SYNDROME, INCLUDED	0.00534759	0.713012
ACRORENAL-MANDIBULAR SYNDROME	0.00534759	0.713012
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4A; CMT4A	0.00534759	0.713012
DYSTONIA, JUVENILE-ONSET	0.00534759	0.713012
ALOPECIA, NEUROLOGIC DEFECTS, AND ENDOCRINOPATHY SYNDROME; ANES	0.00534759	0.713012
ATYPICAL PROGRESSIVE SUPRANUCLEAR PALSY SYNDROME	0.00534759	0.713012
ACROOTOOCULAR SYNDROME	0.00534759	0.713012
SPINAL ARTERIOVENOUS METAMERIC SYNDROME	0.00534759	0.713012
AUTOSOMAL DOMINANT BRACHYOLMIA	0.00534759	0.713012
JOINT LAXITY, SHORT STATURE, AND MYOPIA; JLSM	0.00534759	0.713012
227250 FACIAL ABNORMALITIES, KYPHOSCOLIOSIS, AND MENTAL RETARDATION	0.00534759	0.713012
%109500 BASILAR IMPRESSION, PRIMARY	0.00534759	0.713012
SPONDYLOMETAPHYSEAL DYSPLASIA, KOZLOWSKI TYPE	0.00534759	0.713012
PSEUDOLEPRECHAUNISM SYNDROME, PATTERSON TYPE	0.00534759	0.713012
SPONDYLOCOSTAL DYSOSTOSIS, AUTOSOMAL RECESSIVE 1	0.00534759	0.713012
BRACHYOLMIA TYPE 4 WITH MILD EPIPHYSEAL AND METAPHYSEAL CHANGES; BCYM4	0.00534759	0.713012
SPONDYLOEPIPHYSEAL DYSPLASIA TARDA, AUTOSOMAL DOMINANT	0.00534759	0.713012
OROFACIODIGITAL SYNDROME XI; OFD11	0.00534759	0.713012
VAN MALDERGEM SYNDROME 1; VMLDS1	0.005335817999999999	0.7114423999999998
CONGENITAL ARTHROGRYPOSIS WITH ANTERIOR HORN CELL DISEASE; CAAHD	0.005259096999999999	0.7012129333333332
WIEDEMANN-STEINER SYNDROME; WDSTS	0.005258481000000001	0.7011308
LEIGH SYNDROME, FRENCH CANADIAN TYPE; LSFC	0.005258481000000001	0.7011308
PONTOCEREBELLAR HYPOPLASIA TYPE 10	0.005258481000000001	0.7011308
HYPOGONADOTROPIC HYPOGONADISM 2 WITH OR WITHOUT ANOSMIA	0.00522401	0.6965346666666667
TETRAAMELIA-MULTIPLE MALFORMATIONS SYNDROME	0.00522401	0.6965346666666667
MECKEL SYNDROME, TYPE 1; MKS1	0.00522401	0.6965346666666667
SHORT RIB-POLYDACTYLY SYNDROME, VERMA-NAUMOFF TYPE	0.00522401	0.6965346666666667
ECTODERMAL DYSPLASIA-INTELLECTUAL DISABILITY-CENTRAL NERVOUS SYSTEM MALFORMATION SYNDROME	0.00522401	0.6965346666666667
TRISOMY 1Q	0.00522401	0.6965346666666667
OPTIC ATROPHY 11; OPA11	0.005221562000000001	0.6962082666666668
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IIA; ARCL2A	0.005217427	0.6956569333333333
SKIN CREASES, CONGENITAL SYMMETRIC CIRCUMFERENTIAL, 2; CSCSC2	0.005199597	0.6932796000000001
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CABEZAS TYPE; MRXSC	0.005199597	0.6932796000000001
KHAN-KHAN-KATSANIS SYNDROME; 3KS	0.005191442000000001	0.6921922666666668
ALACRIMA, ACHALASIA, AND MENTAL RETARDATION SYNDROME	0.005191442000000001	0.6921922666666668
MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHRISTIANSON TYPE	0.005191442000000001	0.6921922666666668
NOONAN SYNDROME 7; NS7	0.005187307	0.6916409333333334
HEMIFACIAL MICROSOMIA	0.0051823400000000006	0.6909786666666667
MASA SYNDROME	0.0051823400000000006	0.6909786666666667
OTOMANDIBULAR SYNDROME	0.0051823400000000006	0.6909786666666667
DESMOSTEROLOSIS	0.0051823400000000006	0.6909786666666667
APERT SYNDROME	0.0051823400000000006	0.6909786666666667
HADZISELIMOVIC SYNDROME	0.005162062	0.6882749333333333
NEURODEVELOPMENTAL DISORDER WITH SPASTIC DIPLEGIA AND VISUAL DEFECTS; NEDSDV	0.005162062	0.6882749333333333
JOUBERT SYNDROME 31; JBTS31	0.005162062	0.6882749333333333
JOUBERT SYNDROME 21	0.005162062	0.6882749333333333
INFANTILE CEREBELLAR-RETINAL DEGENERATION	0.005157927	0.6877235999999999
INFANTILE-ONSET AXONAL MOTOR AND SENSORY NEUROPATHY-OPTIC ATROPHY-NEURODEGENERATIVE SYNDROME	0.0051331499999999995	0.6844199999999999
NATIVE AMERICAN MYOPATHY	0.0051331499999999995	0.6844199999999999
MEIER-GORLIN SYNDROME 3; MGORS3	0.0051331499999999995	0.6844199999999999
SUDDEN INFANT DEATH WITH DYSGENESIS OF THE TESTES SYNDROME	0.0051331499999999995	0.6844199999999999
MEIER-GORLIN SYNDROME 5; MGORS5	0.0051331499999999995	0.6844199999999999
SUDDEN INFANT DEATH-DYSGENESIS OF THE TESTES SYNDROME	0.0051331499999999995	0.6844199999999999
FOCAL DERMAL HYPOPLASIA	0.00509148	0.6788639999999999
17Q23.1Q23.2 MICRODELETION SYNDROME	0.00509148	0.6788639999999999
MICROPHTHALMIA WITH CYST, BILATERAL FACIAL CLEFTS, AND LIMB ANOMALIES	0.0050910040000000005	0.6788005333333333
INTELLECTUAL DISABILITY-BRACHYDACTYLY-PIERRE ROBIN SYNDROME	0.0050910040000000005	0.6788005333333333
MANDIBULOFACIAL DYSOSTOSIS-MICROCEPHALY SYNDROME	0.005086869000000001	0.6782492000000001
MEGALENCEPHALY-POLYMICROGYRIA-POSTAXIAL POLYDACTYLY-HYDROCEPHALUS SYNDROME	0.005086869000000001	0.6782492000000001
ZIMMERMANN-LABAND SYNDROME	0.005086869000000001	0.6782492000000001
20P13 MICRODELETION SYNDROME	0.005086869000000001	0.6782492000000001
RITSCHER-SCHINZEL SYNDROME 1	0.005078522	0.6771362666666667
MICROCEPHALY, FACIAL DYSMORPHISM, RENAL AGENESIS, AND AMBIGUOUS GENITALIA SYNDROME; MFRG	0.005074387	0.6765849333333334
METHYLMALONIC ACIDEMIA AND HOMOCYSTEINEMIA, CBLX TYPE	0.005074387	0.6765849333333334
AICAR TRANSFORMYLASE/IMP CYCLOHYDROLASE DEFICIENCY	0.005074387	0.6765849333333334
MENKES DISEASE	0.005074387	0.6765849333333334
ADENYLOSUCCINATE LYASE DEFICIENCY	0.005074387	0.6765849333333334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIA; CDG2A	0.005074387	0.6765849333333334
ASPARTYLGLUCOSAMINURIA; AGU	0.005074387	0.6765849333333334
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO TUD DEFICIENCY	0.005074387	0.6765849333333334
AARSKOG-SCOTT SYNDROME	0.0050425240000000005	0.6723365333333334
3MC SYNDROME 2	0.0050425240000000005	0.6723365333333334
AUTOSOMAL DOMINANT ROBINOW SYNDROME	0.0050425240000000005	0.6723365333333334
INTELLECTUAL DISABILITY, WOLFF TYPE	0.005038389	0.6717852
COG5-CDG	0.005038389	0.6717852
INFANTILE-ONSET X-LINKED SPINAL MUSCULAR ATROPHY	0.005038389	0.6717852
LISSENCEPHALY 7 WITH CEREBELLAR HYPOPLASIA; LIS7	0.005023983000000001	0.6698644000000001
ENCEPHALOCRANIOCUTANEOUS LIPOMATOSIS	0.005023983000000001	0.6698644000000001
MICROCEPHALY 17, PRIMARY, AUTOSOMAL RECESSIVE; MCPH17	0.005023983000000001	0.6698644000000001
HOLOPROSENCEPHALY 7	0.005023983000000001	0.6698644000000001
VICI SYNDROME	0.005023983000000001	0.6698644000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 12; MDDGA12	0.005023983000000001	0.6698644000000001
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME X	0.005023983000000001	0.6698644000000001
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 13; MDDGA13	0.005023983000000001	0.6698644000000001
LISSENCEPHALY 4	0.005023983	0.6698644
GABA-TRANSAMINASE DEFICIENCY	0.005023983	0.6698644
MICROCEPHALY-LYMPHEDEMA-CHORIORETINOPATHY SYNDROME	0.004979334	0.6639112
17Q24.2 MICRODELETION SYNDROME	0.004975199	0.6633598666666667
HEREDITARY FOLATE MALABSORPTION	0.004933123	0.6577497333333334
CANAVAN DISEASE	0.004933122999999999	0.6577497333333332
IMMUNODEFICIENCY 26 WITH OR WITHOUT NEUROLOGIC ABNORMALITIES; IMD26	0.004915699	0.6554265333333333
GOLDBERG-SHPRINTZEN MEGACOLON SYNDROME	0.004915699	0.6554265333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 13; MRT13	0.004915698999999999	0.6554265333333332
ALPORT SYNDROME	0.00490816	0.6544213333333333
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE	0.004898548000000001	0.6531397333333334
CATARACT-INTELLECTUAL DISABILITY-HYPOGONADISM SYNDROME	0.00485843	0.6477906666666667
NON-DISTAL TRISOMY 10Q	0.00485843	0.6477906666666667
601976 OTOFACIOOSSEOUS-GONADAL SYNDROME	0.00485843	0.6477906666666667
ANTLEY-BIXLER SYNDROME WITH GENITAL ANOMALIES AND DISORDERED STEROIDOGENESIS; ABS1	0.00485843	0.6477906666666667
FACIODIGITOGENITAL SYNDROME, AUTOSOMAL RECESSIVE	0.00485843	0.6477906666666667
AUTOSOMAL RECESSIVE SPASTIC ATAXIA OF CHARLEVOIX-SAGUENAY	0.004848659999999999	0.646488
CROUZON SYNDROME-ACANTHOSIS NIGRICANS SYNDROME	0.00481676	0.6422346666666666
MESOMELIC DYSPLASIA, NIEVERGELT TYPE	0.00481676	0.6422346666666666
ANTLEY-BIXLER SYNDROME	0.00481676	0.6422346666666666
COOPER-JABS SYNDROME	0.00481676	0.6422346666666666
CROUZON DISEASE	0.00481676	0.6422346666666666
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 30	0.004807688	0.6410250666666667
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE III	0.004807688	0.6410250666666667
MYASTHENIC SYNDROME, CONGENITAL, 19; CMS19	0.004807688	0.6410250666666667
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE II	0.004807688	0.6410250666666667
CHROMOSOME 16P13.3 DELETION SYNDROME	0.004801443000000001	0.6401924000000001
INTELLECTUAL DISABILITY-HYPERKINETIC MOVEMENT-TRUNCAL ATAXIA SYNDROME	0.004801443000000001	0.6401924000000001
NEUROECTODERMAL MELANOLYSOSOMAL DISEASE	0.004801443000000001	0.6401924000000001
IFAP SYNDROME WITH OR WITHOUT BRESHECK SYNDROME	0.004783612999999999	0.6378150666666665
OHDO SYNDROME	0.004754597	0.6339462666666666
D-BIFUNCTIONAL PROTEIN DEFICIENCY	0.004741943	0.6322590666666666
GALLOWAY-MOWAT SYNDROME 1; GAMOS1	0.004741943	0.6322590666666666
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 51; EIEE51	0.004741943	0.6322590666666666
FIBROSIS, NEURODEGENERATION, AND CEREBRAL ANGIOMATOSIS; FINCA	0.004741943	0.6322590666666666
EPILEPSY, HEARING LOSS, AND MENTAL RETARDATION SYNDROME; EHLMRS	0.004741943	0.6322590666666666
SEVERE INTELLECTUAL DISABILITY AND PROGRESSIVE SPASTIC PARAPLEGIA	0.004741943	0.6322590666666666
SNIJDERS BLOK-CAMPEAU SYNDROME; SNIBCPS	0.004717062000000001	0.6289416000000002
INTELLECTUAL DEVELOPMENTAL DISORDER WITH DYSMORPHIC FACIES AND PTOSIS; IDDDFP	0.004717062000000001	0.6289416000000002
SENGERS SYNDROME	0.004676008000000001	0.6234677333333334
PORETTI-BOLTSHAUSER SYNDROME; PTBHS	0.004676008000000001	0.6234677333333334
FUCOSIDOSIS	0.004658403	0.6211204
MYASTHENIC SYNDROME, CONGENITAL, 4C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY	0.004645888000000001	0.6194517333333334
MYASTHENIC SYNDROME, CONGENITAL, 4A, SLOW-CHANNEL; CMS4A	0.004645888000000001	0.6194517333333334
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 1; NSLH1	0.004616508	0.6155344
MENTAL RETARDATION, X-LINKED, WITH CEREBELLAR HYPOPLASIA AND DISTINCTIVE FACIAL APPEARANCE	0.004580841	0.6107788000000001
STANKIEWICZ-ISIDOR SYNDROME; STISS	0.004580841	0.6107788000000001
CHROMOSOME 16P13.2 DELETION SYNDROME	0.004580841	0.6107788000000001
WEAVER SYNDROME	0.004580841	0.6107788000000001
NEPHROTIC SYNDROME, TYPE 14; NPHS14	0.004580841	0.6107788000000001
AXIAL SPONDYLOMETAPHYSEAL DYSPLASIA	0.00454545	0.60606
CRANIOECTODERMAL DYSPLASIA 3	0.00454545	0.60606
SHORT STATURE WITH MICROCEPHALY AND DISTINCTIVE FACIES; SSMCF	0.00454545	0.60606
%193250 VOLVULUS OF MIDGUT;;INTESTINAL MALROTATION, FAMILIAL	0.00454545	0.60606
WAARDENBURG SYNDROME, TYPE 2D; WS2D	0.00454545	0.60606
CLEFT PALATE-STAPES FIXATION-OLIGODONTIA SYNDROME	0.00454545	0.60606
TELECANTHUS	0.00454545	0.60606
ATELOSTEOGENESIS TYPE I	0.00454545	0.60606
OROFACIODIGITAL SYNDROME X	0.00454545	0.60606
3MC SYNDROME	0.00454545	0.60606
NASOPALPEBRAL LIPOMA-COLOBOMA SYNDROME	0.00454545	0.60606
SCALP-EAR-NIPPLE SYNDROME	0.00454545	0.60606
MUCOPOLYSACCHARIDOSIS-LIKE SYNDROME WITH CONGENITAL HEART DEFECTS AND HEMATOPOIETIC DISORDERS	0.00454545	0.60606
DYSMORPHISM-PECTUS CARINATUM-JOINT LAXITY SYNDROME	0.00454545	0.60606
OROFACIODIGITAL SYNDROME TYPE 10	0.00454545	0.60606
MULTIPLE ACYL-COA DEHYDROGENASE DEFICIENCY; MADD	0.00454545	0.60606
FACIOCARDIOMELIC SYNDROME	0.00454545	0.60606
BLEPHARONASOFACIAL MALFORMATION SYNDROME	0.00454545	0.60606
TERMINAL OSSEOUS DYSPLASIA; TOD	0.00454545	0.60606
RESTRICTIVE DERMOPATHY	0.00454545	0.60606
WAARDENBURG SYNDROME TYPE 2	0.00454545	0.60606
FRONTONASAL DYSPLASIA WITH ALAR CLEFTS	0.00454545	0.60606
PTOSIS-UPPER OCULAR MOVEMENT LIMITATION-ABSENCE OF LACRIMAL PUNCTUM SYNDROME	0.00454545	0.60606
LACRIMOAURICULODENTODIGITAL SYNDROME; LADD	0.00454545	0.60606
WAARDENBURG SYNDROME TYPE 3	0.00454545	0.60606
BARBER-SAY SYNDROME; BBRSAY	0.00454545	0.60606
CRYPTOMICROTIA-BRACHYDACTYLY-EXCESS FINGERTIP ARCH SYNDROME	0.00454545	0.60606
ANIRIDIA, PARTIAL, WITH UNILATERAL RENAL AGENESIS AND PSYCHOMOTORRETARDATION	0.00454545	0.60606
129540 ECTODERMAL DYSPLASIA SYNDROME WITH DISTINCTIVE FACIAL APPEARANCE ANDPREAXIAL POLYDACTYLY OF FEET	0.00454545	0.60606
BRACHYTELEPHALANGY-DYSMORPHISM-KALLMANN SYNDROME	0.00454545	0.60606
22Q11 DUPLICATION SYNDROME	0.00454545	0.60606
2P15-16.1 MICRODELETION SYNDROME	0.00454545	0.60606
PTERYGIUM COLLI AND MENTAL RETARDATION WITH FACIAL AND DIGITAL ANOMALIES	0.004532968	0.6043957333333333
PTERYGIUM COLLI-INTELLECTUAL DISABILITY-DIGITAL ANOMALIES SYNDROME	0.004532968	0.6043957333333333
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IQ	0.004532968	0.6043957333333333
HYPOTONIA, HYPERVENTILATION, IMPAIRED INTELLECTUAL DEVELOPMENT, DYSAUTONOMIA, EPILEPSY, AND EYE ABNORMALITIES; HIDEA	0.004517650999999999	0.6023534666666666
LONG CHAIN 3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.004517650999999999	0.6023534666666666
SCARF SYNDROME	0.00449697	0.599596
100050 AARSKOG SYNDROME, AUTOSOMAL DOMINANT	0.00449697	0.599596
FREEMAN-SHELDON SYNDROME	0.00449697	0.599596
FALLOT COMPLEX-INTELLECTUAL DISABILITY-GROWTH DELAY SYNDROME	0.00449697	0.599596
DISTAL MONOSOMY 10P	0.00449697	0.599596
AUTOSOMAL RECESSIVE ROBINOW SYNDROME	0.00449697	0.599596
SPINOCEREBELLAR ATAXIA TYPE 13	0.0044875309999999995	0.5983374666666665
NIEMANN-PICK DISEASE, TYPE C2	0.0044875309999999995	0.5983374666666665
NIEMANN-PICK DISEASE, TYPE C1; NPC1	0.0044875309999999995	0.5983374666666665
PYRUVATE DEHYDROGENASE PHOSPHATASE DEFICIENCY	0.0044875309999999995	0.5983374666666665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 10; MC1DN10	0.0044875309999999995	0.5983374666666665
METACHROMATIC LEUKODYSTROPHY DUE TO SAPOSIN B DEFICIENCY	0.0044875309999999995	0.5983374666666665
PELIZAEUS-MERZBACHER DISEASE	0.0044875309999999995	0.5983374666666665
SEPTOOPTIC DYSPLASIA	0.0044825640000000005	0.5976752000000001
BRAIN-LUNG-THYROID SYNDROME	0.0044825640000000005	0.5976752000000001
CURRY-JONES SYNDROME	0.0044825640000000005	0.5976752000000001
MARDEN-WALKER SYNDROME	0.0044825640000000005	0.5976752000000001
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO CWF19L1 DEFICIENCY	0.0044825640000000005	0.5976752000000001
BEARE-STEVENSON CUTIS GYRATA SYNDROME; BSTVS	0.0044825640000000005	0.5976752000000001
CRANIOTELENCEPHALIC DYSPLASIA	0.0044825640000000005	0.5976752000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 69	0.0044825640000000005	0.5976752000000001
AUTOSOMAL RECESSIVE PRIMARY MICROCEPHALY	0.0044825640000000005	0.5976752000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 67	0.0044825640000000005	0.5976752000000001
CRANIOTELENCEPHALIC DYSPLASIA	0.0044825640000000005	0.5976752000000001
DUPLICATION OF THE PITUITARY GLAND	0.0044825640000000005	0.5976752000000001
HOLOPROSENCEPHALY 11	0.0044825640000000005	0.5976752000000001
COMBINED PITUITARY HORMONE DEFICIENCIES, GENETIC FORMS	0.004478429000000001	0.5971238666666667
MICROCEPHALY, SHORT STATURE, AND POLYMICROGYRIA WITH OR WITHOUT SEIZURES; MSSP	0.004478429000000001	0.5971238666666667
LISSENCEPHALY, X-LINKED, 1; LISX1	0.004478429000000001	0.5971238666666667
HISTIOCYTOID CARDIOMYOPATHY	0.004478429000000001	0.5971238666666667
EARLY-ONSET PROGRESSIVE ENCEPHALOPATHY-SPASTIC ATAXIA-DISTAL SPINAL MUSCULAR ATROPHY SYNDROME	0.0044581510000000005	0.5944201333333333
XQ25 MICRODUPLICATION SYNDROME	0.0044581510000000005	0.5944201333333333
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 11; COXPD11	0.0044581510000000005	0.5944201333333333
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIB	0.0044581510000000005	0.5944201333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 45	0.0044581510000000005	0.5944201333333333
INTELLECTUAL DISABILITY-SEIZURES-MACROCEPHALY-OBESITY SYNDROME	0.0044581510000000005	0.5944201333333333
PEHO SYNDROME; PEHO	0.0044581510000000005	0.5944201333333333
XQ25 DUPLICATION SYNDROME	0.0044581510000000005	0.5944201333333333
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 3; IECEE3	0.0044581510000000005	0.5944201333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 53; MRT53	0.0044581510000000005	0.5944201333333333
CREATINE DEFICIENCY SYNDROME, X-LINKED	0.0044581510000000005	0.5944201333333333
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-MOVEMENT DISORDER SYNDROME	0.0044581510000000005	0.5944201333333333
PERIVENTRICULAR HETEROTOPIA WITH MICROCEPHALY, AUTOSOMAL RECESSIVE; ARPHM	0.004458150999999999	0.5944201333333332
SPASTIC TETRAPLEGIA, THIN CORPUS CALLOSUM, AND PROGRESSIVE MICROCEPHALY; SPATCCM	0.004458150999999999	0.5944201333333332
INFLAMMATORY BOWEL DISEASE, IMMUNODEFICIENCY, AND ENCEPHALOPATHY; IBDIMDE	0.004458150999999999	0.5944201333333332
MICROCEPHALY 15, PRIMARY, AUTOSOMAL RECESSIVE	0.004458150999999999	0.5944201333333332
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 7	0.004458150999999999	0.5944201333333332
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 5; CDCBM5	0.004458150999999999	0.5944201333333332
DERMOID CYSTS, FAMILIAL FRONTONASAL	0.00440366	0.5871546666666667
POPOV-CHANG SYNDROME; POPCHAS	0.004391704	0.5855605333333334
AROMATIC L-AMINO ACID DECARBOXYLASE DEFICIENCY	0.004391704	0.5855605333333334
PARKINSONISM-DYSTONIA, INFANTILE, 1; PKDYS1	0.004391704	0.5855605333333334
LYMPHEDEMA, HEREDITARY, III	0.004391704	0.5855605333333334
MICROCEPHALY, GROWTH RESTRICTION, AND INCREASED SISTER CHROMATID EXCHANGE 2; MGRISCE2	0.004391704	0.5855605333333334
CLEFT PALATE, CARDIAC DEFECTS, AND MENTAL RETARDATION; CPCMR	0.004391704	0.5855605333333334
INFANTILE DYSTONIA-PARKINSONISM	0.004391704	0.5855605333333334
3Q29 MICRODELETION SYNDROME	0.004391704	0.5855605333333334
HOLMES-GANG SYNDROME	0.004391704	0.5855605333333334
3-PHOSPHOSERINE PHOSPHATASE DEFICIENCY	0.004391704	0.5855605333333334
SCLERODERMA	0.004387569	0.5850092
ATYPICAL RETT SYNDROME	0.004387569	0.5850092
MATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.004387569	0.5850092
HEREDITARY HYPEREKPLEXIA	0.004387569	0.5850092
RETT SYNDROME; RTT	0.004387569	0.5850092
PGM3-CDG	0.004387569	0.5850092
CITRULLINEMIA TYPE I	0.004387569	0.5850092
MIXED CONNECTIVE TISSUE DISEASE	0.004387569	0.5850092
MONOSOMY 13Q14	0.0043742799999999995	0.5832373333333333
FRONTONASAL DYSPLASIA 2; FND2	0.0043742799999999995	0.5832373333333333
FILIPPI SYNDROME	0.004338613	0.5784817333333333
MOSAIC TRISOMY 14	0.004338613	0.5784817333333333
CHROMOSOME 1P35 DELETION SYNDROME	0.004338613	0.5784817333333333
BONE MARROW FAILURE SYNDROME 3; BMFS3	0.004301694	0.5735592
NEUROFIBROMATOSIS TYPE 1	0.004297558999999999	0.5730078666666666
HYPOGONADOTROPIC HYPOGONADISM-SEVERE MICROCEPHALY-SENSORINEURAL HEARING LOSS-DYSMORPHISM SYNDROME	0.004297558999999999	0.5730078666666666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE ID; CDG1D	0.004296943	0.5729257333333334
15Q24 MICRODELETION SYNDROME	0.004296943	0.5729257333333334
OCULOECTODERMAL SYNDROME; OES	0.004296943	0.5729257333333334
CHAR SYNDROME	0.004260024	0.5680032
BARDET-BIEDL SYNDROME 1; BBS1	0.004260024	0.5680032
ATAXIA-INTELLECTUAL DISABILITY-OCULOMOTOR APRAXIA-CEREBELLAR CYSTS SYNDROME	0.004260024	0.5680032
HYPERTRYPTOPHANEMIA; HYPTRP	0.004260024	0.5680032
FRONTOOCULAR SYNDROME	0.004260024	0.5680032
PROTEUS SYNDROME	0.0042558890000000005	0.5674518666666667
OCULODENTODIGITAL DYSPLASIA	0.0042558890000000005	0.5674518666666667
KNOBLOCH SYNDROME	0.0042558890000000005	0.5674518666666667
MUSCLE-EYE-BRAIN DISEASE	0.0042558890000000005	0.5674518666666667
MICROCEPHALY, EPILEPSY, AND DIABETES SYNDROME	0.0042421939999999995	0.5656258666666666
HYPOPARATHYROIDISM-RETARDATION-DYSMORPHISM SYNDROME	0.004238059	0.5650745333333332
SKELETAL DYSPLASIA AND PROGRESSIVE CENTRAL NERVOUS SYSTEM DEGENERATION, LETHAL	0.004238059	0.5650745333333332
INTELLECTUAL DISABILITY-ALACRIMA-ACHALASIA SYNDROME	0.0042299040000000005	0.5639872
STURGE-WEBER SYNDROME	0.004225769	0.5634358666666667
MICROPHTHALMIA, SYNDROMIC 9; MCOPS9	0.004213178	0.5617570666666666
DYSMORPHISM-SHORT STATURE-DEAFNESS-DISORDER OF SEX DEVELOPMENT SYNDROME	0.004213178	0.5617570666666666
MULLERIAN DERIVATIVES, PERSISTENCE OF, WITH LYMPHANGIECTASIA AND POSTAXIAL POLYDACTYLY	0.004213178	0.5617570666666666
EARLY INFANTILE EPILEPTIC ENCEPHALOPATHY	0.004200524	0.5600698666666667
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT SEIZURES AND GAIT ABNORMALITIES; NEDSGA	0.004200524	0.5600698666666667
SPASTIC PARAPLEGIA 55, AUTOSOMAL RECESSIVE; SPG55	0.004200524	0.5600698666666667
SPASTIC PARAPLEGIA 18, AUTOSOMAL RECESSIVE; SPG18	0.004196389	0.5595185333333333
SPASTIC PARAPLEGIA 35, AUTOSOMAL RECESSIVE	0.004196389	0.5595185333333333
SPASTICITY, CHILDHOOD-ONSET, WITH HYPERGLYCINEMIA	0.004196389	0.5595185333333333
5Q14.3 MICRODELETION SYNDROME	0.004196389	0.5595185333333333
TRISOMY 9P	0.004116984	0.5489312
BARDET-BIEDL SYNDROME 8; BBS8	0.004116984	0.5489312
275595 TRIGONOBRACHYCEPHALY, BULBOUS BIFID NOSE, MICROGNATHIA, AND ABNORMALITIESOF THE HANDS AND FEET	0.004116984	0.5489312
CDAGS SYNDROME	0.004116984	0.5489312
X-LINKED INTELLECTUAL DISABILITY, WILSON TYPE	0.004112849	0.5483798666666667
MENTAL RETARDATION, X-LINKED, SYNDROMIC, WU TYPE; MRXSW	0.004112849	0.5483798666666667
MENTAL RETARDATION, AUTOSOMAL DOMINANT 29; MRD29	0.004112849	0.5483798666666667
AICA-RIBOSIDURIA	0.004112849	0.5483798666666667
%309545 MENTAL RETARDATION, X-LINKED, SYNDROMIC 12; MRXS12	0.004112849	0.5483798666666667
MENTAL RETARDATION, AUTOSOMAL DOMINANT 21	0.004039422000000001	0.5385896000000001
DEVELOPMENTAL DELAY, INTELLECTUAL DISABILITY, OBESITY, AND DYSMORPHIC FEATURES; DIDOD	0.004039422000000001	0.5385896000000001
SMITH-KINGSMORE SYNDROME; SKS	0.004035287	0.5380382666666667
PEROXISOME BIOGENESIS DISORDER 1B; PBD1B	0.0040131509999999995	0.5350867999999999
SIALURIA	0.0040131509999999995	0.5350867999999999
PEROXISOME BIOGENESIS DISORDER 12A (ZELLWEGER)	0.0040131509999999995	0.5350867999999999
AMINOACYLASE 1 DEFICIENCY; ACY1D	0.0040131509999999995	0.5350867999999999
NEURODEVELOPMENTAL DISORDER WITH CENTRAL AND PERIPHERAL MOTOR DYSFUNCTION; NEDCPMD	0.0040131509999999995	0.5350867999999999
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 68; MRT68	0.0040131509999999995	0.5350867999999999
INTELLECTUAL DEVELOPMENTAL DISORDER 59; MRD59	0.003976232	0.5301642666666666
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SPEECH DELAY, DYSMORPHIC FACIES, AND T-CELL ABNORMALITIES; IDDSFTA	0.003976232	0.5301642666666666
COHEN SYNDROME	0.003972097	0.5296129333333334
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 20	0.003946112	0.5261482666666667
RECESSIVE MITOCHONDRIAL ATAXIA SYNDROME	0.003941977	0.5255969333333333
RAPID-ONSET DYSTONIA-PARKINSONISM	0.003941977	0.5255969333333333
MYOCLONUS, INTRACTABLE, NEONATAL; NEIMY	0.003941977	0.5255969333333333
MICROHYDRANENCEPHALY; MHAC	0.00393701	0.5249346666666668
HYDROLETHALUS SYNDROME 1	0.00393701	0.5249346666666668
AL-GAZALI-BAKALINOVA SYNDROME; AGBK	0.00393701	0.5249346666666668
MICROCEPHALY-POLYMICROGYRIA-CORPUS CALLOSUM AGENESIS SYNDROME	0.00393701	0.5249346666666668
GOLDENHAR SYNDROME	0.00393701	0.5249346666666668
MULTIPLE EPIPHYSEAL DYSPLASIA, AL-GAZALI TYPE	0.00393701	0.5249346666666668
OROFACIODIGITAL SYNDROME V; OFD5	0.00393701	0.5249346666666668
POLYMICROGYRIA WITH OPTIC NERVE HYPOPLASIA	0.00393701	0.5249346666666668
AMISH LETHAL MICROCEPHALY	0.00393701	0.5249346666666668
%217990 CORPUS CALLOSUM, AGENESIS OF;;ACC	0.00393701	0.5249346666666668
CORPUS CALLOSUM, AGENESIS OF, WITH MENTAL RETARDATION, OCULAR COLOBOMA,AND MICROGNATHIA	0.00393701	0.5249346666666668
HYDROCEPHALUS DUE TO CONGENITAL STENOSIS OF AQUEDUCT OF SYLVIUS	0.00393701	0.5249346666666668
AGNATHIA-OTOCEPHALY COMPLEX	0.00393701	0.5249346666666668
OROFACIODIGITAL SYNDROME TYPE 5	0.00393701	0.5249346666666668
THAKKER-DONNAI SYNDROME	0.00393701	0.5249346666666668
211200 BOWEN SYNDROME OF MULTIPLE MALFORMATIONS	0.00393701	0.5249346666666668
ASPLENIA WITH CARDIOVASCULAR ANOMALIES	0.00393701	0.5249346666666668
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 2; COXPD2	0.00393701	0.5249346666666668
SPINOCEREBELLAR ATAXIA 23; SCA23	0.00393701	0.5249346666666668
MIRROR MOVEMENTS 1; MRMV1	0.00393701	0.5249346666666668
CURRY-JONES SYNDROME	0.00393701	0.5249346666666668
MISMATCH REPAIR CANCER SYNDROME; MMRCS	0.00393701	0.5249346666666668
OSTEOCHONDRODYSPLASIA, RHIZOMELIC, WITH CALLOSAL AGENESIS, THROMBOCYTOPENIA,HYDROCEPHALUS, AND HYPERTENSION	0.00393701	0.5249346666666668
FAMILIAL CONGENITAL MIRROR MOVEMENTS	0.00393701	0.5249346666666668
SCHIZENCEPHALY	0.00393701	0.5249346666666668
CORPUS CALLOSUM AGENESIS-INTELLECTUAL DISABILITY-COLOBOMA-MICROGNATHIA SYNDROME	0.00393701	0.5249346666666668
AGNATHIA-HOLOPROSENCEPHALY-SITUS INVERSUS SYNDROME	0.00393701	0.5249346666666668
MYCOPHENOLATE MOFETIL EMBRYOPATHY	0.00393701	0.5249346666666668
GONADAL DYSGENESIS, DYSMORPHIC FACIES, RETINAL DYSTROPHY, AND MYOPATHY; GDRM	0.00393701	0.5249346666666668
LISSENCEPHALY TYPE III AND BONE DYSPLASIA	0.00393701	0.5249346666666668
MASA SYNDROME	0.00393701	0.5249346666666668
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SEVERE SPEECH AND AMBULATION DEFECTS; IDDSSAD	0.003916732	0.5222309333333334
MICROCEPHALY, PROGRESSIVE, WITH SEIZURES AND CEREBRAL AND CEREBELLAR ATROPHY	0.003916732	0.5222309333333334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 49; MRT49	0.003916732	0.5222309333333334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 48	0.003916732	0.5222309333333334
RARE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.003916731999999999	0.5222309333333331
NEURODEVELOPMENTAL DISORDER WITH EPILEPSY AND HYPOPLASIA OF THE CORPUS CALLOSUM; NEDEHCC	0.003916731999999999	0.5222309333333331
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 57; EIEE57	0.003916731999999999	0.5222309333333331
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 8; MC3DN8	0.003916731999999999	0.5222309333333331
METHYLMALONATE SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.003916731999999999	0.5222309333333331
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 64; EIEE64	0.003916731999999999	0.5222309333333331
AUTOSOMAL RECESSIVE NON-SYNDROMIC INTELLECTUAL DISABILITY	0.003916731999999999	0.5222309333333331
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 21	0.003916731999999999	0.5222309333333331
PONTOCEREBELLAR HYPOPLASIA, TYPE 2B; PCH2B	0.003912597	0.5216796
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 5	0.003912597	0.5216796
MENTAL RETARDATION, X-LINKED 102	0.003912597	0.5216796
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIJ; CDG2J	0.003912597	0.5216796
SEIZURES, CORTICAL BLINDNESS, AND MICROCEPHALY SYNDROME	0.003912597	0.5216796
MICROCEPHALY-CAPILLARY MALFORMATION SYNDROME	0.003912597	0.5216796
LEUKODYSTROPHY, HYPOMYELINATING, 16; HLD16	0.003912597	0.5216796
3-METHYLGLUTACONIC ACIDURIA, TYPE VIII; MGCA8	0.003912597	0.5216796
MICROCEPHALY, SEIZURES, AND DEVELOPMENTAL DELAY	0.003912597	0.5216796
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 9; CDCBM9	0.003912597	0.5216796
MENTAL RETARDATION, AUTOSOMAL DOMINANT 48; MRD48	0.003912597	0.5216796
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 5; COXPD5	0.003912597	0.5216796
FACIAL DYSMORPHISM, HYPERTRICHOSIS, EPILEPSY, INTELLECTUAL/DEVELOPMENTAL DELAY, AND GINGIVAL OVERGROWTH SYNDROME; FHEIG	0.003912597	0.5216796
X-LINKED EHLERS-DANLOS SYNDROME	0.00384615	0.51282
GASTROESOPHAGEAL REFLUX	0.00384615	0.51282
CONGENITAL PULMONARY LYMPHANGIECTASIA	0.00384615	0.51282
CEREBROCOSTOMANDIBULAR SYNDROME; CCMS	0.00384615	0.51282
ISOTRETINOIN-LIKE SYNDROME	0.00384615	0.51282
NEPHROTIC SYNDROME, TYPE 1; NPHS1	0.00384615	0.51282
IDIOPATHIC PULMONARY FIBROSIS	0.00384615	0.51282
PERIVENTRICULAR NODULAR HETEROTOPIA	0.00384615	0.51282
POLYMYOSITIS	0.00384615	0.51282
SANDIFER SYNDROME	0.00384615	0.51282
DERMATOSPARAXIS EHLERS-DANLOS SYNDROME	0.00384615	0.51282
MÉNÉTRIER DISEASE	0.00384615	0.51282
ADENOCARCINOMA OF THE ESOPHAGUS	0.00384615	0.51282
MEIER-GORLIN SYNDROME 2; MGORS2	0.00384615	0.51282
NK-CELL ENTEROPATHY	0.00384615	0.51282
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9B	0.00384615	0.51282
NEUROPATHY, HEREDITARY SENSORY AND AUTONOMIC, TYPE I, WITH COUGH AND GASTROESOPHAGEAL REFLUX	0.00384615	0.51282
SPASTIC PARAPLEGIA 9A, AUTOSOMAL DOMINANT; SPG9A	0.00384615	0.51282
HYPERMOBILE EHLERS-DANLOS SYNDROME	0.00384615	0.51282
PROGERIA-SHORT STATURE-PIGMENTED NEVI SYNDROME	0.00384615	0.51282
ISOLATED POLYCYSTIC LIVER DISEASE	0.00384615	0.51282
CARDIOCRANIAL SYNDROME, PFEIFFER TYPE	0.0037971940000000003	0.5062925333333333
CHROMOSOME 19Q13.11 DELETION SYNDROME, DISTAL	0.0037971940000000003	0.5062925333333333
AGAMMAGLOBULINEMIA-MICROCEPHALY-CRANIOSYNOSTOSIS-SEVERE DERMATITIS SYNDROME	0.0037971940000000003	0.5062925333333333
TRISOMY 8Q	0.0037971940000000003	0.5062925333333333
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIG; CDG2G	0.0037971940000000003	0.5062925333333333
NEUTROPENIA, SEVERE CONGENITAL, 4, AUTOSOMAL RECESSIVE; SCN4	0.0037971940000000003	0.5062925333333333
609945 BRACHYPHALANGY, POLYDACTYLY, AND TIBIAL APLASIA/HYPOPLASIA	0.0037971940000000003	0.5062925333333333
CHROMOSOME 18P DELETION SYNDROME	0.0037971940000000003	0.5062925333333333
OGDEN SYNDROME; OGDNS	0.0037971940000000003	0.5062925333333333
NABLUS MASK-LIKE FACIAL SYNDROME; NMLFS	0.0037971940000000003	0.5062925333333333
OCULOSKELETODENTAL SYNDROME; OCSKD	0.0037971940000000003	0.5062925333333333
PERLMAN SYNDROME	0.0037971940000000003	0.5062925333333333
ACROCARDIOFACIAL SYNDROME	0.003793059	0.5057412
ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME, CHROMOSOME 16-RELATED	0.003793059	0.5057412
FILIPPI SYNDROME; FLPIS	0.003793059	0.5057412
HENNEKAM LYMPHANGIECTASIA-LYMPHEDEMA SYNDROME	0.003793059	0.5057412
POLYDACTYLY-MYOPIA SYNDROME	0.00375614	0.5008186666666666
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, CROSS TYPE	0.00375614	0.5008186666666666
DISTAL LIMB DEFICIENCIES-MICROGNATHIA SYNDROME	0.00375614	0.5008186666666666
POLAND SYNDROME	0.00375614	0.5008186666666666
MIETENS SYNDROME	0.0037555240000000005	0.5007365333333333
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE, FACIAL ANOMALIES, AND SPEECH DEFECTS; IDDSFAS	0.0037555240000000005	0.5007365333333333
AUTOSOMAL RECESSIVE CHORIORETINOPATHY-MICROCEPHALY SYNDROME	0.003751389	0.5001852
NEONATAL ADRENOLEUKODYSTROPHY	0.003751389	0.5001852
CHARGE SYNDROME	0.00372602	0.49680266666666667
NEUROFIBROMATOSIS-NOONAN SYNDROME	0.00372602	0.49680266666666667
HYPOMAGNESEMIA 5, RENAL, WITH OR WITHOUT OCULAR INVOLVEMENT; HOMG5	0.00371447	0.4952626666666667
WHITE FORELOCK WITH MALFORMATIONS	0.00371447	0.4952626666666667
MACROPHTHALMIA, COLOBOMATOUS, WITH MICROCORNEA; MACOM	0.00371447	0.4952626666666667
RETINAL CONE DYSTROPHY 3B	0.00371447	0.4952626666666667
OCULOCUTANEOUS ALBINISM	0.00371447	0.4952626666666667
TURNER SYNDROME	0.00371447	0.4952626666666667
MESOMELIC DWARFISM, REINHARDT-PFEIFFER TYPE	0.00371447	0.4952626666666667
BRACHYMETAPODY-ANODONTIA-HYPOTRICHOSIS-ALBINOIDISM	0.00371447	0.4952626666666667
223330 DIVERTICULOSIS OF BOWEL, HERNIA, AND RETINAL DETACHMENT	0.00371447	0.4952626666666667
X-LINKED RECESSIVE OCULAR ALBINISM	0.00371447	0.4952626666666667
RENAL COLOBOMA SYNDROME	0.00371447	0.4952626666666667
ALPORT SYNDROME-INTELLECTUAL DISABILITY-MIDFACE HYPOPLASIA-ELLIPTOCYTOSIS SYNDROME	0.00371447	0.4952626666666667
16P12.1P12.3 TRIPLICATION SYNDROME	0.00371447	0.4952626666666667
ALAGILLE SYNDROME 1; ALGS1	0.00371447	0.4952626666666667
NIGHT BLINDNESS, CONGENITAL STATIONARY, TYPE 1E	0.00371447	0.4952626666666667
ALBINISM, OCULOCUTANEOUS, TYPE II; OCA2	0.00371447	0.4952626666666667
MOSAIC MONOSOMY X	0.00371447	0.4952626666666667
MONOSOMY X	0.00371447	0.4952626666666667
BLEPHAROPHIMOSIS-EPICANTHUS INVERSUS-PTOSIS SYNDROME	0.00371447	0.4952626666666667
SCHWARTZ-JAMPEL SYNDROME	0.00371447	0.4952626666666667
TURNER SYNDROME DUE TO STRUCTURAL X CHROMOSOME ANOMALIES	0.00371447	0.4952626666666667
GASTROCUTANEOUS SYNDROME	0.00371447	0.4952626666666667
CONGENITAL CATARACT-HYPERTROPHIC CARDIOMYOPATHY-MITOCHONDRIAL MYOPATHY SYNDROME	0.00371447	0.4952626666666667
ALBINISM, OCULOCUTANEOUS, TYPE IA; OCA1A	0.00371447	0.4952626666666667
XQ12-Q13.3 DUPLICATION SYNDROME	0.0036966399999999997	0.4928853333333333
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 2	0.0036843500000000003	0.4912466666666667
MYASTHENIC SYNDROME, CONGENITAL, 25, PRESYNAPTIC; CMS25	0.0036843500000000003	0.4912466666666667
MOEBIUS SYNDROME	0.0036843500000000003	0.4912466666666667
GAUCHER DISEASE	0.0036843500000000003	0.4912466666666667
SPINOCEREBELLAR ATAXIA TYPE 42	0.0036843500000000003	0.4912466666666667
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 1; SCAR1	0.0036843500000000003	0.4912466666666667
MYASTHENIC SYNDROME, CONGENITAL, 6, PRESYNAPTIC; CMS6	0.0036843500000000003	0.4912466666666667
ADULT-ONSET MULTIPLE MITOCHONDRIAL DNA DELETION SYNDROME DUE TO DGUOK DEFICIENCY	0.0036843500000000003	0.4912466666666667
GAUCHER DISEASE TYPE 2	0.0036843500000000003	0.4912466666666667
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 78	0.0036549699999999996	0.4873293333333333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 55	0.0036549699999999996	0.4873293333333333
MYHRE SYNDROME	0.0036193030000000004	0.4825737333333334
X-LINKED INTELLECTUAL DISABILITY-CEREBELLAR HYPOPLASIA SYNDROME	0.003619303	0.4825737333333333
GLYCEROL KINASE DEFICIENCY; GKD	0.003619303	0.4825737333333333
2Q31.1 MICRODELETION SYNDROME	0.003619303	0.4825737333333333
DISTAL 22Q11.2 MICRODUPLICATION SYNDROME	0.003619303	0.4825737333333333
CRANIOSYNOSTOSIS AND DENTAL ANOMALIES; CRSDA	0.00357143	0.4761906666666667
3P25.3 MICRODELETION SYNDROME	0.00357143	0.4761906666666667
METAPHYSEAL CHONDRODYSPLASIA, JANSEN TYPE	0.00357143	0.4761906666666667
PYCNODYSOSTOSIS	0.00357143	0.4761906666666667
CLEIDOCRANIAL DYSPLASIA, RECESSIVE FORM	0.00357143	0.4761906666666667
WEILL-MARCHESANI SYNDROME 2; WMS2	0.00357143	0.4761906666666667
INTELLECTUAL DISABILITY-HYPOTONIA-BRACHYCEPHALY-PYLORIC STENOSIS-CRYPTORCHIDISM SYNDROME	0.00357143	0.4761906666666667
MICROCEPHALY-MICROCORNEA SYNDROME, SEEMANOVA TYPE	0.00357143	0.4761906666666667
CROUZON SYNDROME WITH ACANTHOSIS NIGRICANS	0.00357143	0.4761906666666667
CRANIOSYNOSTOSIS, HERRMANN-OPITZ TYPE	0.00357143	0.4761906666666667
CARTILAGE-HAIR HYPOPLASIA; CHH	0.00357143	0.4761906666666667
PSEUDODIASTROPHIC DYSPLASIA	0.00357143	0.4761906666666667
ACHARD SYNDROME	0.00357143	0.4761906666666667
CRANIODIGITAL-INTELLECTUAL DISABILITY SYNDROME	0.00357143	0.4761906666666667
PFEIFFER SYNDROME TYPE 1	0.00357143	0.4761906666666667
CEREBELLAR ATAXIA-HYPOGONADISM SYNDROME	0.00357143	0.4761906666666667
MULTICENTRIC OSTEOLYSIS-NODULOSIS-ARTHROPATHY SPECTRUM	0.00357143	0.4761906666666667
SHORT-RIB THORACIC DYSPLASIA 6 WITH OR WITHOUT POLYDACTYLY; SRTD6	0.00357143	0.4761906666666667
WEILL-MARCHESANI SYNDROME 1; WMS1	0.00357143	0.4761906666666667
ISOLATED BRACHYCEPHALY	0.00357143	0.4761906666666667
DYSOSTOSIS, STANESCU TYPE	0.00357143	0.4761906666666667
SHORT-RIB THORACIC DYSPLASIA 20 WITH POLYDACTYLY; SRTD20	0.00357143	0.4761906666666667
ANTLEY-BIXLER SYNDROME WITHOUT GENITAL ANOMALIES OR DISORDERED STEROIDOGENESIS; ABS2	0.00357143	0.4761906666666667
239710 ACROFRONTOFACIONASAL DYSOSTOSIS 2;;AFFN DYSOSTOSIS 2; AFFND2;;ACROFRONTOFACIONASAL DYSOSTOSIS WITH GENITOURINARY ANOMALIES;;NAGUIB-RICHIERI-COSTA SYNDROME;;HYPERTELORISM, HYPOSPADIAS, AND POLYSYNDACTYLY SYNDROME	0.00357143	0.4761906666666667
CLEIDOCRANIAL DYSPLASIA	0.00357143	0.4761906666666667
OSTEOGENESIS IMPERFECTA	0.00357143	0.4761906666666667
GORLIN-CHAUDHRY-MOSS SYNDROME	0.00357143	0.4761906666666667
GRANT SYNDROME	0.00357143	0.4761906666666667
COMMON VARIABLE IMMUNODEFICIENCY	0.00357143	0.4761906666666667
OSTEOSCLEROSIS-DEVELOPMENTAL DELAY-CRANIOSYNOSTOSIS SYNDROME	0.00357143	0.4761906666666667
HYPOMANDIBULAR FACIOCRANIAL DYSOSTOSIS	0.00357143	0.4761906666666667
16P11.2P12.2 MICRODUPLICATION SYNDROME	0.003556113	0.47414839999999997
COWDEN SYNDROME	0.0035561129999999996	0.47414839999999997
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 2	0.0035259930000000003	0.47013240000000006
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 64; MRT64	0.0035259930000000003	0.47013240000000006
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 46; EIEE46	0.0035259930000000003	0.47013240000000006
CEREBRAL PALSY, SPASTIC QUADRIPLEGIC, 3; CPSQ3	0.0035259930000000003	0.47013240000000006
ADULT-ONSET DYSTONIA-PARKINSONISM	0.003525993	0.4701324
X-LINKED CEREBRAL-CEREBELLAR-COLOBOMA SYNDROME	0.003525993	0.4701324
AUTOSOMAL DOMINANT OPTIC ATROPHY, CLASSIC FORM	0.003525993	0.4701324
LEIGH SYNDROME WITH CARDIOMYOPATHY	0.003525993	0.4701324
CLASSIC PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.003525993	0.4701324
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 3; PEOA3	0.003525993	0.4701324
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, C; HPABH4C	0.003525993	0.4701324
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, B; HPABH4B	0.003525993	0.4701324
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA DUE TO STUB1 DEFICIENCY	0.003525993	0.4701324
DYSTONIA-APHONIA SYNDROME	0.003525993	0.4701324
6-PYRUVOYL-TETRAHYDROPTERIN SYNTHASE DEFICIENCY	0.003525993	0.4701324
THIAMINE METABOLISM DYSFUNCTION SYNDROME 2 (BIOTIN- OR THIAMINE-RESPONSIVE TYPE); THMD2	0.003525993	0.4701324
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, A; HPABH4A	0.003525993	0.4701324
HSD10 DISEASE	0.003525993	0.4701324
NIEMANN-PICK DISEASE TYPE C	0.003525993	0.4701324
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 55; EIEE55	0.003496613	0.4662150666666667
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN ATROPHY AND THIN CORPUS CALLOSUM; PEBAT	0.003496613	0.4662150666666667
LISSENCEPHALY 8; LIS8	0.003496613	0.4662150666666667
PONTOCEREBELLAR HYPOPLASIA, TYPE 9	0.003496613	0.4662150666666667
NEURODEVELOPMENTAL DISORDER WITH CEREBELLAR ATROPHY AND WITH OR WITHOUT SEIZURES; NEDCAS	0.003496613	0.4662150666666667
PROGRESSIVE ENCEPHALOPATHY WITH LEUKODYSTROPHY DUE TO DECR DEFICIENCY	0.003496613	0.4662150666666667
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 12; COXPD12	0.003496613	0.4662150666666667
PLAA-ASSOCIATED NEURODEVELOPMENTAL DISORDER	0.003496613	0.4662150666666667
LEUKODYSTROPHY, HYPOMYELINATING, 10; HLD10	0.003496613	0.4662150666666667
COFFIN-SIRIS SYNDROME 5	0.003496613	0.4662150666666667
ENCEPHALOPATHY, PROGRESSIVE, WITH AMYOTROPHY AND OPTIC ATROPHY; PEAMO	0.003496613	0.4662150666666667
PONTOCEREBELLAR HYPOPLASIA, TYPE 2D	0.0034966129999999995	0.46621506666666657
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 13; MC1DN13	0.0034966129999999995	0.46621506666666657
MICROCEPHALY, CORPUS CALLOSUM DYSGENESIS, AND CLEFT LIP/PALATE	0.0034966129999999995	0.46621506666666657
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 2; CDCBM2	0.0034966129999999995	0.46621506666666657
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 3; CDCBM3	0.0034966129999999995	0.46621506666666657
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIQ; CDG2Q	0.0034966129999999995	0.46621506666666657
PONTOCEREBELLAR HYPOPLASIA, TYPE 2E; PCH2E	0.0034966129999999995	0.46621506666666657
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 28; EIEE28	0.0034966129999999995	0.46621506666666657
LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6	0.0034966129999999995	0.46621506666666657
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 42; MRT42	0.0034966129999999995	0.46621506666666657
X-LINKED INTELLECTUAL DISABILITY-DYSMORPHISM-CEREBRAL ATROPHY SYNDROME	0.0034938680000000002	0.46584906666666664
PRIETO X-LINKED MENTAL RETARDATION SYNDROME; PRS	0.0034938680000000002	0.46584906666666664
JOHANSON-BLIZZARD SYNDROME; JBS	0.0034938680000000002	0.46584906666666664
ARTHROGRYPOSIS MULTIPLEX CONGENITA, MYOGENIC TYPE; AMCM	0.0034938680000000002	0.46584906666666664
EHLERS-DANLOS SYNDROME, SPONDYLODYSPLASTIC TYPE, 1; EDSSPD1	0.0034717320000000004	0.4628976000000001
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 25; COXPD25	0.0034717320000000004	0.4628976000000001
CHROMOSOME 16Q22 DELETION SYNDROME	0.0034717320000000004	0.4628976000000001
INTELLECTUAL DEVELOPMENTAL DISORDER WITH ABNORMAL BEHAVIOR, MICROCEPHALY, AND SHORT STATURE; IDDABS	0.0034717320000000004	0.4628976000000001
OKUR-CHUNG NEURODEVELOPMENTAL SYNDROME; OCNDS	0.0034717320000000004	0.4628976000000001
NEURODEVELOPMENTAL DISORDER, X-LINKED, WITH CRANIOFACIAL ABNORMALITIES; NEDXCF	0.003471732	0.4628976
LATHOSTEROLOSIS	0.003467597	0.4623462666666667
PEROXISOME BIOGENESIS DISORDER 3A (ZELLWEGER); PBD3A	0.003467597	0.4623462666666667
DEAFNESS, ONYCHODYSTROPHY, OSTEODYSTROPHY, MENTAL RETARDATION, AND SEIZURES SYNDROME; DOORS	0.003467597	0.4623462666666667
TEMPLE-BARAITSER SYNDROME	0.003467597	0.4623462666666667
PEROXISOME BIOGENESIS DISORDER 6A (ZELLWEGER); PBD6A	0.003467597	0.4623462666666667
SPINOCEREBELLAR ATAXIA 47; SCA47	0.003467597	0.4623462666666667
EHLERS-DANLOS SYNDROME, TYPE VI	0.003430678	0.4574237333333333
SINGLETON-MERTEN SYNDROME 1; SGMRT1	0.003430678	0.4574237333333333
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.003430678	0.4574237333333333
DESBUQUOIS DYSPLASIA 1	0.003430678	0.4574237333333333
SPINOCEREBELLAR ATAXIA 2; SCA2	0.003400558	0.45340773333333334
LESCH-NYHAN SYNDROME; LNS	0.003400558	0.45340773333333334
MITOCHONDRIAL DNA DEPLETION SYNDROME, MYOPATHIC FORM	0.003400558	0.45340773333333334
LIPID STORAGE MYOPATHY DUE TO FLAVIN ADENINE DINUCLEOTIDE SYNTHETASE DEFICIENCY	0.003400558	0.45340773333333334
MYASTHENIC SYNDROME, CONGENITAL, 5; CMS5	0.003400558	0.45340773333333334
ADDUCTED THUMBS SYNDROME	0.003400558	0.45340773333333334
MYOTONIC DYSTROPHY 1	0.003400558	0.45340773333333334
SPINOCEREBELLAR ATAXIA 1	0.003400558	0.45340773333333334
STUVE-WIEDEMANN SYNDROME	0.003400558	0.45340773333333334
PARTIAL DELETION OF THE SHORT ARM OF CHROMOSOME 7	0.003400558	0.45340773333333334
MYASTHENIC SYNDROME, CONGENITAL, 3C, ASSOCIATED WITH ACETYLCHOLINE RECEPTOR DEFICIENCY; CMS3C	0.003400558	0.45340773333333334
SPINOCEREBELLAR ATAXIA TYPE 1	0.003400558	0.45340773333333334
MYASTHENIC SYNDROME, CONGENITAL, 20, PRESYNAPTIC; CMS20	0.003400558	0.45340773333333334
LEUKOENCEPHALOPATHY, ARTHRITIS, COLITIS, AND HYPOGAMMAGLOBULINEMA	0.003400558	0.45340773333333334
SKELETAL DYSPLASIA-T-CELL IMMUNODEFICIENCY-DEVELOPMENTAL DELAY SYNDROME	0.003371178	0.4494904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 14; EIEE14	0.003371178	0.4494904
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 7; MDDGA7	0.003371178	0.4494904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 4	0.003371178	0.4494904
ROIFMAN SYNDROME	0.003371178	0.4494904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 73; EIEE73	0.003371178	0.4494904
COMBINED SAPOSIN DEFICIENCY	0.003371178	0.4494904
AICARDI-GOUTIERES SYNDROME 3; AGS3	0.003371178	0.4494904
MICROCEPHALY, CEREBELLAR HYPOPLASIA, AND CARDIAC CONDUCTION DEFECT SYNDROME; MCHCCD	0.003371178	0.4494904
LETHAL CONGENITAL CONTRACTURE SYNDROME 7; LCCS7	0.003371178	0.4494904
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 53; EIEE53	0.003371178	0.4494904
MEND SYNDROME; MEND	0.003335511	0.44473480000000004
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18; GPIBD18	0.003335511	0.44473480000000004
PEROXISOME BIOGENESIS DISORDER 5A (ZELLWEGER)	0.0033355109999999998	0.44473479999999993
MENTAL RETARDATION, AUTOSOMAL DOMINANT 52; MRD52	0.0033355109999999998	0.44473479999999993
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IJ; CDG1J	0.0033355109999999998	0.44473479999999993
STT3B-CDG	0.0033355109999999998	0.44473479999999993
STT3A-CDG	0.0033355109999999998	0.44473479999999993
MICROPHTHALMIA, SYNDROMIC 5; MCOPS5	0.0033355109999999998	0.44473479999999993
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 70; EIEE70	0.0033355109999999998	0.44473479999999993
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IX; CDG1X	0.0033355109999999998	0.44473479999999993
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 18	0.0033355109999999998	0.44473479999999993
MENTAL RETARDATION, AUTOSOMAL DOMINANT 53; MRD53	0.0032938410000000005	0.4391788000000001
NEURODEVELOPMENTAL DISORDER WITH ATAXIC GAIT, ABSENT SPEECH, AND DECREASED CORTICAL WHITE MATTER; NDAGSCW	0.003293841	0.4391788
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIN	0.003293841	0.4391788
RAYNAUD-CLAES SYNDROME; MRXSRC	0.003293841	0.4391788
SCHINDLER DISEASE, TYPE I	0.003293841	0.4391788
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IU; CDG1U	0.003293841	0.4391788
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IF	0.003293841	0.4391788
GALLOWAY-MOWAT SYNDROME 8; GAMOS8	0.003293841	0.4391788
CEREBELLAR ATAXIA, MENTAL RETARDATION, AND DYSEQUILIBRIUM SYNDROME 1; CAMRQ1	0.003293841	0.4391788
CHROMOSOME 17Q11.2 DELETION SYNDROME, 1.4-MB	0.003293841	0.4391788
MENTAL RETARDATION, AUTOSOMAL DOMINANT 49; MRD49	0.003293841	0.4391788
MENTAL RETARDATION, X-LINKED 90	0.003293841	0.4391788
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 4; MC1DN4	0.003293841	0.4391788
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 14; MDDGB14	0.003293841	0.4391788
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 1; MC1DN1	0.003293841	0.4391788
LEUKODYSTROPHY, HYPOMYELINATING, 4	0.003293841	0.4391788
LEIGH SYNDROME; LS	0.003293841	0.4391788
ADAMS-OLIVER SYNDROME 2; AOS2	0.003293841	0.4391788
PONTOCEREBELLAR HYPOPLASIA, TYPE 1B	0.003293841	0.4391788
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2A	0.003293841	0.4391788
MUSCULAR DYSTROPHY, CONGENITAL, WITH CATARACTS AND INTELLECTUAL DISABILITY	0.003293841	0.4391788
MENTAL RETARDATION, AUTOSOMAL DOMINANT 42	0.003293841	0.4391788
MITOCHONDRIAL DNA DEPLETION SYNDROME 5 (ENCEPHALOMYOPATHIC WITH OR WITHOUT METHYLMALONIC ACIDURIA); MTDPS5	0.003293841	0.4391788
NEURODEVELOPMENTAL DISORDER WITH SEVERE MOTOR IMPAIRMENT AND ABSENT LANGUAGE; NEDMIAL	0.003293841	0.4391788
GENITOPALATOCARDIAC SYNDROME	0.00325164	0.433552
DYSSEGMENTAL DYSPLASIA, SILVERMAN-HANDMAKER TYPE; DDSH	0.00325164	0.433552
BEEMER-ERTBRUGGEN SYNDROME	0.00325164	0.433552
14Q24.1Q24.3 MICRODELETION SYNDROME	0.00325164	0.433552
OMODYSPLASIA 1; OMOD1	0.00325164	0.433552
SHORT STATURE-WORMIAN BONES-DEXTROCARDIA SYNDROME	0.00325164	0.433552
FRASER SYNDROME	0.00325164	0.433552
SPONDYLOEPIPHYSEAL DYSPLASIA, CANTU TYPE	0.00325164	0.433552
HYPERTELORISM AND OTHER FACIAL DYSMORPHISM, BRACHYDACTYLY, GENITAL ABNORMALITIES, MENTAL RETARDATION, AND RECURRENT INFLAMMATORY EPISODES	0.00325164	0.433552
ALPHA-THALASSEMIA-INTELLECTUAL DISABILITY SYNDROME LINKED TO CHROMOSOME 16	0.00325164	0.433552
SPONDYLOMETAPHYSEAL DYSPLASIA, X-LINKED	0.0032099700000000004	0.42799600000000004
271960 SUBAORTIC STENOSIS--SHORT STATURE SYNDROME;;ONAT SYNDROME	0.0032099700000000004	0.42799600000000004
AXENFELD-RIEGER SYNDROME, TYPE 1; RIEG1	0.0032099700000000004	0.42799600000000004
NON-DISTAL MONOSOMY 10Q	0.0032099700000000004	0.42799600000000004
DEAFNESS WITH LABYRINTHINE APLASIA, MICROTIA, AND MICRODONTIA	0.0032099700000000004	0.42799600000000004
FOCAL FACIAL DERMAL DYSPLASIA TYPE III	0.0032099700000000004	0.42799600000000004
15Q26 OVERGROWTH SYNDROME	0.0032099700000000004	0.42799600000000004
ATRIOVENTRICULAR DEFECT-BLEPHAROPHIMOSIS-RADIAL AND ANAL DEFECT SYNDROME	0.0032099700000000004	0.42799600000000004
TOLUENE EMBRYOPATHY	0.0030778840000000003	0.4103845333333334
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 3; ICF3	0.0030778840000000003	0.4103845333333334
FANCONI ANEMIA, COMPLEMENTATION GROUP E; FANCE	0.0030778840000000003	0.4103845333333334
FETAL HYDANTOIN SYNDROME	0.0030778840000000003	0.4103845333333334
DYSKERATOSIS CONGENITA, X-LINKED; DKCX	0.0030778840000000003	0.4103845333333334
FANCONI ANEMIA	0.0030778840000000003	0.4103845333333334
VISCERAL NEUROPATHY-BRAIN ANOMALIES-FACIAL DYSMORPHISM-DEVELOPMENTAL DELAY SYNDROME	0.0030778840000000003	0.4103845333333334
QAZI-MARKOUIZOS SYNDROME	0.0030737489999999998	0.40983319999999995
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY DUE TO JARID1C MUTATION	0.0030737489999999998	0.40983319999999995
COCKAYNE SYNDROME A; CSA	0.0030737489999999998	0.40983319999999995
SECKEL SYNDROME 1; SCKL1	0.0030737489999999998	0.40983319999999995
XERODERMA PIGMENTOSUM	0.0030737489999999998	0.40983319999999995
KABUKI SYNDROME	0.0030737489999999998	0.40983319999999995
X-LINKED INTELLECTUAL DISABILITY, NASCIMENTO TYPE	0.0030737489999999998	0.40983319999999995
COCKAYNE SYNDROME	0.0030737489999999998	0.40983319999999995
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 11; GPIBD11	0.0030516130000000003	0.4068817333333334
TETRASOMY 5P	0.003051613	0.4068817333333333
3Q29 MICRODUPLICATION SYNDROME	0.003051613	0.4068817333333333
20P12.3 MICRODELETION SYNDROME	0.003051613	0.4068817333333333
TRIGONOCEPHALY WITH SHORT STATURE AND DEVELOPMENTAL DELAY	0.003051613	0.4068817333333333
TRIGONOCEPHALY-SHORT STATURE-DEVELOPMENTAL DELAY SYNDROME	0.003051613	0.4068817333333333
MAN1B1-CDG	0.003051613	0.4068817333333333
MUCOPOLYSACCHARIDOSIS TYPE 2	0.003051613	0.4068817333333333
BEAULIEU-BOYCOTT-INNES SYNDROME; BBIS	0.003014694	0.40195919999999996
DEAFNESS-EPIPHYSEAL DYSPLASIA-SHORT STATURE SYNDROME	0.003014694	0.40195919999999996
BIOTINIDASE DEFICIENCY	0.003014694	0.40195919999999996
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 45	0.003014694	0.40195919999999996
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY	0.003014694	0.40195919999999996
MYELODYSPLASIA, IMMUNODEFICIENCY, FACIAL DYSMORPHISM, SHORT STATURE,	0.003014694	0.40195919999999996
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 11; MDDGA11	0.003014694	0.40195919999999996
MACROCEPHALY/MEGALENCEPHALY SYNDROME, AUTOSOMAL RECESSIVE	0.003014694	0.40195919999999996
OPHTHALMOPLEGIA-INTELLECTUAL DISABILITY-LINGUA SCROTALIS SYNDROME	0.003014694	0.40195919999999996
ABLEPHARON MACROSTOMIA SYNDROME	0.003014694	0.40195919999999996
BONE FRAGILITY WITH CONTRACTURES, ARTERIAL RUPTURE, AND DEAFNESS	0.003014694	0.40195919999999996
CRANIOSYNOSTOSIS 2	0.003010559	0.4014078666666666
MUCOPOLYSACCHARIDOSIS TYPE 3	0.003010559	0.4014078666666666
COWDEN SYNDROME 6; CWS6	0.003010559	0.4014078666666666
FLYNN-AIRD SYNDROME	0.003010559	0.4014078666666666
ENCEPHALOPATHY DUE TO SULFITE OXIDASE DEFICIENCY	0.003010559	0.4014078666666666
SJÖGREN-LARSSON SYNDROME	0.003010559	0.4014078666666666
5Q35 MICRODUPLICATION SYNDROME	0.003010559	0.4014078666666666
FOUNTAIN SYNDROME	0.003010559	0.4014078666666666
BRAIN SMALL VESSEL DISEASE 1 WITH OR WITHOUT OCULAR ANOMALIES; BSVD1	0.003010559	0.4014078666666666
GYRATE ATROPHY OF CHOROID AND RETINA	0.003010559	0.4014078666666666
COWDEN SYNDROME 5; CWS5	0.003010559	0.4014078666666666
CLASSIC HOMOCYSTINURIA	0.003010559	0.4014078666666666
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 11; SCAR11	0.0029845740000000003	0.39794320000000005
DIHYDROPTERIDINE REDUCTASE DEFICIENCY	0.0029845740000000003	0.39794320000000005
EARLY MYOCLONIC ENCEPHALOPATHY	0.0029845740000000003	0.39794320000000005
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-PSYCHOMOTOR DELAY SYNDROME	0.0029845740000000003	0.39794320000000005
PEROXISOME BIOGENESIS DISORDER 8B; PBD8B	0.0029845740000000003	0.39794320000000005
PLECTIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R17	0.0029845740000000003	0.39794320000000005
ADULT-ONSET AUTOSOMAL DOMINANT LEUKODYSTROPHY	0.0029845740000000003	0.39794320000000005
ATAXIA-TELANGIECTASIA-LIKE DISORDER 2; ATLD2	0.0029845740000000003	0.39794320000000005
SPINOCEREBELLAR ATAXIA TYPE 7	0.0029845740000000003	0.39794320000000005
%300858 MENTAL RETARDATION, X-LINKED, SYNDROMIC 17; MRXS17;;MENTAL RETARDATION, X-LINKED, WITH ALACRIMA AND ACHALASIA	0.0029845740000000003	0.39794320000000005
DEVELOPMENTAL MALFORMATIONS-DEAFNESS-DYSTONIA SYNDROME	0.0029845740000000003	0.39794320000000005
SYNAPTIC CONGENITAL MYASTHENIC SYNDROMES	0.0029845740000000003	0.39794320000000005
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 1; NBIA1	0.0029845740000000003	0.39794320000000005
COENZYME Q10 DEFICIENCY, PRIMARY, 7; COQ10D7	0.002980439	0.3973918666666667
MYASTHENIA GRAVIS	0.002980439	0.3973918666666667
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 2B; NBIA2B	0.002980439	0.3973918666666667
LIPOID PROTEINOSIS	0.002980439	0.3973918666666667
RIBOFLAVIN TRANSPORTER DEFICIENCY	0.002980439	0.3973918666666667
GLYCOGEN STORAGE DISEASE DUE TO ACID MALTASE DEFICIENCY	0.002980439	0.3973918666666667
POSTENCEPHALITIC PARKINSONISM	0.002980439	0.3973918666666667
ECTODERMAL DYSPLASIA SYNDROME	0.002980439	0.3973918666666667
MOYAMOYA DISEASE 6 WITH ACHALASIA	0.002980439	0.3973918666666667
CEREBELLAR ATAXIA-AREFLEXIA-PES CAVUS-OPTIC ATROPHY-SENSORINEURAL HEARING LOSS SYNDROME	0.002980439	0.3973918666666667
ALZHEIMER DISEASE 3; AD	0.002980439	0.3973918666666667
IDIOPATHIC HYPEREOSINOPHILIC SYNDROME	0.002980439	0.3973918666666667
MICROCEPHALY 19, PRIMARY, AUTOSOMAL RECESSIVE; MCPH19	0.0029551939999999995	0.39402586666666656
CONGENITAL CATARACT-PROGRESSIVE MUSCULAR HYPOTONIA-HEARING LOSS-DEVELOPMENTAL DELAY SYNDROME	0.0029551939999999995	0.39402586666666656
606156 SENER SYNDROME;;FRONTONASAL DYSPLASIA AND DILATED VIRCHOW-ROBIN SPACES	0.0029551939999999995	0.39402586666666656
PEHO-LIKE SYNDROME; PEHOL	0.0029551939999999995	0.39402586666666656
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 56	0.0029551939999999995	0.39402586666666656
TERATOCARCINOMA-DERIVED GROWTH FACTOR 1; TDGF1	0.0029551939999999995	0.39402586666666656
SPASTIC PARAPLEGIA 48, AUTOSOMAL RECESSIVE; SPG48	0.0029551939999999995	0.39402586666666656
MICROCEPHALY 25, PRIMARY, AUTOSOMAL RECESSIVE; MCPH25	0.0029551939999999995	0.39402586666666656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 61; MRT61	0.0029551939999999995	0.39402586666666656
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 7	0.0029551939999999995	0.39402586666666656
MICROCEPHALY-THIN CORPUS CALLOSUM-INTELLECTUAL DISABILITY SYNDROME	0.0029551939999999995	0.39402586666666656
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 71	0.0029551939999999995	0.39402586666666656
17P13.3 MICRODUPLICATION SYNDROME	0.0029551939999999995	0.39402586666666656
RARS-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0029551939999999995	0.39402586666666656
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 6; NBIA6	0.0029551939999999995	0.39402586666666656
PONTOCEREBELLAR HYPOPLASIA, TYPE 1C; PCH1C	0.0029551939999999995	0.39402586666666656
LEUKODYSTROPHY, HYPOMYELINATING, 9; HLD9	0.0029551939999999995	0.39402586666666656
COG2-CDG	0.0029551939999999995	0.39402586666666656
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 27; COXPD27	0.0029551939999999995	0.39402586666666656
VPS11-RELATED AUTOSOMAL RECESSIVE HYPOMYELINATING LEUKODYSTROPHY	0.0029551939999999995	0.39402586666666656
POSTNATAL MICROCEPHALY-INFANTILE HYPOTONIA-SPASTIC DIPLEGIA-DYSARTHRIA-INTELLECTUAL DISABILITY SYNDROME	0.0029551939999999995	0.39402586666666656
COG4-CDG	0.0029551939999999995	0.39402586666666656
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 40; MRT40	0.0029551939999999995	0.39402586666666656
MICROCEPHALY-INTELLECTUAL DISABILITY-SENSORINEURAL HEARING LOSS-EPILEPSY-ABNORMAL MUSCLE TONE SYNDROME	0.0029551939999999995	0.39402586666666656
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 15	0.002951059	0.3934745333333333
NEURODEVELOPMENTAL DISORDER WITH OR WITHOUT HYPERKINETIC MOVEMENTS AND SEIZURES, AUTOSOMAL DOMINANT; NDHMSD	0.002951059	0.3934745333333333
20Q13.33 MICRODELETION SYNDROME	0.002951059	0.3934745333333333
FAMILIAL MULTIPLE LIPOMATOSIS	0.002951059	0.3934745333333333
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP A; MOCODA	0.002951059	0.3934745333333333
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP B; MOCODB	0.002951059	0.3934745333333333
HYPOTONIA, INFANTILE, WITH PSYCHOMOTOR RETARDATION AND CHARACTERISTIC FACIES 3; IHPRF3	0.002951059	0.3934745333333333
SPASTIC PARAPLEGIA 44, AUTOSOMAL RECESSIVE; SPG44	0.002951059	0.3934745333333333
SCHINZEL-GIEDION MIDFACE-RETRACTION SYNDROME	0.002951059	0.3934745333333333
MILLER-DIEKER SYNDROME	0.002951059	0.3934745333333333
ASPARAGINE SYNTHETASE DEFICIENCY; ASNSD	0.002951059	0.3934745333333333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 35	0.002951059	0.3934745333333333
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 3; MMDS3	0.002951059	0.3934745333333333
LEUKOENCEPHALOPATHY WITH BRAIN STEM AND SPINAL CORD INVOLVEMENT-HIGH LACTATE SYNDROME	0.002951059	0.3934745333333333
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA WITH SCLEROSING LEUKOENCEPHALOPATHY; PLOSL	0.002951059	0.3934745333333333
BENIGN SAMARITAN CONGENITAL MYOPATHY	0.002926178	0.39015706666666666
JOUBERT SYNDROME 3; JBTS3	0.002926178	0.39015706666666666
CHROMOSOME 8Q21.11 DELETION SYNDROME	0.002926178	0.39015706666666666
TRICHORHINOPHALANGEAL SYNDROME, TYPE II	0.002926178	0.39015706666666666
SHPRINTZEN OMPHALOCELE SYNDROME	0.002926178	0.39015706666666666
ZIMMERMANN-LABAND SYNDROME 2; ZLS2	0.002926178	0.39015706666666666
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 2	0.002926178	0.39015706666666666
CUTANEOUS MASTOCYTOSIS, CONDUCTIVE HEARING LOSS AND MICROTIA	0.002926178	0.39015706666666666
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IG; CDG1G	0.0027940919999999998	0.3725456
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR 2; NSLH2	0.0027940919999999998	0.3725456
OGDEN SYNDROME	0.0027940919999999998	0.3725456
NOONAN SYNDROME-LIKE DISORDER WITH OR WITHOUT JUVENILE MYELOMONOCYTIC LEUKEMIA	0.0027940919999999998	0.3725456
RITSCHER-SCHINZEL SYNDROME 2; RTSC2	0.0027940919999999998	0.3725456
AU-KLINE SYNDROME; AUKS	0.0027940919999999998	0.3725456
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 1; MC5DN1	0.0027940919999999998	0.3725456
PEROXISOME BIOGENESIS DISORDER 2A (ZELLWEGER); PBD2A	0.002789957	0.3719942666666667
BORJESON-FORSSMAN-LEHMANN SYNDROME; BFLS	0.002789957	0.3719942666666667
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 55	0.002752422	0.3669896
CONGENITAL MUSCULAR DYSTROPHY WITH INTELLECTUAL DISABILITY AND SEVERE EPILEPSY	0.002752422	0.3669896
JOUBERT SYNDROME 14	0.002752422	0.3669896
NEURODEGENERATION, CHILDHOOD-ONSET, WITH CEREBELLAR ATROPHY; CONDCA	0.002752422	0.3669896
ENCEPHALOPATHY DUE TO DEFECTIVE MITOCHONDRIAL AND PEROXISOMAL FISSION 1	0.002752422	0.3669896
YUAN-HAREL-LUPSKI SYNDROME; YUHAL	0.002752422	0.3669896
MUCOLIPIDOSIS IV; ML4	0.002752422	0.3669896
COFFIN-SIRIS SYNDROME 7; CSS7	0.002752422	0.3669896
CUTIS LAXA, AUTOSOMAL DOMINANT 3; ADCL3	0.002752422	0.3669896
MARINESCO-SJOGREN SYNDROME; MSS	0.002752422	0.3669896
CHROMOSOME 17P13.1 DELETION SYNDROME	0.002752422	0.3669896
INTELLECTUAL DEVELOPMENTAL DISORDER, X-LINKED 108; MRX108	0.002752422	0.3669896
GLOBAL DEVELOPMENTAL DELAY-NEURO-OPHTHALMOLOGICAL ABNORMALITIES-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.002752422	0.3669896
ENCEPHALOPATHY, PROGRESSIVE, EARLY-ONSET, WITH BRAIN EDEMA AND/OR LEUKOENCEPHALOPATHY, 1; PEBEL1	0.0027482870000000003	0.3664382666666667
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.0027482870000000003	0.3664382666666667
CYCLIC VOMITING SYNDROME	0.0027482870000000003	0.3664382666666667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IE	0.0027482870000000003	0.3664382666666667
PONTOCEREBELLAR HYPOPLASIA, TYPE 2F	0.002748287	0.3664382666666667
SCARF SYNDROME	0.00253233	0.337644
SECKEL SYNDROME 5; SCKL5	0.00253233	0.337644
MCDONOUGH SYNDROME	0.00253233	0.337644
TRISOMY 4P	0.00253233	0.337644
SKELETAL DEFECTS, GENITAL HYPOPLASIA, AND MENTAL RETARDATION	0.00253233	0.337644
URBAN-ROGERS-MEYER SYNDROME	0.00253233	0.337644
ELLIS VAN CREVELD SYNDROME	0.00253233	0.337644
FLOATING-HARBOR SYNDROME	0.00253233	0.337644
X-LINKED INTELLECTUAL DISABILITY-DANDY-WALKER MALFORMATION-BASAL GANGLIA DISEASE-SEIZURES SYNDROME	0.00253233	0.337644
NOONAN SYNDROME	0.00253233	0.337644
STEINERT MYOTONIC DYSTROPHY	0.00253233	0.337644
FANCONI ANEMIA	0.00253233	0.337644
CATARACT-INTELLECTUAL DISABILITY-ANAL ATRESIA-URINARY DEFECTS SYNDROME	0.00253233	0.337644
TREACHER COLLINS-FRANCESCHETTI SYNDROME	0.00253233	0.337644
ROIFMAN-CHITAYAT SYNDROME	0.0025101940000000003	0.3346925333333334
ZECHI-CEIDE SYNDROME	0.0025101940000000003	0.3346925333333334
JOUBERT SYNDROME 10	0.0025101940000000003	0.3346925333333334
HAMEL CEREBRO-PALATO-CARDIAC SYNDROME	0.0025101940000000003	0.3346925333333334
ZELLWEGER-LIKE SYNDROME WITHOUT PEROXISOMAL ANOMALIES	0.0025101940000000003	0.3346925333333334
ALAZAMI SYNDROME; ALAZS	0.0025101940000000003	0.3346925333333334
SYNDROMIC DIARRHEA	0.0025101940000000003	0.3346925333333334
TRISOMY 12P	0.0025101940000000003	0.3346925333333334
HURLER SYNDROME	0.0025101940000000003	0.3346925333333334
DISTAL MONOSOMY 9P	0.0025101940000000003	0.3346925333333334
STEEL SYNDROME; STLS	0.0025101940000000003	0.3346925333333334
HYPOTRICHOSIS-LYMPHEDEMA-TELANGIECTASIA-RENAL DEFECT SYNDROME; HLTRS	0.0025101940000000003	0.3346925333333334
HEREDITARY OROTIC ACIDURIA	0.0025101940000000003	0.3346925333333334
SPASTIC PARAPLEGIA 52, AUTOSOMAL RECESSIVE	0.0025101940000000003	0.3346925333333334
FANCONI ANEMIA, COMPLEMENTATION GROUP L	0.0025101940000000003	0.3346925333333334
RING CHROMOSOME 10 SYNDROME	0.002506059	0.3341412
HALL-RIGGS SYNDROME	0.002506059	0.3341412
HENNEKAM SYNDROME	0.002506059	0.3341412
MACROCEPHALY-DEVELOPMENTAL DELAY SYNDROME	0.002506059	0.3341412
ZLOTOGORA-OGUR SYNDROME	0.002506059	0.3341412
SIALIDOSIS TYPE 1	0.002506059	0.3341412
COFS SYNDROME	0.002506059	0.3341412
FAMILIAL BENIGN COPPER DEFICIENCY	0.002506059	0.3341412
EPIPHYSEAL DYSPLASIA-HEARING LOSS-DYSMORPHISM SYNDROME	0.002506059	0.3341412
ASPARTYLGLUCOSAMINURIA	0.002506059	0.3341412
HENNEKAM-BEEMER SYNDROME	0.002506059	0.3341412
LEBER CONGENITAL AMAUROSIS 15; LCA15	0.00246914	0.32921866666666666
HEMORRHAGIC FEVER-RENAL SYNDROME	0.00246914	0.32921866666666666
USHER SYNDROME TYPE 2	0.00246914	0.32921866666666666
CHORIORETINAL ATROPHY, PROGRESSIVE BIFOCAL	0.00246914	0.32921866666666666
%609259 MYOPIA 10; MYP10	0.00246914	0.32921866666666666
%609256 MYOPIA 7; MYP7	0.00246914	0.32921866666666666
%609257 MYOPIA 8; MYP8	0.00246914	0.32921866666666666
XP22.3 MICRODELETION SYNDROME	0.00246914	0.32921866666666666
%609258 MYOPIA 9; MYP9	0.00246914	0.32921866666666666
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME	0.00246914	0.32921866666666666
PSEUDOXANTHOMA ELASTICUM, FORME FRUSTE	0.00246914	0.32921866666666666
MULTIPLE EPIPHYSEAL DYSPLASIA, BEIGHTON TYPE	0.00246914	0.32921866666666666
GLAUCOMA-RELATED PIGMENT DISPERSION SYNDROME; GPDS1	0.00246914	0.32921866666666666
POLYDACTYLY, POSTAXIAL, WITH PROGRESSIVE MYOPIA	0.00246914	0.32921866666666666
SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA	0.00246914	0.32921866666666666
RETINITIS PIGMENTOSA 1	0.00246914	0.32921866666666666
FUNDUS DYSTROPHY, PSEUDOINFLAMMATORY, RECESSIVE FORM	0.00246914	0.32921866666666666
EPIDERMOLYSIS BULLOSA SIMPLEX WITH ANODONTIA/HYPODONTIA	0.00246914	0.32921866666666666
RETINAL CILIOPATHY DUE TO MUTATION IN USHER GENE	0.00246914	0.32921866666666666
SPASTIC PARAPLEGIA 79, AUTOSOMAL RECESSIVE; SPG79	0.00246914	0.32921866666666666
ANIRIDIA-PTOSIS-INTELLECTUAL DISABILITY-FAMILIAL OBESITY SYNDROME	0.00246914	0.32921866666666666
KNIEST DYSPLASIA	0.00246914	0.32921866666666666
APLASIA CUTIS CONGENITA-INTESTINAL LYMPHANGIECTASIA SYNDROME	0.00246914	0.32921866666666666
CONE-ROD DYSTROPHY, X-LINKED, 3	0.00246914	0.32921866666666666
CATARACT, POSTERIOR POLAR, 1 CTPA CATARACT, CONGENITAL TOTAL, INCLUDED	0.00246914	0.32921866666666666
ALAND ISLAND EYE DISEASE	0.00246914	0.32921866666666666
MULTIPLE EPIPHYSEAL DYSPLASIA	0.00246914	0.32921866666666666
BLEPHAROPTOSIS, MYOPIA, AND ECTOPIA LENTIS	0.00246914	0.32921866666666666
RETINAL DYSTROPHY AND OBESITY; RDOB	0.00246914	0.32921866666666666
NIGHT BLINDNESS-SKELETAL ANOMALIES-DYSMORPHISM SYNDROME	0.00246914	0.32921866666666666
MYOPIA 15; MYP15	0.00246914	0.32921866666666666
SVEINSSON CHORIORETINAL ATROPHY	0.00246914	0.32921866666666666
STICKLER SYNDROME, TYPE I	0.00246914	0.32921866666666666
SPASTIC ATAXIA-CORNEAL DYSTROPHY SYNDROME	0.00246914	0.32921866666666666
CONE-ROD DYSTROPHY, X-LINKED, 1; CORDX1	0.00246914	0.32921866666666666
BLUE CONE MONOCHROMACY; BCM	0.00246914	0.32921866666666666
BLEPHAROPTOSIS-MYOPIA-ECTOPIA LENTIS SYNDROME	0.00246914	0.32921866666666666
SPONDYLOEPIPHYSEAL DYSPLASIA AND SPONDYLOEPIMETAPHYSEAL DYSPLASIA	0.00246914	0.32921866666666666
CATARACT-MICROCORNEA SYNDROME	0.00246914	0.32921866666666666
MYOPIA 24, AUTOSOMAL DOMINANT; MYP24	0.00246914	0.32921866666666666
AUTOSOMAL RECESSIVE STICKLER SYNDROME	0.00246914	0.32921866666666666
CATARACT, AUTOSOMAL DOMINANT, MULTIPLE TYPES 1	0.00246914	0.32921866666666666
RETINOPATHY, PIGMENTARY, AND MENTAL RETARDATION	0.00246914	0.32921866666666666
CONDUCTIVE DEAFNESS-PTOSIS-SKELETAL ANOMALIES SYNDROME	0.00246914	0.32921866666666666
SPINOCEREBELLAR DEGENERATION WITH MACULAR CORNEAL DYSTROPHY, CONGENITALCATARACTS, AND MYOPIA	0.00246914	0.32921866666666666
MICROSPHEROPHAKIA-METAPHYSEAL DYSPLASIA	0.00246914	0.32921866666666666
MICROSPHEROPHAKIA WITH HERNIA	0.00246914	0.32921866666666666
MICROPHTHALMIA, ISOLATED, WITH CORECTOPIA	0.00246914	0.32921866666666666
MICROCORIA, CONGENITAL	0.00246914	0.32921866666666666
EXUDATIVE VITREORETINOPATHY 6; EVR6	0.00246914	0.32921866666666666
RETINAL DEGENERATION-NANOPHTHALMOS-GLAUCOMA SYNDROME	0.00246914	0.32921866666666666
184000 SPONDYLOEPIPHYSEAL DYSPLASIA, MYOPIA, AND SENSORINEURAL DEAFNESS	0.00246914	0.32921866666666666
INTELLECTUAL DISABILITY-MYOPATHY-SHORT STATURE-ENDOCRINE DEFECT SYNDROME	0.00246914	0.32921866666666666
GLAUCOMA, PRIMARY OPEN ANGLE	0.00246914	0.32921866666666666
GLAUCOMA 1, OPEN ANGLE, A	0.00246914	0.32921866666666666
VAN BOGAERT-HOZAY SYNDROME	0.00246914	0.32921866666666666
GASTROCUTANEOUS SYNDROME	0.00246914	0.32921866666666666
ALOPECIA-CONTRACTURES-DWARFISM-INTELLECTUAL DISABILITY SYNDROME	0.00246914	0.32921866666666666
WEILL-MARCHESANI SYNDROME 4; WMS4	0.00246914	0.32921866666666666
OPHTHALMOPLEGIA, EXTERNAL, AND MYOPIA	0.00246914	0.32921866666666666
EHLERS-DANLOS SYNDROME, TYPE I	0.00246914	0.32921866666666666
CRANIOECTODERMAL DYSPLASIA	0.00246914	0.32921866666666666
%310460 MYOPIA 1, X-LINKED; MYP1	0.00246914	0.32921866666666666
MARFAN SYNDROME	0.00246914	0.32921866666666666
SPONDYLO-OCULAR SYNDROME	0.00246914	0.32921866666666666
STICKLER SYNDROME TYPE 2	0.00246914	0.32921866666666666
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH HYPERCALCIURIA AND NEPHROCALCINOSIS WITH SEVERE OCULAR INVOLVEMENT	0.00246914	0.32921866666666666
GAPO SYNDROME	0.00246914	0.32921866666666666
GROWTH DELAY DUE TO INSULIN-LIKE GROWTH FACTOR TYPE 1 DEFICIENCY	0.00246914	0.32921866666666666
CHOROIDEREMIA	0.00246914	0.32921866666666666
BRITTLE CORNEA SYNDROME 2; BCS2	0.00246914	0.32921866666666666
SPONDYLOMETAPHYSEAL DYSPLASIA-CONE-ROD DYSTROPHY SYNDROME	0.00246914	0.32921866666666666
PSEUDOXANTHOMA ELASTICUM	0.00246914	0.32921866666666666
MYOPIA, INFANTILE SEVERE	0.00246914	0.32921866666666666
RETINITIS PIGMENTOSA 75; RP75	0.00246914	0.32921866666666666
ALPORT SYNDROME, X-LINKED; ATS	0.00246914	0.32921866666666666
RETINAL CAPILLARY MALFORMATION	0.00246914	0.32921866666666666
MUCOLIPIDOSIS III GAMMA	0.00246914	0.32921866666666666
ÅLAND ISLANDS EYE DISEASE	0.00246914	0.32921866666666666
ICHTHYOSIFORM ERYTHRODERMA, CORNEAL INVOLVEMENT, AND DEAFNESS	0.00246914	0.32921866666666666
RETINITIS PIGMENTOSA AND ERYTHROCYTIC MICROCYTOSIS; RPEM	0.00246914	0.32921866666666666
DANDY-WALKER MALFORMATION WITH MENTAL RETARDATION, MACROCEPHALY, MYOPIA, AND BRACHYTELEPHALANGY	0.00246914	0.32921866666666666
IMMUNOOSSEOUS DYSPLASIA, SCHIMKE TYPE	0.00246914	0.32921866666666666
ALPORT SYNDROME, AUTOSOMAL RECESSIVE	0.00246914	0.32921866666666666
STICKLER SYNDROME TYPE 1	0.00246914	0.32921866666666666
MICROSPHEROPHAKIA AND/OR MEGALOCORNEA, WITH ECTOPIA LENTIS AND WITH OR WITHOUT SECONDARY GLAUCOMA; MSPKA	0.00246914	0.32921866666666666
AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10	0.00246914	0.32921866666666666
STICKLER SYNDROME, TYPE II	0.00246914	0.32921866666666666
SPONDYLOEPIMETAPHYSEAL DYSPLASIA CONGENITA, STRUDWICK TYPE	0.00246914	0.32921866666666666
PROTEUS-LIKE SYNDROME	0.00246914	0.32921866666666666
SHORT-RIB THORACIC DYSPLASIA 5 WITH OR WITHOUT POLYDACTYLY; SRTD5	0.00246914	0.32921866666666666
WEILL-MARCHESANI SYNDROME 3	0.00246914	0.32921866666666666
USHER SYNDROME	0.00246914	0.32921866666666666
ORNITHINE AMINOTRANSFERASE DEFICIENCY	0.00246914	0.32921866666666666
OSTEOPOROSIS-OCULOCUTANEOUS HYPOPIGMENTATION SYNDROME	0.00246914	0.32921866666666666
KYPHOSCOLIOTIC EHLERS-DANLOS SYNDROME DUE TO LYSYL HYDROXYLASE 1 DEFICIENCY	0.00246914	0.32921866666666666
BARDET-BIEDL SYNDROME 21; BBS21	0.00246914	0.32921866666666666
XYLT1-CDG	0.00246914	0.32921866666666666
BRITTLE CORNEA SYNDROME	0.00246914	0.32921866666666666
HYPOPREBETALIPOPROTEINEMIA, ACANTHOCYTOSIS, RETINITIS PIGMENTOSA,AND PALLIDAL DEGENERATION	0.00243902	0.32520266666666664
MYASTHENIC SYNDROME, CONGENITAL, 3A, SLOW-CHANNEL; CMS3A	0.00243902	0.32520266666666664
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 5; PEOA5	0.00243902	0.32520266666666664
HEREDITARY ANGIOEDEMA TYPE 1	0.00243902	0.32520266666666664
FRONTOTEMPORAL DEMENTIA WITH MOTOR NEURON DISEASE	0.00243902	0.32520266666666664
PAROXYSMAL NOCTURNAL HEMOGLOBINURIA	0.00243902	0.32520266666666664
GAMMA-HEAVY CHAIN DISEASE	0.00243902	0.32520266666666664
MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E	0.00243902	0.32520266666666664
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 4	0.00243902	0.32520266666666664
PRIMARY LATERAL SCLEROSIS, ADULT	0.00243902	0.32520266666666664
CARNEY-STRATAKIS SYNDROME	0.00243902	0.32520266666666664
FACIAL PALSY, CONGENITAL, WITH PTOSIS AND VELOPHARYNGEAL DYSFUNCTION; FPVEPD	0.00243902	0.32520266666666664
BROWN-VIALETTO-VAN LAERE SYNDROME 1; BVVLS1	0.00243902	0.32520266666666664
DYSTONIA 16	0.00243902	0.32520266666666664
ESOPHAGEAL RING, LOWER	0.00243902	0.32520266666666664
CATARACT, CONGENITAL, WITH MENTAL IMPAIRMENT AND DENTATE GYRUS ATROPHY	0.00243902	0.32520266666666664
THYMIC TUMOR	0.00243902	0.32520266666666664
SPASTIC ATAXIA 5, AUTOSOMAL RECESSIVE	0.00243902	0.32520266666666664
ODONTOMATOSIS-AORTAE ESOPHAGUS STENOSIS SYNDROME	0.00243902	0.32520266666666664
JUVENILE PRIMARY LATERAL SCLEROSIS	0.00243902	0.32520266666666664
MAST SYNDROME	0.00243902	0.32520266666666664
WILD TYPE ABETA2M AMYLOIDOSIS	0.00243902	0.32520266666666664
ATYPICAL PANTOTHENATE KINASE-ASSOCIATED NEURODEGENERATION	0.00243902	0.32520266666666664
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 31	0.00243902	0.32520266666666664
%611694 DYSTONIA WITH CEREBELLAR ATROPHY; DYTCA	0.00243902	0.32520266666666664
WILSON DISEASE	0.00243902	0.32520266666666664
DYSTONIA 12; DYT12	0.00243902	0.32520266666666664
DYSTONIA 4, TORSION, AUTOSOMAL DOMINANT; DYT4	0.00243902	0.32520266666666664
PRIMARY PROGRESSIVE FREEZING GAIT	0.00243902	0.32520266666666664
ABETA AMYLOIDOSIS, IOWA TYPE	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA TYPE 6	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA TYPE 8	0.00243902	0.32520266666666664
PARAMYOTONIA CONGENITA OF VON EULENBURG	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA TYPE 11	0.00243902	0.32520266666666664
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 1; EIEE1	0.00243902	0.32520266666666664
MYASTHENIC SYNDROME, CONGENITAL, 24, PRESYNAPTIC; CMS24	0.00243902	0.32520266666666664
SPASTIC PARALYSIS, INFANTILE-ONSET ASCENDING; IAHSP	0.00243902	0.32520266666666664
FACIAL ONSET SENSORY AND MOTOR NEURONOPATHY	0.00243902	0.32520266666666664
MACHADO-JOSEPH DISEASE TYPE 3	0.00243902	0.32520266666666664
MYOTONIA FLUCTUANS	0.00243902	0.32520266666666664
MYOTONIA PERMANENS	0.00243902	0.32520266666666664
ACETAZOLAMIDE-RESPONSIVE MYOTONIA	0.00243902	0.32520266666666664
SEVERE GENERALIZED RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00243902	0.32520266666666664
AMYOTROPHIC LATERAL SCLEROSIS 10 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS10	0.00243902	0.32520266666666664
AUTOSOMAL DOMINANT SPASTIC ATAXIA TYPE 1	0.00243902	0.32520266666666664
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA INVERSA	0.00243902	0.32520266666666664
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 3; NBIA3	0.00243902	0.32520266666666664
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 2; FTDALS2	0.00243902	0.32520266666666664
MADRAS MOTOR NEURON DISEASE	0.00243902	0.32520266666666664
BOTULISM	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA 37; SCA37	0.00243902	0.32520266666666664
THYMOMA	0.00243902	0.32520266666666664
PRIMARY PARATHYROID HYPERPLASIA	0.00243902	0.32520266666666664
ECTODERMAL DYSPLASIA/SHORT STATURE SYNDROME	0.00243902	0.32520266666666664
HYPERPARATHYROIDISM-JAW TUMOR SYNDROME	0.00243902	0.32520266666666664
IATROGENIC BOTULISM	0.00243902	0.32520266666666664
ANTISYNTHETASE SYNDROME	0.00243902	0.32520266666666664
MITOCHONDRIAL DNA-ASSOCIATED LEIGH SYNDROME	0.00243902	0.32520266666666664
RECESSIVE INTELLECTUAL DISABILITY-MOTOR DYSFUNCTION-MULTIPLE JOINT CONTRACTURES SYNDROME	0.00243902	0.32520266666666664
AMYOTROPHIC LATERAL SCLEROSIS 15 WITH OR WITHOUT FRONTOTEMPORAL DEMENTIA; ALS15	0.00243902	0.32520266666666664
MACHADO-JOSEPH DISEASE TYPE 2	0.00243902	0.32520266666666664
CHIARI MALFORMATION TYPE I	0.00243902	0.32520266666666664
SPASTIC ATAXIA 1, AUTOSOMAL DOMINANT; SPAX1	0.00243902	0.32520266666666664
MYOPATHY, MYOFIBRILLAR, 8; MFM8	0.00243902	0.32520266666666664
CYSTINOSIS, NEPHROPATHIC; CTNS	0.00243902	0.32520266666666664
EARLY-ONSET SPASTIC ATAXIA-MYOCLONIC EPILEPSY-NEUROPATHY SYNDROME	0.00243902	0.32520266666666664
BULBAR PALSY, PROGRESSIVE, OF CHILDHOOD	0.00243902	0.32520266666666664
STEVENS-JOHNSON SYNDROME	0.00243902	0.32520266666666664
RECURRENT METABOLIC ENCEPHALOMYOPATHIC CRISES-RHABDOMYOLYSIS-CARDIAC ARRHYTHMIA-INTELLECTUAL DISABILITY SYNDROME	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA 44; SCA44	0.00243902	0.32520266666666664
PARATHYROID CARCINOMA	0.00243902	0.32520266666666664
DYSTONIA, CHILDHOOD-ONSET, WITH OPTIC ATROPHY AND BASAL GANGLIA ABNORMALITIES; DYTOABG	0.00243902	0.32520266666666664
ANAPLASTIC THYROID CARCINOMA	0.00243902	0.32520266666666664
CLEFT LIP AND ALVEOLUS	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA TYPE 36	0.00243902	0.32520266666666664
MACHADO-JOSEPH DISEASE TYPE 1	0.00243902	0.32520266666666664
EARLY-ONSET CEREBELLAR ATAXIA WITH RETAINED TENDON REFLEXES	0.00243902	0.32520266666666664
GASTROINTESTINAL STROMAL TUMOR	0.00243902	0.32520266666666664
EOSINOPHILIC GASTROENTERITIS	0.00243902	0.32520266666666664
DYSTONIA 16; DYT16	0.00243902	0.32520266666666664
MACHADO-JOSEPH DISEASE; MJD	0.00243902	0.32520266666666664
PRIMARY LATERAL SCLEROSIS, JUVENILE; PLSJ	0.00243902	0.32520266666666664
DYSTONIA 2, TORSION, AUTOSOMAL RECESSIVE; DYT2	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 26; SCAR26	0.00243902	0.32520266666666664
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 3	0.00243902	0.32520266666666664
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 26; MC1DN26	0.00243902	0.32520266666666664
PROGRESSIVE SUPRANUCLEAR PALSY	0.00243902	0.32520266666666664
NEMALINE MYOPATHY 1; NEM1	0.00243902	0.32520266666666664
ARNOLD-CHIARI MALFORMATION TYPE I	0.00243902	0.32520266666666664
VOCAL CORD AND PHARYNGEAL DISTAL MYOPATHY	0.00243902	0.32520266666666664
FRAGILE X-ASSOCIATED TREMOR/ATAXIA SYNDROME	0.00243902	0.32520266666666664
RECURRENT RESPIRATORY PAPILLOMATOSIS	0.00243902	0.32520266666666664
NEUROLEPTIC MALIGNANT SYNDROME	0.00243902	0.32520266666666664
NEMALINE MYOPATHY 2; NEM2	0.00243902	0.32520266666666664
PARKINSON DISEASE 1, AUTOSOMAL DOMINANT; PARK1	0.00243902	0.32520266666666664
PARKINSON DISEASE, LATE-ONSET; PD	0.00243902	0.32520266666666664
SPORADIC INFANTILE BILATERAL STRIATAL NECROSIS	0.00243902	0.32520266666666664
MYOTONIA CONGENITA, AUTOSOMAL RECESSIVE	0.00243902	0.32520266666666664
SUPRANUCLEAR PALSY, PROGRESSIVE, 2; PSNP2	0.00243902	0.32520266666666664
HEREDITARY LATE-ONSET PARKINSON DISEASE	0.00243902	0.32520266666666664
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 7, AUTOSOMAL RECESSIVE; IBGC7	0.00243902	0.32520266666666664
MYOPATHY, CONGENITAL, WITH FIBER-TYPE DISPROPORTION; CFTD	0.00243902	0.32520266666666664
GENERALIZED ERUPTIVE KERATOACANTHOMA	0.00243902	0.32520266666666664
ALPHA-B CRYSTALLIN-RELATED LATE-ONSET MYOPATHY	0.00243902	0.32520266666666664
EPILEPSY, PROGRESSIVE MYOCLONIC, 4, WITH OR WITHOUT RENAL FAILURE; EPM4	0.00243902	0.32520266666666664
MOHR-TRANEBJAERG SYNDROME	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA 7 OPCA III OPCA WITH RETINAL DEGENERATION OPCA WITH MACULAR DEGENERATION AND EXTERNAL OPHTHALMOPLEGIA AUTOSOMAL DOMINANT CEREBELLAR ATAXIA, TYPE II ADCA, TYPE II	0.00243902	0.32520266666666664
%601846 VACUOLAR NEUROMYOPATHY;;MUSCULAR DYSTROPHY, AUTOSOMAL DOMINANT, WITH RIMMED VACUOLES; MDRV	0.00243902	0.32520266666666664
ODONTOMA-DYSPHAGIA SYNDROME	0.00243902	0.32520266666666664
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA WITH LATE-ONSET SPASTICITY	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA 48; SCA48	0.00243902	0.32520266666666664
FRIEDREICH ATAXIA	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA 14	0.00243902	0.32520266666666664
DNAJB6-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY D1	0.00243902	0.32520266666666664
TOXIN-MEDIATED INFECTIOUS BOTULISM	0.00243902	0.32520266666666664
SUPRANUCLEAR PALSY, PROGRESSIVE, 1; PSNP1	0.00243902	0.32520266666666664
MYOPATHY, SPHEROID BODY	0.00243902	0.32520266666666664
OROMANDIBULAR DYSTONIA	0.00243902	0.32520266666666664
PLUMMER-VINSON SYNDROME	0.00243902	0.32520266666666664
GENERALIZED DOMINANT DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00243902	0.32520266666666664
PARKINSONIAN-PYRAMIDAL SYNDROME	0.00243902	0.32520266666666664
POSTPOLIOMYELITIS SYNDROME	0.00243902	0.32520266666666664
AUTOSOMAL DOMINANT LIMB-GIRDLE MUSCULAR DYSTROPHY TYPE 1A	0.00243902	0.32520266666666664
JUVENILE DERMATOMYOSITIS	0.00243902	0.32520266666666664
TOXIC EPIDERMAL NECROLYSIS	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA 42	0.00243902	0.32520266666666664
MYASTHENIC SYNDROME, CONGENITAL, 1B, FAST-CHANNEL; CMS1B	0.00243902	0.32520266666666664
GOOD SYNDROME	0.00243902	0.32520266666666664
IMMUNODEFICIENCY 58; IMD58	0.00243902	0.32520266666666664
FOODBORNE BOTULISM	0.00243902	0.32520266666666664
AUTOSOMAL DOMINANT STRIATAL NEURODEGENERATION	0.00243902	0.32520266666666664
DYSFERLIN-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R2	0.00243902	0.32520266666666664
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 5; PEOB5	0.00243902	0.32520266666666664
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA-MYOPATHY-EMACIATION SYNDROME	0.00243902	0.32520266666666664
OCULOPHARYNGODISTAL MYOPATHY; OPDM	0.00243902	0.32520266666666664
MYASTHENIA GRAVIS; MG	0.00243902	0.32520266666666664
LARYNGEAL ABDUCTOR PARALYSIS	0.00243902	0.32520266666666664
MITOCHONDRIAL MEMBRANE PROTEIN-ASSOCIATED NEURODEGENERATION	0.00243902	0.32520266666666664
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL RECESSIVE 2; PEOB2	0.00243902	0.32520266666666664
DYSTROPHIC EPIDERMOLYSIS BULLOSA	0.00243902	0.32520266666666664
STRIATONIGRAL DEGENERATION, CHILDHOOD-ONSET	0.00243902	0.32520266666666664
ESOPHAGITIS, EOSINOPHILIC, 1; EOE1	0.00243902	0.32520266666666664
KINDLER SYNDROME	0.00243902	0.32520266666666664
PARKINSON DISEASE 20, EARLY-ONSET; PARK20	0.00243902	0.32520266666666664
PRIMARY LATERAL SCLEROSIS	0.00243902	0.32520266666666664
RECESSIVE DYSTROPHIC EPIDERMOLYSIS BULLOSA, GENERALIZED INTERMEDIATE	0.00243902	0.32520266666666664
ESOPHAGITIS, EOSINOPHILIC, 2; EOE2	0.00243902	0.32520266666666664
KUFOR-RAKEB SYNDROME	0.00243902	0.32520266666666664
NEUROFERRITINOPATHY	0.00243902	0.32520266666666664
INCLUSION BODY MYOSITIS	0.00243902	0.32520266666666664
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 4; FTDALS4	0.00243902	0.32520266666666664
FRONTOTEMPORAL DEMENTIA AND/OR AMYOTROPHIC LATERAL SCLEROSIS 3; FTDALS3	0.00243902	0.32520266666666664
TETANUS	0.00243902	0.32520266666666664
PLEURAL MESOTHELIOMA	0.00243902	0.32520266666666664
AMYOTROPHIC LATERAL SCLEROSIS, SUSCEPTIBILITY TO, 24; ALS24	0.00243902	0.32520266666666664
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2J	0.00243902	0.32520266666666664
SPINAL AND BULBAR MUSCULAR ATROPHY, X-LINKED 1	0.00243902	0.32520266666666664
PROGRESSIVE SUPRANUCLEAR PALSY-PROGRESSIVE NON-FLUENT APHASIA SYNDROME	0.00243902	0.32520266666666664
CRISPONI/COLD-INDUCED SWEATING SYNDROME 3; CISS3	0.00243902	0.32520266666666664
LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4	0.00243902	0.32520266666666664
CRYPTOSPORIDIOSIS	0.00243902	0.32520266666666664
MEDULLARY THYROID CARCINOMA	0.00243902	0.32520266666666664
MAFFUCCI SYNDROME	0.00243902	0.32520266666666664
NEMALINE MYOPATHY 3; NEM3	0.00243902	0.32520266666666664
LEBER OPTIC ATROPHY AND DYSTONIA	0.00243902	0.32520266666666664
ARTHROGRYPOSIS, DISTAL, TYPE 7	0.00243902	0.32520266666666664
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 27; SCAR27	0.00243902	0.32520266666666664
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA WITH MITOCHONDRIAL DNA DELETIONS, AUTOSOMAL DOMINANT 1; PEOA1	0.00243902	0.32520266666666664
CREST SYNDROME	0.00243902	0.32520266666666664
WOUND BOTULISM	0.00243902	0.32520266666666664
INFANT BOTULISM	0.00243902	0.32520266666666664
AMYOTROPHIC LATERAL SCLEROSIS 2, JUVENILE; ALS2	0.00243902	0.32520266666666664
INTESTINAL BOTULISM	0.00243902	0.32520266666666664
THYROID LYMPHOMA	0.00243902	0.32520266666666664
PROGRESSIVE SUPRANUCLEAR PALSY-CORTICOBASAL SYNDROME	0.00243902	0.32520266666666664
VISCERAL MYOPATHY; VSCM	0.00243902	0.32520266666666664
SPORADIC ADULT-ONSET ATAXIA OF UNKNOWN ETIOLOGY	0.00243902	0.32520266666666664
X-LINKED INTELLECTUAL DISABILITY, HEDERA TYPE	0.00240964	0.3212853333333333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 32	0.00240964	0.3212853333333333
LEUKOENCEPHALOPATHY-PALMOPLANTAR KERATODERMA SYNDROME	0.00240964	0.3212853333333333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 48	0.00240964	0.3212853333333333
LEUKOENCEPHALOPATHY-SPONDYLOMETAPHYSEAL DYSPLASIA SYNDROME	0.00240964	0.3212853333333333
KCNQ2-RELATED EPILEPTIC ENCEPHALOPATHY	0.00240964	0.3212853333333333
GLYCINE ENCEPHALOPATHY	0.00240964	0.3212853333333333
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY	0.00240964	0.3212853333333333
SEVERE ACHONDROPLASIA-DEVELOPMENTAL DELAY-ACANTHOSIS NIGRICANS SYNDROME	0.00240964	0.3212853333333333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 66	0.00240964	0.3212853333333333
EARLY-ONSET EPILEPSY-INTELLECTUAL DISABILITY-BRAIN ANOMALIES SYNDROME	0.00240964	0.3212853333333333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 74	0.00240964	0.3212853333333333
X-LINKED INTELLECTUAL DISABILITY-LIMB SPASTICITY-RETINAL DYSTROPHY-DIABETES INSIPIDUS SYNDROME	0.00240964	0.3212853333333333
ROLANDIC EPILEPSY-SPEECH DYSPRAXIA SYNDROME	0.00240964	0.3212853333333333
EARLY-ONSET EPILEPTIC ENCEPHALOPATHY AND INTELLECTUAL DISABILITY DUE TO GRIN2A MUTATION	0.00240964	0.3212853333333333
LEUKODYSTROPHY, PROGRESSIVE, EARLY CHILDHOOD-ONSET; PLDECO	0.00240964	0.3212853333333333
MECKEL SYNDROME, TYPE 4; MKS4	0.00240964	0.3212853333333333
CHROMOSOME 13Q14 DELETION SYNDROME	0.00240964	0.3212853333333333
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HEDERA TYPE; MRXSH	0.00240964	0.3212853333333333
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 22	0.00240964	0.3212853333333333
SPASTIC PARAPLEGIA 63, AUTOSOMAL RECESSIVE; SPG63	0.00240964	0.3212853333333333
SPASTIC PARAPLEGIA 46, AUTOSOMAL RECESSIVE; SPG46	0.00240964	0.3212853333333333
EPILEPSY, PROGRESSIVE MYOCLONIC, 3, WITH OR WITHOUT INTRACELLULAR INCLUSIONS	0.00240964	0.3212853333333333
%611252 SPASTIC PARAPLEGIA 32, AUTOSOMAL RECESSIVE; SPG32	0.00240964	0.3212853333333333
MITOCHONDRIAL DNA DEPLETION SYNDROME 16 (HEPATIC TYPE); MTDPS16	0.00240964	0.3212853333333333
LEUKODYSTROPHY, HYPOMYELINATING, 12	0.00240964	0.3212853333333333
ANIRIDIA	0.00240964	0.3212853333333333
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 2B, PRENATAL ONSET, AUTOSOMAL DOMINANT; SMALED2B	0.00240964	0.3212853333333333
MENTAL RETARDATION, X-LINKED 103	0.0023739729999999997	0.3165297333333333
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 7; MC3DN7	0.0023739729999999997	0.3165297333333333
8P11.2 DELETION SYNDROME	0.0023739729999999997	0.3165297333333333
17Q12 MICRODELETION SYNDROME	0.0023739729999999997	0.3165297333333333
PITUITARY STALK INTERRUPTION SYNDROME	0.0023739729999999997	0.3165297333333333
PERIPHERAL DEMYELINATING NEUROPATHY, CENTRAL DYSMYELINATION, WAARDENBURG SYNDROME, AND HIRSCHSPRUNG DISEASE; PCWH	0.0023739729999999997	0.3165297333333333
CATEL-MANZKE SYNDROME; CATMANS	0.0023739729999999997	0.3165297333333333
DISTAL TRISOMY 17Q	0.0023739729999999997	0.3165297333333333
RUVALCABA SYNDROME	0.0023739729999999997	0.3165297333333333
PROMINENT GLABELLA-MICROCEPHALY-HYPOGENITALISM SYNDROME	0.0023739729999999997	0.3165297333333333
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 71; MRT71	0.0023739729999999997	0.3165297333333333
X-LINKED INTELLECTUAL DISABILITY, PAI TYPE	0.0023739729999999997	0.3165297333333333
PUERTO RICAN INFANT HYPOTONIA SYNDROME	0.0023739729999999997	0.3165297333333333
RECOMBINANT 8 SYNDROME	0.0023739729999999997	0.3165297333333333
PALLISTER-HALL SYNDROME	0.0023739729999999997	0.3165297333333333
CHROMOSOME 1Q41-Q42 DELETION SYNDROME	0.0023739729999999997	0.3165297333333333
ISOLATED GLYCEROL KINASE DEFICIENCY	0.0023739729999999997	0.3165297333333333
SYNDROMIC RECESSIVE X-LINKED ICHTHYOSIS	0.0023739729999999997	0.3165297333333333
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, SBBYS TYPE	0.0023739729999999997	0.3165297333333333
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 1	0.002332303	0.31097373333333334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IP; CDG1P	0.002332303	0.31097373333333334
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 6	0.002332303	0.31097373333333334
HYPERPHOSPHATASIA WITH MENTAL RETARDATION SYNDROME 6	0.002332303	0.31097373333333334
MONOSOMY 9Q22.3	0.002332303	0.31097373333333334
INCONTINENTIA PIGMENTI	0.002332303	0.31097373333333334
MENTAL RETARDATION, X-LINKED 101; MRX101	0.002332303	0.31097373333333334
HARTNUP DISEASE	0.002332303	0.31097373333333334
LEIGH SYNDROME WITH LEUKODYSTROPHY	0.002332303	0.31097373333333334
ALG11-CDG	0.002332303	0.31097373333333334
CONGENITAL DISORDER OF GLYCOSYLATION	0.002332303	0.31097373333333334
DEAFNESS, DYSTONIA, AND CEREBRAL HYPOMYELINATION; DDCH	0.002332303	0.31097373333333334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IC; CDG1C	0.002332303	0.31097373333333334
OPTIC PATHWAY GLIOMA	0.002332303	0.31097373333333334
CHROMOSOME 19P13.13 DELETION SYNDROME	0.002332303	0.31097373333333334
15Q13.3 MICRODELETION SYNDROME	0.002332303	0.31097373333333334
MICROGNATHIA-RECURRENT INFECTIONS-BEHAVIORAL ABNORMALITIES-MILD INTELLECTUAL DISABILITY SYNDROME	0.002332303	0.31097373333333334
ALPHA-N-ACETYLGALACTOSAMINIDASE DEFICIENCY TYPE 3	0.002332303	0.31097373333333334
SEVERE INTELLECTUAL DISABILITY-PROGRESSIVE POSTNATAL MICROCEPHALY-MIDLINE STEREOTYPIC HAND MOVEMENTS SYNDROME	0.002332303	0.31097373333333334
PERIVENTRICULAR NODULAR HETEROTOPIA 6; PVNH6	0.002332303	0.31097373333333334
NEURODEVELOPMENTAL DISORDER WITH SEIZURES AND NONEPILEPTIC HYPERKINETIC MOVEMENTS; NEDNEH	0.002332303	0.31097373333333334
XQ21 MICRODELETION SYNDROME	0.002332303	0.31097373333333334
AUTOSOMAL DOMINANT CENTRONUCLEAR MYOPATHY	0.002248538	0.2998050666666667
MENTAL RETARDATION, X-LINKED 93	0.002248538	0.2998050666666667
LATERAL MENINGOCELE SYNDROME	0.002248538	0.2998050666666667
OHDO SYNDROME, SBBYS VARIANT; SBBYSS	0.002248538	0.2998050666666667
ARTHROGRYPOSIS, DISTAL, TYPE 1A; DA1A	0.002248538	0.2998050666666667
GROWTH RESTRICTION, SEVERE, WITH DISTINCTIVE FACIES; GRDF	0.002248538	0.2998050666666667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IH; CDG1H	0.002248538	0.2998050666666667
CONGENITAL MULTICORE MYOPATHY WITH EXTERNAL OPHTHALMOPLEGIA	0.002248538	0.2998050666666667
X-LINKED MYOTUBULAR MYOPATHY-ABNORMAL GENITALIA SYNDROME	0.002248538	0.2998050666666667
SIFRIM-HITZ-WEISS SYNDROME	0.002248538	0.2998050666666667
MULTIMINICORE MYOPATHY	0.002206868	0.29424906666666667
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, FADEN-ALKURAYA TYPE; SEMDFA	0.002206868	0.29424906666666667
PERIPHERAL NEUROPATHY, AUTOSOMAL RECESSIVE, WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; PNRIID	0.002206868	0.29424906666666667
NEURODEVELOPMENTAL DISORDER WITH MIDBRAIN AND HINDBRAIN MALFORMATIONS; NEDMHM	0.002206868	0.29424906666666667
SOTOS SYNDROME 2	0.002206868	0.29424906666666667
MICROCEPHALY 20, PRIMARY, AUTOSOMAL RECESSIVE; MCPH20	0.002206868	0.29424906666666667
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 6; MMDS6	0.0020485110000000003	0.2731348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 56; MRD56	0.0020485110000000003	0.2731348
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY-PROGRESSIVE JOINT CONTRACTURES-DYSMORPHISM SYNDROME	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 36; EIEE36	0.0020485110000000003	0.2731348
PILAROWSKI-BJORNSSON SYNDROME; PILBOS	0.0020485110000000003	0.2731348
AUTOSOMAL DOMINANT CHARCOT-MARIE-TOOTH DISEASE TYPE 2Z	0.0020485110000000003	0.2731348
INTELLECTUAL DEVELOPMENTAL DISORDER WITH CARDIAC ARRHYTHMIA	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 1; IECEE1	0.0020485110000000003	0.2731348
GALLOWAY-MOWAT SYNDROME 4; GAMOS4	0.0020485110000000003	0.2731348
SULFOCYSTEINURIA	0.0020485110000000003	0.2731348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 6; COXPD6	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 43	0.0020485110000000003	0.2731348
CARDIAC, FACIAL, AND DIGITAL ANOMALIES WITH DEVELOPMENTAL DELAY; CAFDADD	0.0020485110000000003	0.2731348
GROWTH RETARDATION, IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND HEPATOPATHY; GRIDHH	0.0020485110000000003	0.2731348
FOLATE MALABSORPTION, HEREDITARY	0.0020485110000000003	0.2731348
MITOCHONDRIAL COMPLEX IV DEFICIENCY	0.0020485110000000003	0.2731348
D-2-HYDROXYGLUTARIC ACIDURIA 1	0.0020485110000000003	0.2731348
CHROMOSOME 19Q13.11 DELETION SYNDROME, PROXIMAL	0.0020485110000000003	0.2731348
PETTIGREW SYNDROME	0.0020485110000000003	0.2731348
JOUBERT SYNDROME 30; JBTS30	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 54; EIEE54	0.0020485110000000003	0.2731348
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 17; GPIBD17	0.0020485110000000003	0.2731348
INTELLECTUAL DEVELOPMENTAL DISORDER WITH NEUROPSYCHIATRIC FEATURES; IDDNPF	0.0020485110000000003	0.2731348
NON-PROGRESSIVE PREDOMINANTLY POSTERIOR CAVITATING LEUKOENCEPHALOPATHY WITH PERIPHERAL NEUROPATHY	0.0020485110000000003	0.2731348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 45; MRD45	0.0020485110000000003	0.2731348
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLC TYPE; MAHCC	0.0020485110000000003	0.2731348
COACH SYNDROME	0.0020485110000000003	0.2731348
PONTOCEREBELLAR HYPOPLASIA, TYPE 1D; PCH1D	0.0020485110000000003	0.2731348
GM2-GANGLIOSIDOSIS, AB VARIANT	0.0020485110000000003	0.2731348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 46; MRD46	0.0020485110000000003	0.2731348
IMMUNODEFICIENCY 49; IMD49	0.0020485110000000003	0.2731348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 31	0.0020485110000000003	0.2731348
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLD TYPE	0.0020485110000000003	0.2731348
SHUKLA-VERNON SYNDROME; SHUVER	0.0020485110000000003	0.2731348
WIEACKER-WOLFF SYNDROME	0.0020485110000000003	0.2731348
HSD10 MITOCHONDRIAL DISEASE; HSD10MD	0.0020485110000000003	0.2731348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 29; COXPD29	0.0020485110000000003	0.2731348
MACROCEPHALY, DYSMORPHIC FACIES, AND PSYCHOMOTOR RETARDATION; MDFPMR	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 37; EIEE37	0.0020485110000000003	0.2731348
PONTOCEREBELLAR HYPOPLASIA, TYPE 6	0.0020485110000000003	0.2731348
AICARDI-GOUTIERES SYNDROME 7	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 21; EIEE21	0.0020485110000000003	0.2731348
TEMPLE-BARAITSER SYNDROME; TMBTS	0.0020485110000000003	0.2731348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IN	0.0020485110000000003	0.2731348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IW; CDG1W	0.0020485110000000003	0.2731348
COENZYME Q10 DEFICIENCY, PRIMARY, 4	0.0020485110000000003	0.2731348
ARTHROGRYPOSIS, MENTAL RETARDATION, AND SEIZURES	0.0020485110000000003	0.2731348
INFANTILE LIVER FAILURE SYNDROME 1	0.0020485110000000003	0.2731348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 5	0.0020485110000000003	0.2731348
OSTEOSCLEROTIC METAPHYSEAL DYSPLASIA	0.0020485110000000003	0.2731348
SEIZURES, SENSORINEURAL DEAFNESS, ATAXIA, MENTAL RETARDATION, AND ELECTROLYTE IMBALANCE	0.0020485110000000003	0.2731348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 14; COXPD14	0.0020485110000000003	0.2731348
PEROXISOME BIOGENESIS DISORDER 4B; PBD4B	0.0020485110000000003	0.2731348
ACYL-COA DEHYDROGENASE, MEDIUM-CHAIN, DEFICIENCY OF	0.0020485110000000003	0.2731348
MITOCHONDRIAL PYRUVATE CARRIER DEFICIENCY	0.0020485110000000003	0.2731348
3-METHYLGLUTACONIC ACIDURIA WITH DEAFNESS, ENCEPHALOPATHY, AND LEIGH-LIKE SYNDROME; MEGDEL	0.0020485110000000003	0.2731348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 10	0.0020485110000000003	0.2731348
COENZYME Q10 DEFICIENCY, PRIMARY, 5; COQ10D5	0.0020485110000000003	0.2731348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIL; CDG2L	0.0020485110000000003	0.2731348
ENCEPHALOMYOPATHY, MITOCHONDRIAL, DUE TO VOLTAGE-DEPENDENT ANION CHANNEL DEFICIENCY	0.0020485110000000003	0.2731348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 6, WITH OR WITHOUT SEIZURES; MRD6	0.0020485110000000003	0.2731348
CONGENITAL CATARACTS, HEARING LOSS, AND NEURODEGENERATION; CCHLND	0.0020485110000000003	0.2731348
THIAMINE METABOLISM DYSFUNCTION SYNDROME 5 (EPISODIC ENCEPHALOPATHY TYPE)	0.0020485110000000003	0.2731348
N-ACETYLASPARTATE DEFICIENCY; NACED	0.0020485110000000003	0.2731348
HYPERMETHIONINEMIA DUE TO ADENOSINE KINASE DEFICIENCY	0.0020485110000000003	0.2731348
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 2 WITH HYPERGLYCINEMIA; MMDS2	0.0020485110000000003	0.2731348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 20	0.0020485110000000003	0.2731348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 3	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 26; EIEE26	0.0020485110000000003	0.2731348
SALLA DISEASE	0.0020485110000000003	0.2731348
TIMOTHY SYNDROME; TS	0.0020485110000000003	0.2731348
GRISCELLI SYNDROME, TYPE 1	0.0020485110000000003	0.2731348
ENCEPHALOPATHY, ETHYLMALONIC; EE	0.0020485110000000003	0.2731348
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.0020485110000000003	0.2731348
METABOLIC ENCEPHALOMYOPATHIC CRISES, RECURRENT, WITH RHABDOMYOLYSIS, CARDIAC ARRHYTHMIAS, AND NEURODEGENERATION; MECRCN	0.0020485110000000003	0.2731348
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 4	0.0020485110000000003	0.2731348
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 2	0.0020485110000000003	0.2731348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIF; CDG2F	0.0020485110000000003	0.2731348
LUSCAN-LUMISH SYNDROME; LLS	0.0020485110000000003	0.2731348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIO	0.0020485110000000003	0.2731348
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 2; MC1DN2	0.0020485110000000003	0.2731348
LEUKODYSTROPHY AND ACQUIRED MICROCEPHALY WITH OR WITHOUT DYSTONIA; LDAMD	0.0020485110000000003	0.2731348
SIALIDOSIS TYPE 2	0.0020485110000000003	0.2731348
PITT-HOPKINS-LIKE SYNDROME 1; PTHSL1	0.0020485110000000003	0.2731348
3-METHYLCROTONYL-COA CARBOXYLASE 2 DEFICIENCY; MCC2D	0.0020485110000000003	0.2731348
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IK; CDG1K	0.0020485110000000003	0.2731348
3-METHYLCROTONYL-COA CARBOXYLASE 1 DEFICIENCY; MCC1D	0.0020485110000000003	0.2731348
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 20; SCAR20	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 31; EIEE31	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 29; EIEE29	0.0020485110000000003	0.2731348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 23	0.0020485110000000003	0.2731348
PEROXISOMAL FATTY ACYL-COA REDUCTASE 1 DISORDER	0.0020485110000000003	0.2731348
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 27; EIEE27	0.0020485110000000003	0.2731348
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 46	0.0020485110000000003	0.2731348
2-METHYLBUTYRYL-COA DEHYDROGENASE DEFICIENCY	0.0020485110000000003	0.2731348
SIDEROBLASTIC ANEMIA WITH B-CELL IMMUNODEFICIENCY, PERIODIC FEVERS, AND DEVELOPMENTAL DELAY; SIFD	0.0020485110000000003	0.2731348
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS, FAMILIAL, 1	0.0020485110000000003	0.2731348
MENTAL RETARDATION, AUTOSOMAL DOMINANT 9; MRD9	0.0020485110000000003	0.2731348
MALONYL-COA DECARBOXYLASE DEFICIENCY	0.0020485110000000003	0.2731348
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 31; MC1DN31	0.0020485110000000003	0.2731348
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 17; MC1DN17	0.0020485110000000003	0.2731348
CEROID LIPOFUSCINOSIS, NEURONAL, 1	0.0020485110000000003	0.2731348
HOLOPROSENCEPHALY 12 WITH OR WITHOUT PANCREATIC AGENESIS; HPE12	0.0020485110000000003	0.2731348
ELEJALDE DISEASE	0.0020485110000000003	0.2731348
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.0020485110000000003	0.2731348
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 37; COXPD37	0.0020485110000000003	0.2731348
INTELLECTUAL DISABILITY-AUTISM-SPEECH APRAXIA-CRANIOFACIAL DYSMORPHISM SYNDROME	0.0020485110000000003	0.2731348
KETOADIPICACIDURIA	0.0020485110000000003	0.2731348
HYPERPROLINEMIA, TYPE I	0.0020485110000000003	0.2731348
BIOTINIDASE DEFICIENCYMULTIPLE CARBOXYLASE DEFICIENCY, LATE-ONSET	0.0020485110000000003	0.2731348
MEGA-CORPUS-CALLOSUM SYNDROME WITH CEREBELLAR HYPOPLASIA AND CORTICAL MALFORMATIONS; MCCCHCM	0.0020485110000000003	0.2731348
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLG COMPLEMENTATION TYPE	0.0020485110000000003	0.2731348
PYRUVATE CARBOXYLASE DEFICIENCY	0.0020485110000000003	0.2731348
METHYLMALONIC ACIDURIA, CBLA TYPE	0.0020485110000000003	0.2731348
GRISCELLI SYNDROME TYPE 1	0.0020485110000000003	0.2731348
DIHYDROLIPOAMIDE DEHYDROGENASE DEFICIENCY	0.0020485110000000003	0.2731348
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 19; MC1DN19	0.0020485110000000003	0.2731348
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 1	0.0020485110000000003	0.2731348
METABOLIC CRISES, RECURRENT, WITH VARIABLE ENCEPHALOMYOPATHIC FEATURES AND NEUROLOGIC REGRESSION; MECREN	0.0020485110000000003	0.2731348
HOMOCYSTINURIA-MEGALOBLASTIC ANEMIA, CBLE COMPLEMENTATION TYPE	0.0020485110000000003	0.2731348
BRAIN SMALL VESSEL DISEASE 3; BSVD3	0.0020485110000000003	0.2731348
DISLOCATION OF THE HIP-DYSMORPHISM SYNDROME	0.00196464	0.261952
FEINGOLD SYNDROME 1; FGLDS1	0.00196464	0.261952
ARTHROGRYPOSIS, DISTAL, TYPE 2B	0.00196464	0.261952
BOOMERANG DYSPLASIA	0.00196464	0.261952
608028 THAI SYMPHALANGISM SYNDROME	0.00196464	0.261952
MULTIPLE METAPHYSEAL DYSPLASIA	0.00196464	0.261952
SPONDYLOEPIPHYSEAL DYSPLASIA-BRACHYDACTYLY AND DISTINCTIVE SPEECH	0.00196464	0.261952
PATERNAL 20Q13.2Q13.3 MICRODELETION SYNDROME	0.00196464	0.261952
PFEIFFER SYNDROME	0.00196464	0.261952
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA, CANTU TYPE	0.00196464	0.261952
SHELDON-HALL SYNDROME	0.00196464	0.261952
ADULT SYNDROME	0.00196464	0.261952
AMASTIA, BILATERAL, WITH URETERAL TRIPLICATION AND DYSMORPHISM	0.00196464	0.261952
DANDY-WALKER MALFORMATION WITH POSTAXIAL POLYDACTYLY	0.00196464	0.261952
CHOANAL ATRESIA-HEARING LOSS-CARDIAC DEFECTS-CRANIOFACIAL DYSMORPHISM SYNDROME	0.00196464	0.261952
GELEOPHYSIC DYSPLASIA 3; GPHYSD3	0.00196464	0.261952
PILODENTAL DYSPLASIA WITH REFRACTIVE ERRORS	0.00196464	0.261952
ANKYLOBLEPHARON-ECTODERMAL DEFECTS-CLEFT LIP/PALATE SYNDROME	0.00196464	0.261952
CRANIOFACIOFRONTODIGITAL SYNDROME	0.00196464	0.261952
DILATED CARDIOMYOPATHY-HYPERGONADOTROPIC HYPOGONADISM SYNDROME	0.00196464	0.261952
601450 DISLOCATION OF HIP, CONGENITAL, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM;;HIP, CONGENITAL DISLOCATION OF, WITH HYPEREXTENSIBILITY OF FINGERSAND FACIAL DYSMORPHISM	0.00196464	0.261952
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.261952
MULIBREY NANISM	0.00196464	0.261952
IMMUNODEFICIENCY 59 AND HYPOGLYCEMIA; IMD59	0.00196464	0.261952
ECTODERMAL DYSPLASIA WITH MENTAL RETARDATION AND SYNDACTYLY	0.00196464	0.261952
HYPERTELORISM, TEEBI TYPE; TBHS	0.00196464	0.261952
HISTIDINURIA-RENAL TUBULAR DEFECT SYNDROME	0.00196464	0.261952
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 70; MRT70	0.00196464	0.261952
AUTOSOMAL DOMINANT HYPER-IGE SYNDROME	0.00196464	0.261952
RING CHROMOSOME 6 SYNDROME	0.00196464	0.261952
DIAMOND-BLACKFAN ANEMIA 8	0.00196464	0.261952
%235830 HISTIDINURIA DUE TO A RENAL TUBULAR DEFECT	0.00196464	0.261952
OTOPALATODIGITAL SYNDROME TYPE 1	0.00196464	0.261952
CHARLIE M SYNDROME	0.00196464	0.261952
ZECHI-CEIDE SYNDROME	0.00196464	0.261952
KOSAKI OVERGROWTH SYNDROME; KOGS	0.00196464	0.261952
%309620 MENTAL RETARDATION, SKELETAL DYSPLASIA, AND ABDUCENS PALSY; MRSD;;CHRISTIAN SYNDROME; CHRS	0.00196464	0.261952
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 45; MRT45	0.00196464	0.261952
MANDIBULOFACIAL DYSOSTOSIS WITH ALOPECIA; MFDA	0.00196464	0.261952
ECTODERMAL DYSPLASIA 13, HAIR/TOOTH TYPE; ECTD13	0.00196464	0.261952
INTELLECTUAL DISABILITY, BUENOS-AIRES TYPE	0.00196464	0.261952
FRONTOMETAPHYSEAL DYSPLASIA	0.00196464	0.261952
GLOBAL DEVELOPMENTAL DELAY-OSTEOPENIA-ECTODERMAL DEFECT SYNDROME	0.00196464	0.261952
600736 VELOFACIOSKELETAL SYNDROME	0.00196464	0.261952
AUTOSOMAL DOMINANT SPONDYLOCOSTAL DYSOSTOSIS	0.00196464	0.261952
INTELLECTUAL DISABILITY-CATARACTS-KYPHOSIS SYNDROME	0.00196464	0.261952
OROFACIODIGITAL SYNDROME XVIII; OFD18	0.00196464	0.261952
OCULOMAXILLOFACIAL DYSOSTOSIS	0.00196464	0.261952
MEGALENCEPHALY	0.00196464	0.261952
ISOLATED TRIGONOCEPHALY	0.00196464	0.261952
OSTEOGENESIS IMPERFECTA, TYPE XVIII; OI18	0.00196464	0.261952
DEAFNESS-CRANIOFACIAL SYNDROME	0.00196464	0.261952
ACROFACIAL DYSOSTOSIS SYNDROME OF RODRIGUEZ	0.00196464	0.261952
CRANIODIAPHYSEAL DYSPLASIA	0.00196464	0.261952
NEONATAL MARFAN SYNDROME	0.00196464	0.261952
BRACHYDACTYLY-PREAXIAL HALLUX VARUS SYNDROME	0.00196464	0.261952
HYPERTRICHOTIC OSTEOCHONDRODYSPLASIA	0.00196464	0.261952
CHONDRODYSPLASIA WITH JOINT DISLOCATIONS, GPAPP TYPE	0.00196464	0.261952
MANDIBULOFACIAL DYSOSTOSIS WITH MACROBLEPHARON AND MACROSTOMIA	0.00196464	0.261952
RETINITIS PIGMENTOSA	0.00196464	0.261952
TRICHORHINOPHALANGEAL SYNDROME TYPE 2	0.00196464	0.261952
CRANIODIAPHYSEAL DYSPLASIA, AUTOSOMAL DOMINANT; CDD	0.00196464	0.261952
MONOSOMY 5P	0.00196464	0.261952
FRANK-TER HAAR SYNDROME	0.00196464	0.261952
%265300 LYMPHANGIECTASIA, PULMONARY, CONGENITAL; CPL;;LYMPHANGIOMATOSIS, PULMONARY;;PULMONARY CYSTIC LYMPHANGIECTASIS	0.00196464	0.261952
WEAVER SYNDROME	0.001832554	0.24434053333333333
NOONAN SYNDROME 3; NS3	0.001832554	0.24434053333333333
THUMB, HYPOPLASTIC, WITH CHOROID COLOBOMA, POORLY DEVELOPED ANTIHELIX,AND DEAFNESS	0.001832554	0.24434053333333333
3-@METHYLGLUTACONIC ACIDURIA, TYPE IV	0.001832554	0.24434053333333333
ALAZAMI-YUAN SYNDROME	0.001832554	0.24434053333333333
MOSAIC TRISOMY 9	0.001832554	0.24434053333333333
MENTAL RETARDATION, X-LINKED 106; MRX106	0.001832554	0.24434053333333333
UPPER LIMB DEFECT-EYE AND EAR ABNORMALITIES SYNDROME	0.001832554	0.24434053333333333
INTELLECTUAL DISABILITY-SPARSE HAIR-BRACHYDACTYLY SYNDROME	0.001832554	0.24434053333333333
EAR-PATELLA-SHORT STATURE SYNDROME	0.001832554	0.24434053333333333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 51; MRD51	0.001832554	0.24434053333333333
MCKUSICK-KAUFMAN SYNDROME	0.001832554	0.24434053333333333
600460 CLEFT PALATE, CARDIAC DEFECT, GENITAL ANOMALIES, AND ECTRODACTYLY;;CCGE;;ACROCARDIOFACIAL SYNDROME; ACFS	0.001832554	0.24434053333333333
XQ27.3Q28 DUPLICATION SYNDROME	0.001832554	0.24434053333333333
ACRODYSOSTOSIS WITH MULTIPLE HORMONE RESISTANCE	0.001832554	0.24434053333333333
NOONAN SYNDROME 2; NS2	0.001832554	0.24434053333333333
CHROMOSOME 15Q25 DELETION SYNDROME	0.001832554	0.24434053333333333
CONGENITAL HEART DEFECTS AND SKELETAL MALFORMATIONS SYNDROME; CHDSKM	0.001832554	0.24434053333333333
MULTIPLE BENIGN CIRCUMFERENTIAL SKIN CREASES ON LIMBS	0.001832554	0.24434053333333333
CONGENITAL UNILATERAL HYPOPLASIA OF DEPRESSOR ANGULI ORIS	0.001832554	0.24434053333333333
CULLER-JONES SYNDROME; CJS	0.001832554	0.24434053333333333
LATERAL MENINGOCELE SYNDROME	0.001832554	0.24434053333333333
CHROMOSOME XQ27.3-Q28 DUPLICATION SYNDROME	0.001832554	0.24434053333333333
NOONAN SYNDROME 9; NS9	0.001832554	0.24434053333333333
DISTAL TRISOMY 18Q	0.001832554	0.24434053333333333
7P22.1 MICRODUPLICATION SYNDROME	0.001832554	0.24434053333333333
BRACHYDACTYLY-SHORT STATURE-RETINITIS PIGMENTOSA SYNDROME	0.001832554	0.24434053333333333
%300712 CRANIOFACIOSKELETAL SYNDROME	0.001832554	0.24434053333333333
N SYNDROME	0.001832554	0.24434053333333333
ACRODYSOSTOSIS 2 WITH OR WITHOUT HORMONE RESISTANCE	0.001832554	0.24434053333333333
NEUROFIBROMATOSIS-NOONAN SYNDROME; NFNS	0.001832554	0.24434053333333333
NOONAN SYNDROME 5; NS5	0.001832554	0.24434053333333333
LIG4 SYNDROME	0.001832554	0.24434053333333333
PSEUDOAMINOPTERIN SYNDROME	0.001832554	0.24434053333333333
MEHMO SYNDROME	0.001828419	0.2437892
HARROD SYNDROME	0.001828419	0.2437892
NICOLAIDES-BARAITSER SYNDROME; NCBRS	0.001828419	0.2437892
TRISOMY 13	0.001828419	0.2437892
LOWE OCULOCEREBRORENAL SYNDROME	0.001828419	0.2437892
47,XYY SYNDROME	0.001828419	0.2437892
SANJAD-SAKATI SYNDROME	0.001828419	0.2437892
NORRIE DISEASE	0.001828419	0.2437892
HYPOGONADOTROPIC HYPOGONADISM 3 WITH OR WITHOUT ANOSMIA; HH3	0.001828419	0.2437892
GLUCOCORTICOID DEFICIENCY 4 WITH OR WITHOUT MINERALOCORTICOID DEFICIENCY; GCCD4	0.001828419	0.2437892
224250 DYSMYELINATION WITH JAUNDICE	0.001828419	0.2437892
HYPOGONADOTROPIC HYPOGONADISM 4 WITH OR WITHOUT ANOSMIA; HH4	0.001828419	0.2437892
DISTAL TRISOMY 15Q	0.001828419	0.2437892
BOWEN-CONRADI SYNDROME	0.001828419	0.2437892
KALLMANN SYNDROME	0.001828419	0.2437892
X-LINKED INTELLECTUAL DISABILITY, SEEMANOVA TYPE	0.001828419	0.2437892
KAPUR-TORIELLO SYNDROME	0.001828419	0.2437892
BORJESON-FORSSMAN-LEHMANN SYNDROME	0.001828419	0.2437892
RETINITIS PIGMENTOSA 59; RP59	0.001828419	0.2437892
RICHARDS-RUNDLE SYNDROME; RRNS	0.001790884	0.23878453333333333
SENIOR-LOKEN SYNDROME 9	0.001790884	0.23878453333333333
ISOLATED COMPLEX I DEFICIENCY	0.001790884	0.23878453333333333
INTELLECTUAL DEVELOPMENTAL DISORDER WITH PERSISTENCE OF FETAL HEMOGLOBIN	0.001790884	0.23878453333333333
THAUVIN-ROBINET-FAIVRE SYNDROME	0.001790884	0.23878453333333333
NON-PROGRESSIVE CEREBELLAR ATAXIA WITH INTELLECTUAL DISABILITY	0.001790884	0.23878453333333333
DISTAL TRISOMY 6P	0.001790884	0.23878453333333333
PREAXIAL POLYDACTYLY-COLOBOMATA-INTELLECTUAL DISABILITY SYNDROME	0.001790884	0.23878453333333333
X SMALL RINGS	0.001790884	0.23878453333333333
CEREBELLAR HYPOPLASIA WITH ENDOSTEAL SCLEROSIS	0.001790884	0.23878453333333333
CEREBELLAR ATROPHY WITH SEIZURES AND VARIABLE DEVELOPMENTAL DELAY; CASVDD	0.001790884	0.23878453333333333
DISTAL MONOSOMY 6P	0.001790884	0.23878453333333333
PELGER-HUET ANOMALY; PHA	0.001790884	0.23878453333333333
CLASSIC GLUCOSE TRANSPORTER TYPE 1 DEFICIENCY SYNDROME	0.001790884	0.23878453333333333
TRISOMY 17P	0.001790884	0.23878453333333333
CODAS SYNDROME	0.001790884	0.23878453333333333
PYRIDOXINE-DEPENDENT EPILEPSY	0.001790884	0.23878453333333333
MARINESCO-SJÖGREN SYNDROME	0.001790884	0.23878453333333333
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 21; MC1DN21	0.001790884	0.23878453333333333
BOSCH-BOONSTRA-SCHAAF OPTIC ATROPHY SYNDROME; BBSOAS	0.001790884	0.23878453333333333
INTELLECTUAL DISABILITY-DEVELOPMENTAL DELAY-CONTRACTURES SYNDROME	0.001790884	0.23878453333333333
LEUKOENCEPHALOPATHY WITH BILATERAL ANTERIOR TEMPORAL LOBE CYSTS	0.001790884	0.23878453333333333
NEPHRONOPHTHISIS 11; NPHP11	0.001790884	0.23878453333333333
10Q22.3Q23.3 MICRODUPLICATION SYNDROME	0.001790884	0.23878453333333333
TETRASOMY X	0.001790884	0.23878453333333333
TALL STATURE-INTELLECTUAL DISABILITY-RENAL ANOMALIES SYNDROME	0.001790884	0.23878453333333333
NEUTRAL LIPID STORAGE DISEASE WITH ICHTHYOSIS	0.001790884	0.23878453333333333
RADIOULNAR SYNOSTOSIS-DEVELOPMENTAL DELAY-HYPOTONIA SYNDROME	0.001790884	0.23878453333333333
METHEMOGLOBINEMIA DUE TO DEFICIENCY OF METHEMOGLOBIN REDUCTASE	0.001790884	0.23878453333333333
PMP22-RAI1 CONTIGUOUS GENE DUPLICATION SYNDROME	0.001790884	0.23878453333333333
SPECTRIN-ASSOCIATED AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA	0.001790884	0.23878453333333333
SARCOSINEMIA	0.001790884	0.23878453333333333
CONGENITAL CATARACTS-FACIAL DYSMORPHISM-NEUROPATHY SYNDROME	0.001790884	0.23878453333333333
SPINOCEREBELLAR ATAXIA 42, EARLY-ONSET, SEVERE, WITH NEURODEVELOPMENTAL DEFICITS; SCA42ND	0.001790884	0.23878453333333333
LARSEN-LIKE OSSEOUS DYSPLASIA-SHORT STATURE SYNDROME	0.001790884	0.23878453333333333
X-LINKED SIDEROBLASTIC ANEMIA AND SPINOCEREBELLAR ATAXIA	0.001790884	0.23878453333333333
GAPO SYNDROME; GAPOS	0.001786749	0.2382332
BETA-MERCAPTOLACTATE CYSTEINE DISULFIDURIA	0.001786749	0.2382332
CONGENITAL HYDROCEPHALUS	0.001786749	0.2382332
%300261 ARMFIELD X-LINKED MENTAL RETARDATION SYNDROME; MRXSA;;MENTAL RETARDATION, X-LINKED, SYNDROMIC, ARMFIELD TYPE	0.001786749	0.2382332
SLC39A8-CDG	0.001786749	0.2382332
MENTAL RETARDATION, X-LINKED 21	0.001786749	0.2382332
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 44	0.001786749	0.2382332
ATAXIA-TELANGIECTASIA	0.001786749	0.2382332
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 1	0.001786749	0.2382332
CHROMOSOME 15Q13.3 MICRODELETION SYNDROME	0.001786749	0.2382332
CONGENITAL RUBELLA SYNDROME	0.001786749	0.2382332
SEVERE INTELLECTUAL DISABILITY-HYPOTONIA-STRABISMUS-COARSE FACE-PLANOVALGUS SYNDROME	0.001786749	0.2382332
RENPENNING SYNDROME	0.001786749	0.2382332
MICROCEPHALIC PRIMORDIAL DWARFISM, ALAZAMI TYPE	0.001786749	0.2382332
AUTOSOMAL RECESSIVE ATAXIA DUE TO UBIQUINONE DEFICIENCY	0.001786749	0.2382332
INFANTILE CHOROIDOCEREBRAL CALCIFICATION SYNDROME	0.001786749	0.2382332
X-LINKED INTELLECTUAL DISABILITY, STOCCO DOS SANTOS TYPE	0.001786749	0.2382332
HYDROCEPHALUS, CONGENITAL, 2, WITH OR WITHOUT BRAIN OR EYE ANOMALIES; HYC2	0.001786749	0.2382332
DYSEQUILIBRIUM SYNDROME	0.001786749	0.2382332
OLIVOPONTOCEREBELLAR ATROPHY-DEAFNESS SYNDROME	0.001786749	0.2382332
215480 CHOROID PLEXUS CALCIFICATION AND MENTAL RETARDATION	0.001786749	0.2382332
NEURODEGENERATION, CHILDHOOD-ONSET, STRESS-INDUCED, WITH VARIABLE ATAXIA AND SEIZURES; CONDSIAS	0.001786749	0.2382332
EARLY-ONSET PARKINSONISM-INTELLECTUAL DISABILITY SYNDROME	0.001786749	0.2382332
HYPOGLYCEMIA, LEUCINE-INDUCED; LIH	0.001786749	0.2382332
LEIGH SYNDROME	0.001786749	0.2382332
HEPATIC FIBROSIS-RENAL CYSTS-INTELLECTUAL DISABILITY SYNDROME	0.001786749	0.2382332
GAUCHER DISEASE, TYPE IIIC	0.001786749	0.2382332
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 28	0.001507092	0.20094560000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIP	0.001507092	0.20094560000000003
METHYLMALONIC ACIDURIA, CBLB TYPE	0.001507092	0.20094560000000003
METHYLMALONIC ACIDURIA DUE TO METHYLMALONYL-COA MUTASE DEFICIENCY	0.001507092	0.20094560000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIC; CDG2C	0.001507092	0.20094560000000003
JOUBERT SYNDROME 26	0.001507092	0.20094560000000003
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY; MTPD	0.001507092	0.20094560000000003
BRAIN DOPAMINE-SEROTONIN VESICULAR TRANSPORT DISEASE	0.001507092	0.20094560000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 50; EIEE50	0.001507092	0.20094560000000003
CHROMOSOME 22Q11.2 DUPLICATION SYNDROME	0.001507092	0.20094560000000003
2-AMINOADIPIC 2-OXOADIPIC ACIDURIA; AMOXAD	0.001507092	0.20094560000000003
MIDFACE HYPOPLASIA, OBESITY, DEVELOPMENTAL DELAY, AND NEONATAL HYPOTONIA	0.001507092	0.20094560000000003
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH MENTAL RETARDATION), TYPE B, 6	0.001507092	0.20094560000000003
SALT AND PEPPER DEVELOPMENTAL REGRESSION SYNDROME; SPDRS	0.001507092	0.20094560000000003
MANNOSIDOSIS, ALPHA B, LYSOSOMAL	0.001507092	0.20094560000000003
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 9	0.001507092	0.20094560000000003
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 1	0.001507092	0.20094560000000003
MULTIPLE ENDOCRINE NEOPLASIA, TYPE IIB; MEN2B	0.001507092	0.20094560000000003
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 17; SCAR17	0.001507092	0.20094560000000003
MITOCHONDRIAL SHORT-CHAIN ENOYL-COA HYDRATASE 1 DEFICIENCY; ECHS1D	0.001507092	0.20094560000000003
MENTAL RETARDATION, ENTEROPATHY, DEAFNESS, PERIPHERAL NEUROPATHY, ICHTHYOSIS, AND KERATODERMA	0.001507092	0.20094560000000003
AL-RAQAD SYNDROME; ARS	0.001507092	0.20094560000000003
NEUROPATHY, HEREDITARY MOTOR AND SENSORY, TYPE VIB; HMSN6B	0.001507092	0.20094560000000003
JOUBERT SYNDROME 25	0.001507092	0.20094560000000003
INTELLECTUAL DEVELOPMENTAL DISORDER WITH AUTISM AND SPEECH DELAY; IDDAS	0.001507092	0.20094560000000003
COENZYME Q10 DEFICIENCY, PRIMARY, 8; COQ10D8	0.001507092	0.20094560000000003
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 1; CEMCOX1	0.001507092	0.20094560000000003
MITOCHONDRIAL DNA DEPLETION SYNDROME 4A (ALPERS TYPE)	0.001507092	0.20094560000000003
SALT-AND-PEPPER SYNDROME	0.001507092	0.20094560000000003
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2Z; CMT2Z	0.001507092	0.20094560000000003
JOUBERT SYNDROME 24	0.001507092	0.20094560000000003
RING CHROMOSOME 14 SYNDROME	0.001507092	0.20094560000000003
PONTOCEREBELLAR HYPOPLASIA, TYPE 1A; PCH1A	0.001507092	0.20094560000000003
HYPOTONIA-CYSTINURIA SYNDROME	0.001507092	0.20094560000000003
CEREBELLAR ATAXIA, CAYMAN TYPE	0.001507092	0.20094560000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IID	0.001507092	0.20094560000000003
CHOREOATHETOSIS, HYPOTHYROIDISM, AND NEONATAL RESPIRATORY DISTRESSCHOREOATHETOSIS AND CONGENITAL HYPOTHYROIDISM, INCLUDED	0.001507092	0.20094560000000003
JOUBERT SYNDROME 6	0.001507092	0.20094560000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 26; COXPD26	0.001507092	0.20094560000000003
DIAPHANOSPONDYLODYSOSTOSIS	0.001507092	0.20094560000000003
DYSKINESIA, SEIZURES, AND INTELLECTUAL DEVELOPMENTAL DISORDER	0.001507092	0.20094560000000003
CONGENITAL HYPOTHYROIDISM DUE TO MATERNAL INTAKE OF ANTITHYROID DRUGS	0.001507092	0.20094560000000003
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED INTELLECTUAL DEVELOPMENT, HYPOTONIA, AND ATAXIA; NEDIDHA	0.001507092	0.20094560000000003
ARIMA SYNDROME	0.001507092	0.20094560000000003
CHROMOSOME 16P12.2-P11.2 DELETION SYNDROME, 7.1- TO 8.7-MB	0.001507092	0.20094560000000003
JOUBERT SYNDROME 32; JBTS32	0.001507092	0.20094560000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 27; MC1DN27	0.001507092	0.20094560000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 28; MC1DN28	0.001507092	0.20094560000000003
MENTAL RETARDATION, X-LINKED 41	0.001507092	0.20094560000000003
SHORT STATURE, ONYCHODYSPLASIA, FACIAL DYSMORPHISM, AND HYPOTRICHOSIS	0.001507092	0.20094560000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 7; COXPD7	0.001507092	0.20094560000000003
MENTAL RETARDATION, X-LINKED 99	0.001507092	0.20094560000000003
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 8	0.001507092	0.20094560000000003
PEROXISOME BIOGENESIS DISORDER 10B	0.001507092	0.20094560000000003
CEREBELLAR ATROPHY, DEVELOPMENTAL DELAY, AND SEIZURES; CADEDS	0.001507092	0.20094560000000003
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 75	0.001507092	0.20094560000000003
CHROMOSOME 4Q21 DELETION SYNDROME	0.001507092	0.20094560000000003
ARTHROGRYPOSIS, RENAL DYSFUNCTION, AND CHOLESTASIS 2	0.001507092	0.20094560000000003
WARSAW BREAKAGE SYNDROME; WABS	0.001507092	0.20094560000000003
OROFACIODIGITAL SYNDROME XVI; OFD16	0.001507092	0.20094560000000003
GLOBAL DEVELOPMENTAL DELAY WITH OR WITHOUT IMPAIRED INTELLECTUAL DEVELOPMENT; GDDI	0.001507092	0.20094560000000003
PERIPHERAL HYPOTHYROIDISM	0.001507092	0.20094560000000003
RIGID SPINE SYNDROME	0.001507092	0.20094560000000003
GALACTOSE EPIMERASE DEFICIENCY	0.001507092	0.20094560000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 58; EIEE58	0.001507092	0.20094560000000003
RUBINSTEIN-TAYBI SYNDROME 2; RSTS2	0.001507092	0.20094560000000003
DEVELOPMENTAL DELAY AND SEIZURES WITH OR WITHOUT MOVEMENT ABNORMALITIES; DEDSM	0.001507092	0.20094560000000003
PEROXISOME BIOGENESIS DISORDER 3B	0.001507092	0.20094560000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 66; MRT66	0.001507092	0.20094560000000003
RADIOULNAR SYNOSTOSIS, UNILATERAL, WITH DEVELOPMENTAL RETARDATIONAND HYPOTONIA	0.001507092	0.20094560000000003
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.001507092	0.20094560000000003
COGNITIVE IMPAIRMENT WITH OR WITHOUT CEREBELLAR ATAXIA; CIAT	0.001507092	0.20094560000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 27	0.001507092	0.20094560000000003
SPINOCEREBELLAR ATAXIA WITH DYSMORPHISM	0.001507092	0.20094560000000003
SPONDYLOMETAEPIPHYSEAL DYSPLASIA, SHORT LIMB-HAND TYPE	0.001507092	0.20094560000000003
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.001507092	0.20094560000000003
ACETYL-COA ACETYLTRANSFERASE-2 DEFICIENCY	0.001507092	0.20094560000000003
JOUBERT SYNDROME 15	0.001507092	0.20094560000000003
EPILEPSY, PYRIDOXINE-DEPENDENT	0.001507092	0.20094560000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 63; EIEE63	0.001507092	0.20094560000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 36; COXPD36	0.001507092	0.20094560000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 13	0.001507092	0.20094560000000003
INFANTILE-ONSET AUTOSOMAL RECESSIVE NONPROGRESSIVE CEREBELLAR ATAXIA	0.001507092	0.20094560000000003
METHYLMALONIC ACIDURIA AND HOMOCYSTINURIA, CBLF TYPE	0.001507092	0.20094560000000003
MEGALOBLASTIC ANEMIA DUE TO DIHYDROFOLATE REDUCTASE DEFICIENCY	0.001507092	0.20094560000000003
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 22; MC1DN22	0.001507092	0.20094560000000003
HYPERPHENYLALANINEMIA, MILD, NON-BH4-DEFICIENT; HPANBH4	0.001507092	0.20094560000000003
PEROXISOME BIOGENESIS DISORDER 5B	0.001507092	0.20094560000000003
CONGENITAL HEART DEFECTS AND ECTODERMAL DYSPLASIA	0.001507092	0.20094560000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 47	0.001507092	0.20094560000000003
JOUBERT SYNDROME 28	0.001507092	0.20094560000000003
JOUBERT SYNDROME 27	0.001507092	0.20094560000000003
SPINOCEREBELLAR ATAXIA 5; SCA5	0.001507092	0.20094560000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 18	0.001507092	0.20094560000000003
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IAA	0.001507092	0.20094560000000003
MOLYBDENUM COFACTOR DEFICIENCY, COMPLEMENTATION GROUP C; MOCODC	0.001507092	0.20094560000000003
GROWTH RETARDATION, SMALL AND PUFFY HANDS AND FEET, AND ECZEMA	0.001507092	0.20094560000000003
CHROMOSOMAL INSTABILITY WITH TISSUE-SPECIFIC RADIOSENSITIVITY	0.001507092	0.20094560000000003
JOUBERT SYNDROME 8	0.001507092	0.20094560000000003
PECTUS EXCAVATUM, MACROCEPHALY, SHORT STATURE, AND DYSPLASTIC NAILS	0.001507092	0.20094560000000003
TRIOSEPHOSPHATE ISOMERASE DEFICIENCY	0.001507092	0.20094560000000003
X-LINKED INTELLECTUAL DISABILITY-HYPOTONIA-FACIAL DYSMORPHISM-AGGRESSIVE BEHAVIOR SYNDROME	0.001507092	0.20094560000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 38; EIEE38	0.001507092	0.20094560000000003
RESISTANCE TO THYROTROPIN-RELEASING HORMONE SYNDROME	0.001507092	0.20094560000000003
CEREBELLAR ATAXIA, CAYMAN TYPE; ATCAY	0.001507092	0.20094560000000003
JOUBERT SYNDROME 1	0.001507092	0.20094560000000003
DESBUQUOIS DYSPLASIA 2; DBQD2	0.001507092	0.20094560000000003
NOONAN SYNDROME 11; NS11	0.001507092	0.20094560000000003
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 2; SCAR2	0.001507092	0.20094560000000003
LEUKODYSTROPHY, HYPOMYELINATING, 13; HLD13	0.001507092	0.20094560000000003
IMMUNODEFICIENCY 23; IMD23	0.001507092	0.20094560000000003
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 7; OPTB7	0.001507092	0.20094560000000003
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 17	0.001507092	0.20094560000000003
SPINOCEREBELLAR ATAXIA TYPE 29	0.001507092	0.20094560000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 57; MRT57	0.001507092	0.20094560000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 52; EIEE52	0.001507092	0.20094560000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 15; EIEE15	0.001507092	0.20094560000000003
NIEMANN-PICK DISEASE, TYPE A	0.001507092	0.20094560000000003
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 16; EIEE16	0.001507092	0.20094560000000003
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 4; MC3DN4	0.001507092	0.20094560000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 35	0.001507092	0.20094560000000003
NAVAJO NEUROHEPATOPATHY	0.001507092	0.20094560000000003
PAROXYSMAL NONKINESIGENIC DYSKINESIA, 3, WITH OR WITHOUT GENERALIZED EPILEPSY; PNKD3	0.001507092	0.20094560000000003
STRIATONIGRAL DEGENERATION, INFANTILE, MITOCHONDRIAL	0.001507092	0.20094560000000003
SHWACHMAN-DIAMOND SYNDROME	0.001507092	0.20094560000000003
LANGUAGE DELAY AND ATTENTION DEFICIT-HYPERACTIVITY DISORDER/COGNITIVE IMPAIRMENT WITH OR WITHOUT CARDIAC ARRHYTHMIA; LADCI	0.001507092	0.20094560000000003
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 37	0.001502957	0.20039426666666665
MENTAL RETARDATION, AUTOSOMAL DOMINANT 7	0.001502957	0.20039426666666665
MITOCHONDRIAL DNA DEPLETION SYNDROME 2 (MYOPATHIC TYPE)	0.001502957	0.20039426666666665
PEROXISOME BIOGENESIS DISORDER 13A (ZELLWEGER)	0.001502957	0.20039426666666665
PEROXISOME BIOGENESIS DISORDER 10A (ZELLWEGER); PBD10A	0.001502957	0.20039426666666665
INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.001502957	0.20039426666666665
METACHROMATIC LEUKODYSTROPHY, JUVENILE FORM	0.001502957	0.20039426666666665
PEROXISOME BIOGENESIS DISORDER 8A (ZELLWEGER); PBD8A	0.001502957	0.20039426666666665
EPISODIC ATAXIA, TYPE 6	0.001502957	0.20039426666666665
MAPLE SYRUP URINE DISEASE; MSUD	0.001502957	0.20039426666666665
PEROXISOME BIOGENESIS DISORDER 4A (ZELLWEGER)	0.001502957	0.20039426666666665
METACHROMATIC LEUKODYSTROPHY, ADULT FORM	0.001502957	0.20039426666666665
MANNOSIDOSIS, BETA A, LYSOSOMAL	0.001502957	0.20039426666666665
MITOCHONDRIAL DNA DEPLETION SYNDROME 8A (ENCEPHALOMYOPATHIC TYPE WITH RENAL TUBULOPATHY)	0.001502957	0.20039426666666665
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 22	0.001502957	0.20039426666666665
HYPERGLYCINEMIA, LACTIC ACIDOSIS, AND SEIZURES	0.001502957	0.20039426666666665
METACHROMATIC LEUKODYSTROPHY, LATE INFANTILE FORM	0.001502957	0.20039426666666665
TATTON-BROWN-RAHMAN SYNDROME; TBRS	0.001502957	0.20039426666666665
MENTAL RETARDATION, AUTOSOMAL DOMINANT 20	0.001502957	0.20039426666666665
HYPOPHOSPHATASIA, INFANTILE	0.001502957	0.20039426666666665
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 14; MDDGC14	0.001502957	0.20039426666666665
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 23; SCAR23	0.001502957	0.20039426666666665
SUDDEN CARDIAC FAILURE, INFANTILE	0.001502957	0.20039426666666665
VISCERAL STEATOSIS, CONGENITAL	0.001502957	0.20039426666666665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 59; EIEE59	0.001502957	0.20039426666666665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 15; MC1DN15	0.001502957	0.20039426666666665
PYRUVATE DEHYDROGENASE E3 DEFICIENCY	0.001502957	0.20039426666666665
POSTERIOR COLUMN ATAXIA-RETINITIS PIGMENTOSA SYNDROME	0.001502957	0.20039426666666665
MITOCHONDRIAL MYOPATHY WITH LACTIC ACIDOSIS; MMLA	0.001502957	0.20039426666666665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 65; EIEE65	0.001502957	0.20039426666666665
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 61; EIEE61	0.001502957	0.20039426666666665
MITOCHONDRIAL DNA DEPLETION SYNDROME 3 (HEPATOCEREBRAL TYPE)	0.001502957	0.20039426666666665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 14; MC1DN14	0.001502957	0.20039426666666665
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001502957	0.20039426666666665
OSTEOPENIA-INTELLECTUAL DISABILITY-SPARSE HAIR SYNDROME	0.001502957	0.20039426666666665
GLUTARIC ACIDEMIA I; GA1	0.001502957	0.20039426666666665
ETHYLMALONIC ENCEPHALOPATHY	0.001502957	0.20039426666666665
LEUKOENCEPHALOPATHY WITH VANISHING WHITE MATTER; VWM	0.001502957	0.20039426666666665
PSEUDO-TORCH SYNDROME 2	0.001502957	0.20039426666666665
TAY-SACHS DISEASE; TSD	0.001502957	0.20039426666666665
HUNTINGTON DISEASE-LIKE 1	0.001502957	0.20039426666666665
COFFIN-SIRIS SYNDROME 8; CSS8	0.001502957	0.20039426666666665
LEUKODYSTROPHY, HYPOMYELINATING, 14; HLD14	0.001502957	0.20039426666666665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 32; MC1DN32	0.001502957	0.20039426666666665
XYLOSIDASE DEFICIENCY	0.001502957	0.20039426666666665
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.001502957	0.20039426666666665
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 3; MC1DN3	0.001502957	0.20039426666666665
CARNITINE PALMITOYLTRANSFERASE I DEFICIENCY	0.001502957	0.20039426666666665
NEURAMINIDASE DEFICIENCY	0.001502957	0.20039426666666665
AROMATASE DEFICIENCY	0.001287	0.17159999999999997
184800 STERNUM, PREMATURE OBLITERATION OF SUTURES OF	0.001287	0.17159999999999997
46,XX OVOTESTICULAR DISORDER OF SEX DEVELOPMENT	0.001287	0.17159999999999997
8P23.1 DELETION SYNDROME	0.001287	0.17159999999999997
MACS SYNDROME	0.001287	0.17159999999999997
OCHOA SYNDROME	0.001287	0.17159999999999997
MEACHAM SYNDROME	0.001287	0.17159999999999997
EHLERS-DANLOS SYNDROME, CLASSIC-LIKE, 2; EDSCLL2	0.001287	0.17159999999999997
N SYNDROME	0.001287	0.17159999999999997
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, OHDO TYPE	0.001287	0.17159999999999997
MANDIBULAR HYPOPLASIA, DEAFNESS, PROGEROID FEATURES, AND LIPODYSTROPHY SYNDROME; MDPL	0.001287	0.17159999999999997
TIBIAL HEMIMELIA	0.001287	0.17159999999999997
MYOPATHY, CENTRONUCLEAR, X-LINKED; CNMX	0.001287	0.17159999999999997
LEYDIG CELL HYPOPLASIA	0.001287	0.17159999999999997
AUTOSOMAL DOMINANT OMODYSPLASIA	0.001287	0.17159999999999997
ANTENATAL MULTIMINICORE DISEASE WITH ARTHROGRYPOSIS MULTIPLEX CONGENITA	0.001287	0.17159999999999997
JUBERG-MARSIDI SYNDROME	0.001287	0.17159999999999997
DIASTROPHIC DWARFISM	0.001287	0.17159999999999997
FETAL AKINESIA DEFORMATION SEQUENCE 4; FADS4	0.001287	0.17159999999999997
HYPOGONADOTROPIC HYPOGONADISM 6 WITH OR WITHOUT ANOSMIA; HH6	0.001287	0.17159999999999997
SCHNECKENBECKEN DYSPLASIA	0.001287	0.17159999999999997
VACTERL WITH HYDROCEPHALUS	0.001287	0.17159999999999997
NORMOSMIC CONGENITAL HYPOGONADOTROPIC HYPOGONADISM	0.001287	0.17159999999999997
WIDOW'S PEAK SYNDROME	0.001287	0.17159999999999997
HYPOGONADOTROPIC HYPOGONADISM 1 WITH OR WITHOUT ANOSMIA; HH1	0.001287	0.17159999999999997
OSTEOGLOSPHONIC DYSPLASIA	0.001287	0.17159999999999997
TORTICOLLIS, KELOIDS, CRYPTORCHIDISM, AND RENAL DYSPLASIA; TKCR	0.001287	0.17159999999999997
ISOLATED HEMIHYPERPLASIA	0.001287	0.17159999999999997
REIFENSTEIN SYNDROME	0.001287	0.17159999999999997
NOONAN SYNDROME-LIKE DISORDER WITH LOOSE ANAGEN HAIR	0.001287	0.17159999999999997
NOONAN SYNDROME 8; NS8	0.001287	0.17159999999999997
ULNAR-MAMMARY SYNDROME	0.001287	0.17159999999999997
KALLMANN SYNDROME WITH SPASTIC PARAPLEGIA	0.001287	0.17159999999999997
CRANIOSTENOSIS, SAGITTAL, WITH CONGENITAL HEART DISEASE, MENTAL DEFICIENCY, AND MANDIBULAR ANKYLOSIS	0.001287	0.17159999999999997
HYPOGONADOTROPIC HYPOGONADISM 16 WITH OR WITHOUT ANOSMIA; HH16	0.001287	0.17159999999999997
KID SYNDROME	0.001287	0.17159999999999997
X-LINKED INTELLECTUAL DISABILITY-CRANIOFACIOSKELETAL SYNDROME	0.001287	0.17159999999999997
TETRAGAMETIC CHIMERISM	0.001287	0.17159999999999997
CONGENITAL OSTEOGENESIS IMPERFECTA-MICROCEPHALY-CATARACTS SYNDROME	0.001287	0.17159999999999997
CAUDAL REGRESSION SEQUENCE	0.001287	0.17159999999999997
RECESSIVE X-LINKED ICHTHYOSIS	0.001287	0.17159999999999997
PARTIAL CHROMOSOME Y DELETION	0.001287	0.17159999999999997
CARDIAC-UROGENITAL SYNDROME; CUGS	0.001287	0.17159999999999997
SYNDROMIC X-LINKED INTELLECTUAL DISABILITY 7	0.001287	0.17159999999999997
BECKWITH-WIEDEMANN SYNDROME	0.001287	0.17159999999999997
258040 OEIS COMPLEX;;OMPHALOCELE-EXSTROPHY-IMPERFORATE ANUS-SPINAL DEFECTS	0.001287	0.17159999999999997
IMAGE SYNDROME	0.001287	0.17159999999999997
ATHEROSCLEROSIS-DEAFNESS-DIABETES-EPILEPSY-NEPHROPATHY SYNDROME	0.001287	0.17159999999999997
FETAL MINOXIDIL SYNDROME	0.001287	0.17159999999999997
PSEUDOVAGINAL PERINEOSCROTAL HYPOSPADIAS; PPSH	0.001287	0.17159999999999997
ADRENAL HYPOPLASIA, CONGENITAL	0.001287	0.17159999999999997
PENILE AGENESIS	0.001287	0.17159999999999997
ABRUZZO-ERICKSON SYNDROME	0.001287	0.17159999999999997
MULTISYSTEMIC SMOOTH MUSCLE DYSFUNCTION SYNDROME	0.001287	0.17159999999999997
X-LINKED INTELLECTUAL DISABILITY, VAN ESCH TYPE	0.001287	0.17159999999999997
PRUNE BELLY SYNDROME	0.001287	0.17159999999999997
X-LINKED INTELLECTUAL DISABILITY, CILLIERS TYPE	0.001287	0.17159999999999997
AUTOSOMAL RECESSIVE OMODYSPLASIA	0.001287	0.17159999999999997
CHROMOSOME 17Q12 DELETION SYNDROME	0.001287	0.17159999999999997
RETINITIS PIGMENTOSA-INTELLECTUAL DISABILITY-DEAFNESS-HYPOGONADISM SYNDROME	0.001287	0.17159999999999997
INTELLECTUAL DISABILITY-POLYDACTYLY-UNCOMBABLE HAIR SYNDROME	0.001287	0.17159999999999997
ICHTHYOSIS, X-LINKED	0.001287	0.17159999999999997
HYPOGONADOTROPIC HYPOGONADISM 5 WITH OR WITHOUT ANOSMIA	0.001287	0.17159999999999997
HYPOGONADOTROPIC HYPOGONADISM 15 WITH OR WITHOUT ANOSMIA	0.001287	0.17159999999999997
ADRENAL HYPOPLASIA, CONGENITAL, WITH ABSENT PITUITARY LUTEINIZINGHORMONE	0.001287	0.17159999999999997
POPLITEAL PTERYGIUM SYNDROME	0.001287	0.17159999999999997
FANCONI ANEMIA, COMPLEMENTATION GROUP O	0.001287	0.17159999999999997
TETRA-AMELIA WITH ECTODERMAL DYSPLASIA AND LACRIMAL DUCT ABNORMALITIES	0.001287	0.17159999999999997
LARSEN SYNDROME	0.001287	0.17159999999999997
FANCONI ANEMIA, COMPLEMENTATION GROUP P; FANCP	0.001287	0.17159999999999997
301950 BRANCHIAL ARCH SYNDROME, X-LINKED;;MANDIBULOFACIAL DYSOSTOSIS, TORIELLO TYPE	0.001287	0.17159999999999997
HYPOGONADOTROPIC HYPOGONADISM 12 WITH OR WITHOUT ANOSMIA	0.001287	0.17159999999999997
OLIVER-MCFARLANE SYNDROME	0.001287	0.17159999999999997
HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA; HH8	0.001287	0.17159999999999997
CRANIOSYNOSTOSIS WITH FIBULAR APLASIA	0.001287	0.17159999999999997
ANDROGEN INSENSITIVITY SYNDROME	0.001287	0.17159999999999997
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.001287	0.17159999999999997
RUVALCABA SYNDROME	0.001287	0.17159999999999997
OMODYSPLASIA	0.001287	0.17159999999999997
FAMILIAL GLUCOCORTICOID DEFICIENCY	0.001287	0.17159999999999997
NOONAN SYNDROME 4; NS4	0.001287	0.17159999999999997
BLOOM SYNDROME	0.001287	0.17159999999999997
LUMBAR SYNDROME	0.001287	0.17159999999999997
NON-DISTAL TRISOMY 13Q	0.001287	0.17159999999999997
HEART DEFECT-TONGUE HAMARTOMA-POLYSYNDACTYLY SYNDROME	0.001287	0.17159999999999997
BARDET-BIEDL SYNDROME 4; BBS4	0.001287	0.17159999999999997
NOONAN SYNDROME 10; NS10	0.001287	0.17159999999999997
COMPLETE ANDROGEN INSENSITIVITY SYNDROME	0.001287	0.17159999999999997
ANKYLOBLEPHARON FILIFORME ADNATUM-IMPERFORATE ANUS SYNDROME	0.001287	0.17159999999999997
VELOCARDIOFACIAL SYNDROME	0.001287	0.17159999999999997
CAUDAL DUPLICATION	0.001287	0.17159999999999997
FETAL AKINESIA DEFORMATION SEQUENCE	0.001287	0.17159999999999997
SPONDYLOCOSTAL DYSOSTOSIS-ANAL ATRESIA-GENITOURINARY MALFORMATION SYNDROME	0.001287	0.17159999999999997
BARDET-BIEDL SYNDROME	0.001287	0.17159999999999997
CONGENITAL ADRENAL HYPERPLASIA	0.001287	0.17159999999999997
DISTAL TRISOMY 5Q	0.001287	0.17159999999999997
HYPOGONADOTROPIC HYPOGONADISM 22 WITH OR WITHOUT ANOSMIA; HH22	0.001287	0.17159999999999997
MICROCEPHALIC PRIMORDIAL DWARFISM, MONTREAL TYPE	0.001287	0.17159999999999997
AUTOSOMAL RECESSIVE SPONDYLOCOSTAL DYSOSTOSIS	0.001287	0.17159999999999997
ANIRIDIA-ABSENT PATELLA SYNDROME	0.001287	0.17159999999999997
VERLOOVE VANHORICK-BRUBAKK SYNDROME	0.001287	0.17159999999999997
ULBRIGHT-HODES SYNDROME	0.001287	0.17159999999999997
AUTOSOMAL RECESSIVE AMELIA	0.001287	0.17159999999999997
CONGENITAL ADRENAL HYPERPLASIA DUE TO CYTOCHROME P450 OXIDOREDUCTASE DEFICIENCY	0.001287	0.17159999999999997
MMEP SYNDROME	0.001287	0.17159999999999997
266910 RENAL DYSPLASIA-LIMB DEFECTS SYNDROME;;RL SYNDROME	0.001287	0.17159999999999997
SHORT-RIB THORACIC DYSPLASIA 13 WITH OR WITHOUT POLYDACTYLY; SRTD13	0.001287	0.17159999999999997
ROBINOW SYNDROME, AUTOSOMAL DOMINANT 2; DRS2	0.001287	0.17159999999999997
ACROFACIAL DYSOSTOSIS, CATANIA TYPE	0.001287	0.17159999999999997
DIARRHEA 10, PROTEIN-LOSING ENTEROPATHY TYPE; DIAR10	0.001287	0.17159999999999997
WT LIMB-BLOOD SYNDROME	0.001287	0.17159999999999997
MATTHEW-WOOD SYNDROME	0.001287	0.17159999999999997
46,XY PARTIAL GONADAL DYSGENESIS	0.001287	0.17159999999999997
WAGR SYNDROME	0.001287	0.17159999999999997
HEART-HAND SYNDROME TYPE 2	0.001287	0.17159999999999997
AUTOSOMAL RECESSIVE ATAXIA, BEAUCE TYPE	0.001287	0.17159999999999997
TETRALOGY OF FALLOT	0.001287	0.17159999999999997
MICROPHTHALMIA WITH LIMB ANOMALIES	0.001287	0.17159999999999997
TRISOMY XQ28	0.001287	0.17159999999999997
ECTRODACTYLY, ECTODERMAL DYSPLASIA, AND CLEFT LIP/PALATE SYNDROME 3; EEC3	0.001287	0.17159999999999997
FBLN1-RELATED DEVELOPMENTAL DELAY-CENTRAL NERVOUS SYSTEM ANOMALY-SYNDACTYLY SYNDROME	0.001287	0.17159999999999997
PRIMARY HYPERGONADOTROPIC HYPOGONADISM-PARTIAL ALOPECIA SYNDROME	0.001287	0.17159999999999997
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 5-ALPHA-REDUCTASE 2 DEFICIENCY	0.001287	0.17159999999999997
TESTICULAR GERM CELL TUMOR; TGCT	0.001287	0.17159999999999997
MICROPHTHALMIA, SYNDROMIC 8; MCOPS8	0.001287	0.17159999999999997
AUTOSOMAL DOMINANT POPLITEAL PTERYGIUM SYNDROME	0.001287	0.17159999999999997
601095 HARROD SYNDROME	0.001287	0.17159999999999997
CEREBELLAR ATAXIA-ECTODERMAL DYSPLASIA SYNDROME	0.001287	0.17159999999999997
19Q13.11 MICRODELETION SYNDROME	0.001287	0.17159999999999997
MEGACYSTIS-MICROCOLON-INTESTINAL HYPOPERISTALSIS SYNDROME	0.001287	0.17159999999999997
RIN2 SYNDROME	0.001287	0.17159999999999997
PERSISTENT MÜLLERIAN DUCT SYNDROME	0.001287	0.17159999999999997
BOOMERANG DYSPLASIA	0.001287	0.17159999999999997
46,XY DISORDER OF SEX DEVELOPMENT DUE TO ISOLATED 17,20-LYASE DEFICIENCY	0.001287	0.17159999999999997
HYPOGONADOTROPIC HYPOGONADISM 7 WITH OR WITHOUT ANOSMIA; HH7	0.001287	0.17159999999999997
PARTIAL ANDROGEN INSENSITIVITY SYNDROME	0.001287	0.17159999999999997
PATERNAL UNIPARENTAL DISOMY OF CHROMOSOME 6	0.001287	0.17159999999999997
COLOBOMA-OBESITY-HYPOGENITALISM-MENTAL RETARDATION SYNDROME	0.001287	0.17159999999999997
ELLIS-VAN CREVELD SYNDROME	0.001287	0.17159999999999997
CUTIS GYRATA-ACANTHOSIS NIGRICANS-CRANIOSYNOSTOSIS SYNDROME	0.001287	0.17159999999999997
LEPRECHAUNISM	0.001287	0.17159999999999997
OROFACIAL CLEFT 15	0.001287	0.17159999999999997
DISTAL 7Q11.23 MICRODUPLICATION SYNDROME	0.001287	0.17159999999999997
DIPHALLIA	0.001287	0.17159999999999997
CONGENITAL ADRENAL HYPERPLASIA DUE TO 3-BETA-HYDROXYSTEROID DEHYDROGENASE DEFICIENCY	0.001287	0.17159999999999997
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 3; DKCA3	0.001287	0.17159999999999997
HYPOSMIA-NASAL AND OCULAR HYPOPLASIA-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.001287	0.17159999999999997
PHOCOMELIA, SCHINZEL TYPE	0.001287	0.17159999999999997
UROFACIAL SYNDROME	0.001287	0.17159999999999997
BOSMA ARHINIA MICROPHTHALMIA SYNDROME	0.001287	0.17159999999999997
THROMBOCYTOPENIA WITH CONGENITAL DYSERYTHROPOIETIC ANEMIA	0.001287	0.17159999999999997
CAUDAL APPENDAGE-DEAFNESS SYNDROME	0.001287	0.17159999999999997
46,XY DISORDER OF SEX DEVELOPMENT DUE TO 17-BETA-HYDROXYSTEROID DEHYDROGENASE 3 DEFICIENCY	0.001287	0.17159999999999997
CONGENITAL ADRENAL HYPERPLASIA DUE TO 17-ALPHA-HYDROXYLASE DEFICIENCY	0.001287	0.17159999999999997
CONGENITAL LIPOID ADRENAL HYPERPLASIA DUE TO STAR DEFICENCY	0.001287	0.17159999999999997
X-LINKED MANDIBULOFACIAL DYSOSTOSIS	0.001287	0.17159999999999997
GORDON SYNDROME	0.001287	0.17159999999999997
RENAL AND MULLERIAN DUCT HYPOPLASIA	0.00124533	0.166044
LEBER CONGENITAL AMAUROSIS 16	0.00124533	0.166044
CROSSED POLYSYNDACTYLY	0.00124533	0.166044
VITREORETINOCHOROIDOPATHY; VRCP	0.00124533	0.166044
CHANARIN-DORFMAN SYNDROME	0.00124533	0.166044
PROGEROID SYNDROME, PETTY TYPE	0.00124533	0.166044
BRANCHIOGENIC DEAFNESS SYNDROME	0.00124533	0.166044
RETINOPATHY, PERICENTRAL PIGMENTARY, AUTOSOMAL RECESSIVE	0.00124533	0.166044
OCULOCUTANEOUS ALBINISM TYPE 3	0.00124533	0.166044
RETINOBLASTOMA	0.00124533	0.166044
610319 RHIZOMELIC DYSPLASIA, SCOLIOSIS, AND RETINITIS PIGMENTOSA	0.00124533	0.166044
PETERS ANOMALY	0.00124533	0.166044
PSEUDOHYPOPARATHYROIDISM TYPE 1A	0.00124533	0.166044
OCULOCUTANEOUS ALBINISM TYPE 4	0.00124533	0.166044
PETERS ANOMALY	0.00124533	0.166044
APHONIA-DEAFNESS-RETINAL DYSTROPHY-BIFID HALLUCES-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.166044
SEVERE MOTOR AND INTELLECTUAL DISABILITIES-SENSORINEURAL DEAFNESS-DYSTONIA SYNDROME	0.00124533	0.166044
PROXIMAL SYMPHALANGISM	0.00124533	0.166044
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 8; SCAR8	0.00124533	0.166044
MORNING GLORY DISC ANOMALY	0.00124533	0.166044
NANOPHTHALMOS	0.00124533	0.166044
COATS DISEASE	0.00124533	0.166044
OCULOCUTANEOUS ALBINISM TYPE 1B	0.00124533	0.166044
ECTODERMAL DYSPLASIA, SENSORINEURAL HEARING LOSS, AND DISTINCTIVE FACIAL FEATURES	0.00124533	0.166044
%608703 SPINOCEREBELLAR ATAXIA 25; SCA25	0.00124533	0.166044
METAPHYSEAL DYSOSTOSIS, MENTAL RETARDATION, AND CONDUCTIVE DEAFNESS	0.00124533	0.166044
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 1	0.00124533	0.166044
%609166 BRANCHIOGENIC-DEAFNESS SYNDROME	0.00124533	0.166044
SPINOCEREBELLAR ATAXIA 27; SCA27	0.00124533	0.166044
OCULOCUTANEOUS ALBINISM TYPE 2	0.00124533	0.166044
MENTAL RETARDATION SYNDROME, MIETENS-WEBER TYPE	0.00124533	0.166044
CATARACT 9, MULTIPLE TYPES; CTRCT9	0.00124533	0.166044
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.00124533	0.166044
DEAF BLIND HYPOPIGMENTATION SYNDROME, YEMENITE TYPE	0.00124533	0.166044
TRICHOTHIODYSTROPHY 1, PHOTOSENSITIVE; TTD1	0.00124533	0.166044
SPASTIC PARAPLEGIA 16, X-LINKED	0.00124533	0.166044
%300589 NYSTAGMUS 5, CONGENITAL, X-LINKED; NYS5	0.00124533	0.166044
EXTERNAL AUDITORY CANAL ATRESIA-VERTICAL TALUS-HYPERTELORISM SYNDROME	0.00124533	0.166044
AASE-SMITH SYNDROME	0.00124533	0.166044
GAUCHER DISEASE TYPE 3	0.00124533	0.166044
MUCOLIPIDOSIS TYPE IV	0.00124533	0.166044
X-LINKED INTELLECTUAL DISABILITY-SHORT STATURE-OVERWEIGHT SYNDROME	0.00124533	0.166044
SPINOCEREBELLAR ATAXIA, X-LINKED 1; SCAX1	0.00124533	0.166044
OPHTHALMOPLEGIA TOTALIS WITH PTOSIS AND MIOSIS	0.00124533	0.166044
CONGENITAL INSENSITIVITY TO PAIN WITH SEVERE INTELLECTUAL DISABILITY	0.00124533	0.166044
ALBINISM, OCULOCUTANEOUS, TYPE III	0.00124533	0.166044
PSEUDOXANTHOMA ELASTICUM-LIKE SKIN MANIFESTATIONS WITH RETINITIS PIGMENTOSA	0.00124533	0.166044
OPTIC ATROPHY 7 WITH OR WITHOUT AUDITORY NEUROPATHY; OPA7	0.00124533	0.166044
GLUTATHIONURIA	0.00124533	0.166044
NANCE-HORAN SYNDROME	0.00124533	0.166044
X-LINKED NON PROGRESSIVE CEREBELLAR ATAXIA	0.00124533	0.166044
X-LINKED INTELLECTUAL DISABILITY, SHRIMPTON TYPE	0.00124533	0.166044
%193003 NYSTAGMUS 4, CONGENITAL, AUTOSOMAL DOMINANT; NYS4;;VESTIBULOCEREBELLAR DISORDER WITH PREDOMINANT OCULAR SIGNS	0.00124533	0.166044
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 36	0.00124533	0.166044
DUANE-RADIAL RAY SYNDROME; DRRS	0.00124533	0.166044
LERI PLEONOSTEOSIS	0.00124533	0.166044
IVIC SYNDROME	0.00124533	0.166044
CEREBELLAR, OCULAR, CRANIOFACIAL, AND GENITAL SYNDROME; COFG	0.00124533	0.166044
ABDUCENS PALSY	0.00124533	0.166044
STIFF SKIN SYNDROME	0.00124533	0.166044
PELVISCAPULAR DYSPLASIA	0.00124533	0.166044
FETAL IODINE SYNDROME	0.00124533	0.166044
SPINOCEREBELLAR ATAXIA TYPE 25	0.00124533	0.166044
OCULAR ALBINISM WITH LATE-ONSET SENSORINEURAL DEAFNESS	0.00124533	0.166044
CRANIOSYNOSTOSIS-DANDY-WALKER MALFORMATION-HYDROCEPHALUS SYNDROME	0.00124533	0.166044
JACKSON-WEISS SYNDROME	0.00124533	0.166044
CRYPTORCHIDISM-ARACHNODACTYLY-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.166044
WOOLLY HAIR	0.00124533	0.166044
%153880 MACULAR EDEMA, CYSTOID;;CYSTOID MACULAR DYSTROPHY; CYMD;;MACULAR DYSTROPHY, DOMINANT CYSTOID; MDDC;;DCMD	0.00124533	0.166044
CHARCOT-MARIE-TOOTH DISEASE, TYPE 4B3; CMT4B3	0.00124533	0.166044
SPINOCEREBELLAR ATAXIA TYPE 34	0.00124533	0.166044
UVEAL COLOBOMA-CLEFT LIP AND PALATE-INTELLECTUAL DISABILITY	0.00124533	0.166044
SPEECH DEVELOPMENT, DELAYED, WITH FACIAL ASYMMETRY, STRABISMUS, ANDTRANSVERSE EARLOBE CREASE	0.00124533	0.166044
EXTRASYSTOLES-SHORT STATURE-HYPERPIGMENTATION-MICROCEPHALY SYNDROME	0.00124533	0.166044
MÜLLERIAN DUCT ANOMALIES-LIMB ANOMALIES SYNDROME	0.00124533	0.166044
CONGENITAL STATIONARY NIGHT BLINDNESS	0.00124533	0.166044
BRACHYDACTYLY-NYSTAGMUS-CEREBELLAR ATAXIA	0.00124533	0.166044
183800 SPLIT-HAND WITH CONGENITAL NYSTAGMUS, FUNDAL CHANGES, AND CATARACTS;;NYSTAGMUS-SPLIT HAND SYNDROME;;KARSCH-NEUGEBAUER SYNDROME; KNS	0.00124533	0.166044
METAPHYSEAL DYSOSTOSIS-INTELLECTUAL DISABILITY-CONDUCTIVE DEAFNESS SYNDROME	0.00124533	0.166044
OPTIC ATROPHY 1; OPA1	0.00124533	0.166044
GROENOUW TYPE I CORNEAL DYSTROPHY	0.00124533	0.166044
HEMIFACIAL HYPERPLASIA WITH STRABISMUS	0.00124533	0.166044
ODONTOCHONDRODYSPLASIA	0.00124533	0.166044
SEVERE OCULO-RENAL-CEREBELLAR SYNDROME	0.00124533	0.166044
EEM SYNDROME	0.00124533	0.166044
NYSTAGMUS 2, CONGENITAL, AUTOSOMAL DOMINANT; NYS2	0.00124533	0.166044
FOVEAL HYPOPLASIA-PRESENILE CATARACT SYNDROME	0.00124533	0.166044
MOEBIUS SYNDROME-AXONAL NEUROPATHY-HYPOGONADOTROPIC HYPOGONADISM SYNDROME	0.00124533	0.166044
X-LINKED RETINAL DYSPLASIA	0.00124533	0.166044
CAMPTODACTYLY-JOINT CONTRACTURES-FACIAL SKELETAL DEFECTS SYNDROME	0.00124533	0.166044
SPINOCEREBELLAR ATAXIA TYPE 27	0.00124533	0.166044
PTOSIS, STRABISMUS, AND ECTOPIC PUPILS	0.00124533	0.166044
ACRO-RENAL-OCULAR SYNDROME	0.00124533	0.166044
NEPHRONOPHTHISIS 18; NPHP18	0.00124533	0.166044
BUSCHKE-OLLENDORFF SYNDROME	0.00124533	0.166044
MICROPHTHALMIA/COLOBOMA AND SKELETAL DYSPLASIA SYNDROME; MCSKS	0.00124533	0.166044
OTOSPONDYLOMEGAEPIPHYSEAL DYSPLASIA	0.00124533	0.166044
DYSCHONDROSTEOSIS-NEPHRITIS SYNDROME	0.00124533	0.166044
AUTOSOMAL DOMINANT OPTIC ATROPHY PLUS SYNDROME	0.00124533	0.166044
OPTIC ATROPHY WITH OR WITHOUT DEAFNESS, OPHTHALMOPLEGIA, MYOPATHY, ATAXIA, AND NEUROPATHY	0.00124533	0.166044
CONGENITAL MUSCULAR DYSTROPHY-INFANTILE CATARACT-HYPOGONADISM SYNDROME	0.00124533	0.166044
IVIC SYNDROME	0.00124533	0.166044
POSTAXIAL ACROFACIAL DYSOSTOSIS	0.00124533	0.166044
OCULAR ALBINISM	0.00124533	0.166044
ATAXIA-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.00124533	0.166044
HIDROTIC ECTODERMAL DYSPLASIA	0.00124533	0.166044
HAND-FOOT-GENITAL SYNDROME	0.00124533	0.166044
MICROPHTHALMIA, ISOLATED, WITH CATARACT 1	0.00124533	0.166044
ATAXIA-PHOTOSENSITIVITY-SHORT STATURE SYNDROME	0.00124533	0.166044
MENTAL RETARDATION, X-LINKED, SYNDROMIC 13	0.001086973	0.14492973333333334
2,4-DIENOYL-COA REDUCTASE DEFICIENCY; DECRD	0.001086973	0.14492973333333334
MENTAL RETARDATION, X-LINKED 88	0.001086973	0.14492973333333334
ISOVALERIC ACIDEMIA	0.001086973	0.14492973333333334
%300861 MENTAL RETARDATION, X-LINKED, SYNDROMIC, CHUDLEY-SCHWARTZ TYPE; MRXSCS;;MENTAL RETARDATION, X-LINKED, WITH SEIZURES, HYPOGAMMAGLOBULINEMIA,AND GAIT DISTURBANCE	0.001086973	0.14492973333333334
MENTAL RETARDATION, X-LINKED 91; MRX91	0.001086973	0.14492973333333334
15Q14 MICRODELETION SYNDROME	0.001086973	0.14492973333333334
EPILEPTIC ENCEPHALOPATHY, INFANTILE OR EARLY CHILDHOOD, 2; IECEE2	0.001086973	0.14492973333333334
LATHOSTEROLOSIS	0.001086973	0.14492973333333334
MENTAL RETARDATION, X-LINKED 72	0.001086973	0.14492973333333334
EAST SYNDROME	0.001086973	0.14492973333333334
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 5; MMDS5	0.001086973	0.14492973333333334
MENTAL RETARDATION, X-LINKED, SYNDROMIC, HOUGE TYPE; MRXSHG	0.001086973	0.14492973333333334
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, ATAXIA, AND SEIZURES; NEDMAS	0.001086973	0.14492973333333334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 44	0.001086973	0.14492973333333334
LEUKODYSTROPHY, HYPOMYELINATING, 5; HLD5	0.001086973	0.14492973333333334
NEURODEVELOPMENTAL DISORDER, MITOCHONDRIAL, WITH ABNORMAL MOVEMENTS AND LACTIC ACIDOSIS, WITH OR WITHOUT SEIZURES; NEMMLAS	0.001086973	0.14492973333333334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 6; MRT6	0.001086973	0.14492973333333334
BETA-PROPELLER PROTEIN-ASSOCIATED NEURODEGENERATION	0.001086973	0.14492973333333334
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA	0.001086973	0.14492973333333334
THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.001086973	0.14492973333333334
GLYCOSYLPHOSPHATIDYLINOSITOL BIOSYNTHESIS DEFECT 16; GPIBD16	0.001086973	0.14492973333333334
SRD5A3-CDG	0.001086973	0.14492973333333334
KEUTEL SYNDROME	0.001086973	0.14492973333333334
NEUTROPENIA, SEVERE CONGENITAL, 3, AUTOSOMAL RECESSIVE; SCN3	0.001086973	0.14492973333333334
VAN ESCH-O'DRISCOLL SYNDROME; VEODS	0.001086973	0.14492973333333334
MITOCHONDRIAL DNA DEPLETION SYNDROME, ENCEPHALOMYOPATHIC FORM WITH METHYLMALONIC ACIDURIA	0.001086973	0.14492973333333334
PHOSPHOSERINE AMINOTRANSFERASE DEFICIENCY; PSATD	0.001086973	0.14492973333333334
INFANTILE OSTEOPETROSIS WITH NEUROAXONAL DYSPLASIA	0.001086973	0.14492973333333334
GRUBBEN-DE COCK-BORGHGRAEF SYNDROME	0.001086973	0.14492973333333334
PIGMENTARY DISORDER, RETICULATE, WITH SYSTEMIC MANIFESTATIONS, X-LINKED	0.001086973	0.14492973333333334
BERRY ANEURYSM, CIRRHOSIS, PULMONARY EMPHYSEMA, AND CEREBRAL CALCIFICATION	0.001086973	0.14492973333333334
GALACTOSEMIA	0.001086973	0.14492973333333334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 38; MRD38	0.001086973	0.14492973333333334
MICROCEPHALY 14, PRIMARY, AUTOSOMAL RECESSIVE; MCPH14	0.001086973	0.14492973333333334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 33; EIEE33	0.001086973	0.14492973333333334
RIBOSE 5-PHOSPHATE ISOMERASE DEFICIENCY; RPIAD	0.001086973	0.14492973333333334
GRACILE BONE DYSPLASIA; GCLEB	0.001086973	0.14492973333333334
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION; HOMGSMR	0.001086973	0.14492973333333334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 52	0.001086973	0.14492973333333334
RFT1-CDG	0.001086973	0.14492973333333334
CENTRAL BILATERAL MACROGYRIA	0.001086973	0.14492973333333334
DPAGT1-CDG	0.001086973	0.14492973333333334
CEREBRAL PALSY, SPASTIC, SYMMETRIC, AUTOSOMAL RECESSIVE	0.001086973	0.14492973333333334
GRISCELLI SYNDROME	0.001086973	0.14492973333333334
DISTAL MONOSOMY 19P13.3	0.001086973	0.14492973333333334
RHIZOMELIC CHONDRODYSPLASIA PUNCTATA, TYPE 5; RCDP5	0.001086973	0.14492973333333334
PRIMARY NON-ESSENTIAL CUTIS VERTICIS GYRATA	0.001086973	0.14492973333333334
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE II; CDG1I	0.001086973	0.14492973333333334
PROXIMAL 16P11.2 MICRODUPLICATION SYNDROME	0.001086973	0.14492973333333334
PROPIONIC ACIDEMIA	0.001086973	0.14492973333333334
DIABETES MELLITUS, PERMANENT NEONATAL; PNDM	0.001086973	0.14492973333333334
PHACE ASSOCIATION	0.001086973	0.14492973333333334
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 2; MRT2	0.001086973	0.14492973333333334
15Q11Q13 MICRODUPLICATION SYNDROME	0.001086973	0.14492973333333334
NEPHROGENIC DIABETES INSIPIDUS	0.001086973	0.14492973333333334
CITRULLINEMIA TYPE II	0.001086973	0.14492973333333334
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 3; MVA3	0.001086973	0.14492973333333334
STOMATIN-DEFICIENT CRYOHYDROCYTOSIS WITH NEUROLOGIC DEFECTS; SDCHCN	0.001086973	0.14492973333333334
NEURODEVELOPMENTAL DISORDER WITH HYPOTONIA, NEUROPATHY, AND DEAFNESS; NEDHND	0.001086973	0.14492973333333334
FOIX-CHAVANY-MARIE SYNDROME	0.001086973	0.14492973333333334
COMBINED OXIDATIVE PHOSPHORYLATION DEFECT TYPE 23	0.001086973	0.14492973333333334
MENTAL RETARDATION, X-LINKED 9	0.001086973	0.14492973333333334
ARGININOSUCCINIC ACIDURIA	0.001086973	0.14492973333333334
TRISOMY X	0.001086973	0.14492973333333334
EPILEPSY, EARLY-ONSET, VITAMIN B6-DEPENDENT; EPVB6D	0.001086973	0.14492973333333334
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 2; MCCRP2	0.001086973	0.14492973333333334
FATTY ACYL-COA REDUCTASE 1 DEFICIENCY	0.001086973	0.14492973333333334
WAISMAN SYNDROME; WSMN	0.001086973	0.14492973333333334
GLYCOGEN STORAGE DISEASE DUE TO HEPATIC GLYCOGEN SYNTHASE DEFICIENCY	0.001086973	0.14492973333333334
CHROMOSOME 16P11.2 DELETION SYNDROME, 593-KB	0.001086973	0.14492973333333334
CITRULLINEMIA, CLASSIC	0.001086973	0.14492973333333334
HYPERIMMUNOGLOBULINEMIA D WITH PERIODIC FEVER	0.001086973	0.14492973333333334
3-METHYLGLUTACONIC ACIDURIA WITH CATARACTS, NEUROLOGIC INVOLVEMENT, AND NEUTROPENIA; MEGCANN	0.001086973	0.14492973333333334
NEUROPATHY, ATAXIA, AND RETINITIS PIGMENTOSA	0.001086973	0.14492973333333334
HERNÁNDEZ-AGUIRRE NEGRETE SYNDROME	0.001086973	0.14492973333333334
ARGININEMIA	0.001086973	0.14492973333333334
X-LINKED INTELLECTUAL DISABILITY, TURNER TYPE	0.001086973	0.14492973333333334
HYDRANENCEPHALY	0.001086973	0.14492973333333334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 41	0.001086973	0.14492973333333334
CHROMOSOME 11P13 DELETION SYNDROME, DISTAL	0.001086973	0.14492973333333334
X-LINKED NEURODEGENERATIVE SYNDROME, HAMEL TYPE	0.001086973	0.14492973333333334
DISTAL 16P11.2 MICRODELETION SYNDROME	0.001086973	0.14492973333333334
GMPPB-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R19	0.001086973	0.14492973333333334
PHOSPHOSERINE PHOSPHATASE DEFICIENCY; PSPHD	0.001086973	0.14492973333333334
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO SUR1 DEFICIENCY	0.001086973	0.14492973333333334
HYPERAMMONEMIA DUE TO N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.001086973	0.14492973333333334
CRANIOPHARYNGIOMA	0.001086973	0.14492973333333334
MACDERMOT-WINTER SYNDROME	0.001086973	0.14492973333333334
LANDAU-KLEFFNER SYNDROME	0.001086973	0.14492973333333334
LEUKOENCEPHALOPATHY, BRAIN CALCIFICATIONS, AND CYSTS	0.001086973	0.14492973333333334
PYRUVATE DEHYDROGENASE E3-BINDING PROTEIN DEFICIENCY	0.001086973	0.14492973333333334
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 39	0.001086973	0.14492973333333334
%114100 BASAL GANGLIA CALCIFICATION, IDIOPATHIC, CHILDHOOD-ONSET;;IBGC, CHILDHOOD-ONSET;;STRIOPALLIDODENTATE CALCINOSIS, BILATERAL, CHILDHOOD-ONSET;;CEREBRAL CALCIFICATION, NONARTERIOSCLEROTIC, IDIOPATHIC, CHILDHOOD-ONSET	0.001086973	0.14492973333333334
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA	0.001086973	0.14492973333333334
HEREDITARY CRYOHYDROCYTOSIS WITH REDUCED STOMATIN	0.001086973	0.14492973333333334
FREE SIALIC ACID STORAGE DISEASE	0.001086973	0.14492973333333334
CARNITINE-ACYLCARNITINE TRANSLOCASE DEFICIENCY	0.001086973	0.14492973333333334
CEREBRAL CREATINE DEFICIENCY SYNDROME 2	0.001086973	0.14492973333333334
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 18; MC1DN18	0.001086973	0.14492973333333334
INFANTILE REFSUM DISEASE	0.001086973	0.14492973333333334
MULTIPLE CARBOXYLASE DEFICIENCY	0.001086973	0.14492973333333334
PHOSPHOENOLPYRUVATE CARBOXYKINASE DEFICIENCY, CYTOSOLIC; PCKDC	0.001086973	0.14492973333333334
MELANOSIS, NEUROCUTANEOUS; NCMS	0.001086973	0.14492973333333334
MULTIPLE SULFATASE DEFICIENCY	0.001086973	0.14492973333333334
NEURODEVELOPMENTAL DISORDER WITH MICROCEPHALY, EPILEPSY, AND HYPOMYELINATION; NEDMEHM	0.001086973	0.14492973333333334
DIGEORGE SYNDROME; DGS	0.001086973	0.14492973333333334
PEROXISOME BIOGENESIS DISORDER 11A (ZELLWEGER)	0.001086973	0.14492973333333334
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 10; GEFSP10	0.001086973	0.14492973333333334
3-METHYLGLUTACONIC ACIDURIA TYPE 1	0.001086973	0.14492973333333334
3-METHYLGLUTACONIC ACIDURIA TYPE 4	0.001086973	0.14492973333333334
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 1; MCCRP1	0.001086973	0.14492973333333334
HARTNUP DISORDER	0.001086973	0.14492973333333334
2P21 MICRODELETION SYNDROME	0.001086973	0.14492973333333334
L1 SYNDROME	0.001086973	0.14492973333333334
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME, PREUS TYPE	0.001086973	0.14492973333333334
11P15.4 MICRODUPLICATION SYNDROME	0.001086973	0.14492973333333334
2Q37 MICRODELETION SYNDROME	0.001086973	0.14492973333333334
AUTOSOMAL DOMINANT HYPERINSULINISM DUE TO KIR6.2 DEFICIENCY	0.001086973	0.14492973333333334
17Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.14492973333333334
HOMOCYSTINURIA WITHOUT METHYLMALONIC ACIDURIA	0.001086973	0.14492973333333334
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT-	0.001086973	0.14492973333333334
LEUKODYSTROPHY, HYPOMYELINATING, 18; HLD18	0.001086973	0.14492973333333334
HYPOXANTHINE GUANINE PHOSPHORIBOSYLTRANSFERASE PARTIAL DEFICIENCY	0.001086973	0.14492973333333334
ALSTRÖM SYNDROME	0.001086973	0.14492973333333334
TAY-SACHS DISEASE	0.001086973	0.14492973333333334
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 4; FFEVF4	0.001086973	0.14492973333333334
CHROMOSOME 22Q13 DUPLICATION SYNDROME	0.001086973	0.14492973333333334
NARP SYNDROME	0.001086973	0.14492973333333334
MICROLISSENCEPHALY-MICROMELIA SYNDROME	0.001086973	0.14492973333333334
MICROCEPHALIC PRIMORDIAL DWARFISM, DAUBER TYPE	0.001086973	0.14492973333333334
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 5; MC5DN5	0.001086973	0.14492973333333334
22Q11.2 MICRODUPLICATION SYNDROME	0.001086973	0.14492973333333334
MAPLE SYRUP URINE DISEASE	0.001086973	0.14492973333333334
X-LINKED CREATINE TRANSPORTER DEFICIENCY	0.001086973	0.14492973333333334
LEBER CONGENITAL AMAUROSIS	0.001086973	0.14492973333333334
PFEIFFER SYNDROME TYPE 2	0.001086973	0.14492973333333334
CLASSIC PHENYLKETONURIA	0.001086973	0.14492973333333334
THROMBOPHILIA DUE TO PROTEIN C DEFICIENCY, AUTOSOMAL RECESSIVE; THPH4	0.001086973	0.14492973333333334
GLASS SYNDROME	0.001086973	0.14492973333333334
MENTAL RETARDATION, AUTOSOMAL DOMINANT 2	0.001086973	0.14492973333333334
NEURODEGENERATION, EARLY-ONSET, WITH CHOREOATHETOID MOVEMENTS AND MICROCYTIC ANEMIA; NDCAMA	0.001086973	0.14492973333333334
ALG3-CDG	0.001086973	0.14492973333333334
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 4; CDCBM4	0.001086973	0.14492973333333334
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLD	0.001086973	0.14492973333333334
SPONDYLOEPIMETAPHYSEAL DYSPLASIA, KRAKOW TYPE; SEMDK	0.001086973	0.14492973333333334
NETHERTON SYNDROME	0.001086973	0.14492973333333334
BONE MARROW FAILURE SYNDROME 5; BMFS5	0.001086973	0.14492973333333334
MEVALONIC ACIDURIA	0.001086973	0.14492973333333334
ALG1-CDG	0.001086973	0.14492973333333334
HYPERINSULINISM DUE TO UCP2 DEFICIENCY	0.001086973	0.14492973333333334
10Q22.3Q23.3 MICRODELETION SYNDROME	0.001086973	0.14492973333333334
CHILDHOOD-ONSET SPASTICITY WITH HYPERGLYCINEMIA	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL MYOPATHY, EPISODIC, WITH OR WITHOUT OPTIC ATROPHY AND REVERSIBLE LEUKOENCEPHALOPATHY; MEOAL	0.0009615380000000001	0.12820506666666667
HYPERCALCEMIA, INFANTILE, 1	0.0009615380000000001	0.12820506666666667
HERMANSKY-PUDLAK SYNDROME 10; HPS10	0.0009615380000000001	0.12820506666666667
SHORT STATURE, DEVELOPMENTAL DELAY, AND CONGENITAL HEART DEFECTS	0.0009615380000000001	0.12820506666666667
SPINOCEREBELLAR ATAXIA TYPE 14	0.0009615380000000001	0.12820506666666667
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IB; CDG1B	0.0009615380000000001	0.12820506666666667
PIERRE ROBIN SEQUENCE WITH PECTUS EXCAVATUM AND RIB AND SCAPULAR ANOMALIES	0.0009615380000000001	0.12820506666666667
COFFIN-SIRIS SYNDROME 10; CSS10	0.0009615380000000001	0.12820506666666667
SEVERE X-LINKED MITOCHONDRIAL ENCEPHALOMYOPATHY	0.0009615380000000001	0.12820506666666667
CARNITINE DEFICIENCY, SYSTEMIC PRIMARY	0.0009615380000000001	0.12820506666666667
DYSTONIA 11, MYOCLONIC	0.0009615380000000001	0.12820506666666667
HYPERPARATHYROIDISM, NEONATAL SEVERE	0.0009615380000000001	0.12820506666666667
ACYL-COA DEHYDROGENASE 9 DEFICIENCY	0.0009615380000000001	0.12820506666666667
SPINOCEREBELLAR ATAXIA 13	0.0009615380000000001	0.12820506666666667
CEREBELLAR HYPOPLASIA	0.0009615380000000001	0.12820506666666667
MUSCULAR DYSTROPHY, CONGENITAL, 1B	0.0009615380000000001	0.12820506666666667
JUVENILE POLYPOSIS OF INFANCY	0.0009615380000000001	0.12820506666666667
LONG CHAIN ACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.12820506666666667
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH JOINT LAXITY, TYPE 2	0.0009615380000000001	0.12820506666666667
HYPOPHOSPHATEMIC RICKETS WITH HYPERCALCIURIA, HEREDITARY	0.0009615380000000001	0.12820506666666667
RIGID SPINE MUSCULAR DYSTROPHY 1	0.0009615380000000001	0.12820506666666667
SPONDYLOMETAPHYSEAL DYSPLASIA, SEDAGHATIAN TYPE; SMDS	0.0009615380000000001	0.12820506666666667
AUTOSOMAL RECESSIVE DOPA-RESPONSIVE DYSTONIA	0.0009615380000000001	0.12820506666666667
HYPERORNITHINEMIA-HYPERAMMONEMIA-HOMOCITRULLINURIA SYNDROME	0.0009615380000000001	0.12820506666666667
GLYCOGEN STORAGE DISEASE II	0.0009615380000000001	0.12820506666666667
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1B	0.0009615380000000001	0.12820506666666667
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 2; EDSARTH2	0.0009615380000000001	0.12820506666666667
VITAMIN D HYDROXYLATION-DEFICIENT RICKETS, TYPE 1A	0.0009615380000000001	0.12820506666666667
AUTISM, SUSCEPTIBILITY TO, X-LINKED 4	0.0009615380000000001	0.12820506666666667
AUTOSOMAL RECESSIVE CENTRONUCLEAR MYOPATHY	0.0009615380000000001	0.12820506666666667
PHOSPHORIBOSYLPYROPHOSPHATE SYNTHETASE SUPERACTIVITY	0.0009615380000000001	0.12820506666666667
ENCEPHALOPATHY, RECURRENT, OF CHILDHOOD	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 7; MC1DN7	0.0009615380000000001	0.12820506666666667
MYOPATHY, CENTRONUCLEAR, 6, WITH FIBER-TYPE DISPROPORTION; CNM6	0.0009615380000000001	0.12820506666666667
CHILDHOOD-ONSET NEMALINE MYOPATHY	0.0009615380000000001	0.12820506666666667
CATARACT, ATAXIA, SHORT STATURE, AND MENTAL RETARDATION	0.0009615380000000001	0.12820506666666667
LYSINURIC PROTEIN INTOLERANCE; LPI	0.0009615380000000001	0.12820506666666667
EHLERS-DANLOS SYNDROME, ARTHROCHALASIA TYPE, 1; EDSARTH1	0.0009615380000000001	0.12820506666666667
ETHANOLAMINOSIS	0.0009615380000000001	0.12820506666666667
SPINAL MUSCULAR ATROPHY, TYPE I, WITH CONGENITAL BONE FRACTURES	0.0009615380000000001	0.12820506666666667
RENAL TUBULOPATHY, DIABETES MELLITUS, AND CEREBELLAR ATAXIA	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL DNA DEPLETION SYNDROME 7 (HEPATOCEREBRAL TYPE)	0.0009615380000000001	0.12820506666666667
CAP MYOPATHY	0.0009615380000000001	0.12820506666666667
SPINOCEREBELLAR ATAXIA TYPE 2	0.0009615380000000001	0.12820506666666667
SIMPSON-GOLABI-BEHMEL SYNDROME, TYPE 2; SGBS2	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL MYOPATHY-CEREBELLAR ATAXIA-PIGMENTARY RETINOPATHY SYNDROME	0.0009615380000000001	0.12820506666666667
DYSTONIA 1, TORSION, AUTOSOMAL DOMINANT	0.0009615380000000001	0.12820506666666667
KLIPPEL-FEIL SYNDROME 4, AUTOSOMAL RECESSIVE, WITH NEMALINE MYOPATHY AND FACIAL DYSMORPHISM; KFS4	0.0009615380000000001	0.12820506666666667
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 8; NBIA8	0.0009615380000000001	0.12820506666666667
VITAMIN D-DEPENDENT RICKETS, TYPE 2A	0.0009615380000000001	0.12820506666666667
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 4	0.0009615380000000001	0.12820506666666667
HYPOTONIA, ATAXIA, DEVELOPMENTAL DELAY, AND TOOTH ENAMEL DEFECT SYNDROME; HADDTS	0.0009615380000000001	0.12820506666666667
SHORT-RIB THORACIC DYSPLASIA 19 WITH OR WITHOUT POLYDACTYLY; SRTD19	0.0009615380000000001	0.12820506666666667
HYPERPHENYLALANINEMIA, BH4-DEFICIENT, D	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 23; MC1DN23	0.0009615380000000001	0.12820506666666667
GLYCOGEN STORAGE DISEASE IXB	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 24; MC1DN24	0.0009615380000000001	0.12820506666666667
GIANT AXONAL NEUROPATHY	0.0009615380000000001	0.12820506666666667
MYOPATHY WITH GIANT ABNORMAL MITOCHONDRIA	0.0009615380000000001	0.12820506666666667
CHITAYAT SYNDROME	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL DNA DEPLETION SYNDROME 12A (CARDIOMYOPATHIC TYPE), AUTOSOMAL DOMINANT; MTDPS12A	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL MYOPATHY WITH DIABETES	0.0009615380000000001	0.12820506666666667
MYASTHENIC SYNDROME, CONGENITAL, 21, PRESYNAPTIC	0.0009615380000000001	0.12820506666666667
GLYCOGEN STORAGE DISEASE IV	0.0009615380000000001	0.12820506666666667
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 74; EIEE74	0.0009615380000000001	0.12820506666666667
LEUKOENCEPHALOPATHY, ACUTE REVERSIBLE, WITH INCREASED URINARY ALPHA-KETOGLUTARATE; ARLIAK	0.0009615380000000001	0.12820506666666667
SPINOCEREBELLAR ATAXIA TYPE 10	0.0009615380000000001	0.12820506666666667
MUSCULAR DYSTROPHY, DUCHENNE TYPE; DMD	0.0009615380000000001	0.12820506666666667
COLOBOMA, OSTEOPETROSIS, MICROPHTHALMIA, MACROCEPHALY, ALBINISM, AND DEAFNESS; COMMAD	0.0009615380000000001	0.12820506666666667
ACUTE INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY	0.0009615380000000001	0.12820506666666667
MULCHANDANI-BHOJ-CONLIN SYNDROME	0.0009615380000000001	0.12820506666666667
BRACHYCEPHALY, TRICHOMEGALY, AND DEVELOPMENTAL DELAY; BTDD	0.0009615380000000001	0.12820506666666667
AICARDI SYNDROME; AIC	0.0009615380000000001	0.12820506666666667
OPSISMODYSPLASIA; OPSMD	0.0009615380000000001	0.12820506666666667
OSTEOPENIA AND SPARSE HAIR	0.0009615380000000001	0.12820506666666667
3-HYDROXYACYL-COA DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.12820506666666667
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 5; OPTB5	0.0009615380000000001	0.12820506666666667
NEUTRAL LIPID STORAGE MYOPATHY	0.0009615380000000001	0.12820506666666667
EARLY-ONSET FAMILIAL HYPOALDOSTERONISM	0.0009615380000000001	0.12820506666666667
MENTAL RETARDATION, X-LINKED 12; MRX12	0.0009615380000000001	0.12820506666666667
HYPOTHYROIDISM, CONGENITAL, NONGOITROUS, 2	0.0009615380000000001	0.12820506666666667
MYOPATHY, MITOCHONDRIAL, AND ATAXIA; MMYAT	0.0009615380000000001	0.12820506666666667
ENCEPHALOPATHY, AXONAL, WITH NECROTIZING MYOPATHY, CARDIOMYOPATHY, AND CATARACTS	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL COMPLEX I DEFICIENCY DUE TO ACAD9 DEFICIENCY	0.0009615380000000001	0.12820506666666667
SHORT-RIB THORACIC DYSPLASIA 14 WITH POLYDACTYLY	0.0009615380000000001	0.12820506666666667
LIVER FAILURE, INFANTILE, TRANSIENT	0.0009615380000000001	0.12820506666666667
JOUBERT SYNDROME 4	0.0009615380000000001	0.12820506666666667
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITHOUT MENTAL RETARDATION), TYPE B, 4	0.0009615380000000001	0.12820506666666667
PEROXISOME BIOGENESIS DISORDER 11B	0.0009615380000000001	0.12820506666666667
MYASTHENIC SYNDROME, CONGENITAL, 22; CMS22	0.0009615380000000001	0.12820506666666667
MYASTHENIC SYNDROME, CONGENITAL, 14; CMS14	0.0009615380000000001	0.12820506666666667
LETHAL CONGENITAL CONTRACTURE SYNDROME 8	0.0009615380000000001	0.12820506666666667
FKRP-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R9	0.0009615380000000001	0.12820506666666667
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.0009615380000000001	0.12820506666666667
SYDENHAM CHOREA	0.0009615380000000001	0.12820506666666667
EPILEPSY, HOT WATER, 1	0.0009615380000000001	0.12820506666666667
HEMIPARKINSONISM-HEMIATROPHY SYNDROME	0.0009615380000000001	0.12820506666666667
ATAXIA-MICROCEPHALY-CATARACT SYNDROME	0.0009615380000000001	0.12820506666666667
ATONIC-ASTATIC SYNDROME OF FOERSTER	0.0009615380000000001	0.12820506666666667
PIERSON SYNDROME	0.0009615380000000001	0.12820506666666667
ACYL-COA DEHYDROGENASE, VERY LONG-CHAIN, DEFICIENCY OF	0.0009615380000000001	0.12820506666666667
MYOPATHY, CENTRONUCLEAR, 4; CNM4	0.0009615380000000001	0.12820506666666667
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 4; MMDS4	0.0009615380000000001	0.12820506666666667
MYASTHENIC SYNDROME, CONGENITAL, 13	0.0009615380000000001	0.12820506666666667
TRICHORHINOPHALANGEAL SYNDROME, TYPE I	0.0009615380000000001	0.12820506666666667
ARTERIAL TORTUOSITY SYNDROME	0.0009615380000000001	0.12820506666666667
PITUITARY HORMONE DEFICIENCY, COMBINED, 1	0.0009615380000000001	0.12820506666666667
OSTEOGENESIS IMPERFECTA, TYPE X	0.0009615380000000001	0.12820506666666667
CARDIOENCEPHALOMYOPATHY, FATAL INFANTILE, DUE TO CYTOCHROME C OXIDASE DEFICIENCY 2; CEMCOX2	0.0009615380000000001	0.12820506666666667
CLASSIC MULTIMINICORE MYOPATHY	0.0009615380000000001	0.12820506666666667
MITOCHONDRIAL MYOPATHY WITH REVERSIBLE CYTOCHROME C OXIDASE DEFICIENCY	0.0009615380000000001	0.12820506666666667
ALPHA-KETOGLUTARATE DEHYDROGENASE DEFICIENCY	0.0009615380000000001	0.12820506666666667
ALG13-CDG	0.0009615380000000001	0.12820506666666667
LEGIUS SYNDROME	0.0009615380000000001	0.12820506666666667
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 4; MDDGC4	0.0009615380000000001	0.12820506666666667
NEUTRAL LIPID STORAGE DISEASE WITH MYOPATHY; NLSDM	0.0009615380000000001	0.12820506666666667
NEMALINE MYOPATHY 7; NEM7	0.0009615380000000001	0.12820506666666667
ISOLATED SUCCINATE-COQ REDUCTASE DEFICIENCY	0.0009615380000000001	0.12820506666666667
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 18	0.0009615380000000001	0.12820506666666667
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 43	0.0009615380000000001	0.12820506666666667
JOUBERT SYNDROME 5	0.0009615380000000001	0.12820506666666667
MYOPATHY DUE TO MYOADENYLATE DEAMINASE DEFICIENCY	0.0009615380000000001	0.12820506666666667
CHARCOT-MARIE-TOOTH DISEASE, AXONAL, TYPE 2R; CMT2R	0.0009615380000000001	0.12820506666666667
HEMOLYTIC ANEMIA, CD59-MEDIATED, WITH OR WITHOUT IMMUNE-MEDIATED POLYNEUROPATHY; HACD59	0.0009615380000000001	0.12820506666666667
LETHAL CONGENITAL CONTRACTURE SYNDROME 5	0.0009615380000000001	0.12820506666666667
PORPHYRIA, ACUTE HEPATIC	0.0009615380000000001	0.12820506666666667
GLYCOGEN STORAGE DISEASE IXC	0.0009615380000000001	0.12820506666666667
ATAXIA-TELANGIECTASIA-LIKE DISORDER	0.0009615380000000001	0.12820506666666667
CONGENITAL MYASTHENIC SYNDROMES WITH GLYCOSYLATION DEFECT	0.0009615380000000001	0.12820506666666667
MYOPATHY, CENTRONUCLEAR, 5	0.0009615380000000001	0.12820506666666667
ACETYL-COA CARBOXYLASE DEFICIENCY	0.0009615380000000001	0.12820506666666667
AUTOSOMAL RECESSIVE CONGENITAL CEREBELLAR ATAXIA DUE TO GRID2 DEFICIENCY	0.0009615380000000001	0.12820506666666667
HYPOCALCEMIC VITAMIN D-DEPENDENT RICKETS	0.0009615380000000001	0.12820506666666667
BETHLEM MYOPATHY 2; BTHLM2	0.0009615380000000001	0.12820506666666667
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2B, REMITTING, WITH OR WITHOUT MENTAL RETARDATION; MLC2B	0.0009615380000000001	0.12820506666666667
MOSAIC VARIEGATED ANEUPLOIDY SYNDROME 2; MVA2	0.0009615380000000001	0.12820506666666667
BILIARY MALFORMATION WITH RENAL TUBULAR INSUFFICIENCY	0.0009615380000000001	0.12820506666666667
MICROTRIPLICATION 11Q24.1	0.0009615380000000001	0.12820506666666667
CUTIS LAXA, AUTOSOMAL RECESSIVE, TYPE IB	0.0009615380000000001	0.12820506666666667
ACID PHOSPHATASE DEFICIENCY	0.0009615380000000001	0.12820506666666667
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 6	0.0009615380000000001	0.12820506666666667
CONTRACTURES-ECTODERMAL DYSPLASIA-CLEFT LIP/PALATE SYNDROME	0.000545554	0.07274053333333333
INFANTILE SPASMS-PSYCHOMOTOR RETARDATION-PROGRESSIVE BRAIN ATROPHY-BASAL GANGLIA DISEASE SYNDROME	0.000545554	0.07274053333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 67; EIEE67	0.000545554	0.07274053333333333
ATAXIA, SPASTIC, CHILDHOOD-ONSET, AUTOSOMAL RECESSIVE, WITH OPTIC ATROPHY AND MENTAL RETARDATION	0.000545554	0.07274053333333333
DIAMOND-BLACKFAN ANEMIA 5	0.000545554	0.07274053333333333
DEFICIENCY IN ANTERIOR PITUITARY FUNCTION-VARIABLE IMMUNODEFICIENCY SYNDROME	0.000545554	0.07274053333333333
EPIPHYSEAL DYSPLASIA, MULTIPLE, WITH EARLY-ONSET DIABETES MELLITUS	0.000545554	0.07274053333333333
PRIMARY ALDOSTERONISM, SEIZURES, AND NEUROLOGIC ABNORMALITIES	0.000545554	0.07274053333333333
PILI TORTI-DEVELOPMENTAL DELAY-NEUROLOGICAL ABNORMALITIES SYNDROME	0.000545554	0.07274053333333333
BONE MARROW FAILURE SYNDROME 4; BMFS4	0.000545554	0.07274053333333333
CHROMOSOME 10Q22.3-Q23.2 DELETION SYNDROME	0.000545554	0.07274053333333333
SAUL-WILSON SYNDROME; SWILS	0.000545554	0.07274053333333333
ROBIN SEQUENCE WITH CLEFT MANDIBLE AND LIMB ANOMALIES	0.000545554	0.07274053333333333
DYSKERATOSIS CONGENITA	0.000545554	0.07274053333333333
REVESZ SYNDROME	0.000545554	0.07274053333333333
DEXTROCARDIA	0.000545554	0.07274053333333333
ABNORMAL HAIR, JOINT LAXITY, AND DEVELOPMENTAL DELAY; HJDD	0.000545554	0.07274053333333333
PINEAL HYPERPLASIA, INSULIN-RESISTANT DIABETES MELLITUS, AND SOMATIC ABNORMALITIES	0.000545554	0.07274053333333333
MITOCHONDRIAL COMPLEX III DEFICIENCY, NUCLEAR TYPE 2; MC3DN2	0.000545554	0.07274053333333333
AICARDI-GOUTIERES SYNDROME 5	0.000545554	0.07274053333333333
DUCHENNE MUSCULAR DYSTROPHY	0.000545554	0.07274053333333333
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 5; DKCB5	0.000545554	0.07274053333333333
TRANSIENT NEONATAL DIABETES MELLITUS	0.000545554	0.07274053333333333
NEPHROGENIC DIABETES INSIPIDUS-INTRACRANIAL CALCIFICATION SYNDROME	0.000545554	0.07274053333333333
CEREBRAL CREATINE DEFICIENCY SYNDROME 3	0.000545554	0.07274053333333333
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 11; MC1DN11	0.000545554	0.07274053333333333
NEUTROPENIA, SEVERE CONGENITAL, 5, AUTOSOMAL RECESSIVE; SCN5	0.000545554	0.07274053333333333
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (CONGENITAL WITH BRAIN AND EYE ANOMALIES), TYPE A, 14; MDDGA14	0.000545554	0.07274053333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 68; EIEE68	0.000545554	0.07274053333333333
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 14	0.000545554	0.07274053333333333
DYSTONIA-PARKINSONISM-HYPERMANGANESEMIA SYNDROME	0.000545554	0.07274053333333333
SENIOR-LOKEN SYNDROME	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 63; MRT63	0.000545554	0.07274053333333333
SHWACHMAN-DIAMOND SYNDROME 2; SDS2	0.000545554	0.07274053333333333
LIPODYSTROPHY-INTELLECTUAL DISABILITY-DEAFNESS SYNDROME	0.000545554	0.07274053333333333
WAARDENBURG SYNDROME, TYPE 2E; WS2E	0.000545554	0.07274053333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 9; EIEE9	0.000545554	0.07274053333333333
FANCONI ANEMIA, COMPLEMENTATION GROUP S; FANCS	0.000545554	0.07274053333333333
HYDROXYKYNURENINURIA	0.000545554	0.07274053333333333
MEGALENCEPHALY-POLYMICROGYRIA-POLYDACTYLY-HYDROCEPHALUS SYNDROME 3; MPPH3	0.000545554	0.07274053333333333
GALACTOSE EPIMERASE DEFICIENCY	0.000545554	0.07274053333333333
TRANSKETOLASE DEFICIENCY	0.000545554	0.07274053333333333
CORTICAL MALFORMATIONS, OCCIPITAL; OCCM	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 55, WITH SEIZURES; MRD55	0.000545554	0.07274053333333333
300270 ADRENOMYODYSTROPHY	0.000545554	0.07274053333333333
CONGENITAL DISORDER OF GLYCOSYLATION, TYPE IIH	0.000545554	0.07274053333333333
KRABBE DISEASE	0.000545554	0.07274053333333333
NEURODEGENERATION WITH BRAIN IRON ACCUMULATION 4; NBIA4	0.000545554	0.07274053333333333
HYPOMYELINATION-CONGENITAL CATARACT SYNDROME	0.000545554	0.07274053333333333
VITAMIN B12-UNRESPONSIVE METHYLMALONIC ACIDEMIA TYPE MUT0	0.000545554	0.07274053333333333
ROSSELLI-GULIENETTI SYNDROME	0.000545554	0.07274053333333333
CURRARINO SYNDROME	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 24; MRD24	0.000545554	0.07274053333333333
GLUT1 DEFICIENCY SYNDROME 2; GLUT1DS2	0.000545554	0.07274053333333333
WAARDENBURG-SHAH SYNDROME	0.000545554	0.07274053333333333
PARKINSONISM-DYSTONIA, INFANTILE, 2; PKDYS2	0.000545554	0.07274053333333333
PERMANENT NEONATAL DIABETES MELLITUS	0.000545554	0.07274053333333333
273730 THORACIC DYSPLASIA-HYDROCEPHALUS SYNDROME	0.000545554	0.07274053333333333
IMMUNODEFICIENCY, COMMON VARIABLE, 10; CVID10	0.000545554	0.07274053333333333
COMBINED MALONIC AND METHYLMALONIC ACIDEMIA	0.000545554	0.07274053333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 19; EIEE19	0.000545554	0.07274053333333333
SILVER-RUSSELL SYNDROME; SRS	0.000545554	0.07274053333333333
CARBONIC ANHYDRASE VA DEFICIENCY, HYPERAMMONEMIA DUE TO	0.000545554	0.07274053333333333
16P13.11 MICRODUPLICATION SYNDROME	0.000545554	0.07274053333333333
CHROMOSOME 22Q11.2 DELETION SYNDROME, DISTAL	0.000545554	0.07274053333333333
CORTICAL DYSPLASIA, COMPLEX, WITH OTHER BRAIN MALFORMATIONS 6; CDCBM6	0.000545554	0.07274053333333333
ALG6-CDG	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 43; MRT43	0.000545554	0.07274053333333333
277465 VITILIGO, PROGRESSIVE, WITH MENTAL RETARDATION AND URETHRAL DUPLICATION	0.000545554	0.07274053333333333
METHYLMALONIC ACIDEMIA WITHOUT HOMOCYSTINURIA	0.000545554	0.07274053333333333
LEUKOTRIENE C4 SYNTHASE DEFICIENCY	0.000545554	0.07274053333333333
SPINOCEREBELLAR ATAXIA-DYSMORPHISM SYNDROME	0.000545554	0.07274053333333333
OCULOFACIOCARDIODENTAL SYNDROME	0.000545554	0.07274053333333333
12Q14 MICRODELETION SYNDROME	0.000545554	0.07274053333333333
MICROCEPHALY, SEIZURES, SPASTICITY, AND BRAIN CALCIFICATIONS; MISSBC	0.000545554	0.07274053333333333
ALTERNATING HEMIPLEGIA OF CHILDHOOD 2	0.000545554	0.07274053333333333
BRACHMANN-DE LANGE-LIKE FACIAL CHANGES WITH MICROCEPHALY, METATARSUSADDUCTUS, AND DEVELOPMENTAL DELAY	0.000545554	0.07274053333333333
SPONDYLOEPIMETAPHYSEAL DYSPLASIA WITH MULTIPLE DISLOCATIONS	0.000545554	0.07274053333333333
CHROMOSOME 16P13.3 DUPLICATION SYNDROME	0.000545554	0.07274053333333333
INTELLECTUAL DEVELOPMENTAL DISORDER WITH SHORT STATURE AND VARIABLE SKELETAL ANOMALIES; IDDSSA	0.000545554	0.07274053333333333
INTELLECTUAL DISABILITY-DYSMORPHISM-HYPOGONADISM-DIABETES MELLITUS SYNDROME	0.000545554	0.07274053333333333
THUMBS, STIFF, WITH BRACHYDACTYLY TYPE A1 AND DEVELOPMENTAL DELAY	0.000545554	0.07274053333333333
HYDROCEPHALUS, NORMAL-PRESSURE	0.000545554	0.07274053333333333
NEURODEVELOPMENTAL DISORDER WITH IMPAIRED SPEECH AND HYPERKINETIC MOVEMENTS; NEDISHM	0.000545554	0.07274053333333333
CONGENITAL MUSCULAR DYSTROPHY DUE TO LMNA MUTATION	0.000545554	0.07274053333333333
TRICHOTHIODYSTROPHY 4, NONPHOTOSENSITIVE; TTD4	0.000545554	0.07274053333333333
THANATOPHORIC DYSPLASIA, TYPE I	0.000545554	0.07274053333333333
GLOBAL DEVELOPMENTAL DELAY, PROGRESSIVE ATAXIA, AND ELEVATED GLUTAMINE; GDPAG	0.000545554	0.07274053333333333
AUTOIMMUNE DISEASE, MULTISYSTEM, WITH FACIAL DYSMORPHISM; ADMFD	0.000545554	0.07274053333333333
CHROMOSOME 17Q23.1-Q23.2 DELETION SYNDROME	0.000545554	0.07274053333333333
ADAMS-OLIVER SYNDROME 3; AOS3	0.000545554	0.07274053333333333
JAWAD SYNDROME	0.000545554	0.07274053333333333
OSTEOPETROSIS WITH RENAL TUBULAR ACIDOSIS	0.000545554	0.07274053333333333
OSTEOPOROSIS-PSEUDOGLIOMA SYNDROME	0.000545554	0.07274053333333333
PECTUS EXCAVATUM-MACROCEPHALY-DYSPLASTIC NAILS SYNDROME	0.000545554	0.07274053333333333
ALPERS-HUTTENLOCHER SYNDROME	0.000545554	0.07274053333333333
MUSCULAR DYSTROPHY-DYSTROGLYCANOPATHY (LIMB-GIRDLE), TYPE C, 9; MDDGC9	0.000545554	0.07274053333333333
RETINITIS PIGMENTOSA WITH OR WITHOUT SKELETAL ANOMALIES	0.000545554	0.07274053333333333
GLYCOGEN STORAGE DISEASE DUE TO PHOSPHOGLYCERATE KINASE 1 DEFICIENCY	0.000545554	0.07274053333333333
MARFANOID MENTAL RETARDATION SYNDROME, AUTOSOMAL	0.000545554	0.07274053333333333
FEMALE RESTRICTED EPILEPSY WITH INTELLECTUAL DISABILITY	0.000545554	0.07274053333333333
TRANSALDOLASE DEFICIENCY	0.000545554	0.07274053333333333
ANIRIDIA-CEREBELLAR ATAXIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.07274053333333333
VITAMIN B12-RESPONSIVE METHYLMALONIC ACIDEMIA	0.000545554	0.07274053333333333
8P23.1 DUPLICATION SYNDROME	0.000545554	0.07274053333333333
FORSYTHE-WAKELING SYNDROME; FWS	0.000545554	0.07274053333333333
3-METHYLGLUTACONIC ACIDURIA, TYPE I; MGCA1	0.000545554	0.07274053333333333
OTOFACIOCERVICAL SYNDROME	0.000545554	0.07274053333333333
48,XYYY SYNDROME	0.000545554	0.07274053333333333
HEREDITARY SENSORY AND AUTONOMIC NEUROPATHY TYPE 4	0.000545554	0.07274053333333333
ARACHNODACTYLY-ABNORMAL OSSIFICATION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.07274053333333333
LETHAL ATAXIA WITH DEAFNESS AND OPTIC ATROPHY	0.000545554	0.07274053333333333
OXOGLUTARIC ACIDURIA	0.000545554	0.07274053333333333
LISSENCEPHALY 2; LIS2	0.000545554	0.07274053333333333
OCULOCEREBRAL HYPOPIGMENTATION SYNDROME OF PREUS	0.000545554	0.07274053333333333
SPASTIC PARAPLEGIA 53, AUTOSOMAL RECESSIVE	0.000545554	0.07274053333333333
HYPOMAGNESEMIA, SEIZURES, AND MENTAL RETARDATION 2; HOMGSMR2	0.000545554	0.07274053333333333
OROTIC ACIDURIA	0.000545554	0.07274053333333333
KERATOCONUS POSTICUS CIRCUMSCRIPTUS	0.000545554	0.07274053333333333
AICARDI-GOUTIERES SYNDROME 6	0.000545554	0.07274053333333333
RABSON-MENDENHALL SYNDROME	0.000545554	0.07274053333333333
NETHERTON SYNDROME; NETH	0.000545554	0.07274053333333333
SHWACHMAN-DIAMOND SYNDROME 1; SDS1	0.000545554	0.07274053333333333
RIGIDITY AND MULTIFOCAL SEIZURE SYNDROME, LETHAL NEONATAL; RMFSL	0.000545554	0.07274053333333333
ATELOSTEOGENESIS TYPE III	0.000545554	0.07274053333333333
PELLAGRA-LIKE SYNDROME	0.000545554	0.07274053333333333
GLOBAL DEVELOPMENTAL DELAY, LUNG CYSTS, OVERGROWTH, AND WILMS TUMOR; GLOW	0.000545554	0.07274053333333333
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 2; DKCA2	0.000545554	0.07274053333333333
JOUBERT SYNDROME 17; JBTS17	0.000545554	0.07274053333333333
PURINE NUCLEOSIDE PHOSPHORYLASE DEFICIENCY	0.000545554	0.07274053333333333
GALLOWAY-MOWAT SYNDROME 6; GAMOS6	0.000545554	0.07274053333333333
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 15; EIG15	0.000545554	0.07274053333333333
OROFACIODIGITAL SYNDROME TYPE 4	0.000545554	0.07274053333333333
WOLMAN DISEASE	0.000545554	0.07274053333333333
SPONDYLOMETAPHYSEAL DYSPLASIA, MEGARBANE-DAGHER-MELKI TYPE; SMDMDM	0.000545554	0.07274053333333333
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 39; COXPD39	0.000545554	0.07274053333333333
LYSOSOMAL ACID LIPASE DEFICIENCY	0.000545554	0.07274053333333333
BETA-UREIDOPROPIONASE DEFICIENCY	0.000545554	0.07274053333333333
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 69; MRT69	0.000545554	0.07274053333333333
PEHO SYNDROME	0.000545554	0.07274053333333333
HNF1B-RELATED AUTOSOMAL DOMINANT TUBULOINTERSTITIAL KIDNEY DISEASE	0.000545554	0.07274053333333333
MEDULLOBLASTOMA	0.000545554	0.07274053333333333
ALPHA-MANNOSIDOSIS	0.000545554	0.07274053333333333
PYRUVATE DEHYDROGENASE E2 DEFICIENCY; PDHDD	0.000545554	0.07274053333333333
ABETAL34V AMYLOIDOSIS	0.000545554	0.07274053333333333
COMBINED OXIDATIVE PHOSPHORYLATION DEFICIENCY 38; COXPD38	0.000545554	0.07274053333333333
INSENSITIVITY TO PAIN, CONGENITAL, WITH ANHIDROSIS; CIPA	0.000545554	0.07274053333333333
HYDROXYKYNURENINURIA	0.000545554	0.07274053333333333
MEGALENCEPHALY-CAPILLARY MALFORMATION-POLYMICROGYRIA SYNDROME	0.000545554	0.07274053333333333
CONDUCTIVE DEAFNESS-MALFORMED EXTERNAL EAR SYNDROME	0.000545554	0.07274053333333333
OTOPALATODIGITAL SYNDROME TYPE 2	0.000545554	0.07274053333333333
LOWRY-MACLEAN SYNDROME	0.000545554	0.07274053333333333
PRIMARY CONGENITAL HYPOTHYROIDISM WITHOUT THYROID DEVELOPMENTAL ANOMALY	0.000545554	0.07274053333333333
17Q21.31 MICRODUPLICATION SYNDROME	0.000545554	0.07274053333333333
CONGENITAL VARICELLA SYNDROME	0.000545554	0.07274053333333333
INTRAUTERINE GROWTH RETARDATION WITH INCREASED MITOMYCIN C SENSITIVITY	0.000545554	0.07274053333333333
CONGENITAL HYPOTHYROIDISM DUE TO TRANSPLACENTAL PASSAGE OF TSH-BINDING INHIBITORY ANTIBODIES	0.000545554	0.07274053333333333
HYPERMANGANESEMIA WITH DYSTONIA 2	0.000545554	0.07274053333333333
SUCCINIC SEMIALDEHYDE DEHYDROGENASE DEFICIENCY	0.000545554	0.07274053333333333
XERODERMA PIGMENTOSUM-COCKAYNE SYNDROME COMPLEX	0.000545554	0.07274053333333333
CHOREA, CHILDHOOD-ONSET, WITH PSYCHOMOTOR RETARDATION	0.000545554	0.07274053333333333
FRIED SYNDROME	0.000545554	0.07274053333333333
IMMUNODEFICIENCY-CENTROMERIC INSTABILITY-FACIAL ANOMALIES SYNDROME 4; ICF4	0.000545554	0.07274053333333333
AUSTRALIA ANTIGEN	0.000545554	0.07274053333333333
HYPERTELORISM-MICROTIA-FACIAL CLEFTING SYNDROME	0.000545554	0.07274053333333333
DYSKERATOSIS CONGENITA, AUTOSOMAL RECESSIVE 6	0.000545554	0.07274053333333333
PROPIONIC ACIDEMIA	0.000545554	0.07274053333333333
DEVELOPMENTAL DELAY WITH SHORT STATURE, DYSMORPHIC FEATURES, AND SPARSE HAIR	0.000545554	0.07274053333333333
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 70	0.000545554	0.07274053333333333
HYPERTRICHOSIS CUBITI	0.000545554	0.07274053333333333
FAMILIAL THYROID DYSHORMONOGENESIS	0.000545554	0.07274053333333333
X-LINKED INTELLECTUAL DISABILITY, STEVENSON TYPE	0.000545554	0.07274053333333333
MICROCEPHALY AND CHORIORETINOPATHY, AUTOSOMAL RECESSIVE, 3; MCCRP3	0.000545554	0.07274053333333333
CONGENITAL HYPOTHYROIDISM	0.000545554	0.07274053333333333
BARDET-BIEDL SYNDROME 3; BBS3	0.000545554	0.07274053333333333
HOLOPROSENCEPHALY 5; HPE5	0.000545554	0.07274053333333333
LIGNEOUS CONJUNCTIVITIS	0.000545554	0.07274053333333333
RETINAL DYSTROPHY, JUVENILE CATARACTS, AND SHORT STATURE SYNDROME; RDJCSS	0.000545554	0.07274053333333333
PCNA-RELATED PROGRESSIVE NEURODEGENERATIVE PHOTOSENSITIVITY SYNDROME	0.000545554	0.07274053333333333
GERODERMA OSTEODYSPLASTICA	0.000545554	0.07274053333333333
GENERALIZED EPILEPSY WITH FEBRILE SEIZURES PLUS, TYPE 9; GEFSP9	0.000545554	0.07274053333333333
RETINITIS PIGMENTOSA-JUVENILE CATARACT-SHORT STATURE-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.07274053333333333
DYSTONIA 28, CHILDHOOD-ONSET	0.000545554	0.07274053333333333
THYROID ECTOPIA	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 58; MRT58	0.000545554	0.07274053333333333
MYOPATHY, AUTOPHAGIC VACUOLAR, INFANTILE-ONSET	0.000545554	0.07274053333333333
FETAL AND NEONATAL ALLOIMMUNE THROMBOCYTOPENIA	0.000545554	0.07274053333333333
CEREBELLOFACIODENTAL SYNDROME	0.000545554	0.07274053333333333
FAMILIAL HYPERTHYROIDISM DUE TO MUTATIONS IN TSH RECEPTOR	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 48; MRT48	0.000545554	0.07274053333333333
LOEYS-DIETZ SYNDROME, TYPE 1A LOEYS-DIETZ AORTIC ANEURYSM SYNDROME	0.000545554	0.07274053333333333
HOLOPROSENCEPHALY 3; HPE3	0.000545554	0.07274053333333333
ATHYREOSIS	0.000545554	0.07274053333333333
BARDET-BIEDL SYNDROME 2	0.000545554	0.07274053333333333
PROXIMAL MYOPATHY WITH EXTRAPYRAMIDAL SIGNS	0.000545554	0.07274053333333333
ULNA HYPOPLASIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.07274053333333333
IDIOPATHIC CONGENITAL HYPOTHYROIDISM	0.000545554	0.07274053333333333
THUMB DEFORMITY-ALOPECIA-PIGMENTATION ANOMALY SYNDROME	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 39	0.000545554	0.07274053333333333
MYOCLONIC EPILEPSY OF INFANCY	0.000545554	0.07274053333333333
SHORT ULNA-DYSMORPHISM-HYPOTONIA-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.07274053333333333
HYPERINSULINISM-HYPERAMMONEMIA SYNDROME	0.000545554	0.07274053333333333
MESOMELIC DYSPLASIA, SAVARIRAYAN TYPE	0.000545554	0.07274053333333333
DYGGVE-MELCHIOR-CLAUSEN DISEASE	0.000545554	0.07274053333333333
SPASTIC PARAPLEGIA 75, AUTOSOMAL RECESSIVE	0.000545554	0.07274053333333333
MACROCEPHALY/AUTISM SYNDROME	0.000545554	0.07274053333333333
MULTIPLE MITOCHONDRIAL DYSFUNCTIONS SYNDROME 1; MMDS1	0.000545554	0.07274053333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 35	0.000545554	0.07274053333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 34; EIEE34	0.000545554	0.07274053333333333
OBESITY DUE TO SIM1 DEFICIENCY	0.000545554	0.07274053333333333
DIAMOND-BLACKFAN ANEMIA 15 WITH MANDIBULOFACIAL DYSOSTOSIS; DBA15	0.000545554	0.07274053333333333
EPILEPSY, PROGRESSIVE MYOCLONIC, 9; EPM9	0.000545554	0.07274053333333333
MICROCEPHALIC OSTEODYSPLASTIC PRIMORDIAL DWARFISM, TYPE II; MOPD2	0.000545554	0.07274053333333333
SPASTIC PARAPLEGIA 9B, AUTOSOMAL RECESSIVE; SPG9B	0.000545554	0.07274053333333333
CEREBROOCULOFACIOSKELETAL SYNDROME 3; COFS3	0.000545554	0.07274053333333333
THOC6-RELATED DEVELOPMENTAL DELAY-MICROCEPHALY-FACIAL DYSMORPHISM SYNDROME	0.000545554	0.07274053333333333
DYSKERATOSIS CONGENITA, AUTOSOMAL DOMINANT 6; DKCA6	0.000545554	0.07274053333333333
JOUBERT SYNDROME 23; JBTS23	0.000545554	0.07274053333333333
NEPHROTIC SYNDROME, TYPE 11; NPHS11	0.000545554	0.07274053333333333
USHER SYNDROME TYPE 1	0.000545554	0.07274053333333333
HYPOTHYROIDISM DUE TO DEFICIENT TRANSCRIPTION FACTORS INVOLVED IN PITUITARY DEVELOPMENT OR FUNCTION	0.000545554	0.07274053333333333
CHROMOSOME 15Q14 DELETION SYNDROME	0.000545554	0.07274053333333333
FAMILIAL INFANTILE MYOCLONIC EPILEPSY	0.000545554	0.07274053333333333
PROGRESSIVE MYOCLONIC EPILEPSY WITH DYSTONIA	0.000545554	0.07274053333333333
608279 CRANIOSYNOSTOSIS WITH OCULAR ABNORMALITIES AND HALLUCAL DEFECTS	0.000545554	0.07274053333333333
PERMANENT CONGENITAL HYPOTHYROIDISM	0.000545554	0.07274053333333333
608227 CRANIOFACIAL ABNORMALITIES, CATARACTS, CONGENITAL HEART DISEASE, SACRALNEURAL TUBE DEFECTS, AND GROWTH AND DEVELOPMENTAL RETARDATION	0.000545554	0.07274053333333333
PRIMARY CONGENITAL HYPOTHYROIDISM	0.000545554	0.07274053333333333
THYROID HEMIAGENESIS	0.000545554	0.07274053333333333
ALDH18A1-RELATED DE BARSY SYNDROME	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 51	0.000545554	0.07274053333333333
ICF SYNDROME	0.000545554	0.07274053333333333
ICHTHYOSIS-ALOPECIA-ECLABION-ECTROPION-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.07274053333333333
MICROCEPHALY, CONGENITAL CATARACT, AND PSORIASIFORM DERMATITIS	0.000545554	0.07274053333333333
SYNDROMIC MULTISYSTEM AUTOIMMUNE DISEASE DUE TO ITCH DEFICIENCY	0.000545554	0.07274053333333333
SPINAL MUSCULAR ATROPHY, LOWER EXTREMITY-PREDOMINANT, 1, AUTOSOMAL DOMINANT; SMALED1	0.000545554	0.07274053333333333
MICROVILLUS INCLUSION DISEASE	0.000545554	0.07274053333333333
SECKEL SYNDROME 9; SCKL9	0.000545554	0.07274053333333333
THYROID HYPOPLASIA	0.000545554	0.07274053333333333
FRIAS SYNDROME	0.000545554	0.07274053333333333
MYASTHENIC SYNDROME, CONGENITAL, 18; CMS18	0.000545554	0.07274053333333333
MECKEL SYNDROME 13; MKS13	0.000545554	0.07274053333333333
CHONDRODYSPLASIA PUNCTATA 1, X-LINKED RECESSIVE	0.000545554	0.07274053333333333
CAMPTODACTYLY, TALL STATURE, AND HEARING LOSS SYNDROME	0.000545554	0.07274053333333333
HOYERAAL-HREIDARSSON SYNDROME	0.000545554	0.07274053333333333
NATURAL KILLER CELL AND GLUCOCORTICOID DEFICIENCY WITH DNA REPAIR DEFECT	0.000545554	0.07274053333333333
SPECIFIC GRANULE DEFICIENCY 2; SGD2	0.000545554	0.07274053333333333
IMMUNODEFICIENCY, DEVELOPMENTAL DELAY, AND HYPOHOMOCYSTEINEMIA; IMDDHH	0.000545554	0.07274053333333333
MYOCLONIC-ASTASTIC EPILEPSY	0.000545554	0.07274053333333333
CHARCOT-MARIE-TOOTH DISEASE-DEAFNESS-INTELLECTUAL DISABILITY SYNDROME	0.000545554	0.07274053333333333
ACUTE INFANTILE LIVER FAILURE-CEREBELLAR ATAXIA-PERIPHERAL SENSORY MOTOR NEUROPATHY SYNDROME	0.000545554	0.07274053333333333
BARDET-BIEDL SYNDROME 14; BBS14	0.000545554	0.07274053333333333
BARDET-BIEDL SYNDROME 16; BBS16	0.000545554	0.07274053333333333
FARBER DISEASE	0.000545554	0.07274053333333333
DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH	0.000545554	0.07274053333333333
JOUBERT SYNDROME 33; JBTS33	0.000545554	0.07274053333333333
MENTAL RETARDATION, X-LINKED 107; MRX107	0.000545554	0.07274053333333333
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE 25; SCAR25	0.000545554	0.07274053333333333
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 12; MC1DN12	0.000545554	0.07274053333333333
PROGRESSIVE ESSENTIAL TREMOR-SPEECH IMPAIRMENT-FACIAL DYSMORPHISM-INTELLECTUAL DISABILITY-ABNORMAL BEHAVIOR SYNDROME	0.000545554	0.07274053333333333
MONOCARBOXYLATE TRANSPORTER 1 DEFICIENCY; MCT1D	0.000545554	0.07274053333333333
GALLOWAY-MOWAT SYNDROME 5; GAMOS5	0.000545554	0.07274053333333333
ARTHROGRYPOSIS, ECTODERMAL DYSPLASIA, CLEFT LIP/PALATE, AND DEVELOPMENTAL DELAY	0.000545554	0.07274053333333333
PAGANINI-MIOZZO SYNDROME; MRXSPM	0.000545554	0.07274053333333333
CLEFT PALATE-LARGE EARS-SMALL HEAD SYNDROME	0.000545554	0.07274053333333333
MICROCEPHALY, SHORT STATURE, AND LIMB ABNORMALITIES; MISSLA	0.000545554	0.07274053333333333
BARDET-BIEDL SYNDROME 17; BBS17	0.000545554	0.07274053333333333
ZEBRA BODY MYOPATHY	0.000545554	0.07274053333333333
ALSTROM SYNDROME; ALMS	0.000545554	0.07274053333333333
POMT2-RELATED  LIMB-GIRDLE MUSCULAR DYSTROPHY R14	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 50; MRD50	0.000545554	0.07274053333333333
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 56; EIEE56	0.000545554	0.07274053333333333
PHENOBARBITAL EMBRYOPATHY	0.000545554	0.07274053333333333
GLUTAMATE-CYSTEINE LIGASE DEFICIENCY	0.000545554	0.07274053333333333
VERTEBRAL, CARDIAC, RENAL, AND LIMB DEFECTS SYNDROME 1; VCRL1	0.000545554	0.07274053333333333
20Q11.2 MICRODELETION SYNDROME	0.000545554	0.07274053333333333
MICROCEPHALY-CLEFT PALATE-ABNORMAL RETINAL PIGMENTATION SYNDROME	0.000545554	0.07274053333333333
BILE ACID SYNTHESIS DEFECT, CONGENITAL, 6	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL DOMINANT 30; MRD30	0.000545554	0.07274053333333333
CORTICAL BLINDNESS, RETARDATION, AND POSTAXIAL POLYDACTYLY	0.000545554	0.07274053333333333
BARATELA-SCOTT SYNDROME	0.000545554	0.07274053333333333
BARDET-BIEDL SYNDROME 13; BBS13	0.000545554	0.07274053333333333
COLE-CARPENTER SYNDROME	0.000545554	0.07274053333333333
BRACHYDACTYLY, COLOBOMA, AND ANTERIOR SEGMENT DYSGENESIS	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 60	0.000545554	0.07274053333333333
RETINITIS PIGMENTOSA 80; RP80	0.000545554	0.07274053333333333
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 4	0.000545554	0.07274053333333333
X-LINKED INTELLECTUAL DISABILITY, SCHIMKE TYPE	0.000545554	0.07274053333333333
2Q33.1 DELETION SYNDROME	0.000541419	0.07218920000000001
CEREBELLOPARENCHYMAL DISORDER II	0.000541419	0.07218920000000001
N-ACETYLGLUTAMATE SYNTHASE DEFICIENCY	0.000541419	0.07218920000000001
TRIPLE A SYNDROME	0.000541419	0.07218920000000001
PARIETAL FORAMINA	0.000541419	0.07218920000000001
ANGELMAN SYNDROME (TYPE 2)	0.000541419	0.07218920000000001
NIPAH VIRUS DISEASE	0.000541419	0.07218920000000001
LASSA FEVER	0.000541419	0.07218920000000001
SECONDARY SYRINGOMYELIA	0.000541419	0.07218920000000001
ACTH DEFICIENCY, ISOLATED; IAD	0.000541419	0.07218920000000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 4; PCH4	0.000541419	0.07218920000000001
CEROID LIPOFUSCINOSIS, NEURONAL, 4A, AUTOSOMAL RECESSIVE	0.000541419	0.07218920000000001
KENNY-CAFFEY SYNDROME, TYPE 2; KCS2	0.000541419	0.07218920000000001
FETAL GAUCHER DISEASE	0.000541419	0.07218920000000001
BRACHYDACTYLY, TYPE A2, WITH MICROCEPHALY	0.000541419	0.07218920000000001
PRIMARY INTESTINAL LYMPHANGIECTASIA	0.000541419	0.07218920000000001
CONVULSIVE DISORDER, FAMILIAL, WITH PRENATAL OR EARLY ONSET	0.000541419	0.07218920000000001
HYPER-BETA-ALANINEMIA	0.000541419	0.07218920000000001
HYPERLEUCINE-ISOLEUCINEMIA	0.000541419	0.07218920000000001
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA, TYPE CBLC	0.000541419	0.07218920000000001
ATYPICAL TERATOID RHABDOID TUMOR	0.000541419	0.07218920000000001
BANGSTAD SYNDROME	0.000541419	0.07218920000000001
METHYLMALONIC ACIDEMIA WITH HOMOCYSTINURIA TYPE CBLF	0.000541419	0.07218920000000001
212067 CONGENITAL DISORDER OF GLYCOSYLATION, TYPE I/IIX;;CDG-X	0.000541419	0.07218920000000001
FAMILIAL ACUTE NECROTIZING ENCEPHALOPATHY	0.000541419	0.07218920000000001
HYPERINSULINISM DUE TO GLUCOKINASE DEFICIENCY	0.000541419	0.07218920000000001
PFEIFFER SYNDROME TYPE 3	0.000541419	0.07218920000000001
DIAMINOPENTANURIA	0.000541419	0.07218920000000001
L-2-HYDROXYGLUTARIC ACIDURIA	0.000541419	0.07218920000000001
HYPERLYSINEMIA, TYPE I	0.000541419	0.07218920000000001
1P36 MICRODELETION SYNDROME	0.000541419	0.07218920000000001
JERVELL AND LANGE-NIELSEN SYNDROME	0.000541419	0.07218920000000001
DPM1-CDG	0.000541419	0.07218920000000001
NEUROFIBROMATOSIS, TYPE I	0.000541419	0.07218920000000001
MPDU1-CDG	0.000541419	0.07218920000000001
ALG2-CDG	0.000541419	0.07218920000000001
SPINOCEREBELLAR ATAXIA WITH AXONAL NEUROPATHY TYPE 1	0.000541419	0.07218920000000001
ALG9-CDG	0.000541419	0.07218920000000001
PARTINGTON SYNDROME	0.000541419	0.07218920000000001
ADRENOMYODYSTROPHY	0.000541419	0.07218920000000001
VASCULOPATHY, RETINAL, WITH CEREBRAL LEUKODYSTROPHY; RVCL	0.000541419	0.07218920000000001
CELIAC DISEASE, SUSCEPTIBILITY TO, 1; CELIAC1	0.000541419	0.07218920000000001
EPILEPSY, READING	0.000541419	0.07218920000000001
ADDISON DISEASE	0.000541419	0.07218920000000001
MOGS-CDG	0.000541419	0.07218920000000001
CEROID LIPOFUSCINOSIS, NEURONAL, 3; CLN3	0.000541419	0.07218920000000001
TUBEROUS SCLEROSIS-1	0.000541419	0.07218920000000001
ANGELMAN SYNDROME (TYPE 1)	0.000541419	0.07218920000000001
EPILEPSY, BENIGN OCCIPITAL	0.000541419	0.07218920000000001
CEREBROTENDINOUS XANTHOMATOSIS; CTX	0.000541419	0.07218920000000001
CROME SYNDROME	0.000541419	0.07218920000000001
ACUTE ADRENAL INSUFFICIENCY	0.000541419	0.07218920000000001
NON-FUNCTIONING PITUITARY ADENOMA	0.000541419	0.07218920000000001
X-LINKED INTELLECTUAL DISABILITY-CUBITUS VALGUS-DYSMORPHISM SYNDROME	0.000541419	0.07218920000000001
ATAXIA WITH MYOCLONIC EPILEPSY AND PRESENILE DEMENTIA	0.000541419	0.07218920000000001
TSH-SECRETING PITUITARY ADENOMA	0.000541419	0.07218920000000001
HUNTINGTON DISEASE; HD	0.000541419	0.07218920000000001
182610 SPASTIC PARAPLEGIA, EPILEPSY, AND MENTAL RETARDATION; SPEMR	0.000541419	0.07218920000000001
ENCEPHALITIS LETHARGICA	0.000541419	0.07218920000000001
FRUCTOSE AND GALACTOSE INTOLERANCE	0.000541419	0.07218920000000001
CAMOS SYNDROME	0.000541419	0.07218920000000001
X-LINKED INTELLECTUAL DISABILITY-HYPOGAMMAGLOBULINEMIA-PROGRESSIVE NEUROLOGICAL DETERIORATION SYNDROME	0.000541419	0.07218920000000001
SHIGA TOXIN-ASSOCIATED HEMOLYTIC UREMIC SYNDROME	0.000541419	0.07218920000000001
CHOREOATHETOSIS, FAMILIAL INVERTED	0.000541419	0.07218920000000001
ACROMEGALOID FACIAL APPEARANCE SYNDROME	0.000541419	0.07218920000000001
HEREDITARY CONTINUOUS MUSCLE FIBER ACTIVITY	0.000541419	0.07218920000000001
COG8-CDG	0.000541419	0.07218920000000001
ALEXANDER DISEASE	0.000541419	0.07218920000000001
SUPRABULBAR PARESIS, CONGENITAL	0.000541419	0.07218920000000001
PAPILLORENAL SYNDROME	0.000541419	0.07218920000000001
X-LINKED INTELLECTUAL DISABILITY, SHASHI TYPE	0.000541419	0.07218920000000001
X-LINKED EPILEPSY-LEARNING DISABILITIES-BEHAVIOR DISORDERS SYNDROME	0.000541419	0.07218920000000001
X-LINKED INTELLECTUAL DISABILITY, GOLABI-ITO-HALL TYPE	0.000541419	0.07218920000000001
STURGE-WEBER SYNDROME	0.000541419	0.07218920000000001
CEROID LIPOFUSCINOSIS, NEURONAL, 4B, AUTOSOMAL DOMINANT; CLN4B	0.000541419	0.07218920000000001
SCRUB TYPHUS	0.000541419	0.07218920000000001
SNEDDON SYNDROME	0.000541419	0.07218920000000001
203600 ALOPECIA-EPILEPSY-OLIGOPHRENIA SYNDROME OF MOYNAHAN;;MOYNAHAN ALOPECIA SYNDROME	0.000541419	0.07218920000000001
ISOLATED SPINA BIFIDA	0.000541419	0.07218920000000001
X-LINKED INTELLECTUAL DISABILITY, CABEZAS TYPE	0.000541419	0.07218920000000001
CEREBROTENDINOUS XANTHOMATOSIS	0.000541419	0.07218920000000001
DARIER-WHITE DISEASE; DAR	0.000541419	0.07218920000000001
HYPOPARATHYROIDISM, FAMILIAL ISOLATED; FIH	0.000541419	0.07218920000000001
NEUROFIBROMATOSIS, TYPE II	0.000541419	0.07218920000000001
FOUNTAIN SYNDROME	0.000541419	0.07218920000000001
DIABETES INSIPIDUS, NEPHROGENIC, AUTOSOMAL	0.000541419	0.07218920000000001
EPILEPSY-TELANGIECTASIA	0.000541419	0.07218920000000001
DENTATORUBRAL-PALLIDOLUYSIAN ATROPHY NAITO-OYANAGI DISEASE HAW RIVER SYNDROME ATAXIA, CHOREA, SEIZURES, AND DEMENTIA	0.000541419	0.07218920000000001
MENTAL RETARDATION, FRA12A TYPE	0.000541419	0.07218920000000001
SYSTEMIC SCLEROSIS	0.000541419	0.07218920000000001
CEROID LIPOFUSCINOSIS, NEURONAL, 2	0.000541419	0.07218920000000001
%104130 ALOPECIA, PSYCHOMOTOR EPILEPSY, PYORRHEA, AND MENTAL SUBNORMALITY;;SHOKEIR SYNDROME	0.000541419	0.07218920000000001
AMYLOIDOSIS, HEREDITARY, TRANSTHYRETIN-RELATED	0.000541419	0.07218920000000001
DERMOTRICHIC SYNDROME	0.000541419	0.07218920000000001
CRANIOSYNOSTOSIS-MENTAL RETARDATION-CLEFTING SYNDROME	0.000541419	0.07218920000000001
RENIER-GABREELS-JASPER SYNDROME	0.000541419	0.07218920000000001
HYPOMAGNESEMIA 2, RENAL	0.000541419	0.07218920000000001
X-LINKED INTELLECTUAL DISABILITY-ATAXIA-APRAXIA SYNDROME	0.000541419	0.07218920000000001
ARTERITIS, FAMILIAL GRANULOMATOUS, WITH JUVENILE POLYARTHRITIS	0.000541419	0.07218920000000001
HEMIFACIAL ATROPHY, PROGRESSIVE; HFA	0.000541419	0.07218920000000001
PORPHYRIA VARIEGATA	0.000541419	0.07218920000000001
AUTISM	0.000541419	0.07218920000000001
PREECLAMPSIA/ECLAMPSIA 1	0.000541419	0.07218920000000001
GRISCELLI SYNDROME TYPE 2	0.000541419	0.07218920000000001
PEDIATRIC SYSTEMIC LUPUS ERYTHEMATOSUS	0.000541419	0.07218920000000001
AUTOSOMAL DOMINANT DEAFNESS-ONYCHODYSTROPHY SYNDROME	0.000541419	0.07218920000000001
SNEDDON SYNDROME	0.000541419	0.07218920000000001
SANDHOFF DISEASE	0.000541419	0.07218920000000001
SYSTEMIC LUPUS ERYTHEMATOSUS; SLE	0.000541419	0.07218920000000001
234250 HALL-RIGGS MENTAL RETARDATION SYNDROME	0.000541419	0.07218920000000001
PITUITARY DEFICIENCY DUE TO EMPTY SELLA TURCICA SYNDROME	0.000541419	0.07218920000000001
%149000 KLIPPEL-TRENAUNAY-WEBER SYNDROME;;KTW SYNDROME;;KLIPPEL-TRENAUNAY SYNDROME; KTS;;ANGIOOSTEOHYPERTROPHY SYNDROME	0.000541419	0.07218920000000001
INSULINOMA	0.000541419	0.07218920000000001
PITUITARY DERMOID AND EPIDERMOID CYSTS	0.000541419	0.07218920000000001
THANATOPHORIC DYSPLASIA TYPE 2	0.000541419	0.07218920000000001
CHRONIC MUCOCUTANEOUS CANDIDIASIS	0.000541419	0.07218920000000001
ACUTE INTERMITTENT PORPHYRIA	0.000541419	0.07218920000000001
ADAMS-OLIVER SYNDROME 5; AOS5	0.000541419	0.07218920000000001
IMMUNODEFICIENCY 37; IMD37	0.000541419	0.07218920000000001
MICROCEPHALY-CARDIOMYOPATHY SYNDROME	0.000541419	0.07218920000000001
EPENDYMOMA	0.000541419	0.07218920000000001
SUBEPENDYMOMA	0.000541419	0.07218920000000001
PINEOBLASTOMA	0.000541419	0.07218920000000001
MICROCEPHALY 13, PRIMARY, AUTOSOMAL RECESSIVE; MCPH13	0.000541419	0.07218920000000001
MICROCEPHALY, SHORT STATURE, AND IMPAIRED GLUCOSE METABOLISM 1; MSSGM1	0.000541419	0.07218920000000001
DISTAL 7Q11.23 MICRODELETION SYNDROME	0.000541419	0.07218920000000001
LETHAL INFANTILE MITOCHONDRIAL MYOPATHY	0.000541419	0.07218920000000001
HYPERINSULINISM DUE TO INSR DEFICIENCY	0.000541419	0.07218920000000001
MICROSPORIDIOSIS	0.000541419	0.07218920000000001
ENCEPHALOPATHY, PROGRESSIVE, WITH OR WITHOUT LIPODYSTROPHY; PELD	0.000541419	0.07218920000000001
MOYAMOYA DISEASE	0.000541419	0.07218920000000001
MOYNAHAN SYNDROME	0.000541419	0.07218920000000001
MITOCHONDRIAL MYOPATHY-LACTIC ACIDOSIS-DEAFNESS SYNDROME	0.000541419	0.07218920000000001
MYOPATHY-GROWTH DELAY-INTELLECTUAL DISABILITY-HYPOSPADIAS SYNDROME	0.000541419	0.07218920000000001
17Q12 MICRODUPLICATION SYNDROME	0.000541419	0.07218920000000001
PARKINSON DISEASE 19A, JUVENILE-ONSET	0.000541419	0.07218920000000001
IMMUNODEFICIENCY 38 WITH BASAL GANGLIA CALCIFICATION; IMD38	0.000541419	0.07218920000000001
PERRAULT SYNDROME 5; PRLTS5	0.000541419	0.07218920000000001
EPILEPSY, PROGRESSIVE MYOCLONIC 7; EPM7	0.000541419	0.07218920000000001
GLUTARYL-COA DEHYDROGENASE DEFICIENCY	0.000541419	0.07218920000000001
FAMILIAL CEREBRAL CAVERNOUS MALFORMATION	0.000541419	0.07218920000000001
MATERNAL HYPERTHERMIA-INDUCED BIRTH DEFECTS	0.000541419	0.07218920000000001
FAMILIAL ISOLATED HYPOPARATHYROIDISM	0.000541419	0.07218920000000001
PANCREATIC HYPOPLASIA-DIABETES-CONGENITAL HEART DISEASE SYNDROME	0.000541419	0.07218920000000001
CARNITINE PALMITOYL TRANSFERASE II DEFICIENCY, SEVERE INFANTILE FORM	0.000541419	0.07218920000000001
CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 2; CADASIL2	0.000541419	0.07218920000000001
NEURONAL INTRANUCLEAR INCLUSION DISEASE	0.000541419	0.07218920000000001
FAMILIAL CEREBRAL SACCULAR ANEURYSM	0.000541419	0.07218920000000001
ANGIOOSTEOHYPERTROPHIC SYNDROME	0.000541419	0.07218920000000001
CHOREOACANTHOCYTOSIS	0.000541419	0.07218920000000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 7; IIAE7	0.000541419	0.07218920000000001
INFANTILE LIVER FAILURE SYNDROME 2	0.000541419	0.07218920000000001
MACROCEPHALY-SPASTIC PARAPLEGIA-DYSMORPHISM SYNDROME	0.000541419	0.07218920000000001
BASAL GANGLIA CALCIFICATION, IDIOPATHIC, 6; IBGC6	0.000541419	0.07218920000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 32; EIEE32	0.000541419	0.07218920000000001
RETINAL VASCULOPATHY WITH CEREBRAL LEUKOENCEPHALOPATHY AND SYSTEMIC MANIFESTATIONS	0.000541419	0.07218920000000001
NEUROCUTANEOUS MELANOCYTOSIS	0.000541419	0.07218920000000001
HYPERINSULINISM DUE TO HNF4A DEFICIENCY	0.000541419	0.07218920000000001
CEROID LIPOFUSCINOSIS, NEURONAL, 13; CLN13	0.000541419	0.07218920000000001
HYDROPS, LACTIC ACIDOSIS, AND SIDEROBLASTIC ANEMIA; HLASA	0.000541419	0.07218920000000001
LEUKOCYTE ADHESION DEFICIENCY	0.000541419	0.07218920000000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED, SUSCEPTIBILITY TO, 4; IIAE4	0.000541419	0.07218920000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 16	0.000541419	0.07218920000000001
MECKEL SYNDROME, TYPE 10; MKS10	0.000541419	0.07218920000000001
PERRAULT SYNDROME 3	0.000541419	0.07218920000000001
CRONKHITE-CANADA SYNDROME	0.000541419	0.07218920000000001
BLEPHAROPHIMOSIS-INTELLECTUAL DISABILITY SYNDROME, VERLOES TYPE	0.000541419	0.07218920000000001
PORENCEPHALY	0.000541419	0.07218920000000001
PROLACTINOMA	0.000541419	0.07218920000000001
MEGALENCEPHALIC LEUKOENCEPHALOPATHY WITH SUBCORTICAL CYSTS 2A; MLC2A	0.000541419	0.07218920000000001
THANATOPHORIC DYSPLASIA	0.000541419	0.07218920000000001
OBESITY, HYPERPHAGIA, AND DEVELOPMENTAL DELAY; OBHD	0.000541419	0.07218920000000001
INFECTIONS, RECURRENT, WITH ENCEPHALOPATHY, HEPATIC DYSFUNCTION, AND CARDIOVASCULAR MALFORMATIONS	0.000541419	0.07218920000000001
RAMON SYNDROME	0.000541419	0.07218920000000001
ISOLATED BILIARY ATRESIA	0.000541419	0.07218920000000001
X-LINKED INTELLECTUAL DISABILITY-SEIZURES-PSORIASIS SYNDROME	0.000541419	0.07218920000000001
BENIGN FAMILIAL INFANTILE EPILEPSY	0.000541419	0.07218920000000001
FADD-RELATED IMMUNODEFICIENCY	0.000541419	0.07218920000000001
HEMIDYSTONIA-HEMIATROPHY SYNDROME	0.000541419	0.07218920000000001
EPILEPSY, FAMILIAL TEMPORAL LOBE, 5	0.000541419	0.07218920000000001
PHAKOMATOSIS PIGMENTOVASCULARIS	0.000541419	0.07218920000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 34, WITH VARIANT LISSENCEPHALY; MRT34	0.000541419	0.07218920000000001
ALOPECIA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.07218920000000001
NEPHROTIC SYNDROME, TYPE 8; NPHS8	0.000541419	0.07218920000000001
MITOCHONDRIAL COMPLEX V (ATP SYNTHASE) DEFICIENCY, NUCLEAR TYPE 4; MC5DN4	0.000541419	0.07218920000000001
PORT-WINE NEVI-MEGA CISTERNA MAGNA-HYDROCEPHALUS SYNDROME	0.000541419	0.07218920000000001
EPILEPSY, FAMILIAL ADULT MYOCLONIC, 4; FAME4	0.000541419	0.07218920000000001
AUTISM, SUSCEPTIBILITY TO, 18	0.000541419	0.07218920000000001
HORIZONTAL GAZE PALSY WITH PROGRESSIVE SCOLIOSIS	0.000541419	0.07218920000000001
PEROXISOME BIOGENESIS DISORDER 7A (ZELLWEGER); PBD7A	0.000541419	0.07218920000000001
SECKEL SYNDROME 7; SCKL7	0.000541419	0.07218920000000001
ADULT-ONSET NON-INSULINOMA PERSISTENT HYPERINSULINEMIC HYPOGLYCEMIA	0.000541419	0.07218920000000001
SYMPTOMATIC FORM OF COFFIN-LOWRY SYNDROME IN FEMALE CARRIERS	0.000541419	0.07218920000000001
FAMILIAL OSTEODYSPLASIA, ANDERSON TYPE	0.000541419	0.07218920000000001
NASU-HAKOLA DISEASE	0.000541419	0.07218920000000001
OSTEOGENESIS IMPERFECTA-RETINOPATHY-SEIZURES-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.07218920000000001
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.07218920000000001
INHERITED CREUTZFELDT-JAKOB DISEASE	0.000541419	0.07218920000000001
TYROSINEMIA TYPE 2	0.000541419	0.07218920000000001
CHROMOSOME 17Q12 DUPLICATION SYNDROME	0.000541419	0.07218920000000001
DYSKINESIA, LIMB AND OROFACIAL, INFANTILE-ONSET; IOLOD	0.000541419	0.07218920000000001
MICRODUPLICATION XP11.22P11.23 SYNDROME	0.000541419	0.07218920000000001
SEVERE X-LINKED INTELLECTUAL DISABILITY, GUSTAVSON TYPE	0.000541419	0.07218920000000001
CRYPTOCOCCOSIS	0.000541419	0.07218920000000001
ROMANO-WARD SYNDROME	0.000541419	0.07218920000000001
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 29	0.000541419	0.07218920000000001
DENTATORUBRAL PALLIDOLUYSIAN ATROPHY	0.000541419	0.07218920000000001
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 4	0.000541419	0.07218920000000001
PORPHYRIA DUE TO ALA DEHYDRATASE DEFICIENCY	0.000541419	0.07218920000000001
ALOPECIA-EPILEPSY-PYORRHEA-INTELLECTUAL DISABILITY SYNDROME	0.000541419	0.07218920000000001
ABETA AMYLOIDOSIS, DUTCH TYPE	0.000541419	0.07218920000000001
CRISPONI SYNDROME	0.000541419	0.07218920000000001
CUTIS MARMORATA TELANGIECTATICA CONGENITA	0.000541419	0.07218920000000001
PONTOCEREBELLAR HYPOPLASIA TYPE 4	0.000541419	0.07218920000000001
CARNITINE PALMITOYL TRANSFERASE 1A DEFICIENCY	0.000541419	0.07218920000000001
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY	0.000541419	0.07218920000000001
HUNTINGTON DISEASE-LIKE 3	0.000541419	0.07218920000000001
ROSAÏ-DORFMAN DISEASE	0.000541419	0.07218920000000001
2Q24 MICRODELETION SYNDROME	0.000541419	0.07218920000000001
MICROCEPHALY, GROWTH DEFICIENCY, SEIZURES, AND BRAIN MALFORMATIONS; MIGSB	0.000541419	0.07218920000000001
INTRAUTERINE GROWTH RETARDATION, METAPHYSEAL DYSPLASIA, ADRENAL HYPOPLASIA CONGENITA, GENITAL ANOMALIES, AND IMMUNODEFICIENCY; IMAGEI	0.000541419	0.07218920000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 71; EIEE71	0.000541419	0.07218920000000001
X-LINKED CHARCOT-MARIE-TOOTH DISEASE TYPE 2	0.000541419	0.07218920000000001
X-LINKED COMPLICATED CORPUS CALLOSUM DYSGENESIS	0.000541419	0.07218920000000001
EARLY-ONSET AUTOSOMAL DOMINANT ALZHEIMER DISEASE	0.000541419	0.07218920000000001
HEREDITARY NEUROCUTANEOUS MALFORMATION	0.000541419	0.07218920000000001
BETA-KETOTHIOLASE DEFICIENCY	0.000541419	0.07218920000000001
SYMMETRICAL THALAMIC CALCIFICATIONS	0.000541419	0.07218920000000001
CADASIL	0.000541419	0.07218920000000001
CONGENITAL INTRAUTERINE INFECTION-LIKE SYNDROME	0.000541419	0.07218920000000001
PROGRESSIVE HEMIFACIAL ATROPHY	0.000541419	0.07218920000000001
CATARACT-NEPHROPATHY-ENCEPHALOPATHY SYNDROME	0.000541419	0.07218920000000001
ISOLATED CEREBELLAR AGENESIS	0.000541419	0.07218920000000001
PRIMARY ANGIITIS OF THE CENTRAL NERVOUS SYSTEM	0.000541419	0.07218920000000001
SPASTIC ATAXIA WITH CONGENITAL MIOSIS	0.000541419	0.07218920000000001
BETA-MANNOSIDOSIS	0.000541419	0.07218920000000001
BEHÇET DISEASE	0.000541419	0.07218920000000001
FAMILIAL CALCIUM PYROPHOSPHATE DEPOSITION	0.000541419	0.07218920000000001
ARTHROGRYPOSIS MULTIPLEX CONGENITA-WHISTLING FACE SYNDROME	0.000541419	0.07218920000000001
LYNCH SYNDROME	0.000541419	0.07218920000000001
LUNG AGENESIS-HEART DEFECT-THUMB ANOMALIES SYNDROME	0.000541419	0.07218920000000001
BANNAYAN-RILEY-RUVALCABA SYNDROME	0.000541419	0.07218920000000001
CARBAMOYL-PHOSPHATE SYNTHETASE 1 DEFICIENCY	0.000541419	0.07218920000000001
INTELLECTUAL DEVELOPMENTAL DISORDER, AUTOSOMAL RECESSIVE 67; MRT67	0.000541419	0.07218920000000001
WOLCOTT-RALLISON SYNDROME	0.000541419	0.07218920000000001
MENTAL RETARDATION, AUTOSOMAL DOMINANT 44; MRD44	0.000541419	0.07218920000000001
AUTOSOMAL RECESSIVE SPASTIC PARAPLEGIA TYPE 18	0.000541419	0.07218920000000001
ENCEPHALOPATHY, NEONATAL SEVERE, WITH LACTIC ACIDOSIS AND BRAIN ABNORMALITIES; NELABA	0.000541419	0.07218920000000001
LATE-ONSET ISOLATED ACTH DEFICIENCY	0.000541419	0.07218920000000001
3-HYDROXY-3-METHYLGLUTARIC ACIDURIA	0.000541419	0.07218920000000001
GINGIVAL FIBROMATOSIS-HYPERTRICHOSIS SYNDROME	0.000541419	0.07218920000000001
CRIGLER-NAJJAR SYNDROME	0.000541419	0.07218920000000001
GAUCHER DISEASE-OPHTHALMOPLEGIA-CARDIOVASCULAR CALCIFICATION SYNDROME	0.000541419	0.07218920000000001
X-LINKED INTELLECTUAL DISABILITY-EPILEPSY SYNDROME	0.000541419	0.07218920000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 49; EIEE49	0.000541419	0.07218920000000001
EPISODIC ATAXIA TYPE 6	0.000541419	0.07218920000000001
CONGENITAL NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.07218920000000001
CYSTATHIONINURIA	0.000541419	0.07218920000000001
LISSENCEPHALY TYPE 1 DUE TO DOUBLECORTIN GENE MUTATION	0.000541419	0.07218920000000001
NODULAR NEURONAL HETEROTOPIA	0.000541419	0.07218920000000001
HIRSCHSPRUNG DISEASE-GANGLIONEUROBLASTOMA SYNDROME	0.000541419	0.07218920000000001
NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.07218920000000001
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 3; FFEVF3	0.000541419	0.07218920000000001
EPILEPSY, FAMILIAL FOCAL, WITH VARIABLE FOCI 2; FFEVF2	0.000541419	0.07218920000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 40	0.000541419	0.07218920000000001
BILATERAL STRIOPALLIDODENTATE CALCINOSIS	0.000541419	0.07218920000000001
EPILEPSY-TELANGIECTASIA SYNDROME	0.000541419	0.07218920000000001
BENIGN FAMILIAL NEONATAL EPILEPSY	0.000541419	0.07218920000000001
EPILEPSY-MICROCEPHALY-SKELETAL DYSPLASIA SYNDROME	0.000541419	0.07218920000000001
LATE INFANTILE NEURONAL CEROID LIPOFUSCINOSIS	0.000541419	0.07218920000000001
CHILDHOOD DISINTEGRATIVE DISORDER	0.000541419	0.07218920000000001
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 9; MC1DN9	0.000541419	0.07218920000000001
PERIVENTRICULAR NODULAR HETEROTOPIA 8; PVNH8	0.000541419	0.07218920000000001
MUSCULAR DYSTROPHY, LIMB-GIRDLE, AUTOSOMAL RECESSIVE 23; LGMDR23	0.000541419	0.07218920000000001
ENCEPHALITIS/ENCEPHALOPATHY, MILD, WITH REVERSIBLE MYELIN VACUOLIZATION; MMERV	0.000541419	0.07218920000000001
CENTRAL DIABETES INSIPIDUS	0.000541419	0.07218920000000001
MICROCEPHALY 22, PRIMARY, AUTOSOMAL RECESSIVE; MCPH22	0.000541419	0.07218920000000001
EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 60; EIEE60	0.000541419	0.07218920000000001
NEURODEVELOPMENTAL DISORDER WITH POOR LANGUAGE AND LOSS OF HAND SKILLS; NDPLHS	0.000541419	0.07218920000000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 8; IIAE8	0.000541419	0.07218920000000001
SKELETAL DYSPLASIA-EPILEPSY-SHORT STATURE SYNDROME	0.000541419	0.07218920000000001
THANATOPHORIC DYSPLASIA TYPE 1	0.000541419	0.07218920000000001
EDINBURGH MALFORMATION SYNDROME	0.000541419	0.07218920000000001
VITAMIN K ANTAGONIST EMBRYOFETOPATHY	0.000541419	0.07218920000000001
COMBINED IMMUNODEFICIENCY AND MEGALOBLASTIC ANEMIA WITH OR WITHOUT HYPERHOMOCYSTEINEMIA; CIMAH	0.000541419	0.07218920000000001
AMELOCEREBROHYPOHIDROTIC SYNDROME	0.000541419	0.07218920000000001
TUBEROUS SCLEROSIS 2; TSC2	0.000541419	0.07218920000000001
NEPHRONOPHTHISIS-LIKE NEPHROPATHY 1	0.000541419	0.07218920000000001
HEREDITARY COPROPORPHYRIA	0.000541419	0.07218920000000001
ACUTE BILIRUBIN ENCEPHALOPATHY	0.000541419	0.07218920000000001
AUTOSOMAL RECESSIVE COMPLEX SPASTIC PARAPLEGIA DUE TO KENNEDY PATHWAY DYSFUNCTION	0.000541419	0.07218920000000001
METACHROMATIC LEUKODYSTROPHY	0.000541419	0.07218920000000001
WHIM SYNDROME	0.000541419	0.07218920000000001
SJOGREN-LARSSON SYNDROME; SLS	0.000541419	0.07218920000000001
AUTOIMMUNE POLYENDOCRINE SYNDROME, TYPE II	0.000541419	0.07218920000000001
KNOBLOCH SYNDROME 1; KNO1	0.000541419	0.07218920000000001
RETINAL DEGENERATION AND EPILEPSY	0.000541419	0.07218920000000001
RAMON SYNDROME	0.000541419	0.07218920000000001
CHRONIC BILIRUBIN ENCEPHALOPATHY	0.000541419	0.07218920000000001
CENTRONUCLEAR MYOPATHY	0.000541419	0.07218920000000001
GLUTATHIONE SYNTHETASE DEFICIENCY	0.000541419	0.07218920000000001
GITELMAN SYNDROME	0.000541419	0.07218920000000001
LYMPHANGIOLEIOMYOMATOSIS	0.000541419	0.07218920000000001
GLYCOGEN STORAGE DISEASE OF HEART, LETHAL CONGENITAL	0.000541419	0.07218920000000001
THROMBOTIC THROMBOCYTOPENIC PURPURA	0.000541419	0.07218920000000001
PHENYLKETONURIA	0.000541419	0.07218920000000001
PAPILLOMA OF CHOROID PLEXUS	0.000541419	0.07218920000000001
MENKES DISEASE	0.000541419	0.07218920000000001
THREONINEMIA	0.000541419	0.07218920000000001
THYROCEREBRORETINAL SYNDROME	0.000541419	0.07218920000000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 2A; PCH2A	0.000541419	0.07218920000000001
INTESTINAL PSEUDOOBSTRUCTION, NEURONAL, CHRONIC IDIOPATHIC, X-LINKED	0.000541419	0.07218920000000001
FABRY DISEASE	0.000541419	0.07218920000000001
IMMUNODEFICIENCY 47	0.000541419	0.07218920000000001
PAROXYSMAL EXTREME PAIN DISORDER	0.000541419	0.07218920000000001
MENTAL RETARDATION, X-LINKED 100	0.000541419	0.07218920000000001
ACQUIRED METHEMOGLOBINEMIA	0.000541419	0.07218920000000001
AUTISM, SUSCEPTIBILITY TO, X-LINKED 6	0.000541419	0.07218920000000001
MENTAL RETARDATION, X-LINKED 96; MRX96	0.000541419	0.07218920000000001
HEREDITARY FRUCTOSE INTOLERANCE	0.000541419	0.07218920000000001
FRAGILE X MENTAL RETARDATION SYNDROME	0.000541419	0.07218920000000001
NEPHROGENIC SYNDROME OF INAPPROPRIATE ANTIDIURESIS; NSIAD	0.000541419	0.07218920000000001
MENTAL RETARDATION, X-LINKED 82	0.000541419	0.07218920000000001
AUTISM, SUSCEPTIBILITY TO, X-LINKED 3; AUTSX3	0.000541419	0.07218920000000001
AUTISM, SUSCEPTIBILITY TO, X-LINKED 2; AUTSX2	0.000541419	0.07218920000000001
CUBITUS VALGUS WITH MENTAL RETARDATION AND UNUSUAL FACIES	0.000541419	0.07218920000000001
AUTISM, SUSCEPTIBILITY TO, X-LINKED 1; AUTSX1	0.000541419	0.07218920000000001
MENTAL RETARDATION, X-LINKED, WITH OR WITHOUT SEIZURES, ARX-RELATED	0.000541419	0.07218920000000001
MENTAL RETARDATION, X-LINKED 14	0.000541419	0.07218920000000001
OSTEOPETROSIS, AUTOSOMAL RECESSIVE 1; OPTB1	0.000541419	0.07218920000000001
X-LINKED CENTRONUCLEAR MYOPATHY	0.000541419	0.07218920000000001
DIABETES INSIPIDUS, NEPHROGENIC, X-LINKED	0.000541419	0.07218920000000001
GLYCOGEN STORAGE DISEASE 0, LIVER	0.000541419	0.07218920000000001
MITOCHONDRIAL TRIFUNCTIONAL PROTEIN DEFICIENCY	0.000541419	0.07218920000000001
KRABBE DISEASE	0.000541419	0.07218920000000001
KIFAFA SEIZURE DISORDER	0.000541419	0.07218920000000001
KEUTEL SYNDROME; KTLS	0.000541419	0.07218920000000001
IMMUNOGLOBULIN A VASCULITIS	0.000541419	0.07218920000000001
RABIES	0.000541419	0.07218920000000001
HYPOPHOSPHATASIA, CHILDHOOD	0.000541419	0.07218920000000001
RETT SYNDROME	0.000541419	0.07218920000000001
HYPOADRENOCORTICISM, FAMILIAL	0.000541419	0.07218920000000001
FAMILIAL MULTIPLE NEVI FLAMMEI	0.000541419	0.07218920000000001
ACQUIRED PARTIAL LIPODYSTROPHY	0.000541419	0.07218920000000001
CONGENITAL BILE ACID SYNTHESIS DEFECT TYPE 4	0.000541419	0.07218920000000001
HYPERPROLINEMIA, TYPE II	0.000541419	0.07218920000000001
DEND SYNDROME	0.000541419	0.07218920000000001
EPISODIC ATAXIA TYPE 3	0.000541419	0.07218920000000001
HYPERPHOSPHATEMIA, POLYURIA, AND SEIZURES	0.000541419	0.07218920000000001
CRIGLER-NAJJAR SYNDROME TYPE 1	0.000541419	0.07218920000000001
HOLOCARBOXYLASE SYNTHETASE DEFICIENCY	0.000541419	0.07218920000000001
LIPOID PROTEINOSIS OF URBACH AND WIETHE	0.000541419	0.07218920000000001
PORPHYRIA	0.000541419	0.07218920000000001
MENTAL RETARDATION SYNDROME, BELGIAN TYPE	0.000541419	0.07218920000000001
FAMILIAL THROMBOCYTOSIS	0.000541419	0.07218920000000001
LARGE CONGENITAL MELANOCYTIC NEVUS	0.000541419	0.07218920000000001
NEURAMINIDASE DEFICIENCY WITH BETA-GALACTOSIDASE DEFICIENCY	0.000541419	0.07218920000000001
PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 1; PRAAS1	0.000541419	0.07218920000000001
RECURRENT ACUTE PANCREATITIS	0.000541419	0.07218920000000001
MUSCULAR DYSTROPHY, ADULT-ONSET, WITH LEUKOENCEPHALOPATHY	0.000541419	0.07218920000000001
NEVUS COMEDONICUS SYNDROME	0.000541419	0.07218920000000001
LHERMITTE-DUCLOS DISEASE	0.000541419	0.07218920000000001
MUTILATING PALMOPLANTAR KERATODERMA WITH PERIORIFICIAL KERATOTIC PLAQUES	0.000541419	0.07218920000000001
MUCOPOLYSACCHARIDOSIS TYPE IIIB	0.000541419	0.07218920000000001
ONDINE SYNDROME	0.000541419	0.07218920000000001
MUCOPOLYSACCHARIDOSIS TYPE IIIA	0.000541419	0.07218920000000001
DILATED CARDIOMYOPATHY WITH ATAXIA	0.000541419	0.07218920000000001
MALIGNANT ATROPHIC PAPULOSIS	0.000541419	0.07218920000000001
MICROCEPHALY, PRIMARY AUTOSOMAL RECESSIVE, 1	0.000541419	0.07218920000000001
DOPA-RESPONSIVE DYSTONIA DUE TO SEPIAPTERIN REDUCTASE DEFICIENCY	0.000541419	0.07218920000000001
SENSORY ATAXIC NEUROPATHY-DYSARTHRIA-OPHTHALMOPARESIS SYNDROME	0.000541419	0.07218920000000001
%250900 METHIONINE MALABSORPTION SYNDROME;;SMITH-STRANG DISEASE;;OASTHOUSE URINE DISEASE	0.000541419	0.07218920000000001
CORPUS CALLOSUM, PARTIAL AGENESIS OF, X-LINKED	0.000541419	0.07218920000000001
HYPOPARATHYROIDISM, X-LINKED	0.000541419	0.07218920000000001
GM2 GANGLIOSIDOSIS, AB VARIANT	0.000541419	0.07218920000000001
CEROID LIPOFUSCINOSIS, NEURONAL, 9	0.000541419	0.07218920000000001
FIBRODYSPLASIA OSSIFICANS PROGRESSIVA	0.000541419	0.07218920000000001
MIGRAINE, FAMILIAL HEMIPLEGIC, 3	0.000541419	0.07218920000000001
FAMILIAL MEDITERRANEAN FEVER	0.000541419	0.07218920000000001
WHIPPLE DISEASE	0.000541419	0.07218920000000001
FAMILIAL PRIMARY HYPOMAGNESEMIA WITH NORMOCALCIURIA AND NORMOCALCEMIA	0.000541419	0.07218920000000001
PANCREATIC AND CEREBELLAR AGENESIS; PACA	0.000541419	0.07218920000000001
WOLFRAM SYNDROME	0.000541419	0.07218920000000001
WORSTER-DROUGHT SYNDROME	0.000541419	0.07218920000000001
FRUCTOSE-1,6-BISPHOSPHATASE DEFICIENCY	0.000541419	0.07218920000000001
SENSORY ATAXIC NEUROPATHY, DYSARTHRIA, AND OPHTHALMOPARESIS; SANDO	0.000541419	0.07218920000000001
INFANTILE NEUROAXONAL DYSTROPHY	0.000541419	0.07218920000000001
GALACTOSIALIDOSIS	0.000541419	0.07218920000000001
EPILEPSY, IDIOPATHIC GENERALIZED, SUSCEPTIBILITY TO, 3; EIG3	0.000541419	0.07218920000000001
CHROMOSOME 15Q11-Q13 DUPLICATION SYNDROME	0.000541419	0.07218920000000001
LIPODYSTROPHY, GENERALIZED, WITH MENTAL RETARDATION, DEAFNESS, SHORT STATURE, AND SLENDER BONES	0.000541419	0.07218920000000001
AUTISM, SUSCEPTIBILITY TO, 3; AUTS3	0.000541419	0.07218920000000001
ANK3-RELATED INTELLECTUAL DISABILITY-SLEEP DISTURBANCE SYNDROME	0.000541419	0.07218920000000001
3-HYDROXY-3-METHYLGLUTARYL-COA SYNTHASE DEFICIENCY	0.000541419	0.07218920000000001
THYROCEREBRORENAL SYNDROME	0.000541419	0.07218920000000001
TETRASOMY 18P	0.000541419	0.07218920000000001
PONTOCEREBELLAR HYPOPLASIA, TYPE 5; PCH5	0.000541419	0.07218920000000001
GLYCOSYLPHOSPHATIDYLINOSITOL DEFICIENCY	0.000541419	0.07218920000000001
NEURODEGENERATION DUE TO CEREBRAL FOLATE TRANSPORT DEFICIENCY	0.000541419	0.07218920000000001
NOCARDIOSIS	0.000541419	0.07218920000000001
ENCEPHALOPATHY, ACUTE, INFECTION-INDUCED (HERPES-SPECIFIC), SUSCEPTIBILITY TO, 2; IIAE2	0.000541419	0.07218920000000001
LUJO HEMORRHAGIC FEVER	0.000541419	0.07218920000000001
RIFT VALLEY FEVER	0.000541419	0.07218920000000001
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 2; CPVT2	0.000541419	0.07218920000000001
COCHLEOSACCULAR DEGENERATION-CATARACT SYNDROME	0.000541419	0.07218920000000001
CENTRAL NERVOUS SYSTEM CALCIFICATION-DEAFNESS-TUBULAR ACIDOSIS-ANEMIA SYNDROME	0.000541419	0.07218920000000001
EARLY-ONSET LAFORA BODY DISEASE	0.000541419	0.07218920000000001
HYPERINSULINISM DUE TO HNF1A DEFICIENCY	0.000541419	0.07218920000000001
PAROXYSMAL NONKINESIGENIC DYSKINESIA 2	0.000541419	0.07218920000000001
ABETA AMYLOIDOSIS, ITALIAN TYPE	0.000541419	0.07218920000000001
MENTAL RETARDATION, AUTOSOMAL RECESSIVE 10	0.000541419	0.07218920000000001
AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME	0.000541419	0.07218920000000001
TAKAYASU ARTERITIS	0.000541419	0.07218920000000001
EPILEPSY, NOCTURNAL FRONTAL LOBE, 4; ENFL4	0.000541419	0.07218920000000001
AICARDI-GOUTIERES SYNDROME 4; AGS4	0.000541419	0.07218920000000001
GRISCELLI SYNDROME, TYPE 2; GS2	0.000541419	0.07218920000000001
COENZYME Q10 DEFICIENCY, PRIMARY, 1; COQ10D1	0.000541419	0.07218920000000001
ICHTHYOSIS AND MALE HYPOGONADISM	0.000541419	0.07218920000000001
MYOCLONIC EPILEPSY ASSOCIATED WITH RAGGED-RED FIBERS	0.000541419	0.07218920000000001
CARNITINE PALMITOYLTRANSFERASE II DEFICIENCY, INFANTILE	0.000541419	0.07218920000000001
AUTOSOMAL RECESSIVE CEREBELLAR ATAXIA-EPILEPSY-INTELLECTUAL DISABILITY SYNDROME DUE TO RUBCN DEFICIENCY	0.000541419	0.07218920000000001
TELANGIECTASIA, HEREDITARY HEMORRHAGIC, TYPE 2; HHT2	0.000541419	0.07218920000000001
SPASTIC PARAPLEGIA 6, AUTOSOMAL DOMINANT	0.000541419	0.07218920000000001
600302 FRYNS MACROCEPHALY;;MACROCEPHALY WITH SPASTIC PARAPLEGIA AND DISTINCTIVE CRANIOFACIALAPPEARANCE	0.000541419	0.07218920000000001
CEROID LIPOFUSCINOSIS, NEURONAL, 8	0.000541419	0.07218920000000001
HYPERPROLINEMIA TYPE 1	0.000541419	0.07218920000000001
CONO-SPONDYLAR DYSPLASIA	0.000541419	0.07218920000000001
KEARNS-SAYRE SYNDROME; KSS	0.000541419	0.07218920000000001
AUTISM, SUSCEPTIBILITY TO, 8; AUTS8	0.000541419	0.07218920000000001
KEPPEN-LUBINSKY SYNDROME	0.000541419	0.07218920000000001
HYPOPHOSPHATASIA	0.000541419	0.07218920000000001
INTELLECTUAL DISABILITY-EXPRESSIVE APHASIA-FACIAL DYSMORPHISM SYNDROME	0.000541419	0.07218920000000001
FAMILIAL COLORECTAL CANCER TYPE X	0.000541419	0.07218920000000001
MENTAL RETARDATION WITH OPTIC ATROPHY, DEAFNESS, AND SEIZURES	0.000541419	0.07218920000000001
MENTAL RETARDATION ASSOCIATED WITH PSORIASIS	0.000541419	0.07218920000000001
3-METHYLGLUTACONIC ACIDURIA TYPE 7	0.000541419	0.07218920000000001
AUTOSOMAL DOMINANT SPASTIC PARAPLEGIA TYPE 9A	0.000541419	0.07218920000000001
GURRIERI SYNDROME	0.000541419	0.07218920000000001
HYPOCALCEMIA, AUTOSOMAL DOMINANT 1	0.000541419	0.07218920000000001
MENTAL RETARDATION, MICROCEPHALY, EPILEPSY, AND COARSE FACE	0.000541419	0.07218920000000001
CEROID LIPOFUSCINOSIS, NEURONAL, 6	0.000541419	0.07218920000000001
X-LINKED PARKINSONISM-SPASTICITY SYNDROME	0.000541419	0.07218920000000001
SPINOCEREBELLAR ATAXIA, AUTOSOMAL RECESSIVE, WITH AXONAL NEUROPATHY 1; SCAN1	0.000541419	0.07218920000000001
ADIPOSIS DOLOROSA	0.000541419	0.07218920000000001
GLYCOGEN STORAGE DISEASE DUE TO GLUCOSE-6-PHOSPHATASE DEFICIENCY	0.000541419	0.07218920000000001
KUFOR-RAKEB SYNDROME	0.000541419	0.07218920000000001
HYPOCOMPLEMENTEMIC URTICARIAL VASCULITIS	0.000541419	0.07218920000000001
PERIPHERAL PRIMITIVE NEUROECTODERMAL TUMOR	0.000541419	0.07218920000000001
ALZHEIMER DISEASE, FAMILIAL EARLY-ONSET, WITH COEXISTING AMYLOID AND PRION PATHOLOGY	0.000541419	0.07218920000000001
%604802 HUNTINGTON DISEASE-LIKE 3; HDL3;;HUNTINGTON DISEASE-LIKE NEURODEGENERATIVE DISORDER, AUTOSOMAL RECESSIVE	0.000541419	0.07218920000000001
VENTRICULAR TACHYCARDIA, CATECHOLAMINERGIC POLYMORPHIC, 1, WITH OR WITHOUT ATRIAL DYSFUNCTION AND/OR DILATED CARDIOMYOPATHY; CPVT1	0.000541419	0.07218920000000001
ENCEPHALOPATHY, FAMILIAL, WITH NEUROSERPIN INCLUSION BODIES; FENIB	0.000541419	0.07218920000000001
ATYPICAL JUVENILE PARKINSONISM	0.000541419	0.07218920000000001
CEREBRAL CAVERNOUS MALFORMATIONS 2	0.000541419	0.07218920000000001
PERIPHERAL NEUROPATHY-MYOPATHY-HOARSENESS-HEARING LOSS SYNDROME	0.000541419	0.07218920000000001
MIGRAINE, FAMILIAL HEMIPLEGIC, 2; FHM2	0.000541419	0.07218920000000001
HYPOMAGNESEMIA 1, INTESTINAL; HOMG1	0.000541419	0.07218920000000001
PHOSPHOGLYCERATE DEHYDROGENASE DEFICIENCY	0.000541419	0.07218920000000001
WOLF-HIRSCHHORN SYNDROME	0.000541419	0.07218920000000001
